molregno shortName Count(chemblActivityScoreC) for N Count(chemblActivityScoreC) for Y Gene names EntryNameFull chemblActivityScoreC smn2Score predictionRFRegression countOfScores drugName drugIndication concatenatedMoA concatenatedActionType maxPhase UniqueConcatenate(Protein names) for countRatio ActualPlusPredictedSMN2Score kindOfValue moleculeType molName canonical_smiles 111 0 38 NotRecorded 4.8916919928766 5.35 5.35 38 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 RXRA 0 1 RXRA NR2B1 RXRA_HUMAN 4.8000008748032 5.35 5.35 1 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 5.20852322749435 5.35 5.35 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 ANDR 0 3 AR DHTR NR3C4 ANDR_HUMAN 4.78559242181604 5.35 5.35 3 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.9 5.35 5.35 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 NR1H4 0 1 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.55000045168903 5.35 5.35 1 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 GEMI 0 3 GMNN GEMI_HUMAN 4.53246769248591 5.35 5.35 3 Geminin 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 111 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 7.05 5.35 5.35 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.35 actual molregno [molregno] [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2 27626 ESR1 0 230 ESR1 ESR NR3A1, Esr1 Esr Estr Estra Nr3a1, Esr1 Esr Estr Nr3a1 ESR1_HUMAN, ESR1_MOUSE, ESR1_RAT 8.32969055604713 5.42499999999999 5.42500000000003 230 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 1 5.42499999999999 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SC6A3 0 2 SLC6A3 DAT1 SC6A3_HUMAN 4.88 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ESR2 0 204 ESR2 ESTRB NR3A2, Esr2 Erbeta Nr3a2, Esr2 Estrb Nr3a2 ESR2_HUMAN, ESR2_MOUSE, ESR2_RAT 8.38497966492308 5.42499999999999 5.42500000000003 204 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 1 5.42499999999999 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ANDR 0 18 AR DHTR NR3C4, Ar Nr3c4 ANDR_HUMAN, ANDR_RAT 5.98071907796806 5.425 5.42500000000003 18 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SO1A1 0 2 Slco1a1 Oatp1 Oatp1a1 Slc21a1 SO1A1_RAT 5.07695437047216 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1A1 (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter 1) (Solute carrier family 21 member 1), Solute carrier organic anion transporter family member 1A1 (Sodium-independent organic anion-transporting polypeptide 1) (OATP-1) (Solute carrier family 21 member 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 AOXA 0 6 AOX1, AOX1 AO, Aox1 Ao AOXA_HUMAN, AOXA_MACFA, AOXA_RABIT, AOXA_RAT 5.56 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase) (Retinoic acid synthase) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ST1A1 0 4 SULT1A1 STP STP1 OK/SW-cl.88 ST1A1_HUMAN 5.90587156438028 5.425 5.42500000000003 4 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 LMNA 0 4 LMNA LMN1 LMNA_HUMAN 5.225 5.425 5.42500000000003 4 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 GEMI 0 4 GMNN GEMI_HUMAN 4.53059584150005 5.425 5.42500000000003 4 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Geminin 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 MRP7 0 1 ABCC10 MRP7 SIMRP7 MRP7_HUMAN 5.18879614069983 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 GPER1 0 10 GPER1 CEPR CMKRL2 DRY12 GPER GPR30 GPER1_HUMAN 6.27039244929027 5.425 5.42500000000003 10 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER), G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (G-protein coupled receptor 41) (Membrane estrogen receptor) (mER) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ERR1 0 5 ESRRA ERR1 ESRL1 NR3B1 ERR1_HUMAN 6.978 5.425 5.42500000000003 5 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 LUCI 0 2 LUCI_PHOPY 4.50658513237175 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 7.65 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 4.81120385930017 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 8.49485002168009 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 4.8000008748032 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.49999693194831 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.425 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ERR2 0 3 ESRRB ERRB2 ESRL2 NR3B2 ERR2_HUMAN 8.29666666666667 5.425 5.42500000000003 3 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SCN1A 0 6 SCN1A NAC1 SCN1 SCN1A_HUMAN 4.69647925661465 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SCN2A 0 6 SCN2A NAC2 SCN2A1 SCN2A2 SCN2A_HUMAN 4.69647925661465 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2), Sodium channel protein type 2 subunit alpha (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SCN3A 0 6 SCN3A KIAA1356 NAC3 SCN3A_HUMAN 4.69647925661465 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 KPCG 0 6 Prkcg Pkcc Pkcg Prkcc KPCG_RAT 5.71638010532079 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 KPCB 0 6 Prkcb Pkcb Prkcb1 KPCB_RAT 5.71638010532079 5.425 5.42500000000003 6 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 KPCA 0 8 PRKCA PKCA PRKACA, Prkca Pkca KPCA_HUMAN, KPCA_RAT 4.78728507899059 5.425 5.42500000000003 8 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 CP2B6 0 1 CYP2B6 CP2B6_HUMAN 5.39 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SHBG 0 2 SHBG SHBG_HUMAN 8.065 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP), Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SC6A4 0 2 SLC6A4 HTT SERT SC6A4_HUMAN 5.105 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.5 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 4.8000008748032 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ST1E1 0 1 SULT1E1 STE ST1E1_HUMAN 8.39794000867204 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estrogen sulfotransferase (EC 2.8.2.4) (EST-1) (Sulfotransferase 1E1) (ST1E1) (Sulfotransferase, estrogen-preferring), Estrogen sulfotransferase, testis isoform (EC 2.8.2.4) (Sulfotransferase 1E1) (ST1E1) (Sulfotransferase, estrogen-preferring) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 S22A3 0 2 SLC22A3 EMTH OCT3, Slc22a3 Oct3 S22A3_HUMAN, S22A3_RAT 5.75 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3), Solute carrier family 22 member 3 (Organic cation transporter 3) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 LOX15 0 1 ALOX15 LOX15_RABIT 4.95 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.2 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 S22A1 0 2 SLC22A1 OCT1 S22A1_HUMAN 5.47210126563485 5.425 5.42500000000003 2 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1), Solute carrier family 22 member 1 (Organic cation transporter 1) (mOCT1), Solute carrier family 22 member 1 (Organic cation transporter 1) (rOCT1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 SO2B1 0 1 SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 SO2B1_HUMAN 4.95479259752035 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9), Solute carrier organic anion transporter family member 2B1 (Organic anion transporter moatp1) (Solute carrier family 21 member 9) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.70000050388302 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5.49999693194831 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 TAR DNA-binding protein 43 (TDP-43) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 DHB1 0 1 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 7.52287874528034 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 ABCG2 0 1 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 5 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 27626 CBG 0 1 SERPINA6 CBG CBG_HUMAN 5 5.425 5.42500000000003 1 ESTRADIOL ALZHEIMERS DISEASE, ANOREXIA NERVOSA, ATHEROSCLEROSIS, BREAST CARCINOMA, HIV INFECTION, INFERTILITY, MENOPAUSE, PROSTATE CARCINOMA, SEXUAL DYSFUNCTION, TURNER SYNDROME, UNIPOLAR DEPRESSION, URINARY TRACT INFECTION Estrogen receptor alpha agonist AGONIST 4 Corticosteroid-binding globulin (CBG) (Serpin A6) (Transcortin) 1 5.425 actual drug [drugName] C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O 1564 ANDR 10 0 AR DHTR NR3C4 ANDR_HUMAN 5.02000160595037 4.68 4.68 10 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP19A 4 0 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 5.7425 4.68 4.68 4 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LOX1 6 0 LOX1.1 LOX1 LOX1_SOYBN 5.38046389485736 4.68 4.69444444444444 6 Seed linoleate 13S-lipoxygenase-1 (EC 1.13.11.12) (Lipoxygenase-1) (L-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TAU 8 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.94375 4.68 4.68 8 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.6 4.68 4.68 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LUCI 2 0 LUCI_PHOPY 4.65 4.68 4.68 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 SMN 5 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.68 4.68 4.68 5 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PPARD 4 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.57751260503078 4.68 4.68 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA2 32 0 GABRA2, Gabra2 Gabra-2 GBRA2_HUMAN, GBRA2_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA6 32 0 GABRA6, Gabra6 Gabra-6 GBRA6_HUMAN, GBRA6_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRB1 32 0 GABRB1, Gabrb1 Gabrb-1 GBRB1_HUMAN, GBRB1_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRG2 32 0 GABRG2, Gabrg2 GBRG2_HUMAN, GBRG2_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRB2 32 0 GABRB2, Gabrb2 Gabrb-2 GBRB2_HUMAN, GBRB2_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRP 32 0 GABRP, Gabrp GBRP_HUMAN, GBRP_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA3 32 0 GABRA3, Gabra3 Gabra-3 GBRA3_HUMAN, GBRA3_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRG1 32 0 GABRG1, Gabrg1 GBRG1_HUMAN, GBRG1_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRE 32 0 GABRE, Gabre GBRE_HUMAN, GBRE_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRG3 32 0 GABRG3, Gabrg3 GBRG3_HUMAN, GBRG3_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA5 32 0 GABRA5, Gabra5 Gabra-5 GBRA5_HUMAN, GBRA5_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRD 32 0 GABRD, Gabrd GBRD_HUMAN, GBRD_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA4 32 0 GABRA4, Gabra4 GBRA4_HUMAN, GBRA4_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRA1 32 0 GABRA1, Gabra1 Gabra-1 GBRA1_HUMAN, GBRA1_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRB3 32 0 GABRB3, Gabrb3 Gabrb-3 GBRB3_HUMAN, GBRB3_RAT 5.815 4.68 4.68 32 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GBRT 16 0 GABRQ GBRT_HUMAN 5.52 4.68 4.68 16 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 Q91ZM7 16 0 Gabrq Q91ZM7_RAT 6.11 4.68 4.68 16 GABA theta subunit 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GCR 6 0 NR3C1 GRL GCR_HUMAN 4.78045629597049 4.68 4.68114583333333 6 Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ACES 2 0 ACHE, ache ACES_ELEEL, ACES_HUMAN 6.13656383212784 4.68 4.41875 2 Acetylcholinesterase (AChE) (EC 3.1.1.7), Acetylcholinesterase (AChE) (EC 3.1.1.7) [Cleaved into: Acetylcholinesterase 16 kDa subunit; Acetylcholinesterase 55 kDa subunit] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MPP8 1 0 MPHOSPH8 MPP8 MPP8_HUMAN 6.10001543745061 4.68 4.68 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 POLK 1 0 POLK DINB1 POLK_HUMAN 4.70000050388302 4.68 4.68 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AA3R 1 0 ADORA3 AA3R_HUMAN 5.23113882538659 4.68 4.68 1 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 HCD2 3 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.13333333333333 4.68 4.68 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 Q7ZJM1 3 0 pol Q7ZJM1_9HIV1 5.07264666955735 4.68 4.68 3 Integrase (Fragment) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NF2L2 7 0 NFE2L2 NRF2 NF2L2_HUMAN 4.8765136204809 4.68 4.68 7 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RXRA 4 0 RXRA NR2B1 RXRA_HUMAN 4.70000004884498 4.68 4.68 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 DHB2 2 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 4.61323447362655 4.68 4.68 2 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CCNB3 4 0 CCNB3 CYCB3 CCNB3_HUMAN 5.4 4.68 4.68 4 G2/mitotic-specific cyclin-B3 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CDK1 4 0 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.4 4.68 4.68 4 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CCNB1 4 0 CCNB1 CCNB CCNB1_HUMAN 5.4 4.68 4.68 4 G2/mitotic-specific cyclin-B1 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CCNB2 4 0 CCNB2 CCNB2_HUMAN 5.4 4.68 4.68 4 G2/mitotic-specific cyclin-B2 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PGDH 4 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.7875 4.68 4.68 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 DHB1 2 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 5.09787874528033 4.68 4.68 2 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK09 3 0 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.06069784035361 4.68 4.68 3 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK10 3 0 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 6.06069784035361 4.68 4.68 3 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK08 3 0 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.06069784035361 4.68 4.68 3 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AL1A1 6 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.05833333333333 4.68 4.68 6 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GLCM 5 0 GBA GC GLUC GLCM_HUMAN 4.94999923876871 4.68 4.68 5 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TPO 2 0 THPO MGDF TPO_HUMAN 6.3 4.68 4.68 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CD5R1 2 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.8 4.68 4.68 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CDK5 3 0 CDK5 CDKN5, Cdk5 Cdkn5 CDK5_HUMAN, CDK5_RAT 5.06735333044265 4.68 4.68 3 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AA1R 2 0 Adora1 AA1R_RAT 5.26 4.68 4.68 2 Adenosine receptor A1 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KSYK 3 0 SYK KSYK_HUMAN 5.72625120031761 4.68 4.68 3 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LMNA 3 0 LMNA LMN1 LMNA_HUMAN 4.91666666666667 4.68 4.68 3 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PPARG 3 0 PPARG NR1C3, Pparg Nr1c3 PPARG_HUMAN, PPARG_MOUSE 4.66666668686774 4.68 4.68 3 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 O97447 1 0 ald O97447_GIAIN 5.2 4.68 4.68 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 JUN 1 0 JUN JUN_HUMAN 4.70418668639037 4.68 4.68 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GSK3B 4 0 GSK3B GSK3B_HUMAN 5.62240898203535 4.68 4.68 4 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GSK3A 2 0 GSK3A GSK3A_HUMAN 5.85 4.68 4.68 2 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TTHY 3 0 TTR PALB TTHY_HUMAN 5.84333333333333 4.68 4.68 3 Transthyretin (ATTR) (Prealbumin) (TBPA), Transthyretin (Prealbumin) (TBPA) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NANH 2 0 nanH NANH_CLOPF 4.76 4.68 4.68 2 Sialidase (EC 3.2.1.18) (N-acylneuraminate glycohydrolase) (Neuraminidase) (NANase) (STNA), Sialidase (EC 3.2.1.18) (Neuraminidase), Sialidase (EC 3.2.1.18) (Neuraminidase) (NANase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 HIF1A 4 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.3 4.68 4.68 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CDK6 2 0 CDK6 CDKN6 CDK6_HUMAN 5.77 4.68 4.68 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK11 1 0 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 5.82557590031178 4.68 4.68 1 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ESR1 9 0 ESR1 ESR NR3A1 ESR1_HUMAN, ESR1_SHEEP 5.21222188157128 4.68 4.68 9 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.50000046405718 4.68 4.68 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AA2AR 1 0 Adora2a AA2AR_RAT 5.12 4.68 4.68 1 Adenosine receptor A2a 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP1A2 3 0 CYP1A2 CP1A2_HUMAN 6.73333333333333 4.68 4.68 3 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 IDHC 3 0 IDH1 PICD IDHC_HUMAN 5.67665246652633 4.68 4.68 3 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK01 2 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.1943145854989 4.68 4.68 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 BACE1 3 0 BACE1 BACE KIAA1149 BACE1_HUMAN 4.58884579835818 4.68 4.68 3 Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MK13 1 0 MAPK13 PRKM13 SAPK4 MK13_HUMAN 5.90799732148669 4.68 4.68 1 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CY24B 4 0 CYBB NOX2 CY24B_HUMAN 5 4.68 4.68 4 Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MAPK2 1 0 MAPKAPK2 MAPK2_HUMAN 6.00479888288177 4.68 4.68 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ESR2 5 0 ESR2 ESTRB NR3A2, ESR2 NR3A2 ESR2_HUMAN, ESR2_SHEEP 5.79 4.68 4.68 5 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RGS4 1 0 RGS4 RGS4_HUMAN 4.77382299674291 4.68 4.68 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KS6A5 2 0 RPS6KA5 MSK1 KS6A5_HUMAN 5.15806815492241 4.68 4.68 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 GEMI 1 0 GMNN GEMI_HUMAN 4.9 4.68 4.68 1 Geminin 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ROCK2 1 0 ROCK2 KIAA0619 ROCK2_HUMAN 5.86530142610254 4.68 4.68 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MRP2 1 0 ABCC2 CMOAT CMOAT1 CMRP MRP2 MRP2_HUMAN 6.19497660321606 4.68 4.68 1 Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2), Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ATX2 2 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.17499815754325 4.68 4.68 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP1A1 2 0 CYP1A1 CP1A1_HUMAN 6.39 4.68 4.68 2 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PDPK1 1 0 PDPK1 PDK1 PDPK1_HUMAN 5.78837041556533 4.68 4.68 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AAPK2 1 0 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.1224064000929 4.68 4.68 1 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RORG 4 0 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.23126712389685 4.68 4.68 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KAPCG 3 0 PRKACG KAPCG_HUMAN 5.82557590031178 4.68 4.68 3 cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KAPCA 3 0 PRKACA PKACA KAPCA_HUMAN 5.82557590031178 4.68 4.68 3 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KAPCB 3 0 PRKACB KAPCB_HUMAN 5.82557590031178 4.68 4.68 3 cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.65000022087346 4.68 4.68 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 HSPB1 1 0 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.86005168376475 4.68 4.68 1 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LCK 2 0 LCK LCK_HUMAN 4.91465188641551 4.68 4.68 2 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MRP1 2 0 ABCC1 MRP MRP1 MRP1_HUMAN 5.465 4.68 4.68 2 Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MAPK5 1 0 MAPKAPK5 PRAK MAPK5_HUMAN 6.12338490853968 4.68 4.68 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TNKS1 2 0 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 5.505 4.68 4.68 2 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FFP 1 0 ffp sfp FFP_BACIU 4.5 4.68 4.68 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AOFA 1 0 MAOA AOFA_HUMAN 5.77 4.68 4.68 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AOFB 1 0 MAOB AOFB_HUMAN 4.89 4.68 4.68 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.72679069346755 4.68 4.68 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 Q4Q090 1 0 PGAM LMJF_36_6650 Q4Q090_LEIMA 4.72098361611599 4.68 4.68 1 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 RUNX1 4 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.97499943716937 4.68 4.68 4 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PEBB 4 0 CBFB PEBB_HUMAN 4.97499943716937 4.68 4.68 4 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK21 6 0 CSNK2A1 CK2A1 CSK21_HUMAN 5.94206773334882 4.68 4.68 6 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KS6A1 2 0 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.78837041556533 4.68 4.68 2 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NOX4 1 0 NOX4 RENOX NOX4_HUMAN 5.95 4.68 4.68 1 NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KS6B1 1 0 RPS6KB1 STK14A KS6B1_HUMAN 5.26884531229258 4.68 4.68 1 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MDR1 1 0 ABCB1 MDR1 PGY1 MDR1_HUMAN 5 4.68 4.68 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CFTR 2 0 CFTR ABCC7 CFTR_HUMAN 4.57 4.68 4.68 2 Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FLT3 1 0 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.84 4.68 4.68 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CHK1 1 0 CHEK1 CHK1 CHK1_HUMAN 5.30756086282294 4.68 4.68 1 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NRAM 1 0 NA NRAM_I34A1 4.58705606918888 4.68 4.68 1 Neuraminidase (EC 3.2.1.18) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 IMPA1 1 0 Impa1 Imp IMPA1_RAT 5.4 4.68 4.68 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.95 4.68 4.68 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 4.97382232428338 4.68 4.68 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 UBP1 1 0 USP1 UBP1_HUMAN 5.35000349253396 4.68 4.68 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 XDH 3 0 XDH XDHA XDH_HUMAN 5.97333333333333 4.68 4.68 3 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LOX15 1 0 ALOX15 LOG15 LOX15_HUMAN 5.3 4.68 4.68 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ALDR 1 0 Akr1b1 Akr1b4 Aldr1 ALDR_RAT 5.18 4.68 4.68 1 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LOX5 1 0 ALOX5 LOG5 LOX5_HUMAN 5 4.68 4.68 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 AKT1 1 0 AKT1 PKB RAC AKT1_HUMAN 5.65854134728041 4.68 4.68 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 SGK1 1 0 SGK1 SGK SGK1_HUMAN 4.84193184507759 4.68 4.68 1 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CYSP 1 0 CYSP_TRYCR 4.9 4.68 4.68 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ABCG2 2 0 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 5.37 4.68 4.68 2 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TNKS2 2 0 TNKS2 PARP5B TANK2 TNKL TNKS2_HUMAN 5.535 4.68 4.68 2 Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-like protein) (Tankyrase-related protein), Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.58639103825321 4.68 4.68 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK 1 0 CSK CSK_HUMAN 5.52476288915489 4.68 4.68 1 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 POLI 1 0 POLI RAD30B POLI_HUMAN 4.89999841719865 4.68 4.68 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 END4 1 0 nfo b2159 JW2146 END4_ECOLI 5.25 4.68 4.68 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK2B 3 0 CSNK2B CK2N G5A CSK2B_HUMAN 6.1 4.68 4.68 3 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CSK22 3 0 CSNK2A2 CK2A2 CSK22_HUMAN 6.1 4.68 4.68 3 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 FGR 1 0 FGR SRC2 FGR_HUMAN 4.96523789374079 4.68 4.68 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 MP2K1 1 0 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 6.69019608002851 4.68 4.68 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 CP1B1 2 0 CYP1B1 CP1B1_HUMAN 7.395 4.68 4.68 2 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 TSHR 2 0 TSHR LGR3 TSHR_HUMAN 5.4 4.68 4.68 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 PIM1 3 0 PIM1 PIM1_HUMAN 5.40910388177262 4.68 4.68 3 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 DAPK1 1 0 DAPK1 DAPK DAPK1_HUMAN 4.51 4.68 4.68 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 NPC1 1 0 NPC1 NPC1_HUMAN 5.24 4.68 4.68 1 Niemann-Pick C1 protein 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 M4K5 1 0 MAP4K5 M4K5_HUMAN 6.38021124171161 4.68 4.68 1 Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 1564 LYN 1 0 LYN JTK8 LYN_HUMAN 5.86530142610254 4.68 4.68 1 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 0 4.68 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 485738 PMP22 1 0 PMP22 GAS3 PMP22_HUMAN 4.62 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.675 4.675 4.67500000000002 2 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 GEMI 1 0 GMNN GEMI_HUMAN 6.73612732313478 4.675 4.67500000000001 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Geminin 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 GSK3B 1 0 GSK3B GSK3B_HUMAN 4.69831839958977 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.9612138990678 4.675 4.67500000000001 2 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 SO1B3 1 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.84071036509216 4.675 4.67500000000001 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 RORG 1 0 RORC NR1F3 RORG RZRG RORG_HUMAN 4.72506665764136 4.675 4.67500000000002 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 TPO 2 0 THPO MGDF TPO_HUMAN 4.9 4.675 4.67500000000002 2 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 485738 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 8.4 4.675 4.67500000000001 1 RIBAVIRIN ACUTE MYELOID LEUKEMIA, BREAST CARCINOMA, CANCER, CHRONIC HEPATITIS C INFECTION, HEPATITIS B INFECTION, HEPATITIS C INFECTION, HIV INFECTION, INFECTION, NEOPLASM, VIRAL DISEASE Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor, Inosine-5'-monophosphate dehydrogenase 1 inhibitor, RNA inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.675 actual drug [drugName] NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 1756 VGFR1 0 2 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 5.7209784188282 5.3 5.3 2 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC2D 0 1 CAMK2D CAMKD KCC2D_HUMAN 5.62973141792582 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SGK3 0 1 SGK3 CISK SGKL SGK3_HUMAN 5.95424250943933 5.3 5.3 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.00479888288177 5.3 5.3 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5.85986974618548 5.3 5.3 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HIPK2 0 1 HIPK2 HIPK2_HUMAN 6.50965047954658 5.3 5.3 1 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DCLK2 0 2 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.79315723188788 5.3 5.3 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 6.07202751352768 5.3 5.3 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M3K7 0 2 MAP3K7 TAK1 M3K7_HUMAN 6.32948242133222 5.3 5.3 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PLK1 0 2 PLK1 PLK PLK1_HUMAN 5.55342633632274 5.3 5.3 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 6.50965047954658 5.3 5.3 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EF2K 0 1 EEF2K EF2K_HUMAN 5.78837041556533 5.3 5.3 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KAPCA 0 2 PRKACA PKACA KAPCA_HUMAN 5.6327458351425 5.3 5.3 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AURKB 0 2 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.65134857751572 5.3 5.3 2 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.67155143012972 5.3 5.3 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.1 5.3 5.3 1 Ras-related protein Rab-9A 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.6101647557634 5.3 5.3 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KPCD 0 1 PRKCD KPCD_HUMAN 5.75332766665861 5.3 5.3 1 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HASP 0 2 HASPIN GSG2 HASP_HUMAN 5.75710253565479 5.3 5.3 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IRAK1 0 2 IRAK1 IRAK IRAK1_HUMAN 6.5953058989068 5.3 5.3 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BRSK2 0 1 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 6.50965047954658 5.3 5.3 1 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAPK1 0 10 PRKAA1 AMPK1 AAPK1_HUMAN 5.92264694750582 5.3 5.3 10 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKG1 0 10 PRKAG1 AAKG1_HUMAN 5.92264694750582 5.3 5.3 10 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKB1 0 10 PRKAB1 AMPK AAKB1_HUMAN 5.92264694750582 5.3 5.3 10 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TSSK1 0 1 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 6.50965047954658 5.3 5.3 1 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5.95424250943933 5.3 5.3 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 5.83720090642264 5.3 5.3 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NUAK1 0 2 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 6.12783722178484 5.3 5.3 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.4918220276171 5.3 5.3 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 1 4 NotRecorded 4.81968537526503 5.3 5.11716666666667 5 0.8 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1G1 0 2 CSNK1G1 KC1G1_HUMAN 5.97448040442573 5.3 5.3 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MELK 0 2 MELK KIAA0175 MELK_HUMAN 5.46746867712197 5.3 5.3 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 6.12783722178484 5.3 5.3 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 JAK3 0 4 JAK3 JAK3_HUMAN 6.15996374897717 5.3 5.3 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 6.50965047954658 5.3 5.3 1 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ALK 0 2 ALK ALK_HUMAN 5.41731630316804 5.3 5.3 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 WNK3 0 2 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.22045454103261 5.3 5.3 2 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA3 0 1 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 6.06069784035361 5.3 5.3 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ACK1 0 2 TNK2 ACK1 ACK1_HUMAN 5.47321928524387 5.3 5.3 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AKT2 0 2 AKT2 AKT2_HUMAN 6.00512641505789 5.3 5.3 2 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 6.32221929473392 5.3 5.3 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PGFRB 0 11 PDGFRB PDGFR PDGFR1, Pdgfrb Pdgfr Pdgfr1 PGFRB_HUMAN, PGFRB_MOUSE 5.70962240330083 5.3 5.3 11 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK03 0 2 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.80697315793856 5.3 5.3 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NEK11 0 2 NEK11 NEK11_HUMAN 6.31651769404313 5.3 5.3 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M3K9 0 1 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 6.06069784035361 5.3 5.3 1 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FLT3 0 4 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.34767518340382 5.3 5.3 4 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FRK 0 1 FRK PTK5 RAK FRK_HUMAN 5.86530142610254 5.3 5.3 1 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AKT3 0 2 AKT3 PKBG AKT3_HUMAN 5.88990920487556 5.3 5.3 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA8 0 2 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.59992327978754 5.3 5.3 2 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BMX 0 1 BMX BMX_HUMAN 6.12338490853968 5.3 5.3 1 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TAOK2 0 1 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 6.00479888288177 5.3 5.3 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RAF1 0 2 RAF1 RAF RAF1_HUMAN 6.09913982527219 5.3 5.3 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ATAD5 0 5 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.75561951962184 5.3 5.285 5 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 6.12338490853968 5.3 5.3 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HIPK1 0 1 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.19497660321606 5.3 5.3 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6B1 0 2 RPS6KB1 STK14A KS6B1_HUMAN 5.31841104879359 5.3 5.3 2 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CLK3 0 2 CLK3 CLK3_HUMAN 6.53520366087006 5.3 5.3 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RET 0 1 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 6.38021124171161 5.3 5.3 1 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 P53 0 1 TP53 P53 P53_HUMAN 4.89999841719865 5.3 5.3 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK08 0 1 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.99563519459755 5.3 5.3 1 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GSK3B 0 1 GSK3B GSK3B_HUMAN 5.86530142610254 5.3 5.3 1 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK14 0 2 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.70593450696951 5.3 5.3 2 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AURKC 0 1 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.82557590031178 5.3 5.3 1 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SRPK1 0 1 SRPK1 SRPK1_HUMAN 6.50965047954658 5.3 5.3 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 HCK 0 3 HCK HCK_HUMAN 5.80338143490093 5.3 5.3 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 5.86530142610254 5.3 5.3 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.5283029781462 5.3 5.3 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MTOR 0 5 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.64731936422489 5.3 5.3 5 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC2G 0 1 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 6.19497660321606 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK10 0 1 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.36797678529459 5.3 5.3 1 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 WNK2 0 2 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 6.55951005156861 5.3 5.3 2 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 5.96299963322807 5.3 5.3 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PGFRA 0 5 PDGFRA PDGFR2 RHEPDGFRA, Pdgfra PGFRA_HUMAN, PGFRA_MOUSE 5.69603574063301 5.3 5.3 5 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 5.83720090642264 5.3 5.3 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SRC 0 2 SRC SRC1 SRC_HUMAN 6.34213218279768 5.3 5.3 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PIM1 0 2 PIM1 PIM1_HUMAN 6.11490489147627 5.3 5.3 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A1 0 4 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 6.03356200825908 5.3 5.3 4 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA7 0 2 EPHA7 EHK3 HEK11 EPHA7_HUMAN 6.55951005156861 5.3 5.3 2 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 5.3 5.3 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GEMI 0 1 GMNN GEMI_HUMAN 5.88622371616297 5.3 5.3 1 Geminin 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 M3K5 0 2 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 5.61915054643304 5.3 5.3 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 5.86530142610254 5.3 5.3 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CLK2 0 1 CLK2 CLK2_HUMAN 6.69019608002851 5.3 5.3 1 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GRK7 0 1 GRK7 GPRK7 GRK7_HUMAN 6.19497660321606 5.3 5.3 1 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KGP1 0 2 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.94180288710693 5.3 5.3 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ABL1 0 2 ABL1 ABL JTK7 ABL1_HUMAN 5.9431368703327 5.3 5.3 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK9 0 2 CDK9 CDC2L4 TAK CDK9_HUMAN 5.75332766665861 5.3 5.3 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNT1 0 2 CCNT1 CCNT1_HUMAN 5.75332766665861 5.3 5.3 2 Cyclin-T1 (CycT1) (Cyclin-T) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5.62973141792582 5.3 5.3 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCND3 0 2 CCND3 CCND3_HUMAN 5.86530142610254 5.3 5.3 2 G1/S-specific cyclin-D3 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 5.86530142610254 5.3 5.3 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 INSRR 0 1 INSRR IRR INSRR_HUMAN 5.38886035082012 5.3 5.3 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.81199362955443 5.3 5.3 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.8000008748032 5.3 5.3 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PEBB 0 2 CBFB PEBB_HUMAN 4.8000008748032 5.3 5.3 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PASK 0 1 PASK KIAA0135 PASK_HUMAN 6.19497660321606 5.3 5.3 1 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MP2K6 0 1 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.78837041556533 5.3 5.3 1 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MYLK 0 2 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.95248706543325 5.3 5.3 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NEK3 0 1 NEK3 NEK3_HUMAN 6.12338490853968 5.3 5.3 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 6.99563519459755 5.3 5.3 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IGF1R 0 1 IGF1R IGF1R_HUMAN 6.99563519459755 5.3 5.3 1 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MAPK5 0 1 MAPKAPK5 PRAK MAPK5_HUMAN 5.43195909596147 5.3 5.3 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RON 0 2 MST1R PTK8 RON RON_HUMAN 5.81805281845507 5.3 5.3 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGR 0 1 FGR SRC2 FGR_HUMAN 6.00479888288177 5.3 5.3 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 VGFR2 0 3 KDR FLK1 VEGFR2 VGFR2_HUMAN 5.61536854563671 5.3 5.3 3 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SIK1 0 1 SIK1 SIK SNF1LK SIK1_HUMAN 5.60205999132796 5.3 5.3 1 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ULK3 0 1 ULK3 ULK3_HUMAN 6.38021124171161 5.3 5.3 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NPC1 0 1 NPC1 NPC1_HUMAN 5.9 5.3 5.3 1 Niemann-Pick C1 protein 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ROCK2 0 1 ROCK2 KIAA0619 ROCK2_HUMAN 6.19497660321606 5.3 5.3 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MERTK 0 1 MERTK MER MERTK_HUMAN 5.95424250943933 5.3 5.3 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ZAP70 0 2 ZAP70 SRK ZAP70_HUMAN 6.53520366087006 5.3 5.3 2 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGFR1 0 1 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 5.78837041556533 5.3 5.3 1 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ABL2 0 1 ABL2 ABLL ARG ABL2_HUMAN 6.38021124171161 5.3 5.3 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK33 0 1 STK33 STK33_HUMAN 6.69019608002851 5.3 5.3 1 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1G2 0 2 CSNK1G2 CK1G2 KC1G2_HUMAN 5.34460508352343 5.3 5.3 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 5.47873724164519 5.3 5.3 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BLK 0 1 BLK BLK_HUMAN 6.27875360095283 5.3 5.3 1 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LCK 0 2 LCK LCK_HUMAN 6.25722468121418 5.3 5.3 2 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FYN 0 2 FYN FYN_HUMAN 5.62911849203352 5.3 5.3 2 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PHKG2 0 1 PHKG2 PHKG2_HUMAN 6.19497660321606 5.3 5.3 1 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC1A 0 1 CAMK1 KCC1A_HUMAN 5.90799732148669 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK10 0 2 STK10 LOK STK10_HUMAN 6.01569111501319 5.3 5.3 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ERBB4 0 1 ERBB4 HER4 ERBB4_HUMAN 6.99563519459755 5.3 5.3 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A6 0 2 RPS6KA6 RSK4 KS6A6_HUMAN 6.50965047954658 5.3 5.3 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK2 0 2 PAK2 PAK2_HUMAN 6.35231354138132 5.3 5.3 2 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MRCKB 0 2 CDC42BPB KIAA1124 MRCKB_HUMAN 5.96299963322807 5.3 5.3 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MK09 0 1 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.50965047954658 5.3 5.3 1 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.39999691337226 5.3 5.45 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LYN 0 2 LYN JTK8 LYN_HUMAN 5.46568981323991 5.3 5.3 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.92675897524824 5.3 5.3 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NLK 0 1 NLK LAK1 NLK_HUMAN 6.00479888288177 5.3 5.3 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 EPHA1 0 1 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 6.38021124171161 5.3 5.3 1 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKG2 0 7 PRKAG2 AAKG2_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKB2 0 7 PRKAB2 AAKB2_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAPK2 0 7 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AAKG3 0 7 PRKAG3 AMPKG3 AAKG3_HUMAN 6.12338490853968 5.3 5.3 7 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TIE2 0 2 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 6.2990967007576 5.3 5.3 2 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 VGFR3 0 2 FLT4 VEGFR3 VGFR3_HUMAN 4.84296016570244 5.3 5.3 2 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.5504075317808 5.3 5.3 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NTRK1 0 1 NTRK1 MTC TRK TRKA NTRK1_HUMAN 5.62973141792582 5.3 5.3 1 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KC1D 0 2 CSNK1D HCKID KC1D_HUMAN 5.45636303801534 5.3 5.3 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ITK 0 1 ITK EMT LYK ITK_HUMAN 6.12338490853968 5.3 5.3 1 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NEK2 0 1 NEK2 NEK2A NLK1 NEK2_HUMAN 6.06069784035361 5.3 5.3 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 NTRK2 0 2 NTRK2 TRKB NTRK2_HUMAN 5.62357730744056 5.3 5.3 2 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 RIPK2 0 1 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.65854134728041 5.3 5.3 1 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PIM3 0 1 PIM3 PIM3_HUMAN 6.38021124171161 5.3 5.3 1 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 UFO 0 1 AXL UFO UFO_HUMAN 5.86530142610254 5.3 5.3 1 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MET 0 1 MET MET_HUMAN 5.82557590031178 5.3 5.3 1 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 AURKA 0 2 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 5.95248706543325 5.3 5.3 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MUSK 0 1 MUSK MUSK_HUMAN 5.47712125471966 5.3 5.3 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A3 0 4 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 4.91195437047216 5.3 5.3 4 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KIT 0 2 KIT SCFR KIT_HUMAN 5.57817360042996 5.3 5.3 2 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.82557590031178 5.3 5.3 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.81407831244633 5.3 5.3 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LUCI 0 1 LUCI_PHOPY 6.22098102808513 5.3 5.315 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BTK 0 1 BTK AGMX1 ATK BPK BTK_HUMAN 6.19497660321606 5.3 5.3 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KPCI 0 2 PRKCI DXS1179E KPCI_HUMAN 5.61915054643304 5.3 5.3 2 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GRK6 0 1 GRK6 GPRK6 GRK6_HUMAN 6.27875360095283 5.3 5.3 1 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.3 5.3 5.225 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 6.50965047954658 5.3 5.3 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK7 0 2 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 6.50965047954658 5.3 5.3 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNH 0 2 CCNH CCNH_HUMAN 6.50965047954658 5.3 5.3 2 Cyclin-H (MO15-associated protein) (p34) (p37) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KCC2B 0 1 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 6.06069784035361 5.3 5.3 1 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK2 0 3 CDK2 CDKN2 CDK2_HUMAN 5.65854134728041 5.3 5.3 3 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNA1 0 3 CCNA1 CCNA1_HUMAN 5.65854134728041 5.3 5.3 3 Cyclin-A1 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNA2 0 3 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.65854134728041 5.3 5.3 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 6.99563519459755 5.3 5.3 1 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 6.12338490853968 5.3 5.3 1 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 SGK2 0 1 SGK2 SGK2_HUMAN 6.99563519459755 5.3 5.3 1 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DYRK2 0 1 DYRK2 DYRK2_HUMAN 5.75332766665861 5.3 5.3 1 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CD5R1 0 4 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.15918075587787 5.3 5.3 4 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK5 0 4 CDK5 CDKN5 CDK5_HUMAN 6.15918075587787 5.3 5.3 4 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FES 0 1 FES FPS FES_HUMAN 6.12338490853968 5.3 5.3 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MP2K1 0 1 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.95424250943933 5.3 5.3 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KS6A4 0 2 RPS6KA4 MSK2 KS6A4_HUMAN 6.06069784035361 5.3 5.3 2 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 MAPK2 0 1 MAPKAPK2 MAPK2_HUMAN 6.12338490853968 5.3 5.3 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PAK5 0 1 PAK5 KIAA1264 PAK7 PAK5_HUMAN 6.06069784035361 5.3 5.3 1 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 DAPK2 0 1 DAPK2 DAPK2_HUMAN 6.99563519459755 5.3 5.3 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.7999981345934 5.3 5.315 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 6.16722687557547 5.3 5.3 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNE1 0 6 CCNE1 CCNE CCNE1_HUMAN 6.16722687557547 5.3 5.3 6 G1/S-specific cyclin-E1 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 CCNE2 0 6 CCNE2 CCNE2_HUMAN 6.16722687557547 5.3 5.3 6 G1/S-specific cyclin-E2 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TGFR1 0 1 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 6.00479888288177 5.3 5.3 1 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 5.72015930340596 5.3 5.3 1 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 TLK2 0 1 TLK2 TLK2_HUMAN 6.99563519459755 5.3 5.3 1 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 PLK3 0 2 PLK3 CNK FNK PRK PLK3_HUMAN 5.9431368703327 5.3 5.3 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 BRSK1 0 1 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.82557590031178 5.3 5.3 1 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 IRAK4 0 1 IRAK4 IRAK4_HUMAN 6.19497660321606 5.3 5.3 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FGFR3 0 2 FGFR3 JTK4 FGFR3_HUMAN 6.01604063380572 5.3 5.3 2 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 ST17A 0 2 STK17A DRAK1 ST17A_HUMAN 5.82336519312371 5.3 5.3 2 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 FAK1 0 1 PTK2 FAK FAK1 FAK1_HUMAN 6.06069784035361 5.3 5.3 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 LIMK1 0 1 LIMK1 LIMK LIMK1_HUMAN 6.12338490853968 5.3 5.3 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 GLHA 0 1 CGA GLHA_HUMAN 5.65000410073714 5.3 5.3 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 1756 VRK2 0 1 VRK2 VRK2_HUMAN 6.38021124171161 5.3 5.3 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 5.3 actual molregno [molregno] Cc1cc2ncc(nc2cc1C)c3ccccc3 2516 0 21 NotRecorded 4.68843290135177 7.35 7.35 21 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2516 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.38800156128963 7.35 6.0125 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2516 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 8.46 7.35 7.35 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2516 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.35 7.35 7.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.35 actual molregno [molregno] COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 2249 P53 0 1 TP53 P53 P53_HUMAN 4.6 4.85 4.85000000000001 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 6.04252913805155 4.85 4.85000000000001 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAOK3 0 2 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 5.21667116507053 4.85 4.85000000000001 2 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 0 23 NotRecorded, Protein kinase Pfmrk 5.35113641791829 4.85 4.85000000000001 23 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK03 0 1 MAPK3 ERK1 PRKM3 MK03_HUMAN 6.19497660321606 4.85 4.85000000000001 1 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.77696529855017 4.85 4.85000000000001 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MTOR 0 6 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.83716618347045 4.85 4.85000000000001 6 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FAK1 0 1 PTK2 FAK FAK1 FAK1_HUMAN 4.76886117461341 4.85 4.85000000000001 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MP2K6 0 2 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.81199362955443 4.85 4.85000000000001 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RUNX1 0 6 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.71666610908814 4.85 4.85000000000001 6 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PEBB 0 6 CBFB PEBB_HUMAN 4.71666610908814 4.85 4.85000000000001 6 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK14 0 1 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 4.65730140142663 4.85 4.85000000000001 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.52380738778312 4.85 4.85000000000001 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCND1 0 2 CCND1 BCL1 PRAD1 CCND1_HUMAN 6 4.85 4.85000000000001 2 G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK4 0 2 CDK4 CDK4_HUMAN 6 4.85 4.85000000000001 2 Cyclin-dependent kinase 4 (EC 2.7.11.22) (CRK3) (Cell division protein kinase 4) (PSK-J3), Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MET 0 2 MET MET_HUMAN 5.91518739159678 4.85 4.85000000000001 2 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 JAK2 0 2 JAK2 JAK2_HUMAN 5.95424250943933 4.85 4.85000000000001 2 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 4.78739190711856 4.85 4.85000000000001 1 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CD5R1 0 8 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.08054263877572 4.85 4.85000000000001 8 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK5 0 8 CDK5 CDKN5 CDK5_HUMAN 5.08054263877572 4.85 4.85000000000001 8 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAOK1 0 2 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 5.78091424560582 4.85 4.85000000000001 2 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 YES 0 1 YES1 YES YES_HUMAN 4.69243913717706 4.85 4.85000000000001 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MELK 0 2 MELK KIAA0175 MELK_HUMAN 4.5081779723829 4.85 4.85000000000001 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.02619403472985 4.85 4.85000000000001 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK11 0 2 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.22045454103261 4.85 4.85000000000001 2 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK7 0 4 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 4.56112304401158 4.85 4.85000000000001 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNH 0 4 CCNH CCNH_HUMAN 4.56112304401158 4.85 4.85000000000001 4 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M3K7 0 1 MAP3K7 TAK1 M3K7_HUMAN 5.2498774732166 4.85 4.85000000000001 1 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.32334082330819 4.85 4.85000000000001 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KAPCA 0 8 PRKACA PKACA KAPCA_HUMAN 5.01278813061184 4.85 4.85000000000001 8 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAU 0 6 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.78333333333333 4.85 4.85000000000001 6 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCG 0 37 PRKCG PKCG KPCG_HUMAN 5.30469543287983 4.85 4.85000000000001 37 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCA 0 39 PRKCA PKCA PRKACA KPCA_HUMAN 5.40085406495206 4.85 4.85000000000001 39 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCL 0 37 PRKCH PKCL PRKCL KPCL_HUMAN 5.34444776562891 4.85 4.85000000000001 37 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD1 0 34 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.45948808840165 4.85 4.85000000000001 34 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCI 0 36 PRKCI DXS1179E KPCI_HUMAN 5.461307826829 4.85 4.85000000000001 36 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCB 0 37 PRKCB PKCB PRKCB1 KPCB_HUMAN 5.26146378396025 4.85 4.85000000000001 37 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD 0 36 PRKCD KPCD_HUMAN 5.54457792571445 4.85 4.85000000000001 36 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD3 0 33 PRKD3 EPK2 PRKCN KPCD3_HUMAN 5.47712125471966 4.85 4.85000000000001 33 Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCE 0 37 PRKCE PKCE KPCE_HUMAN 5.5187871270733 4.85 4.85000000000001 37 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCT 0 37 PRKCQ PRKCT KPCT_HUMAN 5.3353977224758 4.85 4.85000000000001 37 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCZ 0 36 PRKCZ PKC2 KPCZ_HUMAN 5.43541712687311 4.85 4.85000000000001 36 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BRSK2 0 2 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 4.91959421447593 4.85 4.85000000000001 2 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TIE2 0 1 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 5.17609125905568 4.85 4.85000000000001 1 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNB3 0 16 CCNB3 CYCB3 CCNB3_HUMAN 5.16525749891599 4.85 4.85000000000001 16 G2/mitotic-specific cyclin-B3 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK1 0 16 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.16525749891599 4.85 4.85000000000001 16 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNB1 0 16 CCNB1 CCNB CCNB1_HUMAN 5.16525749891599 4.85 4.85000000000001 16 G2/mitotic-specific cyclin-B1 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNB2 0 16 CCNB2 CCNB2_HUMAN 5.16525749891599 4.85 4.85000000000001 16 G2/mitotic-specific cyclin-B2 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AKT1 0 1 AKT1 PKB RAC AKT1_HUMAN 5.52476288915489 4.85 4.85000000000001 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK01 0 5 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 6.30075541371934 4.85 4.85000000000001 5 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AURKA 0 1 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 5.60205999132796 4.85 4.85000000000001 1 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KPCD2 0 2 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.0840959134135 4.85 4.85000000000001 2 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5.91421276141055 4.85 4.85000000000001 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK12 0 1 MAPK12 ERK6 SAPK3 MK12_HUMAN 5.90799732148669 4.85 4.85000000000001 1 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK08 0 2 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.34749748145514 4.85 4.85000000000001 2 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 6.11 4.85 4.85000000000001 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LIMK1 0 1 LIMK1 LIMK LIMK1_HUMAN 5.43195909596147 4.85 4.85000000000001 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.61915054643304 4.85 4.85000000000001 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AURKC 0 1 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.41017446508905 4.85 4.85000000000001 1 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ROCK1 0 2 ROCK1 ROCK1_HUMAN 5.79831324624224 4.85 4.85000000000001 2 Rho-associated protein kinase 1 (EC 2.7.11.1) (Liver regeneration-related protein LRRG199) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p150 RhoA-binding kinase ROK beta) (p160 ROCK-1) (p160ROCK), Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRPK1 0 1 SRPK1 SRPK1_HUMAN 5.23113882538659 4.85 4.85000000000001 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MAPK5 0 1 MAPKAPK5 PRAK MAPK5_HUMAN 6.69019608002851 4.85 4.85000000000001 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CLK3 0 2 CLK3 CLK3_HUMAN 4.85632861097154 4.85 4.85000000000001 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ULK3 0 1 ULK3 ULK3_HUMAN 5.19426522798427 4.85 4.85000000000001 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TSSK1 0 2 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5.27861579508937 4.85 4.85000000000001 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PDK1 0 1 PDK1 PDHK1 PDK1_HUMAN 5.75332766665861 4.85 4.85000000000001 1 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1), [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ERBB4 0 1 ERBB4 HER4 ERBB4_HUMAN 5.78837041556533 4.85 4.85000000000001 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK6 0 1 NEK6 NEK6_HUMAN 6.38021124171161 4.85 4.85000000000001 1 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CHK1 0 4 CHEK1 CHK1 CHK1_HUMAN 4.93329731881374 4.85 4.85000000000001 4 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RIPK2 0 2 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.73950269929711 4.85 4.85000000000001 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 STK33 0 2 STK33 STK33_HUMAN 5.03740272299367 4.85 4.85000000000001 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GSK3B 0 6 GSK3B GSK3B_HUMAN 5.23829119498071 4.85 4.85000000000001 6 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MAPK2 0 2 MAPKAPK2 MAPK2_HUMAN 5.6931008027004 4.85 4.85000000000001 2 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGFR2 0 2 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 5.2788702816398 4.85 4.85000000000001 2 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PASK 0 2 PASK KIAA0135 PASK_HUMAN 4.89785851223987 4.85 4.85000000000001 2 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TAOK2 0 1 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 4.98262590393058 4.85 4.85000000000001 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HIPK1 0 2 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 5.5032102605522 4.85 4.85000000000001 2 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.70000050388302 4.85 4.85000000000001 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 6 4.85 4.85000000000001 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SIR2 0 4 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5.09652281476392 4.85 4.85000000000001 4 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FRK 0 1 FRK PTK5 RAK FRK_HUMAN 5.72015930340596 4.85 4.85000000000001 1 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 4.50839689731268 4.85 4.85000000000001 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BRSK1 0 2 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 4.83277803442535 4.85 4.85000000000001 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHB1 0 2 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 5.76913969831701 4.85 4.85000000000001 2 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KIT 0 1 KIT SCFR KIT_HUMAN 6.06069784035361 4.85 4.85000000000001 1 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNE2 0 15 CCNE2 CCNE2_HUMAN 5.35770914610672 4.85 4.85000000000001 15 G1/S-specific cyclin-E2 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK2 0 12 CDK2 CDKN2 CDK2_HUMAN 5.25454926859314 4.85 4.85000000000001 12 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNE1 0 15 CCNE1 CCNE CCNE1_HUMAN 5.35770914610672 4.85 4.85000000000001 15 G1/S-specific cyclin-E1 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HIPK2 0 2 HIPK2 HIPK2_HUMAN 4.88603980017323 4.85 4.85000000000001 2 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ALK 0 2 ALK ALK_HUMAN 6.09988774304892 4.85 4.85000000000001 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA7 0 1 EPHA7 EHK3 HEK11 EPHA7_HUMAN 5.82557590031178 4.85 4.85000000000001 1 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TYRO3 0 2 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 5.9404067961404 4.85 4.85000000000001 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PIM1 0 7 PIM1 PIM1_HUMAN 5.26645387528147 4.85 4.85000000000001 7 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CP2C9 0 2 CYP2C9 CYP2C10 CP2C9_HUMAN 4.8 4.85 4.85000000000001 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DAPK2 0 2 DAPK2 DAPK2_HUMAN 5.05130680113306 4.85 4.85000000000001 2 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CSF1R 0 2 CSF1R FMS CSF1R_HUMAN 4.8160116073527 4.85 4.85000000000001 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NLK 0 1 NLK LAK1 NLK_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GRK5 0 2 GRK5 GPRK5 GRK5_HUMAN 4.59473317255125 4.85 4.85000000000001 2 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M3K5 0 1 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 6.38021124171161 4.85 4.85000000000001 1 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.6 4.85 4.85000000000001 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.6 4.85 4.85000000000001 4 Menin 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 5.47712125471966 4.85 4.85000000000001 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PGFRB 0 1 PDGFRB PDGFR PDGFR1 PGFRB_HUMAN 5.26884531229258 4.85 4.85000000000001 1 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SIK1 0 2 SIK1 SIK SNF1LK SIK1_HUMAN 4.74043151466672 4.85 4.85000000000001 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGR 0 2 FGR SRC2 FGR_HUMAN 5.73368070871526 4.85 4.85000000000001 2 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 JAK3 0 4 JAK3 JAK3_HUMAN 5.30321973429673 4.85 4.85000000000001 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KC1G1 0 1 CSNK1G1 KC1G1_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.79999955049828 4.85 4.85000000000001 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PHKG2 0 2 PHKG2 PHKG2_HUMAN 5.54822012574456 4.85 4.85000000000001 2 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK2 0 1 PAK2 PAK2_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 UFO 0 2 AXL UFO UFO_HUMAN 5.08685577865516 4.85 4.85000000000001 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC4 0 2 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.38907562519182 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MRCKB 0 2 CDC42BPB KIAA1124 MRCKB_HUMAN 5.55133117094858 4.85 4.85000000000001 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RGS4 0 1 RGS4 RGS4_HUMAN 8.22184874961636 4.85 4.85000000000001 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BMX 0 2 BMX BMX_HUMAN 5.30796926603083 4.85 4.85000000000001 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC1D 0 2 CAMK1D CAMKID KCC1D_HUMAN 4.63844815797363 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 5.36797678529459 4.85 4.85000000000001 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRPK2 0 2 SRPK2 SRPK2_HUMAN 5.9063012400607 4.85 4.85000000000001 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK5 0 2 PAK5 KIAA1264 PAK7 PAK5_HUMAN 5.69503215762871 4.85 4.85000000000001 2 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TGFR1 0 2 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5.69682961685094 4.85 4.85000000000001 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 4.87166496248184 4.85 4.85000000000001 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BLK 0 2 BLK BLK_HUMAN 4.7216347059904 4.85 4.85000000000001 2 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.33399064587045 4.85 4.85000000000001 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 BTK 0 2 BTK AGMX1 ATK BPK BTK_HUMAN 5.65908589328787 4.85 4.85000000000001 2 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC1A 0 2 CAMK1 KCC1A_HUMAN 5.44531161270863 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK3 0 2 NEK3 NEK3_HUMAN 6.32221929473392 4.85 4.85000000000001 2 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MERTK 0 2 MERTK MER MERTK_HUMAN 4.6340469687845 4.85 4.85000000000001 2 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M3K9 0 2 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 4.65730140142663 4.85 4.85000000000001 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DAPK3 0 2 DAPK3 ZIPK DAPK3_HUMAN 4.97188139029443 4.85 4.85000000000001 2 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MK09 0 1 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.69019608002851 4.85 4.85000000000001 1 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PDPK1 0 2 PDPK1 PDK1 PDPK1_HUMAN 4.73890557936399 4.85 4.85000000000001 2 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRC 0 2 SRC SRC1 SRC_HUMAN 5.96864747411662 4.85 4.85000000000001 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 INSRR 0 1 INSRR IRR INSRR_HUMAN 5.47712125471966 4.85 4.85000000000001 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 WNK3 0 1 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 4.9637246664257 4.85 4.85000000000001 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SGK3 0 1 SGK3 CISK SGKL SGK3_HUMAN 5.26884531229258 4.85 4.85000000000001 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KCC2B 0 2 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 4.78629873905309 4.85 4.85000000000001 2 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KAPCG 0 6 PRKACG KAPCG_HUMAN 5.08804562952784 4.85 4.85000000000001 6 cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KAPCB 0 6 PRKACB KAPCB_HUMAN 5.08804562952784 4.85 4.85000000000001 6 cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HIPK3 0 2 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 5.2783652940096 4.85 4.85000000000001 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RON 0 1 MST1R PTK8 RON RON_HUMAN 5.82557590031178 4.85 4.85000000000001 1 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ST17A 0 1 STK17A DRAK1 ST17A_HUMAN 4.93036407185861 4.85 4.85000000000001 1 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ITK 0 1 ITK EMT LYK ITK_HUMAN 6.99563519459755 4.85 4.85000000000001 1 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.97780951913406 4.85 4.85000000000001 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 4.89586202878646 4.85 4.85000000000001 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ABL2 0 2 ABL2 ABLL ARG ABL2_HUMAN 5.72742243000426 4.85 4.85000000000001 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IRAK4 0 1 IRAK4 IRAK4_HUMAN 5.05217801166507 4.85 4.85000000000001 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85000000000001 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 5.2788702816398 4.85 4.85000000000001 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK11 0 2 NEK11 NEK11_HUMAN 5.28412131000573 4.85 4.85000000000001 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MKNK2 0 2 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.57907350739944 4.85 4.85000000000001 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 5.32735893438633 4.85 4.85000000000001 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DCLK2 0 2 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 6.12275633390708 4.85 4.85000000000001 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PTK6 0 1 PTK6 BRK PTK6_HUMAN 5.90799732148669 4.85 4.85000000000001 1 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NEK2 0 1 NEK2 NEK2A NLK1 NEK2_HUMAN 6.19497660321606 4.85 4.85000000000001 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.55 4.85 4.85000000000001 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ROCK2 0 2 ROCK2 KIAA0619, Rock2 ROCK2_HUMAN, ROCK2_RAT 5.90977196777093 4.85 4.85000000000001 2 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TEC 0 1 TEC PSCTK4 TEC_HUMAN 5.26884531229258 4.85 4.85000000000001 1 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 AKT2 0 1 AKT2 AKT2_HUMAN 5.17609125905568 4.85 4.85000000000001 1 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 NTRK1 0 2 NTRK1 MTC TRK TRKA NTRK1_HUMAN 4.5698309967145 4.85 4.85000000000001 2 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EGFR 0 1 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 6.69019608002851 4.85 4.85000000000001 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PLK2 0 1 PLK2 SNK PLK2_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 5.47712125471966 4.85 4.85000000000001 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CSK22 0 1 CSNK2A2 CK2A2 CSK22_HUMAN 6.27875360095283 4.85 4.85000000000001 1 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FGFR3 0 2 FGFR3 JTK4 FGFR3_HUMAN 5.40305812619797 4.85 4.85000000000001 2 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 5.86530142610254 4.85 4.85000000000001 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MARK2 0 2 MARK2 EMK1 MARK2_HUMAN 4.87894447047734 4.85 4.85000000000001 2 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IKKA 0 1 CHUK IKKA TCF16 IKKA_HUMAN 5.14017870316504 4.85 4.85000000000001 1 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SGK1 0 4 SGK1 SGK SGK1_HUMAN 4.95319825237927 4.85 4.85000000000001 4 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 4.85982129683496 4.85 4.85000000000001 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA3 0 1 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNA1 0 3 CCNA1 CCNA1_HUMAN 4.78739190711856 4.85 4.85000000000001 3 Cyclin-A1 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCNA2 0 3 CCNA2 CCN1 CCNA CCNA2_HUMAN 4.78739190711856 4.85 4.85000000000001 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CCND3 0 2 CCND3 CCND3_HUMAN 5.05217801166507 4.85 4.85000000000001 2 G1/S-specific cyclin-D3 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 5.05217801166507 4.85 4.85000000000001 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LYN 0 2 LYN JTK8 LYN_HUMAN 5.01286793734412 4.85 4.85000000000001 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HCK 0 3 HCK HCK_HUMAN 5.41468453443584 4.85 4.85000000000001 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5.50060235056919 4.85 4.85000000000001 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 LCK 0 4 LCK LCK_HUMAN 5.31266247768274 4.85 4.85000000000001 4 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 RET 0 2 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5.76431553708471 4.85 4.85000000000001 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.1 4.85 4.85000000000001 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 INSR 0 1 INSR INSR_HUMAN 5.41017446508905 4.85 4.85000000000001 1 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 HASP 0 2 HASPIN GSG2 HASP_HUMAN 4.50614608690228 4.85 4.85000000000001 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 5.24910848296273 4.85 4.85000000000001 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IGF1R 0 2 IGF1R IGF1R_HUMAN 6.68792321815458 4.85 4.85000000000001 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PGFRA 0 1 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 5.54967192186827 4.85 4.85000000000001 1 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KSYK 0 1 SYK KSYK_HUMAN 5.1224064000929 4.85 4.85000000000001 1 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DMPK 0 2 DMPK DM1PK MDPK DMPK_HUMAN 4.58769567418868 4.85 4.85000000000001 2 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ACK1 0 1 TNK2 ACK1 ACK1_HUMAN 4.9128498242811 4.85 4.85000000000001 1 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 DYRK2 0 1 DYRK2 DYRK2_HUMAN 6.50965047954658 4.85 4.85000000000001 1 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FER 0 1 FER TYK3 FER_HUMAN 5.62973141792582 4.85 4.85000000000001 1 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 TSSK2 0 1 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.19497660321606 4.85 4.85000000000001 1 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.0871501757189 4.85 4.85000000000001 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 PLK1 0 1 PLK1 PLK PLK1_HUMAN 5.72015930340596 4.85 4.85000000000001 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 EPHA4 0 1 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 5.65854134728041 4.85 4.85000000000001 1 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 VGFR2 0 2 KDR FLK1 VEGFR2 VGFR2_HUMAN 4.70294740620947 4.85 4.85000000000001 2 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 VRK2 0 1 VRK2 VRK2_HUMAN 5.50060235056919 4.85 4.85000000000001 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 IRAK1 0 1 IRAK1 IRAK IRAK1_HUMAN 5.90799732148669 4.85 4.85000000000001 1 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 5.50060235056919 4.85 4.85000000000001 1 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 KC1D 0 2 CSNK1D HCKID KC1D_HUMAN 5.76482515299792 4.85 4.85000000000001 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 WNK2 0 1 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.78837041556533 4.85 4.85000000000001 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MP2K1 0 1 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.03476210625921 4.85 4.85000000000001 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 MUSK 0 1 MUSK MUSK_HUMAN 5.45425837176016 4.85 4.85000000000001 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2249 FYN 0 1 FYN FYN_HUMAN 5.36797678529459 4.85 4.85000000000001 1 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 4.85 actual molregno [molregno] CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 2658 ALDR 2 0 AKR1B1 ALDR1, Akr1b1 Akr1b4 Aldr1 ALDR_HUMAN, ALDR_RAT 4.525 4.6 4.60000000000001 2 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NR1H4 2 0 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.59999938302362 4.6 4.60000000000001 2 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PPARG 2 0 PPARG NR1C3 PPARG_HUMAN 4.65000010122271 4.6 4.60000000000001 2 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ESR2 41 0 ESR2 ESTRB NR3A2, Esr2 Erbeta Nr3a2 ESR2_HUMAN, ESR2_RAT 6.86619516395008 4.6 4.60000000000001 41 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ESR1 44 0 ESR1 ESR NR3A1, Esr1 Esr Estr Nr3a1 ESR1_HUMAN, ESR1_RAT 5.68867713562138 4.6 4.60000000000001 44 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LOX15 3 0 ALOX15, ALOX15 LOG15 LOX15_HUMAN, LOX15_RABIT 4.74666666666667 4.6 4.60000000000001 3 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AA2AR 4 0 ADORA2A ADORA2, Adora2a AA2AR_HUMAN, AA2AR_RAT 4.6625 4.6 4.60000000000001 4 Adenosine receptor A2a 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TAU 6 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.30833333333333 4.6 4.60000000000001 6 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PGDH 5 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.67 4.6 4.60000000000001 5 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TOP2A 6 0 TOP2A TOP2 TOP2A_HUMAN 4.98566302414106 4.6 4.60000000000001 6 DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.87499883113825 4.6 4.60000000000001 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 THB 1 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 8.49485002168009 4.6 4.60000000000001 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 EGFR 11 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 5.04165151864931 4.6 4.60000000000001 11 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SC6A3 2 0 SLC6A3 DAT1 SC6A3_HUMAN 4.82 4.6 4.60000000000001 2 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 RXRA 4 0 RXRA NR2B1 RXRA_HUMAN 4.65000040771605 4.6 4.60000000000001 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LEF 2 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.7 4.6 4.60000000000001 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 Q7ZJM1 3 0 pol Q7ZJM1_9HIV1 5.11931333622401 4.6 4.60000000000001 3 Integrase (Fragment) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NPC1 2 0 NPC1 NPC1_HUMAN 5.295 4.6 4.60000000000001 2 Niemann-Pick C1 protein 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 5.27381905802915 4.6 4.60000000000001 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.8000008748032 4.6 4.60000000000001 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PPARD 6 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.59625607589676 4.6 4.60000000000001 6 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 MRP1 1 0 ABCC1 MRP MRP1 MRP1_HUMAN 6.24349737657882 4.6 4.60000000000001 1 Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SMN 3 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.60000000000001 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LUCI 2 0 LUCI_PHOPY 4.85658477164208 4.6 4.60000000000001 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AOFA 11 0 MAOA AOFA_HUMAN 5.59959490812582 4.6 4.60000000000001 11 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DNMT1 1 0 DNMT1 AIM CXXC9 DNMT DNMT1_HUMAN 4.52 4.6 4.60000000000001 1 DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT), DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (Met-1) (EC 2.1.1.37) (DNA methyltransferase MmuI) (DNA MTase MmuI) (M.MmuI) (MCMT) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.3 4.6 4.60000000000001 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5 4.6 4.60000000000001 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 P53 4 0 TP53 P53 P53_HUMAN 5.17499941351801 4.6 4.60000000000001 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SO1B3 3 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.24893907329278 4.6 4.60000000000001 3 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AA1R 4 0 ADORA1, Adora1 AA1R_HUMAN, AA1R_RAT 5.06 4.6 4.60000000000001 4 Adenosine receptor A1 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 9.69897000433602 4.6 4.60000000000001 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GLP1R 2 0 GLP1R GLP1R_HUMAN 5.19999875880851 4.6 4.60000000000001 2 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ALDH2 4 0 ALDH2 ALDM ALDH2_HUMAN 5.31620648321977 4.6 4.60000000000001 4 Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1), Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NF2L2 7 0 NFE2L2 NRF2 NF2L2_HUMAN 5.0839659963869 4.6 4.60000000000001 7 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ABL2 2 0 ABL2 ABLL ARG ABL2_HUMAN 5 4.6 4.60000000000001 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ABL1 3 0 ABL1 ABL JTK7 ABL1_HUMAN 5 4.6 4.60000000000001 3 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 MDR1 1 0 ABCB1 MDR1 PGY1 MDR1_HUMAN 4.58 4.6 4.60000000000001 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GRP78 2 0 HSPA5 GRP78 GRP78_HUMAN 5.33300493205124 4.6 4.60000000000001 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PMP22 3 0 PMP22 GAS3, Pmp22 Cd25 Pmp-22 PMP22_HUMAN, PMP22_RAT 4.88750648730812 4.6 4.60000000000001 3 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 RAB9A 2 0 RAB9A RAB9 RAB9A_HUMAN 5.15 4.6 4.60000000000001 2 Ras-related protein Rab-9A 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AOFB 10 0 MAOB AOFB_HUMAN 5.5995543989384 4.6 4.60000000000001 10 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 FABI 1 0 fabI envM b1288 JW1281 FABI_ECOLI 5 4.6 4.60000000000001 1 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI (ENR) (EC 1.3.1.9) (NADH-dependent enoyl-ACP reductase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SO1B1 4 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.60564564812153 4.6 4.60000000000001 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GLCM 4 0 GBA GC GLUC GLCM_HUMAN 4.77500032913753 4.6 4.60000000000001 4 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DHB1 2 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 4.9856854145011 4.6 4.60000000000001 2 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 GLSK 1 0 GLS GLS1 KIAA0838 GLSK_HUMAN 4.89999841719865 4.6 4.60000000000001 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TPO 2 0 THPO MGDF TPO_HUMAN 5.8 4.6 4.60000000000001 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 CAC1C 4 0 CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1, Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1 CAC1C_CAVPO, CAC1C_RAT 4.715 4.6 4.60000000000001 4 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ATAD5 4 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.873890252643 4.6 4.60000000000001 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DHB2 2 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 4.52503603889225 4.6 4.60000000000001 2 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 5.95000714307986 4.6 4.60000000000001 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 LMNA 3 0 LMNA LMN1 LMNA_HUMAN 4.85 4.6 4.60000000000001 3 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ERR2 1 0 ESRRB ERRB2 ESRL2 NR3B2 ERR2_HUMAN 6.4 4.6 4.60000000000001 1 Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NR1H2 1 0 NR1H2 LXRB NER UNR NR1H2_HUMAN 4.66 4.6 4.60000000000001 1 Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor), Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor subfamily 1 group H member 2) (Retinoid X receptor-interacting protein No.15) (Ubiquitously-expressed nuclear receptor) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NANH 1 0 nanH NANH_CLOPF 4.92 4.6 4.60000000000001 1 Sialidase (EC 3.2.1.18) (N-acylneuraminate glycohydrolase) (Neuraminidase) (NANase) (STNA), Sialidase (EC 3.2.1.18) (Neuraminidase), Sialidase (EC 3.2.1.18) (Neuraminidase) (NANase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 THAS 1 0 TBXAS1 CYP5 CYP5A1 THAS_HUMAN 5.11 4.6 4.60000000000001 1 Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 NR1H3 1 0 NR1H3 LXRA NR1H3_HUMAN 4.51 4.6 4.60000000000001 1 Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 MGA 3 0 MGAM MGA MGAML MGA_HUMAN 5.18 4.6 4.60000000000001 3 Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)] 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 VDR 1 0 VDR NR1I1 VDR_HUMAN 5.14999741390754 4.6 4.60000000000001 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 SO2B1 1 0 SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 SO2B1_HUMAN 5.32536474187563 4.6 4.60000000000001 1 Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9), Solute carrier organic anion transporter family member 2B1 (Organic anion transporter moatp1) (Solute carrier family 21 member 9) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 RORG 1 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.8 4.6 4.60000000000001 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 DCOR 1 0 ODC1 DCOR_HUMAN 4.59 4.6 4.60000000000001 1 Ornithine decarboxylase (ODC) (EC 4.1.1.17) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AOXA 1 0 AOX1 AO AOXA_HUMAN 6.47 4.6 4.60000000000001 1 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase) (Retinoic acid synthase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 AMY1 1 0 AMY1A AMY1; AMY1B AMY1; AMY1C AMY1 AMY1_HUMAN 4.52519190378157 4.6 4.60000000000001 1 Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase), Alpha-amylase type A isozyme (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase) (HvAMY1) (Low pI alpha-amylase) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 ERR1 1 0 ESRRA ERR1 ESRL1 NR3B1 ERR1_HUMAN 8 4.6 4.60000000000001 1 Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 TYDP1 1 0 TDP1 TYDP1_HUMAN 5.05 4.6 4.60000000000001 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 5HT2A 2 0 HTR2A HTR2 5HT2A_HUMAN 5.25 4.6 4.60000000000001 2 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-HT2A) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 YES 1 0 YES1 YES YES_HUMAN 4.51219018981841 4.6 4.60000000000001 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 QOR 1 0 Cryz QOR_MOUSE 4.64016451766011 4.6 4.60000000000001 1 Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 PIM1 2 0 PIM1 PIM1_HUMAN 5.32885283155635 4.6 4.60000000000001 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 Q965D7 1 0 fabZ Q965D7_PLAFA 5.15 4.6 4.62000000000001 1 Beta-hydroxyacyl-ACP dehydratase (Fatty acid synthesis protein) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2658 5HT2C 2 0 HTR2C HTR1C 5HT2C_HUMAN 4.97 4.6 4.60000000000001 2 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 0 4.6 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 2994 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.25000102344165 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 SO1B1 0 6 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 4.82133233735511 5.35 5.35000000000002 6 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 FABPL 0 3 Fabp1 FABPL_RAT 5.01751825519221 5.35 5.35000000000002 3 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver basic FABP) (LB-FABP) (Liver bile acid-binding protein) (L-BABP) (Liver-type fatty acid-binding protein) (L-FABP), Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP), Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP) (Squalene- and sterol-carrier protein) (SCP) (Z-protein) (p14) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 PEBB 0 2 CBFB PEBB_HUMAN 4.89999841719865 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 CP2C8 0 2 CYP2C8 CP2C8_HUMAN 4.705 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 GEMI 0 1 GMNN GEMI_HUMAN 6.2500319164906 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Geminin 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 SO1B3 0 3 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 4.9226956500826 5.35 5.35000000000002 3 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 PPARG 0 4 PPARG NR1C3 PPARG_HUMAN 4.70286668124885 5.35 5.35000000000002 4 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 4.8 5.35 5.35000000000002 4 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 4.8000008748032 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 LUCI 0 1 LUCI_PHOPY 4.62098289875995 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 PFKA 0 1 pfk PFKA_TRYBB 4.67098267640138 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.59999938302362 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 TAR DNA-binding protein 43 (TDP-43) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 TTHY 0 2 TTR PALB TTHY_HUMAN 5.37236374744835 5.35 5.35000000000002 2 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Transthyretin (ATTR) (Prealbumin) (TBPA), Transthyretin (Prealbumin) (TBPA) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 2994 JUN 0 1 JUN JUN_HUMAN 5 5.35 5.35000000000002 1 GEMFIBROZIL ALZHEIMERS DISEASE, ANEMIA, CANCER, CARDIOVASCULAR DISEASE, CORONARY HEART DISEASE, NICOTINE DEPENDENCE, SMOKING CESSATION, TYPE II DIABETES MELLITUS Peroxisome proliferator-activated receptor alpha agonist AGONIST 4 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 5.35 actual drug [drugName] Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 3281 RORG 1 0 RORC NR1F3 RORG RZRG RORG_HUMAN 5.92507390287604 4.7 4.7 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP2D6 2 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.8 4.7 4.7 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 SMN 4 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ANDR 9 0 AR DHTR NR3C4 ANDR_HUMAN 4.70675579754694 4.7 4.70069444444445 9 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 KDM4E 4 0 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.7 4.7 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 8.3 4.7 4.7 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 HCD2 5 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.7 4.7 5 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5 4.7 4.7 1 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 6.3 4.7 4.70833333333333 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 4.8 4.7 4.7 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NF2L2 6 0 NFE2L2 NRF2 NF2L2_HUMAN 4.92199748277815 4.7 4.71541666666667 6 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP2CJ 2 0 CYP2C19 CP2CJ_HUMAN 5 4.7 4.7 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH7 1 0 CA7 CAH7_HUMAN 8.38 4.7 4.64375 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.99999952349262 4.7 4.7 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ESR1 18 0 ESR1 ESR NR3A1 ESR1_HUMAN, ESR1_SHEEP 4.69763829036217 4.7 4.70104166666667 18 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.86139082578284 4.7 4.7 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 RGS4 1 0 RGS4 RGS4_HUMAN 6.02424661096371 4.7 4.7925 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.775 4.7 4.7 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 APEX1 2 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.50002974382599 4.7 4.7 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 DHB2 1 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 5.14553249978526 4.7 4.7 1 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ESR2 10 0 ESR2 ESTRB NR3A2, ESR2 NR3A2 ESR2_HUMAN, ESR2_SHEEP 5.403 4.7 4.7025 10 Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 PFKA 1 0 pfk PFKA_TRYBB 6.12096149476276 4.7 4.635 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NFKB1 4 0 NFKB1 NFKB1_HUMAN 5.35 4.7 4.7 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ALDH2 3 0 ALDH2 ALDM ALDH2_HUMAN 5.18475279058672 4.7 4.7 3 Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1), Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAC1C 2 0 Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1 CAC1C_RAT 4.92 4.7 4.7 2 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH12 1 0 CA12 CAH12_HUMAN 7.25 4.7 4.7 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 PGDH 4 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.6 4.7 4.7 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 P53 3 0 TP53 P53 P53_HUMAN 4.96666666666667 4.7 4.7 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 TRXR1 3 0 Txnrd1 Trxr1 TRXR1_RAT 4.95715590510302 4.7 4.7 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 LUCI 1 0 LUCI_PHOPY 5 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 GRP78 2 0 HSPA5 GRP78 GRP78_HUMAN 5.75800529924034 4.7 4.7925 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NRAM 1 0 NA NRAM_I34A1 4.54400224714056 4.7 4.7 1 Neuraminidase (EC 3.2.1.18) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 AOFA 10 0 MAOA AOFA_HUMAN 4.69853961855066 4.7 4.7 10 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 AOFB 10 0 MAOB AOFB_HUMAN 4.69853961855066 4.7 4.7 10 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 GEMI 1 0 GMNN GEMI_HUMAN 6.38626385873813 4.7 4.7 1 Geminin 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.14999741390754 4.7 4.7 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 TPO 2 0 THPO MGDF TPO_HUMAN 5.6 4.7 4.67916666666667 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 DHB1 1 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 4.73115468770742 4.7 4.7 1 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 UD11 5 0 UGT1A1 GNT1 UGT1 UD11_HUMAN 4.81216375079048 4.7 4.7 5 UDP-glucuronosyltransferase 1-1 (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-A) (UGT-1A) (UGT1A) (UDP-glucuronosyltransferase 1A1) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 SO2B1 1 0 SLCO2B1 KIAA0880 OATP2B1 OATPB SLC21A9 SO2B1_HUMAN 4.67264106561367 4.7 4.7 1 Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9), Solute carrier organic anion transporter family member 2B1 (Organic anion transporter moatp1) (Solute carrier family 21 member 9) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 NPC1 1 0 NPC1 NPC1_HUMAN 5.04 4.7 4.7 1 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 THB 1 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 4.65000022087346 4.7 4.7 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CP2C9 2 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.2 4.7 4.7 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH2 1 0 CA2 CAH2_HUMAN 5 4.7 4.7 1 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 4.73115468770742 4.7 4.7 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH1 1 0 CA1 CAH1_HUMAN 5 4.7 4.7 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 CAH4 1 0 CA4 CAH4_HUMAN 6.14 4.7 4.7 1 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 Q965D7 1 0 fabZ Q965D7_PLAFA 4.52 4.7 4.7 1 Beta-hydroxyacyl-ACP dehydratase (Fatty acid synthesis protein) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 3281 PPARD 1 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.84999924507786 4.7 4.7 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.7 actual molregno [molregno] Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 43740 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 2 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 LPXC 0 1 lpxC asmB envA b0096 JW0094 LPXC_ECOLI 5 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 UDP-3-O-acyl-N-acetylglucosamine deacetylase (UDP-3-O-acyl-GlcNAc deacetylase) (EC 3.5.1.108) (Protein EnvA) (UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase), UDP-3-O-acyl-N-acetylglucosamine deacetylase (UDP-3-O-acyl-GlcNAc deacetylase) (EC 3.5.1.108) (UDP-3-O-[R-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE1 0 7 Grin2a NMDE1_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A), Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE4 0 7 Grin2d GluN2D NMDE4_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D), Glutamate receptor ionotropic, NMDA 2D (GluN2D) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDZ1 0 8 Grin1 Nmdar1 NMDZ1_RAT 5.57625 4.85 4.85 8 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1), Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMD3A 0 7 Grin3a NMD3A_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 3A (GluN3A) (Glutamate receptor chi-1) (N-methyl-D-aspartate receptor) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) (NMDAR-L1), Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMD3B 0 7 Grin3b NMD3B_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE3 0 8 Grin2c NMDE3_RAT 5.5275 4.85 4.85 8 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 NMDE2 0 7 Grin2b NMDE2_RAT 5.64 4.85 4.85 7 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B), Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 RGS4 0 1 RGS4 RGS4_HUMAN 6.27384353382724 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 DDLB 0 3 ddlB ddl b0092 JW0090 DDLB_ECOLI 5 4.85 4.85 3 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 D-alanine--D-alanine ligase B (EC 6.3.2.4) (D-Ala-D-Ala ligase B) (D-alanylalanine synthetase B) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.2 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.8 4.85 4.85 2 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 4.85 4.85 4 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.85 4.85 4.85 4 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Menin 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 EHMT2 0 3 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.59999998775496 4.85 4.85 3 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 TSHR 0 8 TSHR LGR3 TSHR_HUMAN 5.4 4.85 4.85 8 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 PPARD 0 2 PPARD NR1C2 PPARB PPARD_HUMAN 4.67509864867999 4.85 4.85 2 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.07382224601261 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 43740 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.3 4.85 4.85 1 CYCLOSERINE ALCOHOL DRINKING, ANXIETY, AUTISM, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, COCAINE DEPENDENCE, DRUG DEPENDENCE, INJURY, NICOTINE DEPENDENCE, OBSESSIVE-COMPULSIVE DISORDER, PAIN, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, PROSTATITIS, SCHIZOPHRENIA, SLEEP APNEA, SMOKING CESSATION, STROKE, UNIPOLAR DEPRESSION Alanine racemase inhibitor, D-alanylalanine synthetase inhibitor INHIBITOR 4 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual drug [drugName] N[C@@H]1CONC1=O 543263 0 72 NotRecorded 5.14491555654766 5.05 5.12842085561247 72 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.575 5.05 5.295 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.18333333333333 5.05 5.14625 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 O97447 0 2 ald O97447_GIAIN 4.95 5.05 5.34166666666667 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 6.64994590642097 5.05 5.26145833333333 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.925 5.05 5.18708333333333 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.35625 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.8546696880553 5.05 5.24322916666667 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.74999985591871 5.05 5.05 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 P53 0 2 TP53 P53 P53_HUMAN 5.05 5.05 5.15208333333333 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.10003828433404 5.05 5.07916666666667 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 ANDR 0 3 AR DHTR NR3C4 ANDR_HUMAN 4.90617136738789 5.05 5.10833333333333 3 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 CHLE 0 3 BCHE CHLE_HORSE 5.34 5.05 5.150625 3 Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase), Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 543263 ACES 0 2 ache ACES_ELEEL 5.075 5.05 5.071875 2 Acetylcholinesterase (AChE) (EC 3.1.1.7), Acetylcholinesterase (AChE) (EC 3.1.1.7) [Cleaved into: Acetylcholinesterase 16 kDa subunit; Acetylcholinesterase 55 kDa subunit] 1 5.05 actual molregno [molregno] Cl.NNc1nncc2ccccc12 3665 PGDH 0 3 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.05 4.9 4.90000000000001 3 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 Q7ZJM1 0 5 pol Q7ZJM1_9HIV1 5.618 4.9 4.9 5 Integrase (Fragment) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 NEP 0 1 Mme NEP_RAT 4.7501225267834 4.9 4.90000000000001 1 Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10), Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10), Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10) (Fragment) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 5 4.9 4.90000000000001 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TAU 0 9 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 4.9 4.90000000000001 9 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TNFA 0 1 Tnf Tnfa Tnfsf2 TNFA_MOUSE 5.39520763311787 4.9 4.90000000000001 1 Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LOX12 0 3 ALOX12 12LO LOG12 LOX12_HUMAN 5.77333333333333 4.9 4.9 3 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 O97447 0 3 ald O97447_GIAIN 5.13333333333333 4.9 4.90500000000001 3 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 AMPN 0 1 ANPEP AMPN_PIG 5.1224064000929 4.9 4.90000000000001 1 Aminopeptidase N (AP-N) (bAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (CD antigen CD13), Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13), Aminopeptidase N (AP-N) (mAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Membrane protein p161) (Microsomal aminopeptidase) (CD antigen CD13), Aminopeptidase N (AP-N) (pAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (gp130) (CD antigen CD13), Aminopeptidase N (AP-N) (rAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Kidney Zn peptidase) (KZP) (Microsomal aminopeptidase) (CD antigen CD13), Aminopeptidase N (EC 3.4.11.2) (Alpha-aminoacylpeptide hydrolase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 POLH 0 2 POLH RAD30 RAD30A XPV POLH_HUMAN 5.16048986040405 4.9 4.90000000000001 2 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 BRCA1 0 2 BRCA1 RNF53 BRCA1_HUMAN 5.07499838464549 4.9 4.90000000000001 2 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 APEX1 0 5 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.76476904778231 4.9 4.9 5 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.56666666666667 4.9 4.9 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LGUL 0 1 GLO1 LGUL_HUMAN 4.96 4.9 4.90000000000001 1 Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 RORG 0 4 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.9 4.90000000000001 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.90000000000001 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA2 0 16 GABRA2 GBRA2_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA6 0 16 GABRA6 GBRA6_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRB1 0 16 GABRB1 GBRB1_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRG2 0 16 GABRG2 GBRG2_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRB2 0 16 GABRB2 GBRB2_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRP 0 16 GABRP GBRP_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA3 0 16 GABRA3 GBRA3_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRG1 0 16 GABRG1 GBRG1_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRE 0 16 GABRE GBRE_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRG3 0 16 GABRG3 GBRG3_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA5 0 16 GABRA5 GBRA5_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRD 0 16 GABRD GBRD_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA4 0 16 GABRA4 GBRA4_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRA1 0 16 GABRA1 GBRA1_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRB3 0 16 GABRB3 GBRB3_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GBRT 0 16 GABRQ GBRT_HUMAN 5.25 4.9 4.9 16 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 POLK 0 4 POLK DINB1 POLK_HUMAN 5.48750277991044 4.9 4.9 4 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.43639347275721 4.9 4.90000000000001 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 KDM4E 0 6 KDM4E KDM4DL KDM4E_HUMAN 5.41666666666667 4.9 4.9 6 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 P53 0 2 TP53 P53 P53_HUMAN 5.8 4.9 4.90000000000001 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 FFP 0 2 ffp sfp FFP_BACIU 4.75 4.9 4.90000000000001 2 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LOX15 0 5 ALOX15 LOG15, Alox15 Alox12l LOX15_HUMAN, LOX15_RAT 5.956 4.9 4.9 5 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 XDH 0 3 XDH, XDH XDHA XDH_BOVIN, XDH_HUMAN 5.60019937083107 4.9 4.9 3 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CYSP 0 1 CYSP_TRYCR 4.6 4.9 4.90000000000001 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 RECQ1 0 3 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.88333333333333 4.9 4.90000000000001 3 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CP1A1 0 1 CYP1A1 CP1A1_HUMAN 5.91 4.9 4.9 1 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 FLT3 0 1 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5 4.9 4.90000000000001 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LX15B 0 2 ALOX15B LX15B_HUMAN 4.54999951742326 4.9 4.90000000000001 2 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.885 4.9 4.90000000000001 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PIN1 0 1 PIN1 PIN1_HUMAN 4.84999924507786 4.9 4.90000000000001 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PFKA 0 3 pfk PFKA_TRYBB 5.32098012328077 4.9 4.90083333333334 3 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 4.9 4.9 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PEBB 0 2 CBFB PEBB_HUMAN 4.89999841719865 4.9 4.9 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TRY3 0 3 PRSS3 PRSS4 TRY3 TRY4 TRY3_HUMAN 5.43 4.9 4.90000000000001 3 Trypsin-3 (EC 3.4.21.4) (Brain trypsinogen) (Mesotrypsinogen) (Serine protease 3) (Serine protease 4) (Trypsin III) (Trypsin IV) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TRY2 0 3 PRSS2 TRY2 TRYP2 TRY2_HUMAN 5.43 4.9 4.90000000000001 3 Anionic trypsin (EC 3.4.21.4), Anionic trypsin-2 (EC 3.4.21.4) (Anionic trypsin II) (Pretrypsinogen II) (Serine protease 2), Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 TRY1 0 3 PRSS1 TRP1 TRY1 TRYP1 TRY1_HUMAN 5.43 4.9 4.90000000000001 3 Anionic trypsin-1 (EC 3.4.21.4) (Anionic trypsin I) (Pretrypsinogen I) (Serine protease 1), Cationic trypsin (EC 3.4.21.4) (Beta-trypsin) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2], Trypsin-1 (EC 3.4.21.4) (Beta-trypsin) (Cationic trypsinogen) (Serine protease 1) (Trypsin I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2], Trypsin-1 (EC 3.4.21.4) (Trypsin I) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CP1B1 0 1 CYP1B1 CP1B1_HUMAN 6.59 4.9 4.9 1 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 UD11 0 2 UGT1A1 GNT1 UGT1 UD11_HUMAN 5.255 4.9 4.90000000000001 2 UDP-glucuronosyltransferase 1-1 (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-A) (UGT-1A) (UGT1A) (UDP-glucuronosyltransferase 1A1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.4 4.9 4.90000000000001 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.96374710820806 4.9 4.9 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 MGA 0 1 MGAM MGA MGAML MGA_HUMAN 5 4.9 4.90000000000001 1 Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)] 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 4.60000016617202 4.9 4.90000000000001 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 DYR1A 0 1 Dyrk1a Dyrk DYR1A_RAT 4.84 4.9 4.90000000000001 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 EGLN1 0 2 EGLN1 C1orf12 PNAS-118 PNAS-137 EGLN1_HUMAN 5 4.9 4.90000000000001 2 Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (Fragment), Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LYAM2 0 1 SELE ELAM1 LYAM2_HUMAN 4.78000325524524 4.9 4.90000000000001 1 E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LYAM3 0 1 SELP GMRP GRMP LYAM3_HUMAN 5.03476210625921 4.9 4.90000000000001 1 P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 HIF1N 0 1 HIF1AN FIH1 HIF1N_HUMAN 5 4.9 4.90000000000001 1 Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.72353819582676 4.9 4.90000000000001 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LYAM1 0 1 SELL LNHR LYAM1 LYAM1_HUMAN 5.02954341234243 4.9 4.90000000000001 1 L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1) (LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1) (LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LMBL1 0 1 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 4.8 4.9 4.90000000000001 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 PPCE 0 7 PREP PEP PPCE_HUMAN 5.25114234840405 4.9 4.90000000000001 7 Prolyl endopeptidase (EC 3.4.21.26) (Post-proline cleaving enzyme) (Proline-specific endopeptidase) (PE) (PSE), Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme), Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) (rPop) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 GEMI 0 1 GMNN GEMI_HUMAN 5.7862167006647 4.9 4.9 1 Geminin 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.008119891066 4.9 4.9 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 LOX5 0 3 ALOX5 LOG5, Alox5 LOX5_HUMAN, LOX5_RAT 4.50617131329263 4.9 4.90000000000001 3 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CDK1 0 1 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.19 4.9 4.90000000000001 1 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 6.3 4.9 4.9 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 3665 WRN 0 1 WRN RECQ3 RECQL2 WRN_HUMAN 5.27381905802915 4.9 4.90000000000001 1 Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) 1 4.9 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2c(O)c1O)c3ccccc3 4421 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.75 5.75 5.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.65000022087346 5.75 5.75 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.4 5.75 5.75 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 0 4 NotRecorded 4.84406061900451 5.75 5.27734375 4 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 4421 THAS 0 1 Tbxas1 Cyp5 Cyp5a1 THAS_RAT 6.50965047954658 5.75 5.425 1 Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) 1 5.75 actual molregno [molregno] O=C(NCCCn1ccnc1)c2occc2 7160 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 0 11 Aberrant vpr protein, NotRecorded 4.76971582294727 5 4.98863636363636 11 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71139001277257 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 C1R 0 2 C1R C1R_HUMAN 5.145 5 5 2 Complement C1r subcomponent (EC 3.4.21.41) (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain] 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 LUCI 0 1 LUCI_PHOPY 4.82098278885978 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 7160 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 6.35 5 4.665625 1 Ras-related protein Rab-9A 0 5 actual molregno [molregno] Clc1ccccc1NC2=Nc3ccccc3C(=O)O2 8715 HYEP 0 2 EPHX1 EPHX EPOX, Ephx1 HYEP_HUMAN, HYEP_MOUSE 6.56 4.95 4.965 2 Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 0 5 NotRecorded 4.80888801976042 4.95 4.96208333333333 5 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 4.9 4.95 4.95 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93621268968233 4.95 4.95 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.1 4.95 4.95 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 NPC1 0 1 NPC1 NPC1_HUMAN 5.95 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.8000008748032 4.95 4.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6.05 4.95 4.95 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.90000876645532 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 LUCI 0 1 LUCI_PHOPY 5.62098471330652 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8715 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 5.05 4.95 4.95 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.95 actual molregno [molregno] Clc1ccc(NC(=O)NC2CCCCC2)cc1 8788 LUCI 0 3 LUCI_PHOPY 5.80356609916456 5.4 5.34798611111111 3 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6.34998404752816 5.4 5.3890625 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 TPO 0 2 THPO MGDF TPO_HUMAN 7.4 5.4 5.3365625 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 LOX15 0 1 ALOX15 LOX15_RABIT 5.44 5.4 5.12875 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.9 5.4 5.3125 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 AOXA 0 1 AOX1 AO AOXA_HUMAN 6.38021124171161 5.4 5.37139423076923 1 Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase), Aldehyde oxidase 1 (EC 1.2.3.1) (Azaheterocycle hydroxylase 1) (EC 1.17.3.-) (Retinal oxidase) (Retinoic acid synthase) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 P53 0 4 TP53 P53 P53_HUMAN 5.6 5.4 5.34950520833333 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 FFP 0 3 ffp sfp FFP_BACIU 4.65928124241724 5.4 5.39416666666667 3 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 TRXR1 0 2 Txnrd1 Trxr1 TRXR1_RAT 4.72382322328385 5.4 5.27458333333334 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.4 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 7.46092390120722 5.4 5.3671875 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999903484653 5.4 5.4 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.26139916069465 5.4 5.3365625 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 O97447 0 1 ald O97447_GIAIN 4.9 5.4 5.34166666666667 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.5 5.4 5.3890625 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 5.4 5.17833333333333 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.93621643940264 5.4 5.3365625 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.3 5.4 5.4 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 NPC1 0 1 NPC1 NPC1_HUMAN 5.59 5.4 5.3890625 1 Niemann-Pick C1 protein 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 CP2C8 0 1 CYP2C8 CP2C8_HUMAN 6.27875360095283 5.4 5.39326923076923 1 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 DNMT1 0 1 DNMT1 AIM CXXC9 DNMT DNMT1_HUMAN 5.78837041556533 5.4 5.26 1 DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT), DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (Met-1) (EC 2.1.1.37) (DNA methyltransferase MmuI) (DNA MTase MmuI) (M.MmuI) (MCMT) 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 8788 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.64 5.4 5.3890625 1 Ras-related protein Rab-9A 1 5.4 actual molregno [molregno] NNc1nncc2ccccc12 9495 ANDR 7 0 AR DHTR NR3C4, Ar Nr3c4 ANDR_HUMAN, ANDR_RAT 5.00524071766508 4.8 4.8 7 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 RORG 2 0 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.23753270593052 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 ITAL 5 1 ITGAL CD11A ITAL_HUMAN 5.24333333333333 4.8 4.8 6 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a), Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (Lymphocyte antigen 15) (Ly-15) (CD antigen CD11a) 0.166666666666667 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 ITB2 4 0 ITGB2 CD18 MFI7 ITB2_HUMAN 5.42 4.8 4.8 4 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HIF1A 3 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.7 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 GEMI 4 0 GMNN GEMI_HUMAN 6.15925534243358 4.8 4.8 4 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Geminin 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HMDH 36 0 HMGCR, Hmgcr HMDH_HUMAN, HMDH_MOUSE, HMDH_RAT 6.69664568778879 4.8 4.8 36 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 CHLE 3 0 BCHE CHLE_HORSE 5.42 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (EQ-BCHE) (Pseudocholinesterase), Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 MDR1 2 4 ABCB1 MDR1 PGY1 MDR1_HUMAN 4.5767365479726 4.8 4.80000000000001 6 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 0.666666666666667 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 NK2R 0 2 TACR2 NK2R NKNAR TAC2R NK2R_HUMAN 4.79 4.8 4.80000000000001 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2) 1 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 CYSP 2 0 CYSP_TRYCR 4.6 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HDAC6 2 0 HDAC6 KIAA0901 JM21 HDAC6_HUMAN 4.79 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone deacetylase 6 (HD6) (EC 3.5.1.98), Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SO1B1 3 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.12961114938538 4.8 4.8 4 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0.25 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HDAC2 2 0 HDAC2 HDAC2_HUMAN 4.59 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone deacetylase 2 (HD2) (EC 3.5.1.98) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 EHMT2 2 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.60000053042989 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SMAD3 2 0 SMAD3 MADH3 SMAD3_HUMAN 5.19999926443762 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 FNTB 2 0 Fntb FNTB_MOUSE 5.95424250943933 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 FNTA 2 0 Fnta FNTA_MOUSE 5.95424250943933 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 AA1R 0 2 ADORA1 AA1R_HUMAN 4.69 4.8 4.80000000000001 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Adenosine receptor A1 1 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 TAU 1 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.7 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 IDHC 3 0 IDH1 PICD IDHC_HUMAN 4.72414201221553 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 PPARD 3 0 PPARD NR1C2 PPARB PPARD_HUMAN 5.1430759717342 4.8 4.8 3 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 LMNA 2 0 LMNA LMN1 LMNA_HUMAN 5.1 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 FRIL 1 0 FTL FRIL_HORSE 4.55 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Ferritin light chain (Ferritin L subunit) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 O97447 1 0 ald O97447_GIAIN 4.8 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SC6A3 2 0 SLC6A3 DAT1 SC6A3_HUMAN 5.05 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SC6A2 2 0 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.06 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SO1A2 1 0 SLCO1A2 OATP OATP1 OATP1A2 SLC21A3 SO1A2_HUMAN 6.27875360095283 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1A2 (OATP-A) (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 HDAC1 2 0 HDAC1 RPD3L1 HDAC1_HUMAN 4.92 4.8 4.8 2 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 Histone deacetylase 1 (HD1) (EC 3.5.1.98) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.59999938302362 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9495 AKT1 1 0 AKT1 PKB RAC AKT1_HUMAN 5 4.8 4.8 1 LOVASTATIN ASTHMA, BREAST CARCINOMA, CARDIOVASCULAR DISEASE, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, FRAGILE X SYNDROME, HIV INFECTION, MELANOMA, NEUROFIBROMATOSIS TYPE 1, PROSTATE CARCINOMA, RETT SYNDROME, RHEUMATOID ARTHRITIS, STROKE HMG-CoA reductase inhibitor INHIBITOR 4 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 0 4.8 actual drug [drugName] CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 9841 GBRG3 31 0 Gabrg3 GBRG3_MOUSE, GBRG3_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA4 37 0 GABRA4, Gabra4 GBRA4_BOVIN, GBRA4_MOUSE, GBRA4_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRG1 31 0 Gabrg1 GBRG1_MOUSE, GBRG1_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRB1 37 0 GABRB1, Gabrb1, Gabrb1 Gabrb-1 GBRB1_BOVIN, GBRB1_MOUSE, GBRB1_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRB3 31 0 Gabrb3 Gabrb-3 GBRB3_MOUSE, GBRB3_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRP 31 0 Gabrp GBRP_MOUSE, GBRP_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA6 31 0 Gabra6 Gabra-6 GBRA6_MOUSE, GBRA6_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 Q91ZM7 16 0 Gabrq Q91ZM7_RAT 9 4.55 4.55 16 GABA theta subunit 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRG2 37 0 GABRG2, Gabrg2 GBRG2_BOVIN, GBRG2_MOUSE, GBRG2_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA1 37 0 GABRA1, Gabra1 Gabra-1 GBRA1_BOVIN, GBRA1_MOUSE, GBRA1_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA3 37 0 GABRA3, Gabra3 Gabra-3 GBRA3_BOVIN, GBRA3_MOUSE, GBRA3_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA5 31 0 Gabra5, Gabra5 Gabra-5 GBRA5_MOUSE, GBRA5_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRA2 37 0 GABRA2, Gabra2 Gabra-2 GBRA2_BOVIN, GBRA2_MOUSE, GBRA2_RAT 7.36279407122515 4.55 4.55 37 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRB2 16 0 Gabrb2 Gabrb-2 GBRB2_RAT 9 4.55 4.55 16 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRE 16 0 Gabre GBRE_RAT 9 4.55 4.55 16 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRD 31 0 Gabrd GBRD_MOUSE, GBRD_RAT 7.17365743984937 4.55 4.55 31 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 GBRT 15 0 Gabrq GBRT_MOUSE 5.22555870902203 4.55 4.55 15 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 18 0 GABA-A receptor; anion channel, NotRecorded 5.1586560008216 4.55 4.56111111111111 18 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.55 4.75 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 RUNX1 2 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 4.55 4.55 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 PEBB 2 0 CBFB PEBB_HUMAN 4.89999841719865 4.55 4.55 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9841 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.55 4.55 4.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.55 actual molregno [molregno] CCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRG3 0 223 GABRG3, Gabrg3 GBRG3_HUMAN, GBRG3_MOUSE, GBRG3_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA4 0 229 GABRA4, Gabra4 GBRA4_BOVIN, GBRA4_HUMAN, GBRA4_MOUSE, GBRA4_RAT 8.11810609541907 4.85000000000001 4.85000000000001 229 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRG1 0 223 GABRG1, Gabrg1 GBRG1_HUMAN, GBRG1_MOUSE, GBRG1_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRB1 0 229 GABRB1, Gabrb1, Gabrb1 Gabrb-1 GBRB1_BOVIN, GBRB1_HUMAN, GBRB1_MOUSE, GBRB1_RAT 8.11810609541907 4.85000000000001 4.85000000000001 229 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRB3 0 268 GABRB3, Gabrb3 Gabrb-3 GBRB3_HUMAN, GBRB3_MOUSE, GBRB3_RAT 8.04002349198123 4.84999999999999 4.84999999999999 268 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 4.84999999999999 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRP 0 223 GABRP, Gabrp GBRP_HUMAN, GBRP_MOUSE, GBRP_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA6 0 232 GABRA6, Gabra6 Gabra-6 GBRA6_HUMAN, GBRA6_MOUSE, GBRA6_RAT 8.00588920625417 4.85000000000001 4.85000000000001 232 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 Q91ZM7 0 192 Gabrq Q91ZM7_RAT 8.30749999999999 4.85000000000001 4.85000000000001 192 GABA theta subunit 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRG2 0 274 GABRG2, Gabrg2 GBRG2_BOVIN, GBRG2_HUMAN, GBRG2_MOUSE, GBRG2_RAT 8.05776020383565 4.84999999999999 4.84999999999999 274 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 4.84999999999999 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA1 0 239 GABRA1, Gabra1 Gabra-1 GBRA1_BOVIN, GBRA1_HUMAN, GBRA1_MOUSE, GBRA1_RAT 8.15199286966932 4.85 4.85 239 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA3 0 238 GABRA3, Gabra3 Gabra-3 GBRA3_BOVIN, GBRA3_HUMAN, GBRA3_MOUSE, GBRA3_RAT 8.12271552878557 4.85 4.85 238 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA5 1 232 GABRA5, Gabra5, Gabra5 Gabra-5 GBRA5_HUMAN, GBRA5_MOUSE, GBRA5_RAT 8.07573517532604 4.85000000000001 4.84694206008584 233 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0.995708154506438 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRA2 0 238 GABRA2, Gabra2 Gabra-2 GBRA2_BOVIN, GBRA2_HUMAN, GBRA2_MOUSE, GBRA2_RAT 8.1253625876091 4.85 4.85 238 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRB2 0 208 GABRB2, Gabrb2 Gabrb-2 GBRB2_HUMAN, GBRB2_RAT 8.30692307692306 4.85000000000002 4.85000000000002 208 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 4.85000000000002 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRE 0 208 GABRE, Gabre GBRE_HUMAN, GBRE_RAT 8.30692307692306 4.85000000000002 4.85000000000002 208 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 4.85000000000002 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRD 0 223 GABRD, Gabrd GBRD_HUMAN, GBRD_MOUSE, GBRD_RAT 8.09841388273976 4.85000000000001 4.85000000000001 223 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 4.85000000000001 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 1 51 GABA-A receptor; anion channel, Nonstructural protein 1, NotRecorded 4.99592174038869 4.85 4.84990384615384 52 0.980769230769231 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 GBRT 0 31 GABRQ, Gabrq GBRT_HUMAN, GBRT_MOUSE 6.80342889841837 4.85 4.85 31 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.5 4.85 4.85 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93621268968233 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 7.05012229596313 4.85 4.91 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 PDE5A 0 1 PDE5A PDE5 PDE5A_BOVIN 6.1 4.85 5.0375 1 cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 LUCI 0 1 LUCI_PHOPY 4.82098278885978 4.85 4.85 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.7 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 9842 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.95 4.85 4.85 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] CCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 10017 5HT2C 3 0 Htr2c 5ht1c Htr1c 5HT2C_RAT 8.25 5.35 4.5125 3 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT2B 3 0 Htr2b Srl 5HT2B_RAT 8.25 5.35 4.5125 3 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 protein) (Serotonin receptor 2B), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (Serotonin receptor 2B) (Stomach fundus serotonin receptor), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT2A 3 0 Htr2a Htr2 5HT2A_RAT 8.25 5.35 4.5125 3 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-HT2A) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 CP2CJ 0 4 CYP2C19 CP2CJ_HUMAN 5.375 5.35 5.35 4 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 5.35 5.35 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 6.55005901122666 5.35 5.35 2 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT1B 1 0 Htr1b 5ht1b 5HT1B_RAT 5.49 5.35 3.884375 1 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B), 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B), 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.84999924507786 5.35 5.35 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 0 7 NotRecorded 4.78376359700597 5.35 4.99107142857143 7 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 GLCM 0 2 GBA GC GLUC GLCM_HUMAN 4.89999841719865 5.35 5.35 2 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 P53 0 3 TP53 P53 P53_HUMAN 4.63333333333333 5.35 5.35 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.75 5.35 5.35 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 5.35 5.35 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 CP2D6 0 4 CYP2D6 CYP2DL1 CP2D6_HUMAN 6.15 5.35 5.35 4 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 5HT1A 1 0 Htr1a 5ht1a 5HT1A_RAT 6.07 5.35 3.884375 1 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A), 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A) 0 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 LX15B 0 1 ALOX15B LX15B_HUMAN 5 5.35 5.35 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.5 5.35 5.35 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 10017 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 4.7 5.35 5.35 2 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.35 actual molregno [molregno] CSc1ccc2Sc3ccccc3C[C@@H](N4CCN(C)CC4)c2c1 11501 HDA10 0 528 HDAC10 HDA10_HUMAN 6.26704908923481 5.84999999999995 5.85000000000002 528 Histone deacetylase 10 (HD10) (EC 3.5.1.98) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 0 306 Histone deacetylase, Histone deacetylase HD1B, Histone deacetylase HD2, NotRecorded, Ribosome maturation protein SDO1 6.3054805697224 5.84999999999998 5.85000000000006 306 1 5.84999999999998 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDA11 0 524 HDAC11 HDA11_HUMAN 6.2508242731221 5.84999999999995 5.85000000000003 524 Histone deacetylase 11 (HD11) (EC 3.5.1.98) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC6 0 559 HDAC6 KIAA0901 JM21, Hdac6 HDAC6_HUMAN, HDAC6_MOUSE 6.35591058032368 5.84999999999994 5.85000000000002 559 Histone deacetylase 6 (HD6) (EC 3.5.1.98), Histone deacetylase 6 (HD6) (EC 3.5.1.98) (Histone deacetylase mHDA2) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC2 0 542 HDAC2 HDAC2_HUMAN 6.29537254449443 5.84999999999994 5.85000000000002 542 Histone deacetylase 2 (HD2) (EC 3.5.1.98) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC1 0 647 HDAC1 RPD3L1, Hdac1 HDAC1_HUMAN, HDAC1_MOUSE, HDAC1_RAT 6.53020548548941 5.84999999999994 5.85 647 Histone deacetylase 1 (HD1) (EC 3.5.1.98) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC9 0 525 HDAC9 HDAC7 HDAC7B HDRP KIAA0744 MITR HDAC9_HUMAN 6.24076556022092 5.84999999999995 5.85000000000002 525 Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC5 0 528 HDAC5 KIAA0600, Hdac5 HDAC5_HUMAN, HDAC5_MOUSE 6.24667030135602 5.84999999999995 5.85000000000002 528 Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9), Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Histone deacetylase mHDA1) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC7 0 598 HDAC7 HDAC7A, Hdac7 Hdac7a HDAC7_HUMAN, HDAC7_RAT 6.39297678933089 5.84999999999994 5.85000000000001 598 Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a), Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a) (Fragment) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC4 0 613 HDAC4 KIAA0288, Hdac4 HDAC4_HUMAN, HDAC4_RAT 6.41137535096494 5.84999999999994 5.85000000000001 613 Histone deacetylase 4 (HD4) (EC 3.5.1.98) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC3 0 607 HDAC3, Hdac3 HDAC3_HUMAN, HDAC3_RAT 6.4419862559585 5.84999999999994 5.85000000000001 607 Histone deacetylase 3 (HD3) (EC 3.5.1.98), Histone deacetylase 3 (HD3) (EC 3.5.1.98) (RPD3-2) (SMAP45) 1 5.84999999999994 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAC8 0 550 HDAC8 HDACL1 CDA07, Hdac8 HDAC8_HUMAN, HDAC8_MOUSE 6.18753639360822 5.84999999999995 5.85000000000002 550 Histone deacetylase 8 (HD8) (EC 3.5.1.98) 1 5.84999999999995 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.85 5.85000000000003 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 Q5RJZ2 0 70 Hdac5 Q5RJZ2_RAT 7.592 5.85000000000001 5.85000000000002 70 Hdac5 protein (Fragment) 1 5.85000000000001 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 Q99P97 0 70 Hdac6 Q99P97_RAT 7.592 5.85000000000001 5.85000000000002 70 Histone deacetylase 6 (Fragment) 1 5.85000000000001 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 TF 0 20 F3, F3 Cf-3 Cf3 TF_HUMAN, TF_MOUSE 6.7855735001946 5.85 5.85000000000003 20 Tissue factor (TF) (Coagulation factor III) (CD antigen CD142), Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 ATAD5 0 5 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.12827226020639 5.85 5.85000000000003 5 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 5.40000359182699 5.85 5.85000000000003 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 HDAH 0 2 hdaH hdaH1 HDAH_ALCSD 6.035 5.85 5.85000000000003 2 Histone deacetylase-like amidohydrolase (HDAC-like amidohydrolase) (HDAH) (EC 3.5.1.-) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 NCOR2 0 6 NCOR2 CTG26 NCOR2_HUMAN 6.87395637513809 5.85 5.85000000000003 6 Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 SIR2 0 2 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5 5.85 5.85000000000003 2 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 SF3B3 0 3 SF3B3 KIAA0017 SAP130 SF3B3_HUMAN 6.04013818129432 5.85 5.85000000000003 3 Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.9 5.85 5.85000000000003 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.74999985591871 5.85 5.85000000000003 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.8000008748032 5.85 5.85000000000003 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 CFTR 0 1 CFTR ABCC7 CFTR_HUMAN 5 5.85 5.85000000000003 1 Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel) 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 11501 WNT3A 0 1 Wnt3a Wnt-3a WNT3A_MOUSE 5 5.85 5.85000000000003 1 Protein Wnt-3a 1 5.85 actual molregno [molregno] C[C@H](\C=C(/C)\C=C\C(=O)NO)C(=O)c1ccc(cc1)N(C)C 14221 KS6A6 0 4 RPS6KA6 RSK4 KS6A6_HUMAN 5 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK2 0 92 CDK2 CDKN2 CDK2_HUMAN 6.2443740393678 4.89999999999999 4.90000000000002 92 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.89999999999999 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNA1 0 45 CCNA1 CCNA1_HUMAN 6.0124464804388 4.9 4.90000000000001 45 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-A1 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNA2 0 46 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.99043677434231 4.9 4.90000000000001 46 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK7 0 20 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 6.03113175285516 4.9 4.90000000000001 20 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNH 0 18 CCNH CCNH_HUMAN 6.04347972539462 4.9 4.90000000000001 18 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK1 0 44 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.9175162973892 4.9 4.90000000000001 44 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNB1 0 37 CCNB1 CCNB CCNB1_HUMAN 5.88637338176052 4.9 4.90000000000001 37 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G2/mitotic-specific cyclin-B1 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK26 0 1 STK26 MASK MST4 STK26_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 COQ8B 0 1 COQ8B ADCK4 COQ8B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PKN2 0 2 PKN2 PRK2 PRKCL2 PKN2_HUMAN 5.45399866074334 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD 0 1 PRKCD KPCD_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AVR2A 0 1 ACVR2A ACVR2 AVR2A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K1 0 3 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.13904110834813 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BRAF 0 2 BRAF BRAF1 RAFB1 BRAF_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf), Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNE1 0 40 CCNE1 CCNE CCNE1_HUMAN 6.32990350070269 4.9 4.90000000000001 40 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G1/S-specific cyclin-E1 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CLK1 0 4 CLK1 CLK, Clk1 Clk Sty CLK1_HUMAN, CLK1_MOUSE 4.7425 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1), Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) (Protein kinase STY) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CD5R1 0 32 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.21682301579253 4.9 4.90000000000001 32 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK5 0 38 CDK5 CDKN5 CDK5_HUMAN 6.24548253961476 4.9 4.90000000000001 38 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCE 0 1 PRKCE PKCE KPCE_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK9 0 18 CDK9 CDC2L4 TAK CDK9_HUMAN 5.79953827582066 4.9 4.90000000000001 18 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNT1 0 16 CCNT1 CCNT1_HUMAN 5.79698056029824 4.9 4.90000000000001 16 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-T1 (CycT1) (Cyclin-T) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ACVL1 0 1 ACVRL1 ACVRLK1 ALK1 ACVL1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BRSK2 0 2 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 5.28770389827826 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCND1 0 11 CCND1 BCL1 PRAD1 CCND1_HUMAN 4.62181818181818 4.9 4.90000000000001 11 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK4 0 10 CDK4 CDK4_HUMAN 4.758 4.9 4.90000000000001 10 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 4 (EC 2.7.11.22) (CRK3) (Cell division protein kinase 4) (PSK-J3), Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PAK4 0 4 PAK4 KIAA1142 PAK4_HUMAN 4.52856062735983 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 P53 0 1 TP53 P53 P53_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AAPK2 0 1 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EGFR 0 11 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 4.72727272727273 4.9 4.90000000000001 11 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TEC 0 1 TEC PSCTK4 TEC_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYR1B 0 1 DYRK1B MIRK DYR1B_HUMAN 5.96 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 1B (EC 2.7.12.1) (Minibrain-related kinase) (Mirk protein kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KIT 0 7 KIT SCFR KIT_HUMAN 4.57142857142857 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYO3A 0 1 MYO3A MYO3A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin-IIIa (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LTK 0 1 LTK TYK1 LTK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PDPK1 0 2 PDPK1 PDK1 PDPK1_HUMAN 5.30102999566398 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK16 0 2 CDK16 PCTAIRE1 PCTK1 CDK16_HUMAN 5.5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNB3 0 20 CCNB3 CYCB3 CCNB3_HUMAN 6.25341732867143 4.9 4.90000000000001 20 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G2/mitotic-specific cyclin-B3 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNB2 0 20 CCNB2 CCNB2_HUMAN 6.25341732867143 4.9 4.90000000000001 20 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G2/mitotic-specific cyclin-B2 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 E2AK4 0 1 EIF2AK4 GCN2 KIAA1338 E2AK4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CAC1C 0 1 CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 CAC1C_HUMAN 4.63 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYRK3 0 1 DYRK3 DYRK3_HUMAN 6.50965047954658 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1AL 0 1 CSNK1A1L KC1AL_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform alpha-like (CKI-alpha-like) (EC 2.7.11.1) (CK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK03 0 4 MAPK3 ERK1 PRKM3 MK03_HUMAN 4.8996353368201 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYRK2 0 1 DYRK2 DYRK2_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1A 0 7 CSNK1A1 KC1A_HUMAN 4.60776640077178 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1), Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) (Fragment) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1G2 0 7 CSNK1G2 CK1G2 KC1G2_HUMAN 4.95714285714286 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1E 0 7 CSNK1E KC1E_HUMAN 5.30571428571429 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1D 0 7 CSNK1D HCKID KC1D_HUMAN 5.13437176436703 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1G1 0 7 CSNK1G1 KC1G1_HUMAN 4.90428571428571 4.9 4.90000000000001 7 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD3 0 1 PRKD3 EPK2 PRKCN KPCD3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 GSK3B 0 6 GSK3B GSK3B_HUMAN 4.55825629059045 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TNK1 0 1 TNK1 TNK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYO3B 0 1 MYO3B MYO3B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin-IIIb (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SRMS 0 1 SRMS C20orf148 SRMS_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Srms (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K2 0 1 MAP2K2 MEK2 MKK2 PRKMK2 MP2K2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K4 0 1 MAP2K4 JNKK1 MEK4 MKK4 PRKMK4 SEK1 SERK1 SKK1 MP2K4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (C-JUN N-terminal kinase kinase 1) (JNK kinase 1) (JNKK 1) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1), Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SIK2 0 1 SIK2 KIAA0781 QIK SNF1LK2 SIK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CTRO 0 1 CIT CRIK KIAA0949 STK21 CTRO_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6A4 0 4 RPS6KA4 MSK2 KS6A4_HUMAN 5 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK15 0 2 MAPK15 ERK7 ERK8 MK15_HUMAN 4.91195437047216 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BRSK1 0 1 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EPHB3 0 1 EPHB3 ETK2 HEK2 TYRO6 EPHB3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6A1 0 6 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.50321682651553 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MAPK2 0 2 MAPKAPK2 MAPK2_HUMAN 5.75482523977329 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK12 0 3 MAPK12 ERK6 SAPK3 MK12_HUMAN 4.66521173153252 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NEK7 0 2 NEK7 NEK7_HUMAN 5.41278795015589 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LIMK2 0 1 LIMK2 LIMK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IRAK3 0 1 IRAK3 IRAK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Interleukin-1 receptor-associated kinase 3 (IRAK-3) (EC 2.7.11.1) (IL-1 receptor-associated kinase M) (IRAK-M) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ROCK2 0 1 ROCK2 KIAA0619 ROCK2_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK13 0 1 MAPK13 PRKM13 SAPK4 MK13_HUMAN 6.06069784035361 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK01 0 5 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.99813783246515 4.9 4.90000000000001 5 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PI51A 0 1 PIP5K1A PI51A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K9 0 1 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EPHB2 0 1 EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 EPHB2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3), Ephrin type-B receptor 2 (EC 2.7.10.1) (Neural kinase) (Nuk receptor tyrosine kinase) (Tyrosine-protein kinase receptor EPH-3) (Tyrosine-protein kinase receptor SEK-3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RIOK1 0 1 RIOK1 RIOK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PK3CA 0 2 PIK3CA PK3CA_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DCLK1 0 1 DCLK1 DCAMKL1 DCDC3A KIAA0369 DCLK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK19 0 1 CDK19 CDC2L6 CDK11 KIAA1028 CDK19_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 19 (EC 2.7.11.22) (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MARK1 0 1 MARK1 KIAA1477 MARK MARK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FES 0 1 FES FPS FES_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MARK3 0 2 MARK3 CTAK1 EMK2 MARK3_HUMAN 5.41278795015589 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TXK 0 1 TXK PTK4 RLK TXK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DYR1A 0 11 DYRK1A DYRK MNB MNBH, Dyrk1a Dyrk DYR1A_HUMAN, DYR1A_MOUSE, DYR1A_RAT 5.39170280704539 4.9 4.90000000000001 11 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LATS2 0 1 LATS2 KPM LATS2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TESK1 0 1 TESK1 TESK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 UFO 0 1 AXL UFO UFO_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD1 0 2 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.47712125471966 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FLT3 0 6 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 4.5 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 COQ8A 0 1 COQ8A ADCK3 CABC1 PP265 COQ8A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CHK2 0 1 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 6.12338490853968 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CD11B 0 1 CDK11B CDC2L1 CDK11 PITSLREA PK58 CD11B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IKKE 0 1 IKBKE IKKE IKKI KIAA0151 IKKE_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MAPK5 0 3 MAPKAPK5 PRAK MAPK5_HUMAN 5.09281823530292 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AKT3 0 1 AKT3 PKBG AKT3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RET 0 2 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SGK1 0 1 SGK1 SGK SGK1_HUMAN 5.47712125471966 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ALK 0 1 ALK ALK_HUMAN 5.64 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 4.7 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RIPK1 0 1 RIPK1 RIP RIP1 RIPK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) (Serine/threonine-protein kinase RIP) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PAK2 0 1 PAK2 PAK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 INSRR 0 1 INSRR IRR INSRR_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CCNE2 0 18 CCNE2 CCNE2_HUMAN 6.04965666811201 4.9 4.90000000000001 18 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 G1/S-specific cyclin-E2 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK07 0 1 MAPK7 BMK1 ERK5 PRKM7 MK07_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 LATS1 0 1 LATS1 WARTS LATS1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BMPR2 0 1 BMPR2 PPH1 BMPR2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AKT2 0 2 AKT2 AKT2_HUMAN 5.3443145854989 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CLK4 0 2 CLK4 CLK4_HUMAN 5.175 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 HIPK3 0 1 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DDR1 0 1 DDR1 CAK EDDR1 NEP NTRK4 PTK3A RTK6 TRKE DDR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RIOK3 0 1 RIOK3 SUDD RIOK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSK22 0 4 CSNK2A2 CK2A2 CSK22_HUMAN 5.79552338026521 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MARK4 0 1 MARK4 KIAA1860 MARKL1 MARK4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYLK 0 3 MYLK MLCK MLCK1 MYLK1, Mylk MYLK_CHICK, MYLK_HUMAN 5.24005310113532 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6A2 0 6 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 5.16333333333333 4.9 4.90000000000001 6 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NTRK3 0 1 NTRK3 TRKC NTRK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KS6B1 0 1 RPS6KB1 STK14A KS6B1_HUMAN 5.95424250943933 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SRPK1 0 2 SRPK1 SRPK1_HUMAN 5.36007965170298 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NTRK2 0 1 NTRK2 TRKB NTRK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PLK3 0 1 PLK3 CNK FNK PRK PLK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK33 0 1 STK33 STK33_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SIK1 0 1 SIK1 SIK SNF1LK SIK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK3 0 4 CDK3 CDKN3 CDK3_HUMAN 4.54845500650403 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K11 0 1 MAP3K11 MLK3 PTK1 SPRK M3K11_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3), Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AVR2B 0 1 ACVR2B AVR2B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCT 0 1 PRKCQ PRKCT KPCT_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 GEMI 0 2 GMNN GEMI_HUMAN 4.74310644979755 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Geminin 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TLK1 0 1 TLK1 KIAA0137 TLK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TTK 0 2 TTK MPS1 MPS1L1 TTK_HUMAN 5.74 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TSSK1 0 1 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK17 0 1 CDK17 PCTAIRE2 PCTK2 CDK17_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ST32C 0 1 STK32C YANK3 ST32C_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 32C (EC 2.7.11.1) (PKE) (Yet another novel kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MKNK2 0 3 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 4.50321682651553 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MRCKG 0 1 CDC42BPG DMPK2 MRCKG_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MRCK gamma (EC 2.7.11.1) (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma) (MRCK gamma) (MRCKG) (Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSK2B 0 3 CSNK2B CK2N G5A CSK2B_HUMAN 6.06069784035361 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSK21 0 4 CSNK2A1 CK2A1 CSK21_HUMAN 5.79552338026521 4.9 4.90000000000001 4 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MELK 0 2 MELK KIAA0175 MELK_HUMAN 5.43265071305127 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M4K4 0 1 MAP4K4 HGK KIAA0687 NIK M4K4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.90000000000001 3 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ZAP70 0 1 ZAP70 SRK ZAP70_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 SRPK2 0 1 SRPK2 SRPK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MET 0 1 MET MET_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PIM3 0 2 PIM3 PIM3_HUMAN 5.3443145854989 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NLK 0 1 NLK LAK1 NLK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 JAK3 0 2 JAK3 JAK3_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K10 0 1 MAP3K10 MLK2 MST M3K10_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 10 (EC 2.7.11.25) (Mixed lineage kinase 2) (Protein kinase MST) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCZ 0 1 PRKCZ PKC2 KPCZ_HUMAN 5.65854134728041 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CD11A 0 1 CDK11A CDC2L2 CDC2L3 PITSLREB CD11A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 11A (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 7.42365864979421 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EPHA1 0 1 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NEK1 0 1 NEK1 KIAA1901 NEK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CAC1B 0 1 CACNA1B CACH5 CACNL1A5 CAC1B_HUMAN 4.56 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III) (BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MERTK 0 1 MERTK MER MERTK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 E2AK2 0 1 EIF2AK2 PKR PRKR E2AK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Serine/threonine-protein kinase TIK) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase), Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K6 0 1 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TBA1A 0 1 Tuba1a Tuba1 TBA1A_RAT 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tubulin alpha-1A chain (Alpha-tubulin 1) (Tubulin alpha-1 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain], Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PI42B 0 1 PIP4K2B PIP5K2B PI42B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M4K3 0 1 MAP4K3 RAB8IPL1 M4K3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MKNK1 0 2 MKNK1 MNK1 MKNK1_HUMAN 5.47712125471966 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ACVR1 0 1 ACVR1 ACVRLK2 ACVR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I), Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I) (TSK-7L) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AURKB 0 2 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.59748830160803 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK06 0 1 MAPK6 ERK3 PRKM6 MK06_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TGFR1 0 1 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M4K1 0 1 MAP4K1 HPK1 M4K1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NEK5 0 1 NEK5 NEK5_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KPCD2 0 1 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TIE1 0 1 TIE1 TIE TIE1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 5.78837041556533 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 4.63 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MRCKB 0 1 CDC42BPB KIAA1124 MRCKB_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 5.41278795015589 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KC1G3 0 1 CSNK1G3 KC1G3_HUMAN 5.54 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TNI3K 0 1 TNNI3K CARK TNI3K_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CLK2 0 2 CLK2 CLK2_HUMAN 6.24 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TGFR2 0 1 TGFBR2 TGFR2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 RAF1 0 1 RAF1 RAF RAF1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MK04 0 1 MAPK4 ERK4 PRKM4 MK04_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase 4 (MAP kinase 4) (MAPK 4) (EC 2.7.11.24) (Extracellular signal-regulated kinase 4) (ERK-4) (MAP kinase isoform p63) (p63-MAPK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK18 0 1 CDK18 PCTAIRE3 PCTK3 CDK18_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NUAK1 0 1 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 VGFR1 0 1 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ITK 0 1 ITK EMT LYK ITK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 M3K20 0 1 MAP3K20 MLTK ZAK HCCS4 M3K20_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK8 0 1 CDK8 CDK8_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PLK1 0 2 PLK1 PLK PLK1_HUMAN 5.50239944144089 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CSF1R 0 1 CSF1R FMS CSF1R_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 NUAK2 0 1 NUAK2 OMPHK2 SNARK NUAK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 NUAK family SNF1-like kinase 2 (EC 2.7.11.1) (Omphalocele kinase 2) (SNF1/AMP kinase-related kinase) (SNARK) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MP2K3 0 1 MAP2K3 MEK3 MKK3 PRKMK3 SKK2 MP2K3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BLK 0 1 BLK BLK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EF2K 0 1 EEF2K EF2K_HUMAN 5.75332766665861 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 AKT1 0 1 AKT1 PKB RAC AKT1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 WEE1 0 1 WEE1 WEE1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PGFRA 0 1 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DCLK2 0 1 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TYRO3 0 1 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TYK2 0 2 TYK2 TYK2_HUMAN 5 4.9 4.90000000000001 2 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 BMR1A 0 1 BMPR1A ACVRLK3 ALK3 BMR1A_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 TLK2 0 1 TLK2 TLK2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ANKK1 0 1 ANKK1 PKK2 SGK288 ANKK1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MYLK4 0 1 MYLK4 SGK085 MYLK4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK25 0 1 STK25 SOK1 YSK1 STK25_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 CDK14 0 1 CDK14 KIAA0834 PFTK1 CDK14_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 ST32B 0 1 STK32B YANK2 UNQ3003/PRO9744 ST32B_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 32B (EC 2.7.11.1) (Yet another novel kinase 2) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KCC4 0 1 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 STK24 0 1 STK24 MST3 STK3 STK24_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KGP2 0 1 PRKG2 PRKGR2 KGP2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 PKN1 0 1 PKN1 PAK1 PKN PRK1 PRKCL1 PKN1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 KGP1 0 1 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 HIPK2 0 1 HIPK2 HIPK2_HUMAN 5.72015930340596 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 MUSK 0 1 MUSK MUSK_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IGF1R 0 1 IGF1R IGF1R_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 5.60205999132796 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14221 DCLK3 0 1 DCLK3 DCAMKL3 DCDC3C KIAA1765 DCLK3_HUMAN 5 4.9 4.90000000000001 1 SELICICLIB CYSTIC FIBROSIS, NON-SMALL CELL LUNG CARCINOMA Cyclin-dependent kinase 1 inhibitor, Cyclin-dependent kinase 2 inhibitor, Cyclin-dependent kinase 5 inhibitor, Cyclin-dependent kinase 7 inhibitor, Cyclin-dependent kinase 9 inhibitor INHIBITOR 2 Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3) 1 4.9 actual drug [drugName] CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 14090 NFKB1 0 4 NFKB1 NFKB1_HUMAN 5.2 5.05 5.05 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNB3 0 20 CCNB3 CYCB3 CCNB3_HUMAN 5.15098039199715 5.05 5.05 20 G2/mitotic-specific cyclin-B3 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CDK1 0 38 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.13973904282696 5.05 5.05 38 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNB1 0 34 CCNB1 CCNB CCNB1_HUMAN 5.13088481257131 5.05 5.05 34 G2/mitotic-specific cyclin-B1 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNB2 0 20 CCNB2 CCNB2_HUMAN 5.15098039199715 5.05 5.05 20 G2/mitotic-specific cyclin-B2 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 MK03 0 2 MAPK3 ERK1 PRKM3 MK03_HUMAN 4.56 5.05 5.05 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNE1 0 25 CCNE1 CCNE CCNE1_HUMAN 5.13397816288384 5.05 5.05 25 G1/S-specific cyclin-E1 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CDK2 0 47 CDK2 CDKN2 CDK2_HUMAN 5.20036044152712 5.05 5.05 47 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNE2 0 21 CCNE2 CCNE2_HUMAN 5.12927170856939 5.05 5.05 21 G1/S-specific cyclin-E2 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.15 5.05 5.05 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CP2D6 2 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.76666666666667 5.05 4.79583333333333 3 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0.333333333333333 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNA1 0 15 CCNA1 CCNA1_HUMAN 5.06551871998142 5.05 5.05 15 Cyclin-A1 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CCNA2 0 15 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.06551871998142 5.05 5.05 15 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.8 5.05 5.05 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.6 5.05 5.05 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 TYDP1 0 1 TDP1 TYDP1_HUMAN 7.05 5.05 5.05 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CD5R1 0 2 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.15 5.05 5.05 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CDK5 0 5 CDK5 CDKN5 CDK5_HUMAN 5.308 5.05 5.05 5 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 LEF 1 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 5.05 4.2875 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.3 5.05 5.05 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.05 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 LYAG 0 1 GAA LYAG_HUMAN 4.85 5.05 5.05 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14090 DRD1 0 1 DRD1 DRD1_HUMAN 8.43179827593301 5.05 5.05 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 5.05 actual molregno [molregno] Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 14384 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.35000349253396 5.6 5.6 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.69999179744619 5.6 5.6 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.6 5.6 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.85 5.6 5.6 1 Ras-related protein Rab-9A 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 LUCI 0 1 LUCI_PHOPY 5.47098052029176 5.6 5.6 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 Q94696 0 1 luc Q94696_PHOPE 4.9 5.6 5.6 1 Luciferase 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 4.84999924507786 5.6 5.6 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.46121794440871 5.6 5.6 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.625 5.6 5.62666666666667 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.29999760285775 5.6 5.6 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.53621149304416 5.6 5.6 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 5.6 5.6 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.6 5.6 5.65 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 14384 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 5.6 5.6 1 Niemann-Pick C1 protein 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2cc(O)c3cc(OC)ccc3n2 15739 TAU 0 4 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.675 5.45 5.42875 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 JUN 0 1 JUN JUN_HUMAN 4.5124473326691 5.45 5.45 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 RORG 0 4 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7125 5.45 5.45 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.45 5.45 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.76244620886047 5.45 5.45 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.65 5.45 5.45 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.65 5.45 5.45 8 Menin 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.35000349253396 5.45 5.45 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 O97447 0 2 ald O97447_GIAIN 5.85 5.45 5.45 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.45 5.45 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 VDR 0 2 VDR NR1I1 VDR_HUMAN 4.52499992972447 5.45 5.45 2 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 15739 P53 0 1 TP53 P53 P53_HUMAN 5.6 5.45 5.45 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.45 actual molregno [molregno] CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 16328 0 23 NotRecorded 5.42444070194053 4.95 4.94804347826087 23 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 GEMI 0 2 GMNN GEMI_HUMAN 6.03620895036107 4.95 4.95 2 Geminin 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 P53 0 3 TP53 P53 P53_HUMAN 4.91666675038119 4.95 4.95166666666667 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.95 4.95 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 LUCI 0 2 LUCI_PHOPY 5.53549202861829 4.95 4.945 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.48620993498024 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 4.95 4.95 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.85001154350852 4.95 4.95 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.95 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.95 4.95 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.5 4.95 4.95 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 IDHC 0 1 IDH1 PICD IDHC_HUMAN 6.1362014613195 4.95 4.89166666666667 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 ABC3G 0 1 APOBEC3G MDS019 ABC3G_HUMAN 6.04997609347667 4.95 4.94 1 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 6.35 4.95 4.95 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.84999924507786 4.95 4.95 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16328 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.33621429654423 4.95 4.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] Cc1ccc2nc(cc(O)c2c1)c3ccccc3 16591 PGH2 0 6 PTGS2 COX2 PGH2_HUMAN 5.94526729449098 7.3 7.02291666666667 6 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 S22A6 0 4 SLC22A6 OAT1 PAHT, Slc22a6 Oat1 S22A6_HUMAN, S22A6_RAT 5.77478883508464 7.3 7.121875 4 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Solute carrier family 22 member 6 (Kidney-specific transport protein) (Novel kidney transcript) (mNKT) (Organic anion transporter 1) (Renal organic anion transporter 1) (mROAT1), Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1), Solute carrier family 22 member 6 (Organic anion transporter 1) (rOAT1) (renal organic anion transporter 1) (rROAT1) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.45 7.3 5.875 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 PGH1 0 7 PTGS1 COX1 PGH1_HUMAN, PGH1_SHEEP 6.31403015887991 7.3 6.97150974025974 7 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 7.64975198166584 7.3 5.875 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 RGS4 0 1 RGS4 RGS4_HUMAN 4.92382212781084 7.3 6.98333333333333 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 S22A7 0 1 Slc22a7 Nlt Oat2 S22A7_RAT 5.74 7.3 6.50833333333333 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Solute carrier family 22 member 7 (Novel liver transporter) (Organic anion transporter 2), Solute carrier family 22 member 7 (Novel liver transporter) (Organic anion transporter 2) (hOAT2), Solute carrier family 22 member 7 (Organic anion transporter 2) (mOAT2) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.4 7.3 6.2075 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 ALBU 0 3 ALB GIG20 GIG42 PRO0903 PRO1708 PRO2044 PRO2619 PRO2675 UNQ696/PRO1341 ALBU_HUMAN 4.9687915551066 7.3 7.28560606060606 3 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Serum albumin, Serum albumin (BSA) (allergen Bos d 6) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.3 7.3 5.875 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 S22AB 0 1 SLC22A11 OAT4 S22AB_HUMAN 5.62973141792582 7.3 7.3 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Solute carrier family 22 member 11 (Organic anion transporter 4) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.94999940171424 7.3 7.22083333333333 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.66121305452969 7.3 7.17765151515151 2 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 PFKA 0 1 pfk PFKA_TRYBB 5.07098490037598 7.3 7.3 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 MRP4 0 1 ABCC4 MRP4 MRP4_HUMAN 4.73115468770742 7.3 7.25681818181818 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.6 7.3 6.82140151515151 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 PMP22 0 1 PMP22 GAS3 PMP22_HUMAN 4.62 7.3 7.17765151515151 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.6 7.3 5.1625 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 GEMI 0 1 GMNN GEMI_HUMAN 6.53625627875294 7.3 6.50833333333333 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Geminin 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.5 7.3 5.79583333333333 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 SO1A4 0 1 Slco1a4 Oatp1a4 Oatp2 Slc21a5 SO1A4_RAT 4.63615152033399 7.3 7.17765151515151 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1A4 (Brain digoxin carrier protein) (Brain-specific organic anion transporter) (OATP-B1) (Sodium-independent organic anion-transporting polypeptide 2) (Solute carrier family 21 member 5), Solute carrier organic anion transporter family member 1A4 (Sodium-independent organic anion-transporting polypeptide 2) (Solute carrier family 21 member 5) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 4.59999938302362 7.3 5.875 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16591 FEN1 0 1 FEN1 RAD2 FEN1_HUMAN 5.22382202741777 7.3 7.22083333333333 1 KETOPROFEN ARTHRALGIA, MIGRAINE DISORDER, MYALGIA, OSTEOARTHRITIS, OSTEOARTHRITIS, KNEE, PAIN, RHEUMATIC DISEASE, SCIATICA Cyclooxygenase inhibitor INHIBITOR 4 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 7.3 actual drug [drugName] CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 16599 0 32 NotRecorded 5.26772061755416 5.55 5.57129557291667 32 INDOPROFEN RHEUMATIC DISEASE 4 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.5 5.55 5.55 1 INDOPROFEN RHEUMATIC DISEASE 4 Ras-related protein Rab-9A 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 5.45000414846935 5.55 5.59375 1 INDOPROFEN RHEUMATIC DISEASE 4 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 RORG 0 4 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.375 5.55 5.68105113636364 4 INDOPROFEN RHEUMATIC DISEASE 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.19999817218203 5.55 5.59375 1 INDOPROFEN RHEUMATIC DISEASE 4 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.54121114141533 5.55 5.55 1 INDOPROFEN RHEUMATIC DISEASE 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 SMN 2 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.7 5.55 4.97291666666667 3 INDOPROFEN RHEUMATIC DISEASE 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0.333333333333333 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 Q94696 0 1 luc Q94696_PHOPE 4.85 5.55 5.59375 1 INDOPROFEN RHEUMATIC DISEASE 4 Luciferase 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 LYAG 0 2 GAA LYAG_HUMAN 6.75 5.55 5.571875 2 INDOPROFEN RHEUMATIC DISEASE 4 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 CXCR2 0 2 CXCR2 IL8RB CXCR2_HUMAN 5.10473535052001 5.55 5.55 2 INDOPROFEN RHEUMATIC DISEASE 4 C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182), C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (CD antigen CD182) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 CXCR1 0 2 CXCR1 CMKAR1 IL8RA CXCR1_HUMAN 5.10473535052001 5.55 5.55 2 INDOPROFEN RHEUMATIC DISEASE 4 C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD antigen CD181) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 NFKB1 0 5 NFKB1 NFKB1_HUMAN 5.82 5.55 5.55 5 INDOPROFEN RHEUMATIC DISEASE 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 TF65 0 5 RELA NFKB3 TF65_HUMAN 5.82 5.55 5.55 5 INDOPROFEN RHEUMATIC DISEASE 4 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 5.82 5.55 5.55 5 INDOPROFEN RHEUMATIC DISEASE 4 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 FABPL 0 2 Fabp1 FABPL_RAT 4.84658706198408 5.55 5.84 2 INDOPROFEN RHEUMATIC DISEASE 4 Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver basic FABP) (LB-FABP) (Liver bile acid-binding protein) (L-BABP) (Liver-type fatty acid-binding protein) (L-FABP), Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP), Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP) (Squalene- and sterol-carrier protein) (SCP) (Z-protein) (p14) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 LUCI 0 2 LUCI_PHOPY 6.65656862982518 5.55 5.55 2 INDOPROFEN RHEUMATIC DISEASE 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.09999903484653 5.55 5.6375 1 INDOPROFEN RHEUMATIC DISEASE 4 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 PGH1 0 3 PTGS1 COX1, Ptgs1 Cox-1 Cox1 PGH1_MOUSE, PGH1_SHEEP 6.33042346306503 5.55 5.55 3 INDOPROFEN RHEUMATIC DISEASE 4 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 PGH2 0 2 Ptgs2 Cox-2 Cox2 Pghs-b Tis10 PGH2_MOUSE 6.99563519459755 5.55 5.55 2 INDOPROFEN RHEUMATIC DISEASE 4 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 P53 0 3 TP53 P53 P53_HUMAN 5 5.55 5.69556818181818 3 INDOPROFEN RHEUMATIC DISEASE 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 NPC1 0 1 NPC1 NPC1_HUMAN 7.05 5.55 5.60104166666667 1 INDOPROFEN RHEUMATIC DISEASE 4 Niemann-Pick C1 protein 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 GEMI 0 2 GMNN GEMI_HUMAN 6.88626695831331 5.55 5.60104166666667 2 INDOPROFEN RHEUMATIC DISEASE 4 Geminin 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.40118425607574 5.55 5.55 1 INDOPROFEN RHEUMATIC DISEASE 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5.7862167006647 5.55 5.55 1 INDOPROFEN RHEUMATIC DISEASE 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.38626385873813 5.55 5.55 1 INDOPROFEN RHEUMATIC DISEASE 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 PTH1R 2 0 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.86540856528912 5.55 4.6625 2 INDOPROFEN RHEUMATIC DISEASE 4 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 0 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16599 ANDR 0 2 AR DHTR NR3C4 ANDR_HUMAN 5.64819114719031 5.55 5.585 2 INDOPROFEN RHEUMATIC DISEASE 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.55 actual drug [drugName] CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 16456 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.9 4.925 2 FENBUFEN RHEUMATIC DISEASE 0 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 LUCI 0 2 LUCI_PHOPY 5.21571932496182 4.9 4.9 2 FENBUFEN RHEUMATIC DISEASE 0 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 2 33 Nonstructural protein 1, NotRecorded 4.63772987599522 4.9 4.87142857142857 35 FENBUFEN RHEUMATIC DISEASE 0 0.942857142857143 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 ALBU 0 2 ALB GIG20 GIG42 PRO0903 PRO1708 PRO2044 PRO2619 PRO2675 UNQ696/PRO1341 ALBU_HUMAN 5.32995903722832 4.9 4.925 2 FENBUFEN RHEUMATIC DISEASE 0 Serum albumin, Serum albumin (BSA) (allergen Bos d 6) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.58621423228026 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 PGH1 0 1 PTGS1 COX1 PGH1_SHEEP 5.41 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 5.14999741390754 4.9 4.9 2 FENBUFEN RHEUMATIC DISEASE 0 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.9 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 ANDR 0 2 AR DHTR NR3C4 ANDR_HUMAN 5.34283080874875 4.9 4.9125 2 FENBUFEN RHEUMATIC DISEASE 0 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 PGH2 0 1 PTGS2 COX2 PGH2_SHEEP 5.09 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.25 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 Ras-related protein Rab-9A 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 6.3 4.9 4.9 2 FENBUFEN RHEUMATIC DISEASE 0 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 16456 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.80024792644601 4.9 4.9 1 FENBUFEN RHEUMATIC DISEASE 0 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.9 actual drug [drugName] OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 40940 F16P1 10 0 FBP1 FBP F16P1_HUMAN, F16P1_PIG 5.908 4.5 4.5 10 Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Fructose-1,6-bisphosphatase isozyme 3) (FBPase 3) (Liver FBPase), Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 JUN 1 0 JUN JUN_HUMAN 4.62133869484683 4.5 4.5 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 PI4KA 4 0 PI4KA PIK4 PIK4CA PI4KA_HUMAN 4.6585876004869 4.5 4.5 4 Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 P4K2A 4 0 PI4K2A P4K2A_HUMAN 4.6585876004869 4.5 4.5 4 Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 P4K2B 4 0 PI4K2B P4K2B_HUMAN 4.6585876004869 4.5 4.5 4 Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 PI4KB 4 0 PI4KB PIK4CB PI4KB_HUMAN 4.6585876004869 4.5 4.5 4 Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 SO1B3 1 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.99008614085847 4.5 4.5 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 Q94696 1 0 luc Q94696_PHOPE 5.7 4.5 4.5 1 Luciferase 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.03284373164656 4.5 4.5 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 AA1R 1 0 ADORA1 AA1R_HUMAN 6.3 4.5 4.5 1 Adenosine receptor A1 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 DNPH1 2 0 DNPH1 C6orf108 RCL, Dnph1 Rcl DNPH1_HUMAN, DNPH1_RAT 4.56 4.5 4.5 2 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (Deoxyribonucleoside 5'-monophosphate N-glycosidase) (c-Myc-responsive protein Rcl), 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 SRC 1 0 SRC SRC1 SRC_HUMAN 7 4.5 4.5 1 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 P2RY2 2 0 P2RY2 P2RU1 P2RY2_HUMAN 6.25 4.5 4.5 2 P2Y purinoceptor 2 (P2Y2) (ATP receptor) (P2U purinoceptor 1) (P2U1) (P2U receptor 1) (Purinergic receptor), P2Y purinoceptor 2 (P2Y2) (ATP receptor) (P2U purinoceptor 1) (P2U1) (Purinergic receptor) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 ANDR 1 0 AR DHTR NR3C4 ANDR_HUMAN 4.92506659342848 4.5 4.5 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 RGS4 1 0 RGS4 RGS4_HUMAN 5.72381402592933 4.5 4.5 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.64994590642097 4.5 4.5 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 40940 5NTD 1 0 NT5E NT5 NTE 5NTD_HUMAN 4.85387196432176 4.5 4.5 1 5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73) 0 4.5 actual molregno [molregno] Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 17411 KDM4E 0 4 KDM4E KDM4DL KDM4E_HUMAN 5.3125 5.2 5.20000000000001 4 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 LYAG 0 7 GAA LYAG_HUMAN 4.53571428571429 5.2 5.20000000000001 7 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 ATX2 0 4 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.10000389098033 5.2 5.20000000000001 4 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 GLCM 0 5 GBA GC GLUC GLCM_HUMAN 4.63000020674483 5.2 5.20000000000001 5 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 CYSP 0 9 CYSP_TRYCR 4.68888888888889 5.2 5.2 9 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 AL1A1 0 5 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.01 5.2 5.20000000000001 5 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 GEMI 0 3 GMNN GEMI_HUMAN 4.95372960821078 5.2 5.20000000000001 3 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Geminin 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 ATAD5 0 3 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.66966439240604 5.2 5.20000000000001 3 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 JUN 0 2 JUN JUN_HUMAN 4.55766970382189 5.2 5.20000000000001 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 NF2L2 0 6 NFE2L2 NRF2 NF2L2_HUMAN 4.56671613289351 5.2 5.2 6 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 IMPA1 0 2 Impa1 Imp IMPA1_RAT 4.925 5.2 5.20000000000001 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 CASP1 0 4 CASP1 IL1BC IL1BCE CASP1_HUMAN 4.96 5.2 5.20000000000001 4 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 LOX12 0 1 ALOX12 12LO LOG12 LOX12_HUMAN 5.05 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 TSHR 0 6 TSHR LGR3 TSHR_HUMAN 4.6 5.2 5.20000000000001 6 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PGDH 0 5 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.34 5.2 5.20000000000001 5 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 TRXR1 0 9 Txnrd1 Trxr1 TRXR1_RAT 4.66879028661107 5.2 5.20000000000001 9 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 RXRA 0 3 RXRA NR2B1 RXRA_HUMAN 4.5666668759345 5.2 5.2 3 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 THB 0 4 THRB ERBA2 NR1A2 THR1 THB_HUMAN 4.58749985302686 5.2 5.2 4 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 NFKB1 0 14 NFKB1 NFKB1_HUMAN 5.06238276155752 5.2 5.20000000000001 14 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999903484653 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 HCD2 0 7 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.97142857142857 5.2 5.20000000000001 7 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PTR1 0 1 PTR1 HMTXR L1063.01 LmjF23.0270 LmjF_23_0270 PTR1_LEIMA 5.47 5.2 5.2 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Pteridine reductase 1 (EC 1.5.1.33) (H region methotrexate resistance protein) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 CASP7 0 3 CASP7 MCH3 CASP7_HUMAN 4.9 5.2 5.20000000000001 3 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 CATG 0 1 CTSG CATG_HUMAN 5.13 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Cathepsin G (CG) (EC 3.4.21.20), Cathepsin G (EC 3.4.21.20) (Vimentin-specific protease) (VSP) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.95 5.2 5.20000000000001 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 CBX1 0 1 CBX1 CBX CBX1_HUMAN 8.22184874961636 5.2 5.13 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PIN1 0 1 PIN1 PIN1_HUMAN 4.67098267640138 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.35984859117276 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PPARD 0 9 PPARD NR1C2 PPARB PPARD_HUMAN 4.8256684879051 5.2 5.2 9 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 APEX1 0 2 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.67499920859933 5.2 5.2 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 6.1 5.2 5.20000000000001 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 JAK2 0 6 JAK2 JAK2_HUMAN 4.71196000578136 5.2 5.20000000000001 6 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PMP22 0 1 PMP22 GAS3 PMP22_HUMAN 4.52 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 5.2 5.20000000000001 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PFKA 0 1 pfk PFKA_TRYBB 6.77108659400531 5.2 5.17187500000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 HIF1A 0 3 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.7 5.2 5.20000000000001 3 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 END4 0 1 nfo b2159 JW2146 END4_ECOLI 5.25 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.5657031281696 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.2 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.89999841719865 5.2 5.2 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 P53 0 2 TP53 P53 P53_HUMAN 4.80000025194151 5.2 5.20000000000001 2 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5.63621884741913 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 KS6B1 0 1 RPS6KB1 STK14A KS6B1_HUMAN 6.27875360095283 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 SGK1 0 1 SGK1 SGK SGK1_HUMAN 6.19497660321606 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 PAPA1 0 1 PAPA1_CARPA 4.65 5.2 5.2 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Papain (EC 3.4.22.2) (Papaya proteinase I) (PPI) (allergen Car p 1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.84999924507786 5.2 5.2 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 17411 MTOR 0 1 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.78 5.2 5.20000000000001 1 TRIAMTERENE CARDIOVASCULAR DISEASE, CIRRHOSIS OF LIVER, CONGESTIVE HEART FAILURE, NEPHROTIC SYNDROME, PROTEINURIA Amiloride-sensitive sodium channel, ENaC blocker BLOCKER 4 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.2 actual drug [drugName] Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 173982 11 0 Cerebroside-sulfatase, NotRecorded 5.09087004156367 4.8 4.8 11 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 SYUA 1 0 SNCA NACP PARK1 SYUA_HUMAN 5.18621225375977 4.8 4.8 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 AA2AR 10 0 ADORA2A ADORA2, Adora2a AA2AR_HUMAN, AA2AR_RAT 6.57477439286435 4.8 4.8 10 Adenosine receptor A2a 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 AA2BR 10 0 ADORA2B, Adora2b AA2BR_HUMAN, AA2BR_RAT 6.57477439286435 4.8 4.8 10 Adenosine receptor A2b 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 NFKB1 4 0 NFKB1 NFKB1_HUMAN 4.95 4.8 4.8 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.8 4.8 4.8 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 AA1R 6 0 ADORA1, Adora1 AA1R_BOVIN, AA1R_CAVPO, AA1R_RAT 8.2 4.8 4.68333333333333 6 Adenosine receptor A1 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 8.3 4.8 4.8 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 EHMT2 2 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.14987610126965 4.8 4.8 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 DRD1 1 0 DRD1 DRD1_HUMAN 8.13667713987954 4.8 4.8 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 4.9 4.8 4.8 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.18621225375977 4.8 4.8 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 PFKA 1 0 pfk PFKA_TRYBB 8.11918640771921 4.8 4.8 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 SO1B3 1 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.19790442990106 4.8 4.8 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 173982 AA3R 1 0 ADORA3 AA3R_HUMAN 5.89 4.8 4.1 1 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 0 4.8 actual molregno [molregno] CN1C(=O)N(C)c2[nH]c(nc2C1=O)C3CCCC3 18145 0 167 3-oxoacyl-acyl-carrier protein reductase, Calmodulin, Dihydroorotate dehydrogenase, Enoyl-acyl-carrier protein reductase, NotRecorded 4.53832617643894 4.85 4.85345808383234 167 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRA2 0 80 GABRA2, Gabra2 Gabra-2 GBRA2_HUMAN, GBRA2_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRA6 0 80 GABRA6, Gabra6 Gabra-6 GBRA6_HUMAN, GBRA6_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRB1 0 80 GABRB1, Gabrb1 Gabrb-1 GBRB1_HUMAN, GBRB1_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRG2 0 80 GABRG2, Gabrg2 GBRG2_HUMAN, GBRG2_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRB2 0 80 GABRB2, Gabrb2 Gabrb-2 GBRB2_HUMAN, GBRB2_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRP 0 80 GABRP, Gabrp GBRP_HUMAN, GBRP_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRA3 0 80 GABRA3, Gabra3 Gabra-3 GBRA3_HUMAN, GBRA3_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRG1 0 80 GABRG1, Gabrg1 GBRG1_HUMAN, GBRG1_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRE 0 80 GABRE, Gabre GBRE_HUMAN, GBRE_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRG3 0 80 GABRG3, Gabrg3 GBRG3_HUMAN, GBRG3_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRA5 0 80 GABRA5, Gabra5 Gabra-5 GBRA5_HUMAN, GBRA5_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRD 0 80 GABRD, Gabrd GBRD_HUMAN, GBRD_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRA4 0 80 GABRA4, Gabra4 GBRA4_HUMAN, GBRA4_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRA1 0 80 GABRA1, Gabra1 Gabra-1 GBRA1_HUMAN, GBRA1_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRB3 0 80 GABRB3, Gabrb3 Gabrb-3 GBRB3_HUMAN, GBRB3_RAT 6.106 4.85000000000001 4.85000000000001 80 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 4.85000000000001 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GBRT 0 32 GABRQ GBRT_HUMAN 6.885 4.85 4.85 32 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 DHB2 0 1 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 5.24799365625274 4.85 4.85 1 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 Q91ZM7 0 48 Gabrq Q91ZM7_RAT 5.58666666666667 4.85 4.85 48 GABA theta subunit 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 CP19A 0 3 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 6.06666666666667 4.85 4.85 3 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 AA1R 0 2 Adora1 AA1R_RAT 5.48 4.85 4.95 2 Adenosine receptor A1 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 ANDR 1 7 AR DHTR NR3C4, Ar Nr3c4 ANDR_HUMAN, ANDR_RAT 5.144005350973 4.85 4.7975 8 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0.875 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 AA2AR 0 3 Adora2a AA2AR_RAT 5.46 4.85 4.85 3 Adenosine receptor A2a 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 NF2L2 0 7 NFE2L2 NRF2 NF2L2_HUMAN 5.13129661344671 4.85 4.84642857142857 7 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 P53 0 1 TP53 P53 P53_HUMAN 8.3 4.85 4.85 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 RXRA 0 2 RXRA NR2B1 RXRA_HUMAN 5.07499857641089 4.85 4.8546875 2 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PDE4D 0 4 PDE4D DPDE3 PDE4D_HUMAN 5 4.85 4.85 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3), cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PDE4A 0 4 PDE4A DPDE2 PDE4A_HUMAN 5 4.85 4.85 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53), cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (DPDE2), cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46), cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (Fragment) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PDE4B 0 4 PDE4B DPDE4 PDE4B_HUMAN 5 4.85 4.85 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4), cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PDE4C 0 4 PDE4C DPDE1 PDE4C_HUMAN 5 4.85 4.85 4 cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53), cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (Fragment), cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (PDE21) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.05 4.85 4.85 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 TNKS2 0 2 TNKS2 PARP5B TANK2 TNKL TNKS2_HUMAN 6.84 4.85 4.85 2 Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-like protein) (Tankyrase-related protein), Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 CAH12 0 2 CA12 CAH12_HUMAN 5.135 4.85 4.85 2 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 CAH1 2 0 CA1 CAH1_HUMAN 5.725 4.85 4.65416666666667 2 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 0 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 CAH9 0 2 CA9 G250 MN CAH9_HUMAN 5.375 4.85 4.85 2 Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 AA3R 0 2 ADORA3 AA3R_HUMAN 4.77 4.85 4.85 2 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 AA2BR 0 2 Adora2b AA2BR_RAT 5.46 4.85 4.85 2 Adenosine receptor A2b 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 CAH2 0 2 CA2 CAH2_HUMAN 5.06 4.85 4.85 2 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PGH2 0 1 Ptgs2 Cox-2 Cox2 Pghs-b Tis10 PGH2_MOUSE 6.07263631836315 4.85 4.85 1 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GEMI 0 2 GMNN GEMI_HUMAN 6.56126088201415 4.85 4.8625 2 Geminin 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 TNKS1 0 4 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 6.4875 4.85 4.85 4 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.76139074796011 4.85 4.85 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 ABCG2 0 2 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 4.68 4.85 4.85 2 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 GLP1R 0 2 GLP1R GLP1R_HUMAN 4.79999946054084 4.85 4.85 2 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 5.82506840647156 4.85 4.875 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 4.89999841719865 4.85 4.85 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 NFKB1 0 2 NFKB1 NFKB1_HUMAN 8.46852108295774 4.85 4.85 2 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 LUCI 0 2 LUCI_PHOPY 4.67517417153645 4.85 4.85 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PRKDC 0 1 PRKDC HYRC HYRC1 PRKDC_HUMAN 5 4.85 4.85 1 DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460), DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (p460) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 DHB1 0 1 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 6.19497660321606 4.85 4.85 1 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PARP1 0 2 PARP1 ADPRT PPOL PARP1_HUMAN 5.855 4.85 4.85 2 Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1), Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 ESR1 0 1 ESR1 ESR NR3A1 ESR1_HUMAN 5.90000876645532 4.85 4.85 1 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 NR1I2 0 2 Nr1i2 Pxr NR1I2_RAT 4.55000053862431 4.85 4.85 2 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR), Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PPARD 1 1 PPARD NR1C2 PPARB PPARD_HUMAN 5.58135880460327 4.85 4.75208333333334 2 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0.5 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 LOX5 0 1 ALOX5 LOG5 LOX5_HUMAN 5 4.85 4.85 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.5 4.85 4.8875 1 Ras-related protein Rab-9A 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 TPIS 0 2 TPIS_TRYCR 5.3616956386285 4.85 4.9921875 2 Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase), Triosephosphate isomerase (TIM) (TPI) (EC 5.3.1.1) (Triose-phosphate isomerase), Triosephosphate isomerase, glycosomal (TIM) (Triose-phosphate isomerase) (EC 5.3.1.1) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 PYRD 0 1 URA1 YKL216W PYRD_YEAST 5 4.85 4.85 1 Dihydroorotate dehydrogenase (fumarate) (DHOD) (DHODase) (DHOdehase) (EC 1.3.98.1) (Dihydroorotate oxidase), Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 AOFA 0 1 MAOA AOFA_HUMAN 4.82390874094432 4.85 4.85 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18145 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.39999691337226 4.85 4.85 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.85 actual molregno [molregno] O=C1C=C(Oc2ccccc12)c3ccccc3 18084 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.81138951044775 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 KAT2A 0 4 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 4.97499943716937 5 5 4 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.05000045714008 5 5 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 2 26 Nonstructural protein 1, NotRecorded 4.70414217753893 5 4.96370535714286 28 0.928571428571429 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.70000050388302 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 P53 0 2 TP53 P53 P53_HUMAN 4.8 5 5 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 NLRP3 0 2 NLRP3 C1orf7 CIAS1 NALP3 PYPAF1 NLRP3_HUMAN 4.89 5 5 2 NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 TNKS1 0 2 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 7.15 5 5.353125 2 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.7 5 5.1375 1 Ras-related protein Rab-9A 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 PGH2 0 1 Ptgs2 Cox-2 Cox2 Pghs-b Tis10 PGH2_MOUSE 4.80390839108315 5 4.975 1 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 5 5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 AOFA 0 1 MAOA AOFA_HUMAN 4.82390874094432 5 5 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 AGAL 0 2 GLA AGAL_HUMAN 4.62499920859933 5 5 2 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 6 5 5.3375 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 IMPA1 0 1 Impa1 Imp IMPA1_RAT 4.55 5 5 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.95 5 5 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 TRXR1 0 2 Txnrd1 Trxr1 TRXR1_RAT 4.72499943444384 5 5 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.95 5 5 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.94999940171424 5 5 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.225 5 5.07708333333334 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 NPC1 0 1 NPC1 NPC1_HUMAN 5.6 5 5.15 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 AOFB 0 1 MAOB AOFB_HUMAN 4.55 5 5 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 GLCM 0 2 GBA GC GLUC GLCM_HUMAN 4.95000062215756 5 5 2 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 LUCI 0 1 LUCI_PHOPY 5.22098102808513 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18084 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.85 5 5 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3ccccc3O2 18033 RGS4 1 0 RGS4 RGS4_HUMAN 5.07382224601261 4.5 4.5 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 ANDR 4 0 AR DHTR NR3C4 ANDR_HUMAN 5.97546218740409 4.5 4.56875 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 AA2AR 1 0 Adora2a AA2AR_RAT 5.21 4.5 4.334375 1 Adenosine receptor A2a 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRG3 16 0 Gabrg3 GBRG3_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRA4 16 0 Gabra4 GBRA4_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRG1 16 0 Gabrg1 GBRG1_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRB1 16 0 Gabrb1 Gabrb-1 GBRB1_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRB3 16 0 Gabrb3 Gabrb-3 GBRB3_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRP 16 0 Gabrp GBRP_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRA6 16 0 Gabra6 Gabra-6 GBRA6_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 Q91ZM7 16 0 Gabrq Q91ZM7_RAT 5.72 4.5 4.5 16 GABA theta subunit 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRG2 16 0 Gabrg2 GBRG2_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRA1 16 0 Gabra1 Gabra-1 GBRA1_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRA3 16 0 Gabra3 Gabra-3 GBRA3_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRA5 16 0 Gabra5 Gabra-5 GBRA5_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRA2 16 0 Gabra2 Gabra-2 GBRA2_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRB2 16 0 Gabrb2 Gabrb-2 GBRB2_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRE 16 0 Gabre GBRE_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GBRD 16 0 Gabrd GBRD_RAT 5.72 4.5 4.5 16 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 AA3R 1 0 ADORA3 AA3R_HUMAN 4.94782198833493 4.5 4.495 1 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 CP1A1 1 0 CYP1A1 CP1A1_HUMAN 5.39 4.5 4.5 1 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GEMI 1 0 GMNN GEMI_HUMAN 5.63621884741913 4.5 4.5 1 Geminin 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 6.51 4.5 4.6 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 TAU 1 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 4.5 4.5 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 GLCM 1 0 GBA GC GLUC GLCM_HUMAN 4.94999940171424 4.5 4.5 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 LOX15 1 0 ALOX15 LOG15 LOX15_HUMAN 4.7 4.5 4.5 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.495 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 AA1R 1 0 Adora1 AA1R_RAT 5.66 4.5 4.49375 1 Adenosine receptor A1 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 18033 PGH2 1 0 Ptgs2 Cox-2 Cox2 Pghs-b Tis10 PGH2_MOUSE 4.9128498242811 4.5 4.5 1 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 0 4.5 actual molregno [molregno] Oc1cccc2OC(=CC(=O)c12)c3ccccc3 17853 NF2L2 0 4 NFE2L2 NRF2 NF2L2_HUMAN 4.71030649217587 4.93333333333333 4.93333333333333 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 ANDR 0 7 AR DHTR NR3C4 ANDR_HUMAN 5.16540856824708 4.93333333333333 4.93333333333333 7 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 TAU 0 5 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.78 4.93333333333333 4.93333333333333 5 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CAH1 0 3 CA1 CAH1_HUMAN 5.17666666666667 4.93333333333333 4.93333333333333 3 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRG3 0 32 GABRG3, Gabrg3 GBRG3_HUMAN, GBRG3_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRA4 0 32 GABRA4, Gabra4 GBRA4_HUMAN, GBRA4_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRG1 0 32 GABRG1, Gabrg1 GBRG1_HUMAN, GBRG1_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRB1 0 32 GABRB1, Gabrb1 Gabrb-1 GBRB1_HUMAN, GBRB1_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRB3 0 32 GABRB3, Gabrb3 Gabrb-3 GBRB3_HUMAN, GBRB3_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRP 0 32 GABRP, Gabrp GBRP_HUMAN, GBRP_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRA6 0 32 GABRA6, Gabra6 Gabra-6 GBRA6_HUMAN, GBRA6_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 Q91ZM7 0 16 Gabrq Q91ZM7_RAT 6.04 4.93333333333333 4.93333333333333 16 GABA theta subunit 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRG2 0 32 GABRG2, Gabrg2 GBRG2_HUMAN, GBRG2_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRA1 0 32 GABRA1, Gabra1 Gabra-1 GBRA1_HUMAN, GBRA1_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRA3 0 32 GABRA3, Gabra3 Gabra-3 GBRA3_HUMAN, GBRA3_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRA5 0 32 GABRA5, Gabra5 Gabra-5 GBRA5_HUMAN, GBRA5_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRA2 0 32 GABRA2, Gabra2 Gabra-2 GBRA2_HUMAN, GBRA2_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRB2 0 32 GABRB2, Gabrb2 Gabrb-2 GBRB2_HUMAN, GBRB2_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRE 0 32 GABRE, Gabre GBRE_HUMAN, GBRE_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRD 0 32 GABRD, Gabrd GBRD_HUMAN, GBRD_RAT 5.78 4.93333333333333 4.93333333333333 32 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 AL1A1 0 4 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.1 4.93333333333333 4.93333333333333 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CY24B 0 4 CYBB NOX2 CY24B_HUMAN 5 4.93333333333333 4.93333333333333 4 Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 FLT3 0 1 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5 4.93333333333333 4.93333333333333 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GSK3B 0 2 GSK3B GSK3B_HUMAN 5.14 4.93333333333333 4.93333333333333 2 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GSK3A 0 2 GSK3A GSK3A_HUMAN 5.14 4.93333333333333 4.93333333333333 2 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 4.94999940171424 4.93333333333333 4.93333333333333 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CD5R1 0 2 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.51 4.93333333333333 4.93333333333333 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CDK5 0 2 CDK5 CDKN5 CDK5_HUMAN 5.51 4.93333333333333 4.93333333333333 2 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CAH2 0 3 CA2 CAH2_HUMAN 5.24333333333333 4.93333333333333 4.93333333333333 3 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 PPARG 0 1 PPARG NR1C3 PPARG_HUMAN 5.05000045714008 4.93333333333333 4.93333333333333 1 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CCNB3 0 4 CCNB3 CYCB3 CCNB3_HUMAN 5.15 4.93333333333333 4.93333333333333 4 G2/mitotic-specific cyclin-B3 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CDK1 0 4 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.15 4.93333333333333 4.93333333333333 4 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CCNB1 0 4 CCNB1 CCNB CCNB1_HUMAN 5.15 4.93333333333333 4.93333333333333 4 G2/mitotic-specific cyclin-B1 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CCNB2 0 4 CCNB2 CCNB2_HUMAN 5.15 4.93333333333333 4.93333333333333 4 G2/mitotic-specific cyclin-B2 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CAH12 0 3 CA12 CAH12_HUMAN 5.85 4.93333333333333 4.93333333333333 3 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 ALDR 0 3 AKR1B1, AKR1B1 ALDR1 ALDR_BOVIN, ALDR_HUMAN 5.09666666666667 4.93333333333333 4.93333333333333 3 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP19A 1 4 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 6.562 4.93333333333333 4.90558333333333 5 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 0.8 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 PGH2 0 4 PTGS2 COX2, Ptgs2 Cox-2 Cox2 Pghs-b Tis10 PGH2_HUMAN, PGH2_MOUSE 4.69207106624472 4.93333333333333 4.93333333333333 4 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 LOX1 0 6 LOX1.1 LOX1 LOX1_SOYBN 5.7735574254005 4.93333333333333 4.885 6 Seed linoleate 13S-lipoxygenase-1 (EC 1.13.11.12) (Lipoxygenase-1) (L-1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 4.93333333333333 4.93333333333333 1 Geminin 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 KMT2A 0 12 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.53333333333333 4.93333333333333 4.93333333333333 12 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 MEN1 0 12 MEN1 SCG2 MEN1_HUMAN 4.53333333333333 4.93333333333333 4.93333333333333 12 Menin 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 5.22 4.93333333333333 4.93333333333333 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP2CJ 0 2 CYP2C19 CP2CJ_HUMAN 6.1 4.93333333333333 4.93333333333333 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 GBRT 0 16 GABRQ GBRT_HUMAN 5.52 4.93333333333333 4.93333333333333 16 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 LCK 0 1 LCK LCK_HUMAN 4.81954393554187 4.93333333333333 4.93333333333333 1 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 RORG 0 4 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.725 4.93333333333333 4.93333333333333 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP2C9 0 3 CYP2C9 CYP2C10 CP2C9_HUMAN 5.29333333333333 4.93333333333333 4.89305555555555 3 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 P53 0 3 TP53 P53 P53_HUMAN 4.56666666666667 4.93333333333333 4.93333333333333 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 ALDH2 0 4 ALDH2 ALDM ALDH2_HUMAN 4.89060064868983 4.93333333333333 4.93333333333333 4 Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1), Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 AOFA 0 10 MAOA AOFA_HUMAN 5.15520133884242 4.93333333333333 4.93333333333333 10 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 AOFB 0 10 MAOB AOFB_HUMAN 5.15520133884242 4.93333333333333 4.93333333333333 10 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 LOX5 0 1 ALOX5 LOG5 LOX5_HUMAN 5 4.93333333333333 4.93333333333333 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP2D6 0 3 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.70034333188799 4.93333333333333 4.89305555555555 3 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.2 4.93333333333333 4.93333333333333 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 NR1H4 0 1 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.74999985591871 4.93333333333333 4.93333333333333 1 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 Q7ZJM1 0 3 pol Q7ZJM1_9HIV1 5.08264666955735 4.93333333333333 4.93333333333333 3 Integrase (Fragment) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP1A2 0 4 CYP1A2 CP1A2_HUMAN 7.0725 4.93333333333333 4.93166666666666 4 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 AK1CL 0 1 Akr1c21 AK1CL_MOUSE 4.7501225267834 4.93333333333333 4.93333333333333 1 Aldo-keto reductase family 1 member C21 (EC 1.1.1.-) (17-alpha-hydroxysteroid dehydrogenase) (17-alpha-HSD) (3(or 17)-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.209) (3-alpha-hydroxysteroid dehydrogenase) (Dihydrodiol dehydrogenase type 1) (DD1) (Dihydrodiol dehydrogenase type 3) (DD3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.93333333333333 4.93333333333333 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 DHB1 0 1 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 4.71193498150039 4.93333333333333 4.93333333333333 1 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CBR1 0 3 CBR1 CBR CRN SDR21C1 CBR1_HUMAN 5.8064873821369 4.93333333333333 4.93333333333333 3 Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.59999765407204 4.93333333333333 4.93333333333333 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP1B1 1 2 CYP1B1 CP1B1_HUMAN 6.80666666666667 4.93333333333333 4.71569444444444 3 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 0.666666666666667 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CAH4 0 1 CA4 CAH4_HUMAN 6.27 4.93333333333333 4.93333333333333 1 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 HSPB1 0 1 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.86010203164046 4.93333333333333 4.93333333333333 1 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 ABCG2 0 2 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 5.705 4.93333333333333 4.98416666666667 2 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 IDHC 0 2 IDH1 PICD IDHC_HUMAN 6.53807555508009 4.93333333333333 4.93333333333333 2 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP1A1 0 4 CYP1A1 CP1A1_HUMAN 6.09165028213063 4.93333333333333 4.91656249999999 4 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP2A6 0 1 CYP2A6 CYP2A3 CP2A6_HUMAN 4.60205999132796 4.93333333333333 4.87291666666666 1 Cytochrome P450 2A6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIA6) (Coumarin 7-hydroxylase) (Cytochrome P450 IIA3) (Cytochrome P450(I)) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.39999691337226 4.93333333333333 4.93333333333333 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 LUCI 0 1 LUCI_PHOPY 4.9 4.93333333333333 4.93333333333333 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.93333333333333 4.93333333333333 4.93333333333333 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.55000045168903 4.93333333333333 4.93333333333333 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 MDR1 0 1 ABCB1 MDR1 PGY1 MDR1_HUMAN 5.05 4.93333333333333 4.93333333333333 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CAH9 0 2 CA9 G250 MN CAH9_HUMAN 5.575 4.93333333333333 4.93333333333333 2 Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CP2B6 0 1 CYP2B6 CP2B6_HUMAN 4.60205999132796 4.93333333333333 4.87291666666666 1 Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.5 4.93333333333333 4.93333333333333 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 DHB2 0 1 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 4.68850457065785 4.93333333333333 4.93333333333333 1 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 XDH 0 1 XDH XDHA XDH_HUMAN 6.08 4.93333333333333 4.93333333333333 1 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 JUN 0 1 JUN JUN_HUMAN 4.86010203164046 4.93333333333333 4.93333333333333 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 CAH7 0 1 CA7 CAH7_HUMAN 6.77 4.93333333333333 4.93333333333333 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5 4.93333333333333 4.93333333333333 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 4.93333333333333 4.93333333333333 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 17853 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.075 4.93333333333333 4.93333333333333 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.93333333333333 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccccc3 18511 0 8 Cerebroside-sulfatase, NotRecorded 5.54659340089495 5.65 5.65 8 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 AA1R 0 18 ADORA1, Adora1 AA1R_BOVIN, AA1R_HUMAN, AA1R_RAT 6.485 5.65 5.65 18 Adenosine receptor A1 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 NPC1 0 1 NPC1 NPC1_HUMAN 5.24 5.65 5.65 1 Niemann-Pick C1 protein 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 AA2AR 0 30 ADORA2A ADORA2, Adora2a AA2AR_HUMAN, AA2AR_RAT 8.33809595817601 5.65 5.65 30 Adenosine receptor A2a 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.74999985591871 5.65 5.65 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 AA3R 0 6 ADORA3 AA3R_HUMAN 5.32 5.65 5.65 6 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.85 5.65 5.65 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.98639184935954 5.65 5.65 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 P53 0 2 TP53 P53 P53_HUMAN 4.75 5.65 5.65 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 TRXR1 0 2 Txnrd1 Trxr1 TRXR1_RAT 5.50000390065092 5.65 5.65 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.2 5.65 5.65 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 AA2BR 0 4 ADORA2B, Adora2b AA2BR_HUMAN, AA2BR_RAT 5.4875 5.65 5.65 4 Adenosine receptor A2b 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 DRD1 0 1 DRD1 DRD1_HUMAN 5.68623820370756 5.65 5.65 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.05 5.65 5.65 1 Ras-related protein Rab-9A 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.7 5.65 5.65 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.75 5.65 5.65 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.25000102344165 5.65 5.65 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.95 5.65 5.65 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 PFKA 0 1 pfk PFKA_TRYBB 5.77098405723659 5.65 5.65 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.65 5.65 5.65 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 5.65 5.65 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 IMPA1 0 1 Impa1 Imp IMPA1_RAT 4.55 5.65 5.65 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 18511 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.7999981345934 5.65 5.65 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.65 actual molregno [molregno] Nc1nc2c(cnn2CCc3ccccc3)c4nc(nn14)c5occc5 357169 FUT9 0 3 FUT9 FUT9_HUMAN 4.60570708490655 4.85 4.85 3 Alpha-(1,3)-fucosyltransferase 9 (EC 2.4.1.-) (Fucosyltransferase 9) (Fucosyltransferase IX) (Fuc-TIX) (FucT-IX) (Galactoside 3-L-fucosyltransferase) 1 4.85 actual molregno [molregno] NC1=Nc2c(ncn2[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)C(=O)N1 357169 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] NC1=Nc2c(ncn2[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)C(=O)N1 357169 RGS4 0 1 RGS4 RGS4_HUMAN 6.22380748525293 4.85 4.85 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.85 actual molregno [molregno] NC1=Nc2c(ncn2[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)C(=O)N1 357169 0 4 Dolichol-phosphate-mannose synthase, NotRecorded 4.93497687251123 4.85 4.85 4 1 4.85 actual molregno [molregno] NC1=Nc2c(ncn2[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O)C(=O)N1 19045 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 4.55 3.275 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 19045 SAV 1 0 SAV_STRAV 7.96 4.55 4.55 1 Streptavidin 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 19045 LOX5 2 0 ALOX5 LOG5, Alox5 LOX5_HUMAN, LOX5_RAT 5.66 4.55 3.275 2 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 19045 3 0 NotRecorded 4.65744124920206 4.55 4.23125 3 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 19045 RGS4 1 0 RGS4 RGS4_HUMAN 8.22184874961636 4.55 4.55 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 19045 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.55 4.55 3.275 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 19045 MK14 1 0 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 7.96 4.55 4.55 1 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 0 4.55 actual molregno [molregno] CS(=O)(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4 428706 0 9 NotRecorded 4.97382628349628 5.95 5.95 9 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 AA2AR 0 17 ADORA2A ADORA2, Adora2a AA2AR_HUMAN, AA2AR_RAT 7.77058823529412 5.95 5.95 17 Adenosine receptor A2a 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 AA1R 0 12 Adora1 AA1R_RAT 6.5175 5.95 5.95 12 Adenosine receptor A1 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 CYSP 0 1 CYSP_TRYCR 4.5 5.95 5.95 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 AA2BR 0 12 ADORA2B, Adora2b AA2BR_HUMAN, AA2BR_RAT 7.80666666666667 5.95 5.95 12 Adenosine receptor A2b 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 END4 0 1 nfo b2159 JW2146 END4_ECOLI 5.4 5.95 5.95 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 AGAL 0 1 GLA AGAL_HUMAN 4.9 5.95 5.95 1 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 AA3R 0 1 Adora3 AA3R_RAT 7.59 5.95 5.95 1 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.1 5.95 5.95 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 4.55000045168903 5.95 5.95 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.95 5.95 5.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 428706 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.55005901122666 5.95 5.95 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.95 actual molregno [molregno] CCCCC#Cc1nc(N)c2ncn([C@@H]3O[C@@H]([C@@H](O)[C@H]3O)C(=O)NCC)c2n1 21298 5HT1B 0 1 Htr1b 5ht1b 5HT1B_RAT 5.18 7.75 7.75 1 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B), 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B), 5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (Serotonin receptor 1B) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 5HT1A 0 2 HTR1A ADRB2RL1 ADRBRL1, Htr1a 5ht1a 5HT1A_HUMAN, 5HT1A_RAT 5.685 7.75 7.75 2 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A), 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 0 46 Cerebroside-sulfatase, NotRecorded 5.16814014155653 7.75 7.75 46 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 5.4 7.75 7.75 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 TPO 0 2 THPO MGDF TPO_HUMAN 4.7 7.75 7.75 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.70000050388302 7.75 7.75 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 KDM4E 0 3 KDM4E KDM4DL KDM4E_HUMAN 4.5 7.75 7.75 3 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 KPYM 0 2 PKM OIP3 PK2 PK3 PKM2 KPYM_HUMAN 5.1 7.75 7.75 2 Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58), Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 CP2D6 0 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.1 7.75 7.75 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 5HT2C 0 7 HTR2C HTR1C, Htr2c 5ht1c Htr1c 5HT2C_HUMAN, 5HT2C_RAT 8.96857142857143 7.75 7.75 7 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 5HT2B 0 6 Htr2b Srl 5HT2B_RAT 9.26 7.75 7.75 6 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 protein) (Serotonin receptor 2B), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (Serotonin receptor 2B) (Stomach fundus serotonin receptor), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 5HT2A 0 6 Htr2a Htr2 5HT2A_RAT 9.26 7.75 7.75 6 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-HT2A) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 ACM1 0 2 Chrm1 Chrm-1 ACM1_RAT 4.95 7.75 7.75 2 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.18536709495007 7.75 7.75 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.7250989422218 7.75 7.75 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.725 7.75 7.75 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.03639159221443 7.75 7.75 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 7.64975198166584 7.75 7.75 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 DRD1 0 2 DRD1 DRD1_HUMAN 5.79313804438413 7.75 7.75 2 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 5.35000349253396 7.75 7.75 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 21298 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.75 7.75 7.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.75 actual molregno [molregno] CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1 23093 ADA1D 0 25 ADRA1D ADRA1A, Adra1d Adra1a ADA1D_HUMAN, ADA1D_RAT 8.12824719895936 5.4 5.4 25 Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor), Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a), Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (RA42) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 ADA1A 0 39 ADRA1A ADRA1C, Adra1a Adra1c ADA1A_BOVIN, ADA1A_HUMAN, ADA1A_RABIT, ADA1A_RAT 7.9442580156121 5.4 5.4 39 Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor), Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 ADA1B 0 27 ADRA1B, Adra1b ADA1B_HUMAN, ADA1B_MESAU, ADA1B_RAT 8.2743029619994 5.4 5.4 27 Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 ADA2A 0 6 ADRA2A ADRA2R ADRAR ADA2A_HUMAN 5.65333333333333 5.4 5.4 6 Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor) (CA2-47) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 ASM 0 1 SMPD1 ASM ASM_HUMAN 4.59999938302362 5.4 5.4 1 Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 S22A1 0 2 SLC22A1 OCT1 S22A1_HUMAN 5.07738144457745 5.4 5.4 2 Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1), Solute carrier family 22 member 1 (Organic cation transporter 1) (mOCT1), Solute carrier family 22 member 1 (Organic cation transporter 1) (rOCT1) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 ADA2B 0 6 ADRA2B ADRA2L1 ADRA2RL1, Adra2b ADA2B_HUMAN, ADA2B_RAT 7.11166666666667 5.4 5.4 6 Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR), Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 5.4 5.4 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 ADA2C 0 6 ADRA2C ADRA2L2 ADRA2RL2 ADA2C_HUMAN 6.41333333333333 5.4 5.4 6 Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.4 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 6.2 5.4 5.4 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 5.4 5.4 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 LYAG 0 2 GAA LYAG_HUMAN 4.6 5.4 5.4 2 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 CAC1S 0 3 Cacna1s Cach1 Cacn1 Cacnl1a3 Cchl1a3 CAC1S_RAT 5 5.4 5.4 3 Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Dihydropyridine receptor alpha-1S subunit) (DHPR) (Voltage-gated calcium channel subunit alpha Cav1.1), Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (ROB1) (Voltage-gated calcium channel subunit alpha Cav1.1), Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 CAC1C 0 3 Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1 CAC1C_RAT 5 5.4 5.4 3 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 CAC1D 0 3 Cacna1d Cach3 Cacn4 Cacnl1a2 Cchl1a2 CAC1D_RAT 5 5.4 5.4 3 Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Rat brain class D) (RBD) (Voltage-gated calcium channel subunit alpha Cav1.3), Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 MRP2 0 1 ABCC2 CMOAT CMOAT1 CMRP MRP2 MRP2_HUMAN 6.19497660321606 5.4 5.4 1 Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2), Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 HD 0 1 HTT HD IT15 HD_HUMAN 5.35 5.4 5.4 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.95 5.4 5.4 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.4 5.4 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.73621248726524 5.4 5.4 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 23093 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 5.39999691337226 5.4 5.4 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.4 actual molregno [molregno] COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 543658 0 92 NotRecorded 4.75728471673113 5.52287874528033 5.52287874528033 92 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 SC6A4 0 1 Slc6a4 SC6A4_RAT 7.38 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.57499993386445 5.52287874528033 5.52287874528033 2 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 TRPV1 0 1 TRPV1 VR1 TRPV1_HUMAN 4.70000050388302 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1), Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1) (Vanilloid receptor type 1-like), Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 GEMI 0 2 GMNN GEMI_HUMAN 5.83625196393691 5.52287874528033 5.52287874528033 2 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Geminin 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.94999940171424 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 6.84985783815144 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.85 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.61374188050137 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 SC6A3 0 1 Slc6a3 SC6A3_RAT 5 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.10852458016995 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 RXRA 0 1 RXRA NR2B1 RXRA_HUMAN 4.84999924507786 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.59999938302362 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.20438390210068 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 JUN 0 1 JUN JUN_HUMAN 5.16010106069114 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 Q9WTR4 0 2 Slc6a2 Q9WTR4_RAT 8.255 5.52287874528033 5.52287874528033 2 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Transporter 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.94999940171424 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 THB 0 2 THRB ERBA2 NR1A2 THR1 THB_HUMAN 6.72242471169717 5.52287874528033 5.52287874528033 2 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.7499949715131 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 LX15B 0 1 ALOX15B LX15B_HUMAN 4.70000050388302 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.96010227870023 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.7 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.52287874528033 5.52287874528033 5.52287874528033 2 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 543658 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 4.57382231378381 5.52287874528033 5.52287874528033 1 IMIPRAMINE HYDROCHLORIDE UNIPOLAR DEPRESSION Norepinephrine transporter inhibitor, Serotonin transporter inhibitor INHIBITOR 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.52287874528033 actual drug [drugName] Cl.CN(C)CCCN1c2ccccc2CCc3ccccc13 26590 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 6.95000714307986 4.9375 4.9375 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 SMN 0 4 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9375 4.9375 4.95234375 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 P53 0 3 TP53 P53 P53_HUMAN 4.75000007362449 4.9375 4.9375 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 TSHR 0 8 TSHR LGR3 TSHR_HUMAN 4.7 4.9375 4.9375 8 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 AHR 0 2 AHR BHLHE76 AHR_HUMAN 4.69999904792786 4.9375 4.9375 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 4.83418291013748 4.9375 4.9375 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 NR1I2 0 2 Nr1i2 Pxr NR1I2_RAT 4.77499975563593 4.9375 4.9375 2 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR), Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6.19997064075587 4.9375 4.9375 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.6 4.9375 4.9375 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 LUCI 0 2 LUCI_PHOPY 4.85658536756583 4.9375 4.9375 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 4.9375 4.9375 1 Niemann-Pick C1 protein 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 4.9375 4.84 1 Ras-related protein Rab-9A 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.9375 4.9375 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.22312604112455 4.9375 4.9375 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68621284836475 4.9375 4.9375 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 5.02506481187865 4.9375 4.9375 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 MAP2 0 2 METAP2 MNPEP P67EIF2 MAP2_HUMAN 4.51132053280683 4.9375 4.9375 2 Methionine aminopeptidase (MAP) (MetAP) (EC 3.4.11.18) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.51855909595872 4.9375 4.9375 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 5.16010106069114 4.9375 4.9375 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 5.54219377091702 4.9375 4.84 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 Q72547 0 1 pol Q72547_9HIV1 4.84 4.9375 4.9375 1 Reverse transcriptase/RNaseH (Fragment) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26590 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 6.5 4.9375 4.9375 2 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9375 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cscn3 26598 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.75 4.85 4.85 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 0 24 NotRecorded 4.94531456317867 4.85 4.85 24 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 LUCI 0 1 LUCI_PHOPY 5.24218658099522 4.85 4.85 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5 4.85 4.85 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 5 4.85 4.85 4 Menin 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.92509948691138 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.52506584911424 4.85 4.85 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.65 4.85 4.85 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 CLTR1 1 0 CYSLTR1 CLTR1_CAVPO 8.19 4.85 3.5675 1 Cysteinyl leukotriene receptor 1 (CysLTR1), Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor), Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81) 0 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 P53 0 2 TP53 P53 P53_HUMAN 4.7 4.85 4.85 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.6 4.85 4.85833333333333 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 PPARD 1 0 PPARD NR1C2 PPARB PPARD_HUMAN 5.37509939779551 4.85 4.28 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.6 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.95 4.85 4.85 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 26598 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CCC(CC)(CC(=O)Nc1cccc(\C=C\c2nc(cs2)C3CCC3)c1)C(=O)O 372552 GEMI 0 2 GMNN GEMI_HUMAN 6.3363658267808 4.925 4.925 2 BROXURIDINE PROSTATE CARCINOMA 2 Geminin 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 MTOR 0 1 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.88 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.43621466522961 4.925 4.925 2 BROXURIDINE PROSTATE CARCINOMA 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.925 4.925 4.925 2 BROXURIDINE PROSTATE CARCINOMA 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 5.12506614834429 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 5.19999817218203 4.925 4.925 2 BROXURIDINE PROSTATE CARCINOMA 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 PMP22 0 2 Pmp22 Cd25 Pmp-22 PMP22_RAT 5.24625922799462 4.925 4.925 2 BROXURIDINE PROSTATE CARCINOMA 2 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 IDHC 0 1 IDH1 PICD IDHC_HUMAN 6.23619777592541 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.65000410073714 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 4.85 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 KITH 2 0 TK1 KITH_HUMAN 4.95 4.925 4.19375 2 BROXURIDINE PROSTATE CARCINOMA 2 Thymidine kinase (EC 2.7.1.21), Thymidine kinase, cytosolic (EC 2.7.1.21) 0 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 P53 0 1 TP53 P53 P53_HUMAN 4.5 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68639005935126 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 372552 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.59999938302362 4.925 4.925 1 BROXURIDINE PROSTATE CARCINOMA 2 Uncharacterized protein 1 4.925 actual drug [drugName] OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(Br)C(=O)NC2=O 27812 ACHA7 53 0 CHRNA7 NACHRA7, Chrna7 Acra7 ACHA7_HUMAN, ACHA7_RAT 5.30596622540305 4.6 4.6 53 Neuronal acetylcholine receptor subunit alpha-7 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACM1 44 0 CHRM1, Chrm1 Chrm-1 ACM1_HUMAN, ACM1_RAT 6.22369682061907 4.6 4.6 44 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHA4 87 0 CHRNA4 NACRA4, Chrna4 Acra4 ACHA4_HUMAN, ACHA4_RAT 5.96559105669634 4.60000000000001 4.60000000000001 87 Neuronal acetylcholine receptor subunit alpha-4 0 4.60000000000001 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHB2 81 0 CHRNB2, Chrnb2 Acrb2 ACHB2_HUMAN, ACHB2_RAT 5.95275583111207 4.6 4.6 81 Neuronal acetylcholine receptor subunit beta-2, Neuronal acetylcholine receptor subunit beta-2 (Neuronal acetylcholine receptor non-alpha-1 chain) (N-alpha 1) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHD 5 0 chrnd ACHD_TETCF 6.02533943162236 4.6 4.6 5 Acetylcholine receptor subunit delta 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 36 0 Nicotinic acetylcholine receptor alpha8 subunit, NotRecorded 4.96905332062899 4.6 4.56791666666666 36 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHA5 33 0 Chrna5 Acra5 ACHA5_RAT 5.73398636532049 4.6 4.6 33 Neuronal acetylcholine receptor subunit alpha-5 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHA6 33 0 Chrna6 Acra6 ACHA6_RAT 5.73398636532049 4.6 4.6 33 Neuronal acetylcholine receptor subunit alpha-6 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHB4 63 0 CHRNB4, Chrnb4 Acrb4 ACHB4_HUMAN, ACHB4_RAT 5.78410671097296 4.6 4.6 63 Neuronal acetylcholine receptor subunit beta-4, Neuronal acetylcholine receptor subunit beta-4 (Neuronal acetylcholine receptor non-alpha-2 chain) (N-alpha 2) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHA2 35 0 Chrna2 Acra2 ACHA2_RAT 5.86118714444504 4.6 4.6 35 Neuronal acetylcholine receptor subunit alpha-2 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHA3 62 0 CHRNA3 NACHRA3, Chrna3 Acra3 ACHA3_HUMAN, ACHA3_RAT 5.53801872075319 4.6 4.6 62 Neuronal acetylcholine receptor subunit alpha-3 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHB3 33 0 Chrnb3 Acrb3 ACHB3_RAT 5.73398636532049 4.6 4.6 33 Neuronal acetylcholine receptor subunit beta-3 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACH10 33 0 Chrna10 ACH10_RAT 5.73398636532049 4.6 4.6 33 Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHA9 33 0 Chrna9 Acra9 ACHA9_RAT 5.73398636532049 4.6 4.6 33 Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACM2 35 0 CHRM2, Chrm2 Chrm-2 ACM2_HUMAN, ACM2_RAT 6.3863386059566 4.6 4.6 35 Muscarinic acetylcholine receptor M2 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACM5 37 0 CHRM5, Chrm5 Chrm-5 ACM5_HUMAN, ACM5_RAT 6.44384822353262 4.6 4.6 37 Muscarinic acetylcholine receptor M5 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACM4 37 0 CHRM4, Chrm4 Chrm-4 ACM4_HUMAN, ACM4_RAT 6.36364085626034 4.6 4.6 37 Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M4 (Mm4 mAChR) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACM3 34 0 CHRM3, Chrm3 Chrm-3 ACM3_HUMAN, ACM3_RAT 6.38 4.6 4.6 34 Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M3 (Mm3 mAChR) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 ACHP 2 0 ACHP_LYMST 5.35 4.6 4.69 2 Acetylcholine-binding protein (ACh-binding protein) (AchBP) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 S22A5 1 0 Slc22a5 Octn2 S22A5_MOUSE 4.71580021244218 4.6 4.69 1 Solute carrier family 22 member 5 (CT1) (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2) (UST2r), Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 Q8VH26 1 0 GPM3 Q8VH26_CAVPO 5 4.6 4.6 1 Muscarinic acetylcholine receptor 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.69 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27812 EDNRA 1 0 EDNRA ETA ETRA EDNRA_HUMAN 5 4.6 4.6 1 Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ET-AR), Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR) 0 4.6 actual molregno [molregno] CC(=O)OCC[N+](C)(C)C 27846 ACHA5 0 33 Chrna5 Acra5 ACHA5_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit alpha-5 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHA6 0 33 Chrna6 Acra6 ACHA6_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit alpha-6 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHB4 0 33 Chrnb4 Acrb4 ACHB4_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit beta-4, Neuronal acetylcholine receptor subunit beta-4 (Neuronal acetylcholine receptor non-alpha-2 chain) (N-alpha 2) 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHA4 0 35 CHRNA4 NACRA4, Chrna4 Acra4 ACHA4_HUMAN, ACHA4_RAT 4.95341173818069 4.85 4.85 35 Neuronal acetylcholine receptor subunit alpha-4 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHA2 0 33 Chrna2 Acra2 ACHA2_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit alpha-2 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHA7 0 34 CHRNA7 NACHRA7, Chrna7 Acra7 ACHA7_HUMAN, ACHA7_RAT 4.87174737753895 4.85 4.85 34 Neuronal acetylcholine receptor subunit alpha-7 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHA3 0 33 Chrna3 Acra3 ACHA3_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit alpha-3 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHB3 0 33 Chrnb3 Acrb3 ACHB3_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit beta-3 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHB2 0 35 CHRNB2, Chrnb2 Acrb2 ACHB2_HUMAN, ACHB2_RAT 4.95341173818069 4.85 4.85 35 Neuronal acetylcholine receptor subunit beta-2, Neuronal acetylcholine receptor subunit beta-2 (Neuronal acetylcholine receptor non-alpha-1 chain) (N-alpha 1) 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACH10 0 33 Chrna10 ACH10_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10) 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 ACHA9 0 33 Chrna9 Acra9 ACHA9_RAT 4.82695184352498 4.85 4.85 33 Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 0 6 Nicotinic acetylcholine receptor alpha 5 subunit, NotRecorded 5.41500003681224 4.85 4.84375 6 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.1375 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 DPOLB 1 0 POLB DPOLB_HUMAN 5.45 4.85 4.1375 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 0 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27846 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5 4.85 4.85 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 4.85 actual molregno [molregno] C1CCC(NC1)c2cccnc2 27743 NMDE1 0 63 GRIN2A NMDAR2A, Grin2a NMDE1_HUMAN, NMDE1_RAT 6.07041083324807 4.94999999999999 4.94999999999999 63 Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A), Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 NMDE4 0 63 GRIN2D GluN2D NMDAR2D, Grin2d GluN2D NMDE4_HUMAN, NMDE4_RAT 6.07041083324807 4.94999999999999 4.94999999999999 63 Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D), Glutamate receptor ionotropic, NMDA 2D (GluN2D) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 NMDZ1 0 69 GRIN1 NMDAR1, Grin1 Nmdar1 NMDZ1_HUMAN, NMDZ1_RAT 6.10342485944051 4.94999999999999 4.94999999999999 69 Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1), Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 NMD3A 0 63 GRIN3A KIAA1973, Grin3a NMD3A_HUMAN, NMD3A_RAT 6.07041083324807 4.94999999999999 4.94999999999999 63 Glutamate receptor ionotropic, NMDA 3A (GluN3A) (Glutamate receptor chi-1) (N-methyl-D-aspartate receptor) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) (NMDAR-L1), Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 NMD3B 0 63 GRIN3B, Grin3b NMD3B_HUMAN, NMD3B_RAT 6.07041083324807 4.94999999999999 4.94999999999999 63 Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 NMDE3 0 64 GRIN2C NMDAR2C, Grin2c NMDE3_HUMAN, NMDE3_RAT 6.03806066397857 4.94999999999999 4.94999999999999 64 Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 NMDE2 0 63 GRIN2B NMDAR2B, Grin2b NMDE2_HUMAN, NMDE2_RAT 6.07041083324807 4.94999999999999 4.94999999999999 63 Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B), Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) 1 4.94999999999999 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIA1 0 20 GRIA1 GLUH1 GLUR1, Gria1 Glur1 GRIA1_HUMAN, GRIA1_RAT 5.17653406678875 4.95 4.95 20 Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIA4 0 20 GRIA4 GLUR4, Gria4 Glur4 GRIA4_HUMAN, GRIA4_RAT 5.17653406678875 4.95 4.95 20 Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIA2 0 20 GRIA2 GLUR2, Gria2 Glur2 GRIA2_HUMAN, GRIA2_RAT 5.17653406678875 4.95 4.95 20 Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIA3 0 20 GRIA3 GLUR3 GLURC, Gria3 Glur3 GRIA3_HUMAN, GRIA3_RAT 5.17653406678875 4.95 4.95 20 Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 4.95 4.95 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.85 4.95 4.95 4 Menin 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 0 23 NotRecorded 5.19156527483396 4.95 4.95 23 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIK4 0 5 Grik4 GRIK4_RAT 5.04575749056067 4.95 4.95 5 Glutamate receptor ionotropic, kainate 4 (GluK4) (Excitatory amino acid receptor 1) (EAA1) (Glutamate receptor KA-1) (KA1), Glutamate receptor ionotropic, kainate 4 (GluK4) (Glutamate receptor KA-1) (KA1) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIK1 0 5 Grik1 Glur5 GRIK1_RAT 5.04575749056067 4.95 4.95 5 Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5), Glutamate receptor ionotropic, kainate 1 (GluK1) (Glutamate receptor 5) (GluR-5) (GluR5) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIK2 0 5 Grik2 Glur6 GRIK2_RAT 5.04575749056067 4.95 4.95 5 Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6), Glutamate receptor ionotropic, kainate 2 (GluK2) (Glutamate receptor 6) (GluR-6) (GluR6) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIK5 0 5 Grik5 GRIK5_RAT 5.04575749056067 4.95 4.95 5 Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2), Glutamate receptor ionotropic, kainate 5 (GluK5) (Glutamate receptor KA-2) (KA2) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GRIK3 0 5 Grik3 Glur7 GRIK3_RAT 5.04575749056067 4.95 4.95 5 Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7), Glutamate receptor ionotropic, kainate 3 (GluK3) (Glutamate receptor 7) (GluR-7) (GluR7) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 TAU 0 4 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.325 4.95 4.95 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.525 4.95 4.95 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 PFKA 0 1 pfk PFKA_TRYBB 6.12096149476276 4.95 4.95 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 GLCM 0 3 GBA GC GLUC GLCM_HUMAN 5.1666647946645 4.95 4.95 3 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.45000414846935 4.95 4.95 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.73638967203328 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 TPO 0 2 THPO MGDF TPO_HUMAN 4.9 4.95 4.95 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 4.95 4.95 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 5.2 4.95 4.95 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.525 4.95 4.95 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.78088016071771 4.95 4.95 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.3 4.95 4.95 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 PMP22 0 1 PMP22 GAS3 PMP22_HUMAN 4.92 4.95 4.95 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 27743 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.52308372746611 4.95 4.95 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.95 actual molregno [molregno] Oc1nc2cc(Cl)c(Cl)cc2nc1O 32842 BAZ2B 2 0 BAZ2B KIAA1476 BAZ2B_HUMAN 6.15002808767115 4.75 4.0625 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.59999938302362 4.75 4.725 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 FFP 1 0 ffp sfp FFP_BACIU 6.2 4.75 4.77 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.4420430989367 4.75 4.75 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 CYSP 1 0 CYSP_TRYCR 5.6 4.75 4.72291666666667 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 GEMI 1 0 GMNN GEMI_HUMAN 6.19997064075587 4.75 4.71666666666667 1 Geminin 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 ANDR 1 0 AR DHTR NR3C4 ANDR_HUMAN 6.39093945006991 4.75 4.77 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 32842 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.75 4.75 4.725 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.75 actual molregno [molregno] Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 33809 ACACA 0 2 Acaca Acac Gm738 ACACA_MOUSE 5.71547288568131 5.4 5.40625 2 Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) (Acetyl-CoA carboxylase 265) [Includes: Biotin carboxylase (EC 6.3.4.14)], Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 SOAT1 0 6 Soat1 Acact SOAT1_MOUSE 5.2097041681854 5.4 5.39270833333333 6 Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 CP7A1 0 4 Cyp7a1 Cyp7 CP7A1_MOUSE 5.05271334132872 5.4 5.4 4 Cholesterol 7-alpha-monooxygenase (EC 1.14.14.23) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cytochrome P450 7A1) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 ACSA 0 5 Acss2 Acas2 Acecs1 ACSA_MOUSE 5.9139773003029 5.4 5.38 5 Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.575 5.4 5.4 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 5.4 5.4 1 Niemann-Pick C1 protein 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 LOX5 0 1 Alox5 LOX5_RAT 5.04 5.4 5.4 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.61121294271091 5.4 5.4 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 LUCI 0 1 LUCI_PHOPY 5.27098107996347 5.4 5.4 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.15002808767115 5.4 4.72708333333334 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.35 5.4 5.4 1 Ras-related protein Rab-9A 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.49180543160104 5.4 5.4 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 Q94696 0 1 luc Q94696_PHOPE 4.95 5.4 5.4 1 Luciferase 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.46867012033585 5.4 5.4 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 P53 0 2 TP53 P53 P53_HUMAN 4.95 5.4 5.4 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.2875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.35 5.4 5.4 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 33809 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 7 5.4 5.275 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.4 actual molregno [molregno] COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 35158 JUN 0 1 JUN JUN_HUMAN 4.504869341059 4.9 4.90000000000001 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 MTOR 0 3 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.21333333333333 4.9 4.90000000000001 3 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 GEMI 0 2 GMNN GEMI_HUMAN 5.54310073065975 4.9 4.90000000000001 2 Geminin 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.1 4.9 4.90000000000001 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 FYN 0 1 FYN FYN_HUMAN 4.76 4.9 4.90000000000001 1 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.85 4.9 4.90000000000001 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 NFKB1 0 6 NFKB1 NFKB1_HUMAN 5.78669385987698 4.9 4.90000000000001 6 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 4.88300063791642 4.9 4.90000000000001 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.33333333333333 4.9 4.90000000000001 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 Q962Y6 0 1 TGR Q962Y6_SCHMA 4.8 4.9 4.90000000000001 1 Thioredoxin glutathione reductase (EC 1.6.4.5) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 NF2L2 0 6 NFE2L2 NRF2 NF2L2_HUMAN 4.50975930720091 4.9 4.90000000000001 6 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.8 4.9 4.90000000000001 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 EHMT2 0 3 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.81666729085394 4.9 4.90000000000001 3 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 4.7 4.9 4.90000000000001 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 TPO 0 2 THPO MGDF TPO_HUMAN 5.3 4.9 4.90000000000001 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.98621510845326 4.9 4.90000000000001 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 LOX15 0 2 ALOX15, ALOX15 LOG15 LOX15_HUMAN, LOX15_RABIT 5.43 4.9 4.90000000000001 2 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 CAH13 0 2 Ca13 Car13 CAH13_MOUSE 4.91 4.9 4.90000000000001 2 Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 CAH4 0 3 CA4 CAH4_HUMAN 4.96 4.9 4.90000000000001 3 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 LX15B 0 1 ALOX15B LX15B_HUMAN 4.89999841719865 4.9 4.90000000000001 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 CAH12 0 2 CA12 CAH12_HUMAN 5.05 4.9 4.90000000000001 2 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 CAH3 0 3 CA3 CAH3_BOVIN, CAH3_HUMAN 5.08 4.9 4.90000000000001 3 Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.90000000000001 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 CAH5B 0 2 CA5B CAH5B_HUMAN 5.38 4.9 4.90000000000001 2 Carbonic anhydrase 5B, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VB) (Carbonic anhydrase VB) (CA-VB) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 EGFR 0 1 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 4.58 4.9 4.90000000000001 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 TRXR1 0 5 Txnrd1 Trxr1 TRXR1_RAT 5.07428741321601 4.9 4.90000000000001 5 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 LMBL1 0 1 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 4.75 4.9 4.90000000000001 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 5.22382202741777 4.9 4.90000000000001 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.9 4.9 4.90000000000001 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.25 4.9 4.90000000000001 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 APEX1 0 2 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.50000022584451 4.9 4.90000000000001 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 PGKC 0 1 PGKC_TRYBB 4.52098213050232 4.9 4.90000000000001 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 LOX5 0 1 ALOX5 LOG5 LOX5_HUMAN 5.90799732148669 4.9 4.90000000000001 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.85 4.9 4.90000000000001 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 CAH15 0 1 Ca15 Car15 CAH15_MOUSE 4.99 4.9 4.90000000000001 1 Carbonic anhydrase 15 (EC 4.2.1.1) (Carbonate dehydratase XV) (Carbonic anhydrase XV) (CA-XV) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 NR1H4 0 1 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.65000022087346 4.9 4.90000000000001 1 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 4.75486997595825 4.9 4.90000000000001 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 MMP8 0 1 MMP8 CLG1 MMP8_HUMAN 4.65251260309702 4.9 4.90000000000001 1 Neutrophil collagenase (EC 3.4.24.34) (Matrix metalloproteinase-8) (MMP-8) (PMNL collagenase) (PMNL-CL) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.8 4.9 4.90000000000001 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 HSPB1 0 1 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.85486888285984 4.9 4.90000000000001 1 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 PFKA 0 1 pfk PFKA_TRYBB 5.27098107996347 4.9 4.90000000000001 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 RGS4 0 1 RGS4 RGS4_HUMAN 4.72382322328385 4.9 4.90000000000001 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 TYDP1 0 1 TDP1 TYDP1_HUMAN 4.7 4.9 4.90000000000001 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.94782198833493 4.9 4.90000000000001 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.9 actual molregno [molregno] Oc1ccccc1O 35158 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 5.2250671866126 4.9 4.90000000000001 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Oc1ccccc1O 418921 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.63620005452089 5.7 5.7 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 JAK2 0 6 JAK2 JAK2_HUMAN 4.65529333911469 5.7 5.7 6 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.78621404606106 5.7 5.7 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.65 5.7 5.7 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 P53 0 1 TP53 P53 P53_HUMAN 4.9 5.7 5.7 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 Q8IL88 0 1 PF14_0359 PF3D7_1437900 Q8IL88_PLAF7 4.92081875395237 5.7 5.7 1 HSP40, subfamily A, putative 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 GLP1R 0 1 GLP1R GLP1R_HUMAN 6 5.7 5.7 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 5.25000102344165 5.7 5.7 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.7 5.7 5.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 SKN7 0 1 SKN7 BRY1 POS9 YHR206W SKN7_YEAST 6.05453141486818 5.7 5.7 1 Transcription factor SKN7 (Peroxide sensitivity protein 9) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 418921 CBX1 0 1 CBX1 CBX CBX1_HUMAN 6.4000078224159 5.7 5.7 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 5.7 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O 38581 0 285 Aberrant vpr protein, NotRecorded 4.82576050462576 6.15 6.15000000000001 285 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5 6.15 6.15 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 NR1H4 0 1 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.70000050388302 6.15 6.15 1 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.94442322982834 6.15 6.15 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 5.30888312891225 6.15 6.15 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 6.15 6.15 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 CP3A4 0 2 CYP3A4 CYP3A3 CP3A4_HUMAN 5 6.15 6.15 2 Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 DPOLB 0 1 POLB DPOLB_HUMAN 5.6 6.15 6.15 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 JUN 0 1 JUN JUN_HUMAN 4.5713388619675 6.15 6.15 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 CAH2 0 1 CA2 CAH2_HUMAN 6.2 6.15 6.15 1 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.15 6.15 6.15 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 RXRA 0 2 RXRA NR2B1 RXRA_HUMAN 4.74999985591871 6.15 6.15 2 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 CP2D6 0 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 5 6.15 6.15 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 5 6.15 6.15 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.57382231378381 6.15 6.15 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 5 6.15 6.15 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 GEMI 0 1 GMNN GEMI_HUMAN 6.73612732313478 6.15 6.15 1 Geminin 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 38581 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.94999940171424 6.15 6.15000000000001 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 6.15 actual molregno [molregno] Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 406787 1 270 NotRecorded, Progesterone receptor 4.79484976578312 5.29999999999999 5.29711715867158 271 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 0.996309963099631 5.29999999999999 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.6 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 GEMI 0 4 GMNN GEMI_HUMAN 6.21514624045417 5.3 5.3 4 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Geminin 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 SO1B3 1 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.36948212319846 5.3 4.75 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 ABC3G 0 2 APOBEC3G MDS019 ABC3G_HUMAN 5.97500357153993 5.3 5.3 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.53621149304416 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 P53 0 2 TP53 P53 P53_HUMAN 4.9 5.3 5.3 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 GLP1R 0 2 GLP1R GLP1R_HUMAN 5.57500081356368 5.3 5.3 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.9 5.3 5.3 4 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.9 5.3 5.3 4 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Menin 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 LUCI 0 2 LUCI_PHOPY 5.74072668343724 5.3 5.3 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 CP2J2 0 2 CYP2J2 CP2J2_HUMAN 4.94793520573786 5.3 5.3 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Cytochrome P450 2J2 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ2) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.3 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 HSPB1 0 2 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.6926012512983 5.3 5.421875 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 ATAD5 0 3 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.17990653539106 5.3 5.340625 3 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.2 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 JUN 0 1 JUN JUN_HUMAN 5.31010537176042 5.3 5.421875 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5.6862171168448 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 PMP22 0 2 Pmp22 Cd25 Pmp-22 PMP22_RAT 5.46610460035052 5.3 5.3609375 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 6.175 5.3 5.3 2 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 CP2C8 0 1 CYP2C8 CP2C8_HUMAN 4.52287874528034 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 IMPA1 0 1 Impa1 Imp IMPA1_RAT 4.55 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 406787 I23O2 0 1 Ido2 Indol1 I23O2_MOUSE 5.0871501757189 5.3 5.3 1 ALBENDAZOLE DIGESTIVE SYSTEM DISEASE, INFECTION, PERIODONTITIS Tubulin inhibitor INHIBITOR 4 Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1) 1 5.3 actual drug [drugName] CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 38898 LMNA 5 0 LMNA LMN1 LMNA_HUMAN 4.94 4.6 4.6 5 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SC6A2 2 0 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.76 4.6 4.615625 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 4.77382299674291 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 LYAG 2 0 GAA LYAG_HUMAN 5.25 4.6 4.6 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 PTR1 2 0 PTR1 HMTXR L1063.01 LmjF23.0270 LmjF_23_0270 PTR1_LEIMA 4.85 4.6 4.6 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Pteridine reductase 1 (EC 1.5.1.33) (H region methotrexate resistance protein) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.78621404606106 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 P53 2 0 TP53 P53 P53_HUMAN 4.7 4.6 4.6 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.325 4.6 4.605 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 NFKB1 4 0 NFKB1 NFKB1_HUMAN 4.9 4.6 4.6 4 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 GEMI 2 0 GMNN GEMI_HUMAN 6.5169983281826 4.6 4.61 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Geminin 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 NPC1 1 0 NPC1 NPC1_HUMAN 4.99 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Niemann-Pick C1 protein 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SCN2A 5 0 SCN2A NAC2 SCN2A1 SCN2A2, Scn2a Scn2a1 SCN2A_HUMAN, SCN2A_RAT 5.18757554235835 4.6 4.602 5 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2), Sodium channel protein type 2 subunit alpha (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 ATAD5 3 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.98633104253236 4.6 4.6 3 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 4.89999841719865 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 TAR DNA-binding protein 43 (TDP-43) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 LUCI 2 0 LUCI_PHOPY 4.75658579121653 4.6 4.6 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 JUN 1 0 JUN JUN_HUMAN 4.5713388619675 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 PMP22 2 0 PMP22 GAS3, Pmp22 Cd25 Pmp-22 PMP22_HUMAN, PMP22_RAT 5.08109035779135 4.6 4.605 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SCN1A 3 0 Scn1a SCN1A_RAT 4.98262590393058 4.6 4.6 3 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SCN3A 3 0 Scn3a SCN3A_RAT 4.98262590393058 4.6 4.6 3 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.35887133676246 4.6 4.15625 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 SYUA 1 0 SNCA NACP PARK1 SYUA_HUMAN 4.93621268968233 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 4.77382299674291 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 4.99 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Ras-related protein Rab-9A 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.28621554657693 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 ATX2 2 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.3500025859555 4.6 4.6 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 RGS4 2 0 RGS4 RGS4_HUMAN 6.17382370021365 4.6 4.615 2 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38898 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 4.6 4.6 1 RILUZOLE ALZHEIMERS DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA, AUTISM SPECTRUM DISORDER, BIPOLAR DISORDER, CANCER, CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS, CUTANEOUS MELANOMA, FRAGILE X SYNDROME, MEMORY IMPAIRMENT, OBSESSIVE-COMPULSIVE DISORDER, POST-TRAUMATIC STRESS DISORDER, PROXIMAL SPINAL MUSCULAR ATROPHY, TOURETTE SYNDROME, UNIPOLAR DEPRESSION Sodium channel alpha subunit blocker BLOCKER 4 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.6 actual drug [drugName] Nc1nc2ccc(OC(F)(F)F)cc2s1 38643 GRM6 0 2 GRM6 GPRC1F MGLUR6, Grm6 Gprc1f Mglur6 GRM6_HUMAN, GRM6_RAT 6.275 5.45 5.45 2 Metabotropic glutamate receptor 6 (mGluR6) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 GRM4 0 1 GRM4 GPRC1D MGLUR4 GRM4_HUMAN 6.48 5.45 5.45 1 Metabotropic glutamate receptor 4 (mGluR4) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 GRM8 0 1 GRM8 GPRC1H MGLUR8 GRM8_HUMAN 8.29 5.45 5.45 1 Metabotropic glutamate receptor 8 (mGluR8) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 7.64975198166584 5.45 5.45 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 IMPA1 0 1 Impa1 Imp IMPA1_RAT 4.65 5.45 5.45 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 END4 0 1 nfo b2159 JW2146 END4_ECOLI 5.35 5.45 5.45 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 6.04997609347667 5.45 5.45 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 38643 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.4 5.45 5.45 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.45 actual molregno [molregno] NC(CCP(=O)(O)O)C(=O)O 70784 AA2AR 0 39 ADORA2A, ADORA2A ADORA2, Adora2a AA2AR_CAVPO, AA2AR_HUMAN, AA2AR_RAT 7.21958541673257 5.45 5.45 39 Adenosine receptor A2a 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 AA2BR 0 36 ADORA2B, Adora2b AA2BR_HUMAN, AA2BR_RAT 7.24788420146028 5.45 5.45 36 Adenosine receptor A2b 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 0 26 Cerebroside-sulfatase, NotRecorded 5.21900398628038 5.45 5.45 26 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 AA1R 0 33 ADORA1, Adora1 AA1R_BOVIN, AA1R_CHICK, AA1R_HUMAN, AA1R_RAT 8.65705693167516 5.45 5.45 33 Adenosine receptor A1 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 AA3R 0 17 Adora3 AA3R_RAT 8.54588235294118 5.45 5.45 17 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 5.05000045714008 5.45 5.45 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 PEBB 0 2 CBFB PEBB_HUMAN 5.05000045714008 5.45 5.45 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 PFKA 0 1 pfk PFKA_TRYBB 6.12096149476276 5.45 5.45 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 TRXR1 0 2 Txnrd1 Trxr1 TRXR1_RAT 5.5238207375183 5.45 5.45 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 DRD1 0 1 DRD1 DRD1_HUMAN 7.23657200643706 5.45 5.45 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 70784 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.68638584042187 5.45 5.45 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.45 actual molregno [molregno] OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NC4CCCCC4)ncnc23 10881 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.8875 1 SEMUSTINE GLIOBLASTOMA MULTIFORME, NEOPLASM 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual drug [drugName] CC1CCC(CC1)NC(=O)N(CCCl)N=O 10881 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 4.69218744896267 4.9 4.9 1 SEMUSTINE GLIOBLASTOMA MULTIFORME, NEOPLASM 3 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.9 actual drug [drugName] CC1CCC(CC1)NC(=O)N(CCCl)N=O 10881 ADA2A 0 2 ADRA2A ADRA2R ADRAR ADA2A_HUMAN 5.53 4.9 4.9 2 SEMUSTINE GLIOBLASTOMA MULTIFORME, NEOPLASM 3 Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor) (CA2-47) 1 4.9 actual drug [drugName] CC1CCC(CC1)NC(=O)N(CCCl)N=O 10881 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.29999760285775 4.9 4.9 1 SEMUSTINE GLIOBLASTOMA MULTIFORME, NEOPLASM 3 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual drug [drugName] CC1CCC(CC1)NC(=O)N(CCCl)N=O 10881 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.9 4.9 4.9 1 SEMUSTINE GLIOBLASTOMA MULTIFORME, NEOPLASM 3 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual drug [drugName] CC1CCC(CC1)NC(=O)N(CCCl)N=O 44648 0 23 Cerebroside-sulfatase, NotRecorded 5.19438882943006 6.15 6.07771739130435 23 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 5.57506938555012 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 5.96070488191569 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 TPO 0 2 THPO MGDF TPO_HUMAN 5 6.15 6.15 2 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 GLP1R 0 2 GLP1R GLP1R_HUMAN 5.57499594244268 6.15 6.15 2 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 5.85 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.89987592469737 6.15 6.15 2 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 GLSK 0 1 GLS GLS1 KIAA0838 GLSK_HUMAN 4.94999940171424 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 TRXR1 0 4 Txnrd1 Trxr1 TRXR1_RAT 4.56786744954644 6.15 6.15 4 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.15 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.65000022087346 6.15 5.825 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.65 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 8.55 6.15 6.15 2 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 NMUR2 0 1 NMUR2 NMU2R TGR1 NMUR2_HUMAN 5.18 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Neuromedin-U receptor 2 (NMU-R2), Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 44648 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 4.75 6.15 6.15 1 OXEDRINE CARDIOVASCULAR DISEASE, EYE ALLERGY 0 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 6.15 actual drug [drugName] CNCC(O)c1ccc(O)cc1 45979 5HT4R 0 8 HTR4, Htr4 5HT4R_CAVPO, 5HT4R_HUMAN, 5HT4R_RAT 7.4775 4.85 4.85 8 5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 PFKA 0 1 pfk PFKA_TRYBB 5.17097941513958 4.85 4.85 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 6.4 4.85 4.85 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 5HT3A 0 3 HTR3A 5HT3R HTR3, Htr3a 5ht3 Htr3 5HT3A_HUMAN, 5HT3A_RAT 6.76 4.85 4.85 3 5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 CP2D6 0 2 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.8 4.85 4.85 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 4.75 4.85 4.85 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 0 3 Cerebroside-sulfatase, NotRecorded 6.80584119275603 4.85 4.85 3 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 5HT3B 0 2 Htr3b 5HT3B_RAT 6.69 4.85 4.85 2 5-hydroxytryptamine receptor 3B (5-HT3-B) (5-HT3B) (Serotonin receptor 3B) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.9 4.85 4.85 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 45979 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 75167 0 40 Nonstructural protein 1, NotRecorded 4.54718080577119 5.35 5.35 40 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 TOP2B 0 1 TOP2B TOP2B_HUMAN 6.57839607313017 5.35 5.35 1 DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 LUCI 0 1 LUCI_PHOPY 5.4 5.35 5.35 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 MP2K5 0 2 MAP2K5 MEK5 MKK5 PRKMK5 MP2K5_HUMAN 5 5.35 5.35 2 Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 TERT 0 2 TERT EST2 TCS1 TRT TERT_HUMAN 5.1708331997131 5.35 5.35 2 Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2), Telomerase reverse transcriptase (EC 2.7.7.49) (Telomerase catalytic subunit) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 LX15B 0 1 ALOX15B LX15B_HUMAN 5.39999691337226 5.35 5.35 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 MP2K1 0 4 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5 5.35 5.35 4 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 MP2K2 0 4 MAP2K2 MEK2 MKK2 PRKMK2 MP2K2_HUMAN 5 5.35 5.35 4 Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 TOP2A 0 1 TOP2A TOP2 TOP2A_HUMAN 4.54 5.35 5.35 1 DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.15 5.35 5.35 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 TOP1 0 2 TOP1 TOP1_HUMAN 5.00398839264729 5.35 5.35 2 DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I), DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I) (Maintenance of killer protein 1) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.5 5.35 5.35 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 75167 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.5 5.35 5.35 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.35 actual molregno [molregno] CN1CCN(CC1)c2ccc3[nH]c(nc3c2)c4ccc5[nH]c(nc5c4)c6ccc(O)cc6 47109 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.25 6.25 5.1875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.25 actual molregno [molregno] [Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C(=O)[O-])C(=O)[O-])NC[C@H](O)c3cccc(Cl)c3 47109 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.49999693194831 6.25 5.1875 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 6.25 actual molregno [molregno] [Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C(=O)[O-])C(=O)[O-])NC[C@H](O)c3cccc(Cl)c3 47109 ADRB3 0 8 ADRB3 ADRB3R B3AR, Adrb3 Adrb3r ADRB3_HUMAN, ADRB3_RAT 5.97261955530236 6.25 5.3203125 8 Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor) 1 6.25 actual molregno [molregno] [Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C(=O)[O-])C(=O)[O-])NC[C@H](O)c3cccc(Cl)c3 47109 1 1 NotRecorded 5.09306009002746 6.25 5.15416666666667 2 0.5 6.25 actual molregno [molregno] [Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C(=O)[O-])C(=O)[O-])NC[C@H](O)c3cccc(Cl)c3 47109 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.6 6.25 5.1875 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 6.25 actual molregno [molregno] [Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C(=O)[O-])C(=O)[O-])NC[C@H](O)c3cccc(Cl)c3 47209 AA1R 0 2 Adora1 AA1R_RAT 5.795 5.05 5.05 2 Adenosine receptor A1 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 0 358 3-oxoacyl-acyl-carrier protein reductase, Enoyl-acyl-carrier protein reductase, NotRecorded, Phenol oxidase 4.64726261447883 5.04999999999999 5.04889664804468 358 1 5.04999999999999 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PLMN 0 1 PLG PLMN_HUMAN 4.60479236688213 5.05 5.05000000000001 1 Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B], Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Plasmin heavy chain A, short form; Plasmin light chain B] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LOX1 0 8 LOX1.1 LOX1 LOX1_SOYBN 5.42646510995346 5.05 5.05 8 Seed linoleate 13S-lipoxygenase-1 (EC 1.13.11.12) (Lipoxygenase-1) (L-1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TOP1 0 4 TOP1, Top1 TOP1_HUMAN, TOP1_RAT 5.87759932521419 5.05 5.05 4 DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I), DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I) (Maintenance of killer protein 1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 POLK 0 5 POLK DINB1 POLK_HUMAN 5.69952191524494 5.05 5.05 5 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 RUNX1 0 4 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.97499970085712 5.05 5.05 4 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PEBB 0 4 CBFB PEBB_HUMAN 4.97499970085712 5.05 5.05 4 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TOP2A 0 1 TOP2A TOP2 TOP2A_HUMAN 5.75332766665861 5.05 5.05 1 DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PPARG 0 1 Pparg Nr1c3 PPARG_MOUSE 5.64 5.05 5.05 1 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CDK5 0 3 CDK5 CDKN5, Cdk5 Cdkn5 CDK5_HUMAN, CDK5_RAT 4.81401999710932 5.05 5.05000000000001 3 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CD38 0 1 CD38 CD38_HUMAN 5.09 5.05 5.05 1 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPr hydrolase 1) (I-19) (NIM-R5 antigen) (CD antigen CD38), ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPr hydrolase 1) (T10) (CD antigen CD38) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MMP9 0 2 MMP9 CLG4B MMP9_HUMAN 4.9410116073527 5.05 5.05 2 Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB), Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 GEMI 0 2 GMNN GEMI_HUMAN 6.58569634296018 5.05 5.05 2 Geminin 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MMP3 0 2 MMP3 STMY1 MMP3_HUMAN 4.71101160735271 5.05 5.05000000000001 2 Stromelysin-1 (SL-1) (EC 3.4.24.17) (Matrix metalloproteinase-3) (MMP-3) (Transin-1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 IDHC 0 2 IDH1 PICD IDHC_HUMAN 6.32291062687136 5.05 5.05 2 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 RORG 0 6 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.68333333333333 5.05 5.05 6 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 FABI 0 2 fabI envM b1288 JW1281 FABI_ECOLI 5.075 5.05 5.05000000000001 2 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI (ENR) (EC 1.3.1.9) (NADH-dependent enoyl-ACP reductase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 Q7ZJM1 0 5 pol Q7ZJM1_9HIV1 5.0357940008672 5.05 5.05000000000001 5 Integrase (Fragment) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 POLI 0 2 POLI RAD30B POLI_HUMAN 4.82499858225792 5.05 5.05 2 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PFKA 0 3 pfk PFKA_TRYBB 4.82098284976779 5.05 5.05000000000001 3 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LOX5 0 1 ALOX5 LOG5 LOX5_HUMAN 5.8 5.05 5.05 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 XDH 0 10 XDH, XDH XDHA XDH_BOVIN, XDH_HUMAN 5.13406827392737 5.05 5.05000000000001 10 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 GSK3B 0 3 GSK3B GSK3B_HUMAN 6.00666666666667 5.05 5.05 3 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 GSK3A 0 2 GSK3A GSK3A_HUMAN 6.1 5.05 5.05 2 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LT 0 2 LT_SV40 4.62192280480784 5.05 5.05000000000001 2 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CAH7 0 1 CA7 CAH7_HUMAN 8.33 5.05 5.05 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 KMT2A 0 20 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.68 5.05 5.05 20 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MEN1 0 20 MEN1 SCG2 MEN1_HUMAN 4.68 5.05 5.05 20 Menin 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PGH1 0 1 PTGS1 COX1 PGH1_HUMAN 5.47712125471966 5.05 5.05000000000001 1 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 GPR35 0 6 GPR35 GPR35_HUMAN 4.56 5.05 5.05 6 G-protein coupled receptor 35 (Kynurenic acid receptor) (KYNA receptor) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.82499995279863 5.05 5.05 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 6.4 5.05 5.025 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TTHY 0 2 TTR PALB TTHY_HUMAN 6.15 5.05 5.05 2 Transthyretin (ATTR) (Prealbumin) (TBPA), Transthyretin (Prealbumin) (TBPA) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TAU 0 4 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.775 5.05 5.05 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 4.87500013825872 5.05 5.05000000000001 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 BLM 0 4 BLM RECQ2 RECQL3 BLM_HUMAN 4.84177687364964 5.05 5.05000000000001 4 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PGH2 0 5 PTGS2 COX2 PGH2_HUMAN 4.89504621368901 5.05 5.05 5 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CP1B1 0 2 CYP1B1 CP1B1_HUMAN 7.175 5.05 5.05 2 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.08639163122089 5.05 5.05 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 Q965D7 0 2 fabZ Q965D7_PLAFA 5.12 5.05 5.05000000000001 2 Beta-hydroxyacyl-ACP dehydratase (Fatty acid synthesis protein) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.93333333333333 5.05 5.05000000000001 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LYAG 0 3 GAA LYAG_HUMAN 5.76713233603611 5.05 5.05000000000001 3 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 6.035 5.05 5.05 2 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.3 5.05 5.05 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 ALDR 0 4 AKR1B1, AKR1B1 ALDR1, Akr1b1 Akr1b4 Aldr1 ALDR_BOVIN, ALDR_HUMAN, ALDR_RAT 5.7925 5.05 5.05 4 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PARP1 0 2 PARP1 ADPRT PPOL PARP1_HUMAN 5.375 5.05 5.05 2 Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1), Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 KDM4E 0 3 KDM4E KDM4DL KDM4E_HUMAN 5 5.05 5.05 3 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MMP13 0 2 MMP13 MMP13_HUMAN 4.8160116073527 5.05 5.05000000000001 2 Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13), Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13) (UMRCASE) (Fragment) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.875 5.05 5.05000000000001 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 GLCM 0 2 GBA GC GLUC GLCM_HUMAN 4.72499943444384 5.05 5.05000000000001 2 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LX15B 0 2 ALOX15B LX15B_HUMAN 4.9000004374016 5.05 5.05000000000001 2 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LOX12 0 2 ALOX12 12LO LOG12 LOX12_HUMAN 5.2 5.05 5.05 2 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TNKS1 0 2 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 5.62 5.05 5.05 2 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 RECQ1 0 6 RECQL RECQ1 RECQL1 RECQ1_HUMAN 5.02499948865805 5.05 5.05000000000001 6 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 NRAM 0 1 NA NRAM_I34A1 4.5339866265341 5.05 5.05000000000001 1 Neuraminidase (EC 3.2.1.18) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MMP12 0 2 MMP12 HME MMP12_HUMAN 5.32101160735271 5.05 5.05 2 Macrophage metalloelastase (MME) (EC 3.4.24.65) (Macrophage elastase) (ME) (hME) (Matrix metalloproteinase-12) (MMP-12), Macrophage metalloelastase (MME) (EC 3.4.24.65) (Matrix metalloproteinase-12) (MMP-12) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TNKS2 0 2 TNKS2 PARP5B TANK2 TNKL TNKS2_HUMAN 5.965 5.05 5.05 2 Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-like protein) (Tankyrase-related protein), Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 WRN 0 2 WRN RECQ3 RECQL2 WRN_HUMAN 5.25854892266285 5.05 5.05 2 Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CCNB3 0 4 CCNB3 CYCB3 CCNB3_HUMAN 5.21 5.05 5.05 4 G2/mitotic-specific cyclin-B3 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CDK1 0 4 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.21 5.05 5.05 4 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CCNB1 0 4 CCNB1 CCNB CCNB1_HUMAN 5.21 5.05 5.05 4 G2/mitotic-specific cyclin-B1 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CCNB2 0 4 CCNB2 CCNB2_HUMAN 5.21 5.05 5.05 4 G2/mitotic-specific cyclin-B2 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 TR10B 0 1 TNFRSF10B DR5 KILLER TRAILR2 TRICK2 ZTNFR9 UNQ160/PRO186 TR10B_HUMAN 5 5.05 5.05 1 Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 KSYK 0 2 SYK KSYK_HUMAN 5.135 5.05 5.05 2 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LUCI 0 1 LUCI_PHOPY 4.62098289875995 5.05 5.05000000000001 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 APEX1 0 4 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.3249997580514 5.05 5.05000000000001 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 NANH 0 1 nanH NANH_CLOPF 5.37 5.05 5.05000000000001 1 Sialidase (EC 3.2.1.18) (N-acylneuraminate glycohydrolase) (Neuraminidase) (NANase) (STNA), Sialidase (EC 3.2.1.18) (Neuraminidase), Sialidase (EC 3.2.1.18) (Neuraminidase) (NANase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 SC6A3 0 1 Slc6a3 SC6A3_RAT 5.84 5.05 5.05 1 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CD5R1 0 2 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.42 5.05 5.05000000000001 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 5.05 5.05 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.95 5.05 5.05000000000001 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LOX15 0 2 ALOX15 LOG15 LOX15_HUMAN 5.7 5.05 5.05 2 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 4.68 5.05 5.05000000000001 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 Q8IEK1 0 1 PF3D7_1311800 Q8IEK1_PLAF7 4.64 5.05 5.05000000000001 1 M1-family alanyl aminopeptidase (EC 3.4.11.2) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.74472749489669 5.05 5.05 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MEX5 0 1 mex-5 W02A2.7 MEX5_CAEEL 4.51 5.05 5.05 1 Zinc finger protein mex-5 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 AMY1 0 2 AMY1A AMY1; AMY1B AMY1; AMY1C AMY1 AMY1_HUMAN 5.31959747155421 5.05 5.05 2 Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase), Alpha-amylase type A isozyme (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase) (HvAMY1) (Low pI alpha-amylase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CDK2 0 1 CDK2 CDKN2 CDK2_HUMAN 4.7 5.05 5.05000000000001 1 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CP1A1 0 2 CYP1A1 CP1A1_HUMAN 5.975 5.05 5.05 2 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 FLT3 0 1 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 6.08 5.05 5.05 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 5.49999693194831 5.05 5.05 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MMP2 0 2 MMP2 CLG4A MMP2_HUMAN 5.03601160735271 5.05 5.05 2 72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX], 72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) [Cleaved into: PEX] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LGUL 0 1 GLO1 LGUL_HUMAN 5.11 5.05 5.05 1 Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MDR1 0 1 ABCB1 MDR1 PGY1 MDR1_HUMAN 4.71 5.05 5.05 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CAH12 0 1 CA12 CAH12_HUMAN 7.22 5.05 5.05 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 ABCG2 0 1 ABCG2 ABCP BCRP BCRP1 MXR ABCG2_HUMAN 5.05 5.05 5.05 1 ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein 1 homolog) (Urate exporter) (CD antigen CD338), ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.5 5.05 5.05 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CAH4 0 1 CA4 CAH4_HUMAN 6.53 5.05 5.05 1 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 4.89999841719865 5.05 5.05 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 PGKC 0 1 PGKC_TRYBB 4.55000045168903 5.05 5.05000000000001 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 DPOLB 0 1 POLB DPOLB_HUMAN 5.15 5.05 5.05 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CAH2 0 1 CA2 CAH2_HUMAN 5.43 5.05 5.05 1 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 LIPP 0 1 PNLIP LIPP_PIG 5 5.05 5.05000000000001 1 Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.94999940171424 5.05 5.05 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 AOFA 0 1 MAOA AOFA_HUMAN 5.31 5.05 5.05000000000001 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 NOX4 0 1 NOX4 RENOX NOX4_HUMAN 6.07 5.05 5.05 1 NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.68621289959511 5.05 5.05 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 CAH1 0 1 CA1 CAH1_HUMAN 5 5.05 5.05000000000001 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 47209 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.74999985591871 5.05 5.05 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.05 actual molregno [molregno] Oc1cc(O)c2C(=O)C=C(Oc2c1)c3ccc(O)c(O)c3 50822 ROCK2 19 0 ROCK2 KIAA0619, Rock2 ROCK2_HUMAN, ROCK2_RAT 5.70728784224991 4.75 4.75 19 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KAPCA 9 0 PRKACA PKACA KAPCA_HUMAN 5.81476122225707 4.75 4.76666666666667 9 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SGK1 4 0 SGK1 SGK SGK1_HUMAN 5.82268739252475 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KKCC2 1 0 CAMKK2 CAMKKB KIAA0787 KKCC2_HUMAN 5.82557590031178 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCG 4 0 PRKCG PKCG KPCG_HUMAN 5.63519732623329 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCE 3 0 PRKCE PKCE KPCE_HUMAN 5.46249579896766 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNE2 9 0 CCNE2 CCNE2_HUMAN 6.41371595413723 4.75 4.75347222222222 9 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 G1/S-specific cyclin-E2 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDK2 11 2 CDK2 CDKN2 CDK2_HUMAN 5.80419986704659 4.75 4.76346153846154 13 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 0.153846153846154 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNE1 9 0 CCNE1 CCNE CCNE1_HUMAN 6.41371595413723 4.75 4.75347222222222 9 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 G1/S-specific cyclin-E1 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNA1 4 2 CCNA1 CCNA1_HUMAN 5.55450982711304 4.75 4.77916666666667 6 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-A1 0.333333333333333 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNA2 4 2 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.55450982711304 4.75 4.77916666666667 6 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 0.333333333333333 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PAK2 1 0 PAK2 PAK2_HUMAN 6.69019608002851 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6A3 10 0 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 5.41559129382088 4.75 4.75 10 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 ULK2 1 0 ULK2 KIAA0623 ULK2_HUMAN 6.38021124171161 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 UFO 1 0 AXL UFO UFO_HUMAN 6.69019608002851 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 39 0 NotRecorded, Protein kinase Pfmrk 4.94072469554913 4.75 4.74016025641026 39 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FGFR2 1 0 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 5.75332766665861 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAKG2 7 0 PRKAG2 AAKG2_HUMAN 5.52476288915489 4.75 4.75 7 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAKB2 7 0 PRKAB2 AAKB2_HUMAN 5.52476288915489 4.75 4.75 7 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAPK1 14 0 PRKAA1 AMPK1 AAPK1_HUMAN 5.62765867659801 4.75 4.75 14 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAPK2 7 0 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.52476288915489 4.75 4.75 7 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAKB1 13 0 PRKAB1 AMPK AAKB1_HUMAN 5.90670934402863 4.75 4.75 13 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAKG1 13 0 PRKAG1 AAKG1_HUMAN 5.90670934402863 4.75 4.75 13 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AAKG3 7 0 PRKAG3 AMPKG3 AAKG3_HUMAN 5.52476288915489 4.75 4.75 7 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FGR 2 0 FGR SRC2 FGR_HUMAN 6.34749748145514 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 VRK2 1 0 VRK2 VRK2_HUMAN 6.99563519459755 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 BMX 2 0 BMX BMX_HUMAN 6.44258634162228 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 TEC 2 0 TEC PSCTK4 TEC_HUMAN 6.07460955632769 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase Tec (EC 2.7.10.2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AURKC 3 0 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.6567461641985 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 ROCK1 15 0 ROCK1 ROCK1_HUMAN 6.39468790712079 4.75 4.75 15 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Rho-associated protein kinase 1 (EC 2.7.11.1) (Liver regeneration-related protein LRRG199) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p150 RhoA-binding kinase ROK beta) (p160 ROCK-1) (p160ROCK), Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PKN1 1 0 PKN1 PAK1 PKN PRK1 PRKCL1 PKN1_HUMAN 5.77 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MKNK2 3 0 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.72529224655759 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KCC2G 1 0 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 5.65854134728041 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DAPK3 4 0 DAPK3 ZIPK DAPK3_HUMAN 5.91337948762412 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 TSSK2 2 0 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.55951005156861 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MK14 5 0 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.2959531854943 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 TSSK1 1 0 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5.62973141792582 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDK7 3 1 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 5.4155694126933 4.75 4.771875 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 0.25 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SRPK2 1 0 SRPK2 SRPK2_HUMAN 6.00479888288177 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 NEK11 2 0 NEK11 NEK11_HUMAN 6.09337546121976 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KGP1 4 0 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 4.75195212420571 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FYN 3 0 FYN FYN_HUMAN 4.52848690983617 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DAPK1 2 0 DAPK1 DAPK DAPK1_HUMAN 5.88664937379462 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 TXK 2 0 TXK PTK4 RLK TXK_HUMAN 5.91518739159678 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.75 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KCC2D 1 0 CAMK2D CAMKD KCC2D_HUMAN 5.2498774732166 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCD1 3 0 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 4.84756383850716 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MAPK5 3 0 MAPKAPK5 PRAK MAPK5_HUMAN 5.86341987079676 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PRKX 5 0 PRKX PKX1 PRKX_HUMAN 5.46687922468299 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNT1 4 0 CCNT1 CCNT1_HUMAN 5.12043553355285 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-T1 (CycT1) (Cyclin-T) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6A2 4 0 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 5.10626866603479 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CP2D6 3 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 6.28123249974424 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCD2 3 0 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 5.88843380870085 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 M3K9 1 0 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 5.72015930340596 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 ABL2 2 0 ABL2 ABLL ARG ABL2_HUMAN 5.89851829727201 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCD 4 0 PRKCD KPCD_HUMAN 5.40649218306807 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DAPK2 2 0 DAPK2 DAPK2_HUMAN 6.50021703873966 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KAPCB 4 0 PRKACB KAPCB_HUMAN 6.005 4.75 4.7875 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6A6 4 0 RPS6KA6 RSK4 KS6A6_HUMAN 5.36797678529459 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 ACK1 3 0 TNK2 ACK1 ACK1_HUMAN 4.58604218318013 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 BTK 3 0 BTK AGMX1 ATK BPK BTK_HUMAN 4.82457673472296 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 HIPK3 1 0 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 6.69019608002851 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 LRRK2 2 0 LRRK2 PARK8 LRRK2_HUMAN 5.7 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1), Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (Dardarin) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDK1 5 0 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.75215686402281 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AKT3 4 0 AKT3 PKBG AKT3_HUMAN 5.49920016381637 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PAK6 3 0 PAK6 PAK5 PAK6_HUMAN 5.89790898297455 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KCC2B 1 0 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.50060235056919 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MELK 3 0 MELK KIAA0175 MELK_HUMAN 4.75211986691484 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SIK1 1 0 SIK1 SIK SNF1LK SIK1_HUMAN 6.38021124171161 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AKT1 5 0 AKT1 PKB RAC AKT1_HUMAN 5.7006638988932 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PIM3 3 0 PIM3 PIM3_HUMAN 6.32596880921237 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MYLK 5 0 MYLK MLCK MLCK1 MYLK1, Mylk MYLK_CHICK, MYLK_HUMAN 5.23479745182178 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 LCK 5 0 LCK, Lck Lsk-t LCK_HUMAN, LCK_MOUSE 5.33341978781293 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PAK5 1 0 PAK5 KIAA1264 PAK7 PAK5_HUMAN 5.52476288915489 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6A4 4 0 RPS6KA4 MSK2 KS6A4_HUMAN 4.78238545330426 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SGK2 2 0 SGK2 SGK2_HUMAN 5.25378043141147 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 WNK3 1 0 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.38021124171161 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PIM1 4 0 PIM1 PIM1_HUMAN 4.85196708965796 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EF2K 2 0 EEF2K EF2K_HUMAN 6.00512641505789 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CHK2 5 0 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.30238869121607 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 NUAK1 2 0 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 5.7722062929029 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MK03 2 0 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.9431368703327 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CSK21 5 0 CSNK2A1 CK2A1 CSK21_HUMAN 4.70579028772795 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 BRSK2 2 0 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 5.25745490780453 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KCNH2 1 0 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.6 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCB 4 0 PRKCB PKCB PRKCB1 KPCB_HUMAN 5.38515552242825 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 NEK3 1 0 NEK3 NEK3_HUMAN 6.06069784035361 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CSK22 4 0 CSNK2A2 CK2A2 CSK22_HUMAN 6.45192625989814 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 M4K4 2 0 MAP4K4 HGK KIAA0687 NIK M4K4_HUMAN 5.6 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 RAF1 2 0 RAF1 RAF RAF1_HUMAN 5.7276536591188 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CD5R1 2 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.00479888288177 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDK5 4 0 CDK5 CDKN5 CDK5_HUMAN 5.80239944144089 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCL2 1 0 CCL2 MCP1 SCYA2 CCL2_HUMAN 5.16 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DMPK 2 0 DMPK DM1PK MDPK DMPK_HUMAN 5.68783180698044 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DYRK2 1 0 DYRK2 DYRK2_HUMAN 6.00479888288177 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CHK1 4 0 CHEK1 CHK1 CHK1_HUMAN 4.97288436441814 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6A1 6 0 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.01274995793836 4.75 4.75 6 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 AURKB 3 0 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.44391372531859 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCD3 2 0 PRKD3 EPK2 PRKCN KPCD3_HUMAN 6 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCA 3 0 PRKCA PKCA PRKACA KPCA_HUMAN 5.59795018161097 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CLK4 2 0 CLK4 CLK4_HUMAN 6.5 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 HASP 2 0 HASPIN GSG2 HASP_HUMAN 4.55769670935103 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDK3 3 0 CDK3 CDKN3 CDK3_HUMAN 5.86530142610254 4.75 4.76041666666667 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 STK3 4 0 STK3 KRS1 MST2 STK3_HUMAN 4.83443286522804 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EPHA3 1 0 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 6.99563519459755 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MP2K6 1 0 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.62973141792582 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CLK3 2 0 CLK3 CLK3_HUMAN 5.91235401057094 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 GRK7 1 0 GRK7 GPRK7 GRK7_HUMAN 5.90799732148669 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EPHA1 1 0 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.72015930340596 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FGFR4 2 0 FGFR4 JTK2 TKF FGFR4_HUMAN 6.01937629449601 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCL 2 0 PRKCH PKCL PRKCL KPCL_HUMAN 5.0739008097839 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FKB1A 2 0 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.50060235056919 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MTOR 4 0 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.7158611330161 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6B1 5 0 RPS6KB1 STK14A KS6B1_HUMAN 5.14791757104886 4.75 4.75 5 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 STK33 1 0 STK33 STK33_HUMAN 6.12338490853968 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EPHB1 1 0 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 6.69019608002851 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SMAD3 1 0 SMAD3 MADH3 SMAD3_HUMAN 5.54999736982681 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FRK 1 0 FRK PTK5 RAK FRK_HUMAN 6.50965047954658 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNB3 4 0 CCNB3 CYCB3 CCNB3_HUMAN 6.69019608002851 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 G2/mitotic-specific cyclin-B3 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNB1 4 0 CCNB1 CCNB CCNB1_HUMAN 6.69019608002851 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 G2/mitotic-specific cyclin-B1 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNB2 4 0 CCNB2 CCNB2_HUMAN 6.69019608002851 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 G2/mitotic-specific cyclin-B2 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 IKKA 3 0 CHUK IKKA TCF16 IKKA_HUMAN 4.83207918172225 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CCNH 1 1 CCNH CCNH_HUMAN 5.23113882538659 4.75 4.79375 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-H (MO15-associated protein) (p34) (p37) 0.5 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CSK 2 0 CSK CSK_HUMAN 6.2029048298433 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDK8 2 0 CDK8 CDK8_HUMAN 5.9 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PKN2 7 0 PKN2 PRK2 PRKCL2 PKN2_HUMAN 4.98482575226891 4.75 4.75 7 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 FER 1 0 FER TYK3 FER_HUMAN 6.06069784035361 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 INSRR 2 0 INSRR IRR INSRR_HUMAN 6.5953058989068 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EPHA8 1 0 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.27875360095283 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EPHA7 1 0 EPHA7 EHK3 HEK11 EPHA7_HUMAN 6.38021124171161 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DDR2 1 0 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.99563519459755 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KPCT 4 0 PRKCQ PRKCT KPCT_HUMAN 6.05430283559238 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MARK1 1 0 MARK1 KIAA1477 MARK MARK1_HUMAN 5.95424250943933 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KS6A5 10 0 RPS6KA5 MSK1 KS6A5_HUMAN 4.90797437074993 4.75 4.75 10 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 ULK3 1 0 ULK3 ULK3_HUMAN 6.69019608002851 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CSK2B 3 0 CSNK2B CK2N G5A CSK2B_HUMAN 6.50965047954658 4.75 4.75 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 ST17A 1 0 STK17A DRAK1 ST17A_HUMAN 5.75332766665861 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 DYRK3 1 0 DYRK3 DYRK3_HUMAN 4.67264106561367 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 STK4 1 0 STK4 KRS2 MST1 STK4_HUMAN 6.50965047954658 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PAK3 2 0 PAK3 OPHN3 PAK3_HUMAN 5.89851829727201 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MP2K7 2 0 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 6.13148907310259 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 GSK3B 4 0 GSK3B GSK3B_HUMAN 5.00339122771354 4.75 4.75 4 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 HCK 2 0 HCK HCK_HUMAN 6.84291563731303 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MK15 1 0 MAPK15 ERK7 ERK8 MK15_HUMAN 5.38886035082012 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MRCKB 1 0 CDC42BPB KIAA1124 MRCKB_HUMAN 5.82557590031178 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PASK 1 0 PASK KIAA0135 PASK_HUMAN 5.6886291709978 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 SGK3 1 0 SGK3 CISK SGKL SGK3_HUMAN 5.60205999132796 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KAPCG 3 0 PRKACG KAPCG_HUMAN 6.34 4.75 4.8 3 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KKCC1 1 0 CAMKK1 CAMKKA KKCC1_HUMAN 6.27875360095283 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MERTK 1 0 MERTK MER MERTK_HUMAN 5.52476288915489 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 BRSK1 1 0 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.72015930340596 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 STK11 1 0 STK11 LKB1 PJS STK11_HUMAN 5.90799732148669 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 STK10 1 0 STK10 LOK STK10_HUMAN 5.75332766665861 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 CDC42 2 0 CDC42 CDC42_HUMAN 5.19897000433602 4.75 4.75 2 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Cell division control protein 42 homolog (G25K GTP-binding protein) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MKNK1 1 0 MKNK1 MNK1 MKNK1_HUMAN 4.63202321470541 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 KCC4 1 0 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.95424250943933 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 LEF 1 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MK11 1 0 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.50965047954658 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 GRK6 1 0 GRK6 GPRK6 GRK6_HUMAN 6.69019608002851 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 EPHB4 1 0 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 6.99563519459755 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 PDK1 1 0 PDK1 PDHK1 PDK1_HUMAN 6.06069784035361 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1), [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 NLK 1 0 NLK LAK1 NLK_HUMAN 6.27875360095283 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50822 MYLK2 1 0 MYLK2 MYLK2_HUMAN 6.12338490853968 4.75 4.75 1 FASUDIL AMYOTROPHIC LATERAL SCLEROSIS, CARDIOVASCULAR DISEASE, INTERNAL CAROTID ARTERY STENOSIS 3 Myosin light chain kinase 2, skeletal/cardiac muscle (MLCK2) (EC 2.7.11.18) 0 4.75 actual drug [drugName] O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 50222 NTRK1 0 2 NTRK1 MTC TRK TRKA NTRK1_HUMAN 6.52816651747558 5.03333333333333 5.03333333333333 2 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 6.53520366087006 5.03333333333333 5.03333333333333 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 VGFR1 0 1 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 1 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KCC2B 0 2 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.9431368703327 5.03333333333333 5.03333333333333 2 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 5.03333333333333 4.95625 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.93835628759915 5.03333333333333 5.03333333333333 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MP2K1 0 5 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.44 5.03333333333333 5.27861111111111 5 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK14 0 3 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.91222489514667 5.03333333333333 5.03333333333333 3 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TAOK3 0 2 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 6.05216475063231 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.69 5.03333333333333 5.03333333333333 1 Ras-related protein Rab-9A 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.5 5.03333333333333 5.03333333333333 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 DDR2 0 2 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.50021703873966 5.03333333333333 5.03333333333333 2 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NEK11 0 2 NEK11 NEK11_HUMAN 5.39977469754244 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 LYN 0 2 LYN JTK8 LYN_HUMAN 5.86272244993382 5.03333333333333 5.03333333333333 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KPCD1 0 2 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 6.01604063380572 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AL1A1 0 4 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.755 5.03333333333333 5.03333333333333 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CDK2 0 12 CDK2 CDKN2 CDK2_HUMAN 5.57567032686764 5.03333333333333 5.00888888888889 12 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNA1 0 6 CCNA1 CCNA1_HUMAN 5.08457119955018 5.03333333333333 4.98444444444444 6 Cyclin-A1 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNA2 0 6 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.08457119955018 5.03333333333333 4.98444444444444 6 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RAF1 0 4 RAF1 RAF RAF1_HUMAN 5.66042452055598 5.03333333333333 5.34166666666667 4 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 M3K9 0 1 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 1 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ABL2 0 1 ABL2 ABLL ARG ABL2_HUMAN 5.45425837176016 5.03333333333333 5.03333333333333 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.40287225581737 5.03333333333333 5.03333333333333 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MTOR 0 6 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.63259529536047 5.03333333333333 5.03333333333333 6 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TGFR1 0 1 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 6.12338490853968 5.03333333333333 5.03333333333333 1 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 SRC 0 1 SRC SRC1 SRC_HUMAN 5.82557590031178 5.03333333333333 5.03333333333333 1 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 BMX 0 2 BMX BMX_HUMAN 5.63030066930419 5.03333333333333 5.03333333333333 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.2 5.03333333333333 5.03333333333333 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK01 0 8 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.48544236354628 5.03333333333333 5.03333333333333 8 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.74999985591871 5.03333333333333 5.03333333333333 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PEBB 0 2 CBFB PEBB_HUMAN 4.74999985591871 5.03333333333333 5.03333333333333 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 VRK2 0 2 VRK2 VRK2_HUMAN 6.68792321815458 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNE2 0 12 CCNE2 CCNE2_HUMAN 5.95198518030388 5.03333333333333 5.03333333333333 12 G1/S-specific cyclin-E2 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNE1 0 12 CCNE1 CCNE CCNE1_HUMAN 5.95198518030388 5.03333333333333 5.03333333333333 12 G1/S-specific cyclin-E1 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EPHA5 0 1 EPHA5 BSK EHK1 HEK7 TYRO4 EPHA5_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 1 Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK03 0 4 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.23856062735983 5.03333333333333 5.03333333333333 4 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 STK4 0 1 STK4 KRS2 MST1 STK4_HUMAN 5.78837041556533 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 M3K7 0 1 MAP3K7 TAK1 M3K7_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 1 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NUAK1 0 1 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 6.12338490853968 5.03333333333333 5.03333333333333 1 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 LCK 0 4 LCK LCK_HUMAN 5.84584197712888 5.03333333333333 5.03333333333333 4 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TLK2 0 1 TLK2 TLK2_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TAU 0 5 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.69 5.03333333333333 5.03333333333333 5 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.58175106587383 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 6.59992327978754 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 4.78300063017279 5.03333333333333 5.03333333333333 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PIM1 0 2 PIM1 PIM1_HUMAN 5.39936002522273 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NF2L2 0 5 NFE2L2 NRF2, Nfe2l2 Nrf2 NF2L2_HUMAN, NF2L2_RAT 4.5672425380076 5.03333333333333 5.03333333333333 5 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 6.14410428159915 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 P53 0 2 TP53 P53 P53_HUMAN 5.2 5.03333333333333 5.00625 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EPHB4 0 1 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 6.19497660321606 5.03333333333333 5.03333333333333 1 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NEK3 0 1 NEK3 NEK3_HUMAN 6.12338490853968 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CD5R1 0 4 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.45181625804212 5.03333333333333 5.03333333333333 4 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CDK5 0 4 CDK5 CDKN5 CDK5_HUMAN 6.45181625804212 5.03333333333333 5.03333333333333 4 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 INSR 0 3 INSR INSR_HUMAN 6.21196189509376 5.03333333333333 5.03333333333333 3 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 IRAK1 0 2 IRAK1 IRAK IRAK1_HUMAN 6.53520366087006 5.03333333333333 5.03333333333333 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 VGFR3 0 2 FLT4 VEGFR3 VGFR3_HUMAN 5.94040679614039 5.03333333333333 5.03333333333333 2 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KCC1A 0 2 CAMK1 KCC1A_HUMAN 6.0840959134135 5.03333333333333 5.03333333333333 2 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CBX1 0 1 CBX1 CBX CBX1_HUMAN 4.57382231378381 5.03333333333333 5.03333333333333 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 IGF1R 0 3 IGF1R IGF1R_HUMAN 6.21261142365601 5.03333333333333 5.03333333333333 3 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 6.68792321815458 5.03333333333333 5.03333333333333 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KCC2G 0 2 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 2 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 IKKA 0 1 CHUK IKKA TCF16 IKKA_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TBK1 0 2 TBK1 NAK TBK1_HUMAN 6.3942020402497 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 LUCI 0 2 LUCI_PHOPY 4.75 5.03333333333333 5.03333333333333 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 DAPK2 0 2 DAPK2 DAPK2_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 2 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNB3 0 8 CCNB3 CYCB3 CCNB3_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 8 G2/mitotic-specific cyclin-B3 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CDK1 0 8 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 8 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNB1 0 8 CCNB1 CCNB CCNB1_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 8 G2/mitotic-specific cyclin-B1 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNB2 0 8 CCNB2 CCNB2_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 8 G2/mitotic-specific cyclin-B2 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PGH1 0 1 PTGS1 COX1 PGH1_HUMAN 6 5.03333333333333 5.02638888888889 1 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KS6A4 0 4 RPS6KA4 MSK2 KS6A4_HUMAN 6.44258634162228 5.03333333333333 5.03333333333333 4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MARK2 0 2 MARK2 EMK1 MARK2_HUMAN 6.23686510208444 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EPHA7 0 2 EPHA7 EHK3 HEK11 EPHA7_HUMAN 6.59992327978754 5.03333333333333 5.03333333333333 2 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PRKX 0 2 PRKX PKX1 PRKX_HUMAN 5.32334082330819 5.03333333333333 5.03333333333333 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CP2D6 0 2 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.1 5.03333333333333 5.03333333333333 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CSK2B 0 6 CSNK2B CK2N G5A CSK2B_HUMAN 6.28759392246383 5.03333333333333 5.03333333333333 6 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CSK22 0 6 CSNK2A2 CK2A2 CSK22_HUMAN 6.28759392246383 5.03333333333333 5.03333333333333 6 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CSK21 0 6 CSNK2A1 CK2A1 CSK21_HUMAN 6.28759392246383 5.03333333333333 5.03333333333333 6 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PDPK1 0 1 PDPK1 PDK1 PDPK1_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.91518739159678 5.03333333333333 5.03333333333333 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PLK1 0 1 PLK1 PLK PLK1_HUMAN 5.62973141792582 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CP2C9 0 3 CYP2C9 CYP2C10 CP2C9_HUMAN 4.5 5.03333333333333 5.03333333333333 3 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.7119111305119 5.03333333333333 5.03333333333333 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KCC2D 0 1 CAMK2D CAMKD KCC2D_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK11 0 2 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.16972572065322 5.03333333333333 5.03333333333333 2 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.8 5.03333333333333 5.03333333333333 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK13 0 3 MAPK13 PRKM13 SAPK4 MK13_HUMAN 6.52360767984174 5.03333333333333 5.03333333333333 3 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RON 0 2 MST1R PTK8 RON RON_HUMAN 6.31651769404313 5.03333333333333 5.03333333333333 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PIM3 0 2 PIM3 PIM3_HUMAN 5.95639810218423 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 GEMI 0 1 GMNN GEMI_HUMAN 4.8 5.03333333333333 5.03333333333333 1 Geminin 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 5.84818386852601 5.03333333333333 5.03333333333333 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ROCK2 0 3 ROCK2 KIAA0619, Rock2 ROCK2_HUMAN, ROCK2_RAT 6.16397390419538 5.03333333333333 5.03333333333333 3 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TPO 0 2 THPO MGDF TPO_HUMAN 6.4 5.03333333333333 5.03333333333333 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 HIPK2 0 1 HIPK2 HIPK2_HUMAN 6.27875360095283 5.03333333333333 5.03333333333333 1 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FYN 0 2 FYN FYN_HUMAN 5.4645598402777 5.03333333333333 5.03333333333333 2 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK12 0 2 MAPK12 ERK6 SAPK3 MK12_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 2 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ALK 0 2 ALK ALK_HUMAN 5.98369138597531 5.03333333333333 5.03333333333333 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NPC1 0 1 NPC1 NPC1_HUMAN 5.64 5.03333333333333 5.03333333333333 1 Niemann-Pick C1 protein 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 SGK1 0 2 SGK1 SGK SGK1_HUMAN 5.76482515299792 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CP2CJ 0 3 CYP2C19 CP2CJ_HUMAN 5 5.03333333333333 5.03333333333333 3 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CLK3 0 2 CLK3 CLK3_HUMAN 5.67155143012972 5.03333333333333 5.03333333333333 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KPCD2 0 1 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KS6A1 0 4 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.8172651504038 5.03333333333333 5.03333333333333 4 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FGR 0 1 FGR SRC2 FGR_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 6.47493885201844 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 WNK3 0 1 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 5.65854134728041 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 IRAK4 0 1 IRAK4 IRAK4_HUMAN 6.19497660321606 5.03333333333333 5.03333333333333 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TSSK1 0 1 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5.90799732148669 5.03333333333333 5.03333333333333 1 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RGS4 0 1 RGS4 RGS4_HUMAN 4.67382190675771 5.03333333333333 5.03333333333333 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAPK1 0 17 PRKAA1 AMPK1 AAPK1_HUMAN 6.43157897104981 5.03333333333333 5.03333333333333 17 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAKG1 0 17 PRKAG1 AAKG1_HUMAN 6.43157897104981 5.03333333333333 5.03333333333333 17 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAKB1 0 17 PRKAB1 AMPK AAKB1_HUMAN 6.43157897104981 5.03333333333333 5.03333333333333 17 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PMP22 0 1 PMP22 GAS3 PMP22_HUMAN 5.77 5.03333333333333 5.03333333333333 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 BRSK2 0 1 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 HIPK3 0 2 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 6.84291563731303 5.03333333333333 5.03333333333333 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AURKC 0 2 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 6.5953058989068 5.03333333333333 5.03333333333333 2 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FES 0 1 FES FPS FES_HUMAN 6.19497660321606 5.03333333333333 5.03333333333333 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 6.44493086062909 5.03333333333333 5.03333333333333 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.63638913146377 5.03333333333333 5.03333333333333 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ACK1 0 2 TNK2 ACK1 ACK1_HUMAN 5.5283029781462 5.03333333333333 5.03333333333333 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 5.83720090642264 5.03333333333333 5.03333333333333 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAKG2 0 14 PRKAG2 AAKG2_HUMAN 6.44258634162229 5.03333333333333 5.03333333333333 14 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAKB2 0 14 PRKAB2 AAKB2_HUMAN 6.44258634162229 5.03333333333333 5.03333333333333 14 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAPK2 0 14 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 6.44258634162229 5.03333333333333 5.03333333333333 14 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AAKG3 0 14 PRKAG3 AMPKG3 AAKG3_HUMAN 6.44258634162229 5.03333333333333 5.03333333333333 14 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 INSRR 0 1 INSRR IRR INSRR_HUMAN 6.00479888288177 5.03333333333333 5.03333333333333 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6 5.03333333333333 5.01979166666667 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PAK5 0 1 PAK5 KIAA1264 PAK7 PAK5_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KAPCA 0 2 PRKACA PKACA KAPCA_HUMAN 6.32948242133222 5.03333333333333 5.03333333333333 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RIPK2 0 1 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 1 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MYLK 0 1 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.52476288915489 5.03333333333333 5.03333333333333 1 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KC1D 0 1 CSNK1D HCKID KC1D_HUMAN 5.82557590031178 5.03333333333333 5.03333333333333 1 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TAOK1 0 2 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 6.37448143062808 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NTRK2 0 1 NTRK2 TRKB NTRK2_HUMAN 5.82557590031178 5.03333333333333 5.03333333333333 1 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EF2K 0 1 EEF2K EF2K_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 LIMK1 0 2 LIMK1 LIMK LIMK1_HUMAN 6.12338490853968 5.03333333333333 5.03333333333333 2 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.05 5.03333333333333 5.03333333333333 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.03333333333333 5.03333333333333 5.03333333333333 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 6.19497660321606 5.03333333333333 5.03333333333333 1 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ST17A 0 1 STK17A DRAK1 ST17A_HUMAN 5.36797678529459 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ERBB4 0 2 ERBB4 HER4 ERBB4_HUMAN 6.0388137089895 5.03333333333333 5.03333333333333 2 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MERTK 0 1 MERTK MER MERTK_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FRK 0 2 FRK PTK5 RAK FRK_HUMAN 5.9558776620525 5.03333333333333 5.03333333333333 2 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 5.47836099255818 5.03333333333333 5.03333333333333 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KGP1 0 2 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 6.09337546121976 5.03333333333333 5.03333333333333 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 5.79198696368258 5.03333333333333 5.03333333333333 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 SGK2 0 2 SGK2 SGK2_HUMAN 6.09337546121976 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 5.95639810218423 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TAOK2 0 1 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 BTK 0 1 BTK AGMX1 ATK BPK BTK_HUMAN 6.19497660321606 5.03333333333333 5.03333333333333 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 HIPK1 0 1 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CSF1R 0 1 CSF1R FMS CSF1R_HUMAN 5.86530142610254 5.03333333333333 5.03333333333333 1 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MK10 0 2 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.99945645217939 5.03333333333333 5.03333333333333 2 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KPCT 0 2 PRKCQ PRKCT KPCT_HUMAN 6.2851741599501 5.03333333333333 5.03333333333333 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FLT3 0 2 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.78945178348519 5.03333333333333 5.03333333333333 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 STK33 0 1 STK33 STK33_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 5.83167011508109 5.03333333333333 5.03333333333333 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TYRO3 0 1 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 5.54967192186827 5.03333333333333 5.03333333333333 1 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 RET 0 1 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5.6886291709978 5.03333333333333 5.03333333333333 1 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KS6A5 0 2 RPS6KA5 MSK1 KS6A5_HUMAN 5.78837041556533 5.03333333333333 5.03333333333333 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 HASP 0 1 HASPIN GSG2 HASP_HUMAN 5.62973141792582 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FGFR2 0 1 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 1 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 SRPK2 0 1 SRPK2 SRPK2_HUMAN 5.86530142610254 5.03333333333333 5.03333333333333 1 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KS6A6 0 2 RPS6KA6 RSK4 KS6A6_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 6.38021124171161 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MAPK2 0 3 MAPKAPK2 MAPK2_HUMAN 6.27468690580622 5.03333333333333 5.03333333333333 3 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 6.52816651747558 5.03333333333333 5.03333333333333 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 6.2500319164906 5.03333333333333 4.9875 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PKN2 0 2 PKN2 PRK2 PRKCL2 PKN2_HUMAN 6.07460955632769 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PDK1 0 1 PDK1 PDHK1 PDK1_HUMAN 5.78837041556533 5.03333333333333 5.03333333333333 1 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1), [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AKT1 0 1 AKT1 PKB RAC AKT1_HUMAN 5.65854134728041 5.03333333333333 5.03333333333333 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KPCA 0 1 PRKCA PKCA PRKACA KPCA_HUMAN 6.12338490853968 5.03333333333333 5.03333333333333 1 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CDK7 0 2 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 5.90799732148669 5.03333333333333 5.03333333333333 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CCNH 0 2 CCNH CCNH_HUMAN 5.90799732148669 5.03333333333333 5.03333333333333 2 Cyclin-H (MO15-associated protein) (p34) (p37) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ABL1 0 1 ABL1 ABL JTK7 ABL1_HUMAN 6.06069784035361 5.03333333333333 5.03333333333333 1 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 HCK 0 2 HCK HCK_HUMAN 5.84543866320716 5.03333333333333 5.03333333333333 2 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 SGK3 0 1 SGK3 CISK SGKL SGK3_HUMAN 5.78837041556533 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 GSK3A 0 1 GSK3A GSK3A_HUMAN 5.52476288915489 5.03333333333333 5.03333333333333 1 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MP2K6 0 1 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.52476288915489 5.03333333333333 5.03333333333333 1 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 5.78945178348519 5.03333333333333 5.03333333333333 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 KC1G1 0 2 CSNK1G1 KC1G1_HUMAN 6.07202751352768 5.03333333333333 5.03333333333333 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 5.5 5.03333333333333 5.03916666666667 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.89999841719865 5.03333333333333 5.03333333333333 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NLK 0 1 NLK LAK1 NLK_HUMAN 5.82557590031178 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 AKT3 0 1 AKT3 PKBG AKT3_HUMAN 6.27875360095283 5.03333333333333 5.03333333333333 1 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 NEK2 0 1 NEK2 NEK2A NLK1 NEK2_HUMAN 6.69019608002851 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 6.7 5.03333333333333 5.02638888888889 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MUSK 0 1 MUSK MUSK_HUMAN 6.50965047954658 5.03333333333333 5.03333333333333 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 FGFR3 0 1 FGFR3 JTK4 FGFR3_HUMAN 6.99563519459755 5.03333333333333 5.03333333333333 1 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 PFKA 0 1 pfk PFKA_TRYBB 7.42136079003193 5.03333333333333 5.03333333333333 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MP2K7 0 1 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.72015930340596 5.03333333333333 5.03333333333333 1 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 MRCKB 0 1 CDC42BPB KIAA1124 MRCKB_HUMAN 6.27875360095283 5.03333333333333 5.03333333333333 1 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 50222 DYRK2 0 1 DYRK2 DYRK2_HUMAN 6.19497660321606 5.03333333333333 5.03333333333333 1 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 5.03333333333333 actual molregno [molregno] COc1cccc(C2=CC(=O)c3ccccc3O2)c1N 712090 CDK1 9 0 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.08444444444444 4.7 4.7 9 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 TAU 6 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 6.76666666666667 4.7 4.7 6 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 CCNB3 8 0 CCNB3 CYCB3 CCNB3_HUMAN 5.095 4.7 4.7 8 G2/mitotic-specific cyclin-B3 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 CCNB1 8 0 CCNB1 CCNB CCNB1_HUMAN 5.095 4.7 4.7 8 G2/mitotic-specific cyclin-B1 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 CCNB2 8 0 CCNB2 CCNB2_HUMAN 5.095 4.7 4.7 8 G2/mitotic-specific cyclin-B2 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 CD5R1 6 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.1 4.7 4.7 6 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 CDK5 6 0 CDK5 CDKN5 CDK5_HUMAN 5.1 4.7 4.7 6 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 GSK3B 6 0 GSK3B GSK3B_HUMAN 5.86666666666667 4.7 4.7 6 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 GSK3A 6 0 GSK3A GSK3A_HUMAN 5.86666666666667 4.7 4.7 6 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.25 4.7 4.7 1 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 GEMI 1 0 GMNN GEMI_HUMAN 6.89997426989214 4.7 4.7 1 Geminin 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.95 4.7 4.7 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 5.95 4.7 4.7 4 Menin 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 FLT3 1 0 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5 4.7 4.7 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.5 4.7 4.7 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 CDK2 1 0 CDK2 CDKN2 CDK2_HUMAN 5.66 4.7 4.7 1 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 MDH 1 0 mdh MDH_THETH 4.52 4.7 4.7 1 Malate dehydrogenase (EC 1.1.1.37) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 712090 SRC 1 0 SRC SRC1 SRC_HUMAN 4.74 4.7 4.7 1 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0 4.7 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C\3/Nc4ccccc4C3=O 55444 LUCI 0 1 LUCI_PHOPY 4.77098149412752 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 6.35 5 4.98 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.05000045714008 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 FRIL 0 2 FTL FRIL_HORSE 4.60000023821267 5 5 2 Ferritin light chain (Ferritin L subunit) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6 5 5 1 Ras-related protein Rab-9A 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 P53 0 1 TP53 P53 P53_HUMAN 4.84999924507786 5 5 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 CP3A4 0 1 CYP3A4 CYP3A3 CP3A4_HUMAN 4.7 5 5 1 Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5 5 5 1 TAR DNA-binding protein 43 (TDP-43) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 6.1 5 4.98 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5.0625 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 6.9 5 4.98 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.05000045714008 5 5 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 GSK3B 0 1 GSK3B GSK3B_HUMAN 4.92 5 5 1 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 55444 CP2D6 0 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.7 5 4.98 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 5 actual molregno [molregno] Clc1ccccc1CSc2oc(nn2)c3ccncc3 56506 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.18621225375977 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.84999924507786 4.85 4.85 1 Uncharacterized protein 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.13639167022735 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 5.49999693194831 4.85 4.85 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.95000714307986 4.85 4.85 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.95 4.85 4.85 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.55 4.85 4.85 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 4.89999841719865 4.85 4.85 2 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.45000414846935 4.85 4.85 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 0 5 NotRecorded 4.81092925532263 4.85 4.85375 5 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.2 4.85 4.85 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 CBX1 0 1 CBX1 CBX CBX1_HUMAN 4.70000050388302 4.85 4.85 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.62382285083096 4.85 4.85 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 ABC3G 0 1 APOBEC3G MDS019 ABC3G_HUMAN 6.05 4.85 4.85 1 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 ALR 0 1 GFER ALR HERV1 HPO ALR_HUMAN 5.72 4.85 4.85 1 Alanine racemase (EC 5.1.1.1), FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.75 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 56506 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Sc1nnc(Nc2ccccc2)s1 58424 0 139 Fluoroquinolone resistance protein, NotRecorded 4.6140182708728 4.85 4.8505920263789 139 PIPERINE PAIN 1 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.86402777777778 1 PIPERINE PAIN 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 ANDR 0 4 AR DHTR NR3C4 ANDR_HUMAN 4.97463670914854 4.85 4.85520833333333 4 PIPERINE PAIN 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.8 4.85 4.86819444444445 1 PIPERINE PAIN 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 AOFB 0 4 MAOB, Maob AOFB_HUMAN, AOFB_MOUSE, AOFB_RAT 5.6125 4.85 4.86302083333334 4 PIPERINE PAIN 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 NF2L2 0 4 NFE2L2 NRF2 NF2L2_HUMAN 4.80663660902252 4.85 4.85684027777778 4 PIPERINE PAIN 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 NR1I2 0 1 Nr1i2 Pxr NR1I2_RAT 5.14999741390754 4.85 4.85902777777778 1 PIPERINE PAIN 1 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR), Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.96139040545189 4.85 4.87152777777778 2 PIPERINE PAIN 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 AOFA 0 4 MAOA, Maoa AOFA_HUMAN, AOFA_MOUSE, AOFA_RAT 4.9125 4.85 4.86197916666667 4 PIPERINE PAIN 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.70000050388302 4.85 4.85777777777778 1 PIPERINE PAIN 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.65095990678114 4.85 4.86294642857143 1 PIPERINE PAIN 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 AHR 0 1 AHR BHLHE76 AHR_HUMAN 4.84999924507786 4.85 4.87375 1 PIPERINE PAIN 1 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 4.85 4.85777777777778 1 PIPERINE PAIN 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 5.15909759269947 4.85 4.85625 1 PIPERINE PAIN 1 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.05000045714008 4.85 4.87152777777778 1 PIPERINE PAIN 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 ALBU 0 1 ALB ALBU_BOVIN 5 4.85 4.87465277777778 1 PIPERINE PAIN 1 Serum albumin, Serum albumin (BSA) (allergen Bos d 6) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.25 4.85 4.86875 1 PIPERINE PAIN 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 NPC1 0 1 NPC1 NPC1_HUMAN 5.6 4.85 4.86190476190476 1 PIPERINE PAIN 1 Niemann-Pick C1 protein 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 LUCI 0 1 LUCI_PHOPY 5.07098490037598 4.85 4.86875 1 PIPERINE PAIN 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 58424 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 4.85 4.86190476190476 1 PIPERINE PAIN 1 Ras-related protein Rab-9A 1 4.85 actual drug [drugName] O=C(\C=C\C=C\c1ccc2OCOc2c1)N3CCCCC3 60268 58 0 Glycerol-3-phosphate dehydrogenase, NADP-dependent malic enzyme, NotRecorded, Thyroid hormone receptor beta-1 5.14966273098579 4.7 4.7 58 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 ANDR 6 0 AR DHTR NR3C4 ANDR_HUMAN 4.88244400102831 4.7 4.7 6 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 HIF1A 4 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.2 4.7 4.7 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 THB 3 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 10.3433333333333 4.7 4.7 3 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 THA 2 0 THRA EAR7 ERBA1 NR1A1 THRA1 THRA2 THA_HUMAN 9.85 4.7 4.7 2 Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7) (EAR-7) (c-erbA-1) (c-erbA-alpha), Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (c-erbA-1) (c-erbA-alpha) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 MOT8 2 0 SLC16A2 Mct8 MOT8_RAT 5.22421216945206 4.7 4.7 2 Monocarboxylate transporter 8 (MCT 8) (Solute carrier family 16 member 2) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 VDR 1 0 VDR NR1I1 VDR_HUMAN 4.59999938302362 4.7 4.7 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 KAT2A 2 0 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 6.29998893767789 4.7 4.7 2 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 PCNA 1 0 PCNA PCNA_HUMAN 4.6 4.7 4.7 1 Proliferating cell nuclear antigen (PCNA) (Cyclin) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 HCD2 2 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.95 4.7 4.7 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 CP2C9 2 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.3 4.7 4.7 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 PPARD 2 0 PPARD NR1C2 PPARB PPARD_HUMAN 5.58504022608333 4.7 4.7 2 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.8 4.7 4.7 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 4.9 4.7 4.7 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.8 4.7 4.7 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.81374169422763 4.7 4.7 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 SO1C1 1 0 Slco1c1 Oatp1c1 Oatpf Slc21a14 SO1C1_MOUSE 5.67 4.7 4.7 1 Solute carrier organic anion transporter family member 1C1 (Organic anion transporter 2) (OATP2) (Organic anion transporter F) (OATP-F) (Organic anion-transporting polypeptide 14) (OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter), Solute carrier organic anion transporter family member 1C1 (Organic anion transporter F) (OATP-F) (Organic anion transporter polypeptide-related protein 5) (OAT-RP-5) (OATPRP5) (Organic anion-transporting polypeptide 14) (OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 GEMI 1 0 GMNN GEMI_HUMAN 4.73621248726524 4.7 4.7 1 Geminin 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60268 JUN 1 0 JUN JUN_HUMAN 4.61005111884004 4.7 4.7 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 0 4.7 actual molregno [molregno] OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 60597 CP2C9 1 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.15 4.8 4.8 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK11 1 0 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 4.96523789374079 4.8 4.8 1 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 48 3 Nonstructural protein 1, NotRecorded 4.7622432633605 4.8 4.78124183006536 51 0.0588235294117647 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 RGS4 1 0 RGS4 RGS4_HUMAN 4.62382285083096 4.8 4.8 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 6 4.8 4.8 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KS6B1 1 0 RPS6KB1 STK14A KS6B1_HUMAN 5.19426522798427 4.8 4.8 1 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 RIPK2 2 0 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.79830754573016 4.8 4.8 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KAPCA 2 0 PRKACA PKACA KAPCA_HUMAN 5.65 4.8 4.8 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PLK1 1 0 PLK1 PLK PLK1_HUMAN 5.78837041556533 4.8 4.8 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK10 2 0 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.74403250924981 4.8 4.8 2 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SRC 14 2 SRC, SRC SRC1 SRC_CHICK, SRC_HUMAN 6.01851318741777 4.8 4.815625 16 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0.125 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 FYN 1 0 FYN FYN_HUMAN 7.5 4.8 4.8 1 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 VGFR2 1 0 KDR FLK1 VEGFR2 VGFR2_HUMAN 6.4 4.8 4.8 1 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 ACVR1 1 0 ACVR1 ACVRLK2 ACVR1_HUMAN 7.2 4.8 4.8 1 Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I), Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I) (TSK-7L) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 AKT2 1 0 AKT2 AKT2_HUMAN 5.95424250943933 4.8 4.8 1 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MAPK2 1 0 MAPKAPK2 MAPK2_HUMAN 5.41017446508905 4.8 4.8 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KCC1A 1 0 CAMK1 KCC1A_HUMAN 6.00479888288177 4.8 4.8 1 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SRPK1 1 0 SRPK1 SRPK1_HUMAN 5.78837041556533 4.8 4.8 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CLK4 1 0 CLK4 CLK4_HUMAN 6 4.8 4.8 1 Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 DMPK 1 0 DMPK DM1PK MDPK DMPK_HUMAN 4.67264106561367 4.8 4.8 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KC1A 1 0 CSNK1A1 KC1A_HUMAN 6.2 4.8 4.8 1 Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1), Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) (Fragment) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 DYRK3 1 0 DYRK3 DYRK3_HUMAN 6.27875360095283 4.8 4.8 1 Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 Q8IL88 1 0 PF14_0359 PF3D7_1437900 Q8IL88_PLAF7 5.80743254666345 4.8 4.56666666666667 1 HSP40, subfamily A, putative 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 NEK6 1 0 NEK6 NEK6_HUMAN 5.72015930340596 4.8 4.8 1 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PAK6 1 0 PAK6 PAK5 PAK6_HUMAN 6.69019608002851 4.8 4.8 1 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 LCK 5 1 LCK, Lck Lsk-t LCK_HUMAN, LCK_MOUSE 7.42595958176011 4.8 4.82083333333333 6 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0.166666666666667 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CDK5 1 0 CDK5 CDKN5 CDK5_HUMAN 5.5 4.8 4.8 1 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 AURKC 1 0 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.6886291709978 4.8 4.8 1 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 ABL1 1 1 ABL1 ABL JTK7 ABL1_HUMAN 6.7 4.8 4.8625 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 0.5 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SMAD3 2 0 SMAD3 MADH3 SMAD3_HUMAN 5.94999329587496 4.8 4.56666666666667 2 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CDK2 3 0 CDK2 CDKN2 CDK2_HUMAN 5.82557590031178 4.8 4.8 3 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CCNA1 3 0 CCNA1 CCNA1_HUMAN 5.82557590031178 4.8 4.8 3 Cyclin-A1 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CCNA2 3 0 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.82557590031178 4.8 4.8 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.78621404606106 4.8 4.8 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KC1D 2 0 CSNK1D HCKID KC1D_HUMAN 5.63330754573016 4.8 4.8 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 LUCI 1 0 LUCI_PHOPY 4.63 4.8 4.8 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK14 2 0 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.64131295196529 4.8 4.8 2 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MP2K1 2 0 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 6.0503011752846 4.8 4.8 2 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MELK 2 0 MELK KIAA0175 MELK_HUMAN 5.66120320004645 4.8 4.8 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 DAPK3 1 0 DAPK3 ZIPK DAPK3_HUMAN 5.4 4.8 4.8 1 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MAPK5 1 0 MAPKAPK5 PRAK MAPK5_HUMAN 6.06069784035361 4.8 4.8 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PIM3 1 0 PIM3 PIM3_HUMAN 5.95424250943933 4.8 4.8 1 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK09 2 0 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 5.71486570896291 4.8 4.8 2 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KS6A5 2 0 RPS6KA5 MSK1 KS6A5_HUMAN 5.6886291709978 4.8 4.8 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 HCK 2 0 HCK HCK_HUMAN 7.6 4.8 4.45 2 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SGK1 1 0 SGK1 SGK SGK1_HUMAN 5.86530142610254 4.8 4.8 1 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CDK8 1 0 CDK8 CDK8_HUMAN 6.1 4.8 4.8 1 Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK13 1 0 MAPK13 PRKM13 SAPK4 MK13_HUMAN 6.12338490853968 4.8 4.8 1 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.75332766665861 4.8 4.8 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PAK5 1 0 PAK5 KIAA1264 PAK7 PAK5_HUMAN 6.19497660321606 4.8 4.8 1 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PGFRA 1 0 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 6.6 4.8 4.8 1 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CSK 1 0 CSK CSK_HUMAN 4.54574162823984 4.8 4.8 1 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 BRSK2 1 0 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 5.78837041556533 4.8 4.8 1 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.25000102344165 4.8 4.8 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PDPK1 1 0 PDPK1 PDK1 PDPK1_HUMAN 5.86530142610254 4.8 4.8 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 ACK1 1 0 TNK2 ACK1 ACK1_HUMAN 6 4.8 4.8 1 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KPCD1 1 0 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.47712125471966 4.8 4.8 1 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 AKT1 1 0 AKT1 PKB RAC AKT1_HUMAN 6.69019608002851 4.8 4.8 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MK08 2 0 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 5.73034892017681 4.8 4.8 2 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 PGFRB 1 0 PDGFRB PDGFR PDGFR1 PGFRB_HUMAN 6.7 4.8 4.8 1 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SKN7 1 0 SKN7 BRY1 POS9 YHR206W SKN7_YEAST 4.89928491342692 4.8 4.8 1 Transcription factor SKN7 (Peroxide sensitivity protein 9) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 ST32B 1 0 STK32B YANK2 UNQ3003/PRO9744 ST32B_HUMAN 4.82390874094432 4.8 4.8 1 Serine/threonine-protein kinase 32B (EC 2.7.11.1) (Yet another novel kinase 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KKCC1 1 0 CAMKK1 CAMKKA KKCC1_HUMAN 6.99563519459755 4.8 4.8 1 Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MYLK 1 0 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 6.00479888288177 4.8 4.8 1 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 IKKB 1 0 IKBKB IKKB IKKB_HUMAN 5.90799732148669 4.8 4.8 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 GEMI 1 0 GMNN GEMI_HUMAN 4.84999924507786 4.8 4.8 1 Geminin 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 BTK 1 0 BTK AGMX1 ATK BPK BTK_HUMAN 6.2 4.8 4.8 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MP2K2 1 0 MAP2K2 MEK2 MKK2 PRKMK2 MP2K2_HUMAN 6.4 4.8 4.8 1 Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KPCZ 1 0 PRKCZ PKC2 KPCZ_HUMAN 5.78837041556533 4.8 4.8 1 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 MKNK1 1 0 MKNK1 MNK1 MKNK1_HUMAN 5.54967192186827 4.8 4.8 1 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SYUA 2 0 SNCA NACP PARK1 SYUA_HUMAN 5.62500087740459 4.8 4.56666666666667 2 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 CP2CJ 1 0 CYP2C19 CP2CJ_HUMAN 5.7 4.8 4.8 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 KPCA 1 0 PRKCA PKCA PRKACA KPCA_HUMAN 5.38886035082012 4.8 4.8 1 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 RL19A 1 0 RPL19A RPL23A YL14A YBR084C-A YBR084BC RL19A_YEAST 5.89 4.8 4.56666666666667 1 60S ribosomal protein L19-A (L23) (Large ribosomal subunit protein eL19-A) (RP15L) (RP33) (YL14) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 EGFR 1 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 6.32 4.8 4.8 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 5.54999736982681 4.8 4.56666666666667 1 TAR DNA-binding protein 43 (TDP-43) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 60597 SIK2 1 0 SIK2 KIAA0781 QIK SNF1LK2 SIK2_HUMAN 7.6 4.8 4.8 1 Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2) 0 4.8 actual molregno [molregno] CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 62073 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.6 4.8 4.8 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 22 1 NotRecorded 4.94815240447162 4.8 4.80347826086957 23 0.0434782608695652 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.25000102344165 4.8 4.834375 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.8 4.8 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.57497751609793 4.8 4.8 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.5 4.8 4.834375 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.25 4.8 4.8 1 Ras-related protein Rab-9A 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.95 4.8 4.8 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 NPC1 1 0 NPC1 NPC1_HUMAN 5.2 4.8 4.8 1 Niemann-Pick C1 protein 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.91121389924563 4.8 4.8 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 ANDR 1 0 AR DHTR NR3C4 ANDR_HUMAN 5.01374345640117 4.8 4.8 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.834375 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 62073 LUCI 1 0 LUCI_PHOPY 5.22098102808513 4.8 4.8 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.8 actual molregno [molregno] CCc1ccc2C(=O)c3ccccc3C(=O)c2c1 60938 12 5 Cerebroside-sulfatase, NotRecorded 5.21005775551882 8.49 3.46617649156208 17 0.294117647058824 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 60938 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 6.05 8.49 6.95511904761905 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 60938 EHMT2 2 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.3367555898169 8.49 2.67805803571429 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 60938 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 8.49 8.49 3.23166666666667 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 60938 SOAT1 2 0 SOAT1 ACACT ACACT1 ACAT ACAT1 SOAT STAT, Soat1 Acact Acat SOAT1_HUMAN, SOAT1_RAT 5.80357508785945 8.49 2.51198863636364 2 Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1) 0 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 60938 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 6.50003813440381 8.49 3.298 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 60938 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 9.04575749056067 8.49 6.8675 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 8.49 actual molregno [molregno] CCCCCCCCCC[Si](C)(C)CCC(=O)NC(Cc1ccc(C)cc1)c2ccccc2 62864 PPARA 0 49 PPARA NR1C1 PPAR, Ppara Nr1c1 Ppar PPARA_HUMAN, PPARA_MOUSE, PPARA_RAT 5.23485770538262 4.85 4.85000000000002 49 Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 ALDR 0 1 Akr1b1 Akr1b4 Aldr1 ALDR_RAT 5.55 4.85 4.85000000000002 1 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 O97447 0 1 ald O97447_GIAIN 4.6 4.85 4.85000000000002 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 VDR 0 1 VDR NR1I1 VDR_HUMAN 8.10237290870956 4.85 4.85000000000002 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.87500000000001 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 4.54645046955027 4.85 4.85000000000002 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 AL1A1 0 3 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.60666666666667 4.85 4.85000000000002 3 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 8.10237290870956 4.85 4.85000000000002 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 62864 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.6 4.85 4.85000000000002 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 68396 0 386 NotRecorded, Progesterone receptor 4.65151050912559 6.3 6.30000000000003 386 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 PPARG 0 3 PPARG NR1C3 PPARG_HUMAN 5.15141945725339 6.3 6.30000000000003 3 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 IMDH1 0 13 IMPDH1 IMPD1 IMDH1_HUMAN 7.04692307692308 6.3 6.30000000000003 13 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.59999938302362 6.3 6.30000000000003 2 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 PEBB 0 2 CBFB PEBB_HUMAN 4.59999938302362 6.3 6.30000000000003 2 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 SMN 0 7 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.62142857142857 6.3 6.30000000000003 7 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 IMDH2 0 24 IMPDH2 IMPD2 IMDH2_HUMAN 7.47833333333333 6.3 6.30000000000003 24 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 PGDH 0 4 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5625 6.3 6.30000000000003 4 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 KDM4E 0 4 KDM4E KDM4DL KDM4E_HUMAN 4.625 6.3 6.30000000000003 4 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.9 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 GEMI 0 1 GMNN GEMI_HUMAN 6.43616308133546 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Geminin 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.63333333333333 6.3 6.30000000000003 3 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 NFKB1 0 2 NFKB1 NFKB1_HUMAN 4.97133929511026 6.3 6.30000000000003 2 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.63621884741913 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 PMP22 0 2 Pmp22 Cd25 Pmp-22 PMP22_RAT 5.6161115480421 6.3 6.30000000000003 2 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 6.525 6.3 6.30000000000003 2 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 GLP1R 0 1 GLP1R GLP1R_HUMAN 6.04997609347667 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 4.82510034106342 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 UD17 0 1 UGT1A7 GNT1 UGT1 UD17_HUMAN 4.52287874528034 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 UDP-glucuronosyltransferase 1-7 (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G) (UDP-glucuronosyltransferase 1A7) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 68396 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 5.14999741390754 6.3 6.30000000000003 1 MYCOPHENOLIC ACID ACUTE GRAFT VS. HOST DISEASE, CHRONIC KIDNEY DISEASE, IMMUNE SYSTEM DISEASE, INFECTION, INJURY Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor INHIBITOR 4 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 6.3 actual drug [drugName] COc1c(C)c2COC(=O)c2c(O)c1C\C=C(/C)\CCC(=O)O 77762 CCNB3 0 40 CCNB3 CYCB3 CCNB3_HUMAN 6.12838351876992 4.875 4.875 40 G2/mitotic-specific cyclin-B3 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK1 0 45 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 6.15856312779549 4.875 4.875 45 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCNB1 0 44 CCNB1 CCNB CCNB1_HUMAN 6.15307592615447 4.875 4.875 44 G2/mitotic-specific cyclin-B1 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCNB2 0 40 CCNB2 CCNB2_HUMAN 6.12838351876992 4.875 4.875 40 G2/mitotic-specific cyclin-B2 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TGFR1 0 2 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5.5016025699376 4.875 4.875 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK15 0 1 MAPK15 ERK7 ERK8 MK15_HUMAN 5.47712125471966 4.875 4.875 1 Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SRC 0 5 SRC, SRC SRC1 SRC_CHICK, SRC_HUMAN 5.13427484355709 4.875 4.875 5 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KCC2D 0 2 CAMK2D CAMKD KCC2D_HUMAN 4.71000969987954 4.875 4.875 2 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RON 0 2 MST1R PTK8 RON RON_HUMAN 5.46746867712197 4.875 4.875 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK09 0 4 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 5.00596388771404 4.875 4.875 4 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PKN2 0 3 PKN2 PRK2 PRKCL2 PKN2_HUMAN 4.95400386348685 4.875 4.875 3 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CD5R1 0 18 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.30351793462432 4.875 4.875 18 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK5 0 19 CDK5 CDKN5 CDK5_HUMAN 5.32964856964409 4.875 4.875 19 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AURKB 0 4 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 4.94419640854374 4.875 4.875 4 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCD 0 3 PRKCD KPCD_HUMAN 5.03967336771241 4.875 4.875 3 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ROCK2 0 4 ROCK2 KIAA0619 ROCK2_HUMAN 5.1834280594685 4.875 4.875 4 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PAK2 0 2 PAK2 PAK2_HUMAN 5.74096006880072 4.875 4.875 2 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK10 0 3 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.61641964834896 4.875 4.875 3 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 BTK 0 2 BTK AGMX1 ATK BPK BTK_HUMAN 5.69152954229221 4.875 4.875 2 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.92500216726297 4.875 4.87500000000001 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 4.59999938302362 4.875 4.875 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RAF1 0 2 RAF1 RAF RAF1_HUMAN 5.41230432581132 4.875 4.875 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AURKC 0 3 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.52603062412904 4.875 4.875 3 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ULK3 0 2 ULK3 ULK3_HUMAN 5.03269901047002 4.875 4.875 2 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TRXR1 0 4 Txnrd1 Trxr1 TRXR1_RAT 4.67440998756908 4.875 4.87500000000001 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GSK3B 0 13 GSK3B GSK3B_HUMAN 6.44294538355889 4.875 4.875 13 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 LYN 0 3 LYN JTK8 LYN_HUMAN 4.65004076532104 4.875 4.875 3 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HIPK3 0 2 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 6.25179807512565 4.875 4.875 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 VRK2 0 2 VRK2 VRK2_HUMAN 6.47493885201844 4.875 4.875 2 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KCC2B 0 2 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.37606890900936 4.875 4.875 2 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GEMI 0 3 GMNN GEMI_HUMAN 5.1408079017515 4.875 4.87500000000001 3 Geminin 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TAOK1 0 2 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 5.04521394274007 4.875 4.875 2 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KGP1 0 4 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 6.08568352558326 4.875 4.875 4 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MAPK5 0 3 MAPKAPK5 PRAK MAPK5_HUMAN 5.82656241872304 4.875 4.875 3 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HD 1 2 HTT HD IT15 HD_HUMAN 6.7 4.875 4.75520833333334 3 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 0.666666666666667 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FGR 0 2 FGR SRC2 FGR_HUMAN 4.66775323790749 4.875 4.875 2 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CLK2 0 2 CLK2 CLK2_HUMAN 5.35339767092399 4.875 4.875 2 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MARK3 0 2 MARK3 CTAK1 EMK2 MARK3_HUMAN 5.4750612633917 4.875 4.87500000000001 2 MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FEN1 0 1 FEN1 RAD2 FEN1_HUMAN 5.37382393584527 4.875 4.87500000000001 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TAOK3 0 2 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 5.12105552952267 4.875 4.875 2 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAKG2 0 14 PRKAG2 AAKG2_HUMAN 4.94335218258067 4.875 4.875 14 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAKB2 0 14 PRKAB2 AAKB2_HUMAN 4.94335218258067 4.875 4.875 14 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAPK1 0 21 PRKAA1 AMPK1 AAPK1_HUMAN 4.8725756318442 4.875 4.875 21 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAPK2 0 14 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 4.94335218258067 4.875 4.875 14 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAKB1 0 20 PRKAB1 AMPK AAKB1_HUMAN 5.01620441343641 4.875 4.875 20 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAKG1 0 20 PRKAG1 AAKG1_HUMAN 5.01620441343641 4.875 4.875 20 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AAKG3 0 14 PRKAG3 AMPKG3 AAKG3_HUMAN 4.94335218258067 4.875 4.875 14 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK12 0 3 MAPK12 ERK6 SAPK3 MK12_HUMAN 4.56545591235067 4.875 4.875 3 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PMP22 0 1 PMP22 GAS3 PMP22_HUMAN 6.87 4.875 4.87500000000001 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AKT2 0 4 AKT2 AKT2_HUMAN 4.90389187439616 4.875 4.875 4 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK01 0 4 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.67591796041697 4.875 4.875 4 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MERTK 0 2 MERTK MER MERTK_HUMAN 5.06974872838961 4.875 4.875 2 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TSSK1 0 2 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5.40410090212118 4.875 4.875 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 6.28623422570369 4.875 4.87500000000001 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHB4 0 2 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 5.64842883615341 4.875 4.875 2 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 4.88670887434053 4.875 4.875 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHA7 0 2 EPHA7 EHK3 HEK11 EPHA7_HUMAN 6.05018527255878 4.875 4.875 2 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK13 0 4 MAPK13 PRKM13 SAPK4 MK13_HUMAN 5.03523498073863 4.875 4.875 4 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 STK4 0 2 STK4 KRS2 MST1 STK4_HUMAN 4.81320966859371 4.875 4.875 2 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCA 0 3 PRKCA PKCA PRKACA KPCA_HUMAN 5.7159317316819 4.875 4.875 3 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK2 0 22 CDK2 CDKN2 CDK2_HUMAN 4.79944926797468 4.875 4.875 22 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCNA1 0 15 CCNA1 CCNA1_HUMAN 4.96054030367856 4.875 4.875 15 Cyclin-A1 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCNA2 0 15 CCNA2 CCN1 CCNA CCNA2_HUMAN 4.96054030367856 4.875 4.875 15 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MYLK 0 3 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.58944510935256 4.875 4.875 3 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KC1G3 0 1 CSNK1G3 KC1G3_HUMAN 5.43195909596147 4.875 4.875 1 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FAK1 0 2 PTK2 FAK FAK1 FAK1_HUMAN 5.12418344109568 4.875 4.875 2 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PDPK1 0 4 PDPK1 PDK1 PDPK1_HUMAN 5.35291934694497 4.875 4.875 4 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCT 0 2 PRKCQ PRKCT KPCT_HUMAN 4.8175692535138 4.875 4.875 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 VGFR3 0 3 FLT4 VEGFR3 VGFR3_HUMAN 5.31835447621725 4.875 4.875 3 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MTOR 0 4 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.69504902000713 4.875 4.87500000000001 4 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FLT3 0 3 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.26026009793099 4.875 4.875 3 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NEK3 0 2 NEK3 NEK3_HUMAN 5.51995294150744 4.875 4.875 2 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 STK3 0 4 STK3 KRS1 MST2 STK3_HUMAN 5.36433332007508 4.875 4.875 4 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 UFO 0 2 AXL UFO UFO_HUMAN 5.46470946285714 4.875 4.875 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ABL1 0 3 ABL1 ABL JTK7 ABL1_HUMAN 5.61853741507744 4.875 4.875 3 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ALK 0 2 ALK ALK_HUMAN 5.48501838831127 4.875 4.875 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDC7 0 1 CDC7 CDC7L1 CDC7_HUMAN 7 4.875 4.87500000000001 1 Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK9 0 6 CDK9 CDC2L4 TAK CDK9_HUMAN 4.63853706814987 4.875 4.875 6 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCNT1 0 6 CCNT1 CCNT1_HUMAN 4.63853706814987 4.875 4.875 6 Cyclin-T1 (CycT1) (Cyclin-T) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SGK1 0 3 SGK1 SGK SGK1_HUMAN 5.83684833673554 4.875 4.875 3 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GSK3A 1 3 GSK3A GSK3A_HUMAN 6.77531159976179 4.875 4.78515625 4 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 0.75 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RGS4 0 1 RGS4 RGS4_HUMAN 4.87382311925681 4.875 4.87500000000001 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 6.38021124171161 4.875 4.875 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SMAD3 0 3 SMAD3 MADH3 SMAD3_HUMAN 5.70747367850847 4.875 4.87500000000001 3 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DMPK 0 2 DMPK DM1PK MDPK DMPK_HUMAN 6.09913982527219 4.875 4.875 2 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FGFR2 0 1 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 5.43195909596147 4.875 4.875 1 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CSK21 0 11 CSNK2A1 CK2A1 CSK21_HUMAN 5.43060815294828 4.875 4.875 11 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 BMX 0 2 BMX BMX_HUMAN 5.33002596915282 4.875 4.875 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DDR2 0 2 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 5.83066249407265 4.875 4.875 2 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KCC1A 0 4 CAMK1 KCC1A_HUMAN 4.87863410026969 4.875 4.875 4 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CSK22 0 10 CSNK2A2 CK2A2 CSK22_HUMAN 5.46973875227847 4.875 4.875 10 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NEK2 0 4 NEK2 NEK2A NLK1 NEK2_HUMAN 4.92659737314814 4.875 4.875 4 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PIM1 0 4 PIM1 PIM1_HUMAN 5.29112062729256 4.875 4.875 4 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CHK2 0 4 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 4.81998327714288 4.875 4.875 4 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 IRAK1 0 2 IRAK1 IRAK IRAK1_HUMAN 5.7611677688012 4.875 4.875 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CSK 0 2 CSK CSK_HUMAN 5.57724715354036 4.875 4.875 2 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHA5 0 1 EPHA5 BSK EHK1 HEK7 TYRO4 EPHA5_HUMAN 5.60205999132796 4.875 4.875 1 Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 LCK 0 7 LCK, Lck Lsk-t LCK_HUMAN, LCK_MOUSE 4.90047250631229 4.875 4.875 7 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 M3K7 0 2 MAP3K7 TAK1 M3K7_HUMAN 5.47854517615608 4.875 4.875 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DYRK3 0 1 DYRK3 DYRK3_HUMAN 5.62973141792582 4.875 4.875 1 Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RIPK2 0 2 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 4.71647699103116 4.875 4.875 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PIM3 0 3 PIM3 PIM3_HUMAN 5.28462083415509 4.875 4.875 3 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MRCKA 0 1 CDC42BPA KIAA0451 MRCKA_HUMAN 5.3 4.875 4.87500000000001 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ABC3G 0 1 APOBEC3G MDS019 ABC3G_HUMAN 4.62497687101211 4.875 4.87500000000001 1 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK11 0 3 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.29231566748934 4.875 4.875 3 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SRPK3 0 2 SRPK3 MSSK1 STK23 SRPK3_HUMAN 6.25788599017014 4.875 4.875 2 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHA3 0 2 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 5.41440393708142 4.875 4.875 2 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHA4 0 1 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 6.50965047954658 4.875 4.875 1 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HIPK2 0 3 HIPK2 HIPK2_HUMAN 5.85660165705698 4.875 4.875 3 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 INSR 0 5 INSR INSR_HUMAN 4.80637398548367 4.875 4.875 5 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HCK 0 4 HCK HCK_HUMAN 4.60618241503919 4.875 4.875 4 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MKNK2 0 2 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.37998864072753 4.875 4.875 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FES 0 2 FES FPS FES_HUMAN 5.00926536625258 4.875 4.875 2 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.875 4.875 4.875 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KAPCA 0 4 PRKACA PKACA KAPCA_HUMAN 4.83352818752233 4.875 4.875 4 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MP2K6 0 1 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.52476288915489 4.875 4.875 1 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KS6A4 0 4 RPS6KA4 MSK2 KS6A4_HUMAN 5.4448400863335 4.875 4.875 4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 5.9404067961404 4.875 4.875 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KSYK 0 2 SYK KSYK_HUMAN 4.9665266051847 4.875 4.875 2 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 INSRR 0 1 INSRR IRR INSRR_HUMAN 5.65854134728041 4.875 4.875 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PHKG2 0 1 PHKG2 PHKG2_HUMAN 5.90799732148669 4.875 4.875 1 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PLK1 0 5 PLK1 PLK PLK1_HUMAN 4.58639322294564 4.875 4.875 5 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 VGFR2 0 4 KDR FLK1 VEGFR2 VGFR2_HUMAN 4.9516927437143 4.875 4.875 4 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 WNK3 0 2 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 5.61663910569856 4.875 4.875 2 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DYRK2 0 3 DYRK2 DYRK2_HUMAN 5.46850225353206 4.875 4.875 3 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHB1 0 2 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 6.09539921529885 4.875 4.875 2 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK7 0 4 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 5.80342943710486 4.875 4.875 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCNH 0 4 CCNH CCNH_HUMAN 5.80342943710486 4.875 4.875 4 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TLK2 0 2 TLK2 TLK2_HUMAN 5.72883462167748 4.875 4.875 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AURKA 0 3 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 5.89923849934873 4.875 4.875 3 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KCC2G 0 2 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 4.60581479221733 4.875 4.875 2 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.08333333333333 4.875 4.87500000000001 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ROCK1 0 1 ROCK1 ROCK1_HUMAN 5.7 4.875 4.87500000000001 1 Rho-associated protein kinase 1 (EC 2.7.11.1) (Liver regeneration-related protein LRRG199) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p150 RhoA-binding kinase ROK beta) (p160 ROCK-1) (p160ROCK), Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NEK7 0 2 NEK7 NEK7_HUMAN 6.35231354138132 4.875 4.875 2 Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CSF1R 0 3 CSF1R FMS CSF1R_HUMAN 5.05262100492523 4.875 4.875 3 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCL 0 2 PRKCH PKCL PRKCL KPCL_HUMAN 5.80257553415256 4.875 4.875 2 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 6.8 4.875 4.87500000000001 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ULK2 0 2 ULK2 KIAA0623 ULK2_HUMAN 5.0932737228682 4.875 4.875 2 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.46138011433565 4.875 4.87500000000001 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 STK33 0 2 STK33 STK33_HUMAN 6.0696909487362 4.875 4.875 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.05000045714008 4.875 4.87500000000001 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PRKX 0 2 PRKX PKX1 PRKX_HUMAN 5.2976297558681 4.875 4.875 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 P53 0 2 TP53 P53 P53_HUMAN 4.8 4.875 4.87500000000001 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.74568084691713 4.875 4.875 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.875 4.87500000000001 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NR0B1 0 1 NR0B1 AHC DAX1 NR0B1_HUMAN 6.07908397497763 4.875 4.87500000000001 1 Nuclear receptor subfamily 0 group B member 1 (DSS-AHC critical region on the X chromosome protein 1) (Nuclear receptor DAX-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TPO 0 2 THPO MGDF TPO_HUMAN 6.8 4.875 4.87500000000001 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 M3K5 0 2 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 5.68935032534318 4.875 4.875 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TYRO3 0 2 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 5.8746635056757 4.875 4.875 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CLK3 0 2 CLK3 CLK3_HUMAN 5.4286163923456 4.875 4.875 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 4.53241852262981 4.875 4.875 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 STK10 0 2 STK10 LOK STK10_HUMAN 5.74247329611581 4.875 4.875 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 5.83066249407265 4.875 4.875 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CSK2B 0 9 CSNK2B CK2N G5A CSK2B_HUMAN 5.40407663138123 4.875 4.875 9 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCD1 0 3 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 6.1410903620791 4.875 4.875 3 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MDHM 0 1 MDH2 MDHM_HUMAN 5.46561609231434 4.875 4.875 1 Malate dehydrogenase, mitochondrial (EC 1.1.1.37) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NFKB1 0 4 NFKB1 NFKB1_HUMAN 5.7 4.875 4.87500000000001 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 VDR 0 1 VDR NR1I1 VDR_HUMAN 4.55000045168903 4.875 4.87500000000001 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 STK11 0 2 STK11 LKB1 PJS STK11_HUMAN 6.3942020402497 4.875 4.875 2 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FRK 0 2 FRK PTK5 RAK FRK_HUMAN 5.07563383766533 4.875 4.875 2 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KKCC2 0 1 CAMKK2 CAMKKB KIAA0787 KKCC2_HUMAN 5.19426522798427 4.875 4.875 1 Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FYN 0 3 FYN FYN_HUMAN 5.31483842720344 4.875 4.875 3 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ABL2 0 2 ABL2 ABLL ARG ABL2_HUMAN 5.20672608742515 4.875 4.875 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CCND3 0 4 CCND3 CCND3_HUMAN 5.09084756828684 4.875 4.875 4 G1/S-specific cyclin-D3 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CDK6 0 4 CDK6 CDKN6 CDK6_HUMAN 5.09084756828684 4.875 4.875 4 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.53691104640714 4.875 4.875 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 5.04637702661845 4.875 4.875 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PAK6 0 3 PAK6 PAK5 PAK6_HUMAN 5.03842915596143 4.875 4.875 3 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KKCC1 0 1 CAMKK1 CAMKKA KKCC1_HUMAN 5.45425837176016 4.875 4.875 1 Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CHK1 0 4 CHEK1 CHK1 CHK1_HUMAN 5.34677884147725 4.875 4.875 4 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KS6A1 0 6 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.58768799400699 4.875 4.875 6 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NPC1 0 1 NPC1 NPC1_HUMAN 6.29 4.875 4.87500000000001 1 Niemann-Pick C1 protein 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK14 0 3 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.95645947202045 4.875 4.875 3 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PTK6 0 2 PTK6 BRK PTK6_HUMAN 5.84446403302094 4.875 4.875 2 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHA8 0 2 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 5.96864747411662 4.875 4.875 2 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 BRSK1 0 2 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.009369323915 4.875 4.875 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.6 4.875 4.875 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DYR1A 0 3 DYRK1A DYRK MNB MNBH, Dyrk1a Dyrk DYR1A_HUMAN, DYR1A_RAT 5.30068666377599 4.875 4.875 3 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 VGFR1 0 3 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 5.57683255372354 4.875 4.875 3 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 LIMK1 0 3 LIMK1 LIMK LIMK1_HUMAN 5.53668577093822 4.875 4.875 3 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 5.77286760185887 4.875 4.875 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.77723540237502 4.875 4.875 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TAOK2 0 2 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 5.29887645165653 4.875 4.875 2 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FER 0 2 FER TYK3 FER_HUMAN 5.65656665236011 4.875 4.875 2 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PLK3 0 3 PLK3 CNK FNK PRK PLK3_HUMAN 4.65579425731688 4.875 4.875 3 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 4.57603633498344 4.875 4.875 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KCC1D 0 2 CAMK1D CAMKID KCC1D_HUMAN 5.77767200225057 4.875 4.875 2 Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MARK2 0 3 MARK2 EMK1 MARK2_HUMAN 5.22928173457552 4.875 4.875 3 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MP2K1 0 2 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.76192138669147 4.875 4.875 2 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MELK 0 3 MELK KIAA0175 MELK_HUMAN 5.44083547719731 4.875 4.875 3 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NEK11 0 2 NEK11 NEK11_HUMAN 4.69926577814922 4.875 4.875 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TBK1 0 2 TBK1 NAK TBK1_HUMAN 4.85234530738104 4.875 4.875 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SGK2 0 3 SGK2 SGK2_HUMAN 4.8166311887859 4.875 4.875 3 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MAPK3 0 3 MAPKAPK3 MAPK3_HUMAN 4.80588260034442 4.875 4.875 3 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KS6A5 0 4 RPS6KA5 MSK1 KS6A5_HUMAN 6.43046831035004 4.875 4.875 4 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GRK5 0 2 GRK5 GPRK5 GRK5_HUMAN 6.32948242133222 4.875 4.875 2 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK03 0 4 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.38731473626172 4.875 4.875 4 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KC1D 0 4 CSNK1D HCKID KC1D_HUMAN 4.9049037514357 4.875 4.875 4 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.85986974618548 4.875 4.875 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCB 0 2 PRKCB PKCB PRKCB1 KPCB_HUMAN 6.43046831035004 4.875 4.875 2 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SRPK1 0 2 SRPK1 SRPK1_HUMAN 6.52816651747558 4.875 4.875 2 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CP2D6 0 2 CYP2D6 CYP2DL1 CP2D6_HUMAN 6.4 4.875 4.87500000000001 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HASP 0 2 HASPIN GSG2 HASP_HUMAN 5.03567795426783 4.875 4.875 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NEK6 0 1 NEK6 NEK6_HUMAN 6.12338490853968 4.875 4.875 1 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.57392400803626 4.875 4.875 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MK08 0 4 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 5.01301308713551 4.875 4.875 4 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KC1G1 0 1 CSNK1G1 KC1G1_HUMAN 5.38886035082012 4.875 4.875 1 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KS6A6 0 2 RPS6KA6 RSK4 KS6A6_HUMAN 5.75332766665861 4.875 4.875 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PLK2 0 2 PLK2 SNK PLK2_HUMAN 6.50021703873966 4.875 4.875 2 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.44 4.875 4.87500000000001 1 Ras-related protein Rab-9A 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ST17A 0 2 STK17A DRAK1 ST17A_HUMAN 5.15316856129246 4.875 4.875 2 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 TIE2 0 1 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 6.69019608002851 4.875 4.875 1 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 5.92453412795947 4.875 4.875 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 5.41017446508905 4.875 4.875 1 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 CLK1 0 1 CLK1 CLK CLK1_HUMAN 5 4.875 4.875 1 Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1), Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) (Protein kinase STY) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 FAK2 0 2 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 5.52408801232586 4.875 4.875 2 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SGK3 0 2 SGK3 CISK SGKL SGK3_HUMAN 5.84671402693979 4.875 4.875 2 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MRCKB 0 2 CDC42BPB KIAA1124 MRCKB_HUMAN 5.22246828567413 4.875 4.875 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.6 4.875 4.87500000000001 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 PLK4 0 1 PLK4 SAK STK18 PLK4_HUMAN 6.4 4.875 4.87500000000001 1 Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DCLK2 0 1 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.78837041556533 4.875 4.875 1 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HIPK1 0 1 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 5.95424250943933 4.875 4.875 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 5.75332766665861 4.875 4.875 1 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.5 4.875 4.87500000000001 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 MKNK1 0 1 MKNK1 MNK1 MKNK1_HUMAN 5.75332766665861 4.875 4.875 1 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KCC4 0 1 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.72015930340596 4.875 4.875 1 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KPCE 0 1 PRKCE PKCE KPCE_HUMAN 5.75332766665861 4.875 4.875 1 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 BRSK2 0 3 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 4.87638758443772 4.875 4.875 3 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 END4 0 1 nfo b2159 JW2146 END4_ECOLI 5.2 4.875 4.87500000000001 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SIK1 0 2 SIK1 SIK SNF1LK SIK1_HUMAN 5.37746070483259 4.875 4.875 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 WNK2 0 2 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.71547288568131 4.875 4.875 2 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 NLK 0 2 NLK LAK1 NLK_HUMAN 5.3791325495696 4.875 4.875 2 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 RET 0 2 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5.76677968681437 4.875 4.875 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 LUCI 0 1 LUCI_PHOPY 4.8 4.875 4.87500000000001 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DRD1 0 1 DRD1 DRD1_HUMAN 5.48623654453125 4.875 4.87500000000001 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KC1A 0 1 CSNK1A1 KC1A_PIG 5 4.875 4.875 1 Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1), Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1) (Fragment) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.25 4.875 4.87500000000001 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 7.28316227670048 4.875 4.875 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 EF2K 0 1 EEF2K EF2K_HUMAN 5.75332766665861 4.875 4.875 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 DAPK2 0 1 DAPK2 DAPK2_HUMAN 6.12338490853968 4.875 4.875 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 SRPK2 0 1 SRPK2 SRPK2_HUMAN 5.78837041556533 4.875 4.875 1 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 KC1G2 0 1 CSNK1G2 CK1G2 KC1G2_HUMAN 5.6886291709978 4.875 4.875 1 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 77762 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 5.15 4.875 4.87500000000001 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.875 actual molregno [molregno] Brc1ccc2[nH]c3c(CC(=O)Nc4ccccc34)c2c1 81827 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.7 4.85 4.85 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 4.85 4.85 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 5.19999817218203 4.85 4.85 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CAH12 0 1 CA12 CAH12_HUMAN 5.11 4.85 4.85 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 GEMI 0 1 GMNN GEMI_HUMAN 6.18621892182592 4.85 4.85 1 Geminin 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 4.6 4.85 4.85 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 4.85 4.85 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 GLSK 0 1 GLS GLS1 KIAA0838 GLSK_HUMAN 4.89999841719865 4.85 4.85 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 O97447 0 2 ald O97447_GIAIN 4.65 4.85 4.85 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CAH9 0 1 CA9 G250 MN CAH9_HUMAN 6.21 4.85 4.85 1 Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CAH1 0 1 CA1 CAH1_HUMAN 5.31 4.85 4.85 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.66666666666667 4.85 4.85 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.3449427964134 4.85 4.85 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 MK01 0 2 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.65 4.85 4.85 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CAH13 0 1 CA13 CAH13_HUMAN 5.01 4.85 4.85 1 Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 POLK 0 3 POLK DINB1 POLK_HUMAN 4.79999974576398 4.85 4.85 3 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CASP7 0 2 CASP7 MCH3 CASP7_HUMAN 4.75 4.85 4.85 2 Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.5 4.85 4.85 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 FEN1 0 1 FEN1 RAD2 FEN1_HUMAN 5.05000045714008 4.85 4.85 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 TYDP1 0 1 TDP1 TYDP1_HUMAN 4.85 4.85 4.85 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CAH7 0 1 CA7 CAH7_HUMAN 5.36 4.85 4.85 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.9 4.85 4.85 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 CASP1 0 2 CASP1 IL1BC IL1BCE CASP1_HUMAN 4.65 4.85 4.85 2 Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 5 4.85 4.85 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.59999938302362 4.85 4.85 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.70000050388302 4.85 4.85 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 81827 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.54999736982681 4.85 4.85 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.85 actual molregno [molregno] COc1cc2C=CC(=O)Oc2c(O)c1O 82429 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.26121414276647 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 LUCI 0 1 LUCI_PHOPY 5.22098102808513 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.4 4.9 5.1475 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.4 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 NPC1 0 1 NPC1 NPC1_HUMAN 5.55 4.9 5.1125 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.59999938302362 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 82429 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.59999765407204 4.9 5.025 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] COc1ccc2C(=O)c3ccccc3C(=O)c2c1OC 83492 5HT1A 0 1 Htr1a 5ht1a 5HT1A_RAT 8.82 4.9 4.9 1 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A), 5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (Serotonin receptor 1A) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 RGS4 0 2 RGS4 RGS4_HUMAN 6.99869064898506 4.9 4.9 2 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 ADA2C 0 3 ADRA2C ADRA2L2 ADRA2RL2 ADA2C_HUMAN 5.65 4.9 4.9 3 Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 ADA2A 0 3 ADRA2A ADRA2R ADRAR ADA2A_HUMAN 5.65 4.9 4.9 3 Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor) (CA2-47) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 ADA2B 0 3 ADRA2B ADRA2L1 ADRA2RL1 ADA2B_HUMAN 5.65 4.9 4.9 3 Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR), Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.975 4.9 4.9 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 ADA1A 0 1 Adra1a Adra1c ADA1A_RAT 9.49 4.9 4.9 1 Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor), Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.85 4.9 4.9 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 83492 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.74999985591871 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] COc1ccccc1N2CCN(CCN3C(=O)N(C)c4c(C3=O)n(C)c5ccccc45)CC2 84814 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.80333333333333 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5.38621101521651 4.9 4.87833333333333 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.1 4.9 4.82857142857143 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 5.1 4.9 4.82857142857143 4 Menin 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.68621284836475 4.9 4.8 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 HD 0 1 HTT HD IT15 HD_HUMAN 6 4.9 4.83333333333333 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 4.9 4.81666666666667 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 HMDH 0 16 HMGCR, Hmgcr HMDH_HUMAN, HMDH_RAT 7.54375 4.9 4.9 16 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.89999841719865 4.9 4.84166666666667 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 MTOR 0 2 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.905 4.9 4.81166666666667 2 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 GEMI 0 2 GMNN GEMI_HUMAN 5.31121164095809 4.9 4.84583333333333 2 Geminin 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.8 4.9 4.85625 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 84814 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.98639184935954 4.9 4.82916666666667 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 86617 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.8 4.5 4.5 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 NTRK2 1 0 Ntrk2 Trkb NTRK2_RAT 5 4.5 4.5 1 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 CASP1 1 0 CASP1 IL1BC IL1BCE CASP1_HUMAN 4.7 4.5 4.5 1 Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 LX15B 1 0 ALOX15B LX15B_HUMAN 4.59999938302362 4.5 4.5 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 LOX15 1 0 ALOX15 LOG15 LOX15_HUMAN 4.8 4.5 4.5 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 6 0 NotRecorded 5.0977082066699 4.5 4.58453125 6 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 LOX12 1 0 ALOX12 12LO LOG12 LOX12_HUMAN 8.1 4.5 3.875 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 CP19A 1 0 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 8.06 4.5 4.49375 1 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.95000714307986 4.5 4.5 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.975 4.5 4.5 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.5 4.5 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 ALDR 1 0 AKR1B1 ALDR_BOVIN 5.4 4.5 4.5 1 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.75 4.5 4.5 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 CASP7 1 0 CASP7 MCH3 CASP7_HUMAN 4.6 4.5 4.5 1 Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 P53 2 0 TP53 P53 P53_HUMAN 5.65 4.5 4.5 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 86617 POLK 1 0 POLK DINB1 POLK_HUMAN 5.49999693194831 4.5 4.5 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.5 actual molregno [molregno] Oc1cc2OC(=CC(=O)c2cc1O)c3ccccc3 88123 EHMT2 3 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.0166653633242 4.65 4.65 3 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 42 0 26S proteasome non-ATPase regulatory subunit 14, Cerebroside-sulfatase, NotRecorded 4.66823286034267 4.65 4.65178571428572 42 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 LT 2 0 LT_SV40 4.59171365198695 4.65 4.65 2 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 TRXR1 3 0 Txnrd1 Trxr1 TRXR1_RAT 5.7077895508156 4.65 4.65 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 KMT2A 19 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.68421052631579 4.65 4.65 19 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 MEN1 16 0 MEN1 SCG2 MEN1_HUMAN 4.7375 4.65 4.65 16 Menin 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 LEF 1 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.6 4.65 4.65 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 FEN1 2 0 FEN1 RAD2 FEN1_HUMAN 4.97382262535081 4.65 4.65 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 GEMI 4 0 GMNN GEMI_HUMAN 5.9772456920473 4.65 4.65 4 Geminin 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 POLH 1 0 POLH RAD30 RAD30A XPV POLH_HUMAN 4.89999841719865 4.65 4.65 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 MPP8 2 0 MPHOSPH8 MPP8 MPP8_HUMAN 4.93691037074101 4.65 4.65 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.06819593618431 4.65 4.65 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 VDR 1 0 VDR NR1I1 VDR_HUMAN 4.89999841719865 4.65 4.65 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 O97447 1 0 ald O97447_GIAIN 4.6 4.65 4.65 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 LOX12 1 0 ALOX12 12LO LOG12 LOX12_HUMAN 4.85 4.65 4.65 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 EGFR 7 0 EGFR ERBB ERBB1 HER1, Egfr EGFR_HUMAN, EGFR_MOUSE 5.54627267727776 4.65 4.65 7 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 BAZ2B 2 0 BAZ2B KIAA1476 BAZ2B_HUMAN 4.89999841719865 4.65 4.65 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 LUCI 2 0 LUCI_PHOPY 4.56049106525116 4.65 4.65 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.65 4.65 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 RGS4 1 0 RGS4 RGS4_HUMAN 4.67382190675771 4.65 4.65 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 KDM4E 2 0 KDM4E KDM4DL KDM4E_HUMAN 4.9 4.65 4.65 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.6 4.65 4.65 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 CBX1 2 0 CBX1 CBX CBX1_HUMAN 4.92499890945644 4.65 4.65 2 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 KDM4A 3 0 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.74999985591871 4.65 4.65 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 NFKB1 4 0 NFKB1 NFKB1_HUMAN 6 4.65 4.65 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 5.1 4.65 4.65 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 PGFRB 2 0 Pdgfrb Pdgfr Pdgfr1 PGFRB_MOUSE 5 4.65 4.65 2 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 PGFRA 2 0 Pdgfra PGFRA_MOUSE 5 4.65 4.65 2 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 4.65 4.65 4.65 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 LOX15 1 0 ALOX15 LOG15 LOX15_HUMAN 5.5 4.65 4.65 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.65000022087346 4.65 4.65 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 ATX2 3 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.86666806348155 4.65 4.65 3 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 HCD2 3 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.53333333333333 4.65 4.65 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 5.29999760285775 4.65 4.65 1 TAR DNA-binding protein 43 (TDP-43) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 TAU 4 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.85 4.65 4.65 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 P53 2 0 TP53 P53 P53_HUMAN 4.95 4.65 4.65 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 PIN1 2 0 PIN1 PIN1_HUMAN 4.78548980059808 4.65 4.65 2 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.63621273654598 4.65 4.65 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 GRP78 3 0 HSPA5 GRP78 GRP78_HUMAN 4.71100020484593 4.65 4.65 3 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 RUNX1 2 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 4.65 4.65 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 PEBB 2 0 CBFB PEBB_HUMAN 4.89999841719865 4.65 4.65 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 POLK 3 0 POLK DINB1 POLK_HUMAN 4.54127362688929 4.65 4.65 3 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.15 4.65 4.65 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 CP2CJ 2 0 CYP2C19 CP2CJ_HUMAN 4.9 4.65 4.65 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.65 4.65 4.65 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 ACM1 1 0 Chrm1 Chrm-1 ACM1_RAT 4.7 4.65 4.65 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 GLSK 1 0 GLS GLS1 KIAA0838 GLSK_HUMAN 4.65000022087346 4.65 4.65 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 6.3 4.65 4.65 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.6 4.65 4.65 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 88123 FRIL 1 0 FTL FRIL_HORSE 4.9 4.65 4.65 1 Ferritin light chain (Ferritin L subunit) 0 4.65 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)Nc2ccccc2)cc1O 87221 CDK2 6 0 CDK2 CDKN2 CDK2_HUMAN 6.22176187334356 4.76666666666667 4.76666666666668 6 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCNA1 3 0 CCNA1 CCNA1_HUMAN 5.75332766665861 4.76666666666667 4.76666666666668 3 Cyclin-A1 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCNA2 3 0 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.75332766665861 4.76666666666667 4.76666666666668 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 64 0 Cerebroside-sulfatase, Nonstructural protein 1, NotRecorded, T-complex protein 1 subunit beta 4.656414572099 4.76666666666667 4.76666666666668 64 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 VGFR2 1 0 KDR FLK1 VEGFR2 VGFR2_HUMAN 5.82557590031178 4.76666666666667 4.76666666666668 1 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EPHA8 1 0 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.50965047954658 4.76666666666667 4.76666666666668 1 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ALK 1 0 ALK ALK_HUMAN 6.19497660321606 4.76666666666667 4.76666666666668 1 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GLSK 1 0 GLS GLS1 KIAA0838 GLSK_HUMAN 5.19999817218203 4.76666666666667 4.76666666666668 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MRCKA 2 0 CDC42BPA KIAA0451 MRCKA_HUMAN 6.05216475063231 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 HCK 3 0 HCK HCK_HUMAN 5.50656956616361 4.76666666666667 4.76666666666668 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TLK2 2 0 TLK2 TLK2_HUMAN 6.06676945418511 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MPP8 2 0 MPHOSPH8 MPP8 MPP8_HUMAN 4.63691064489067 4.76666666666667 4.76666666666668 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EGFR 9 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 6.15229976003929 4.76666666666667 4.76666666666668 9 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 HIPK1 1 0 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TIE2 2 0 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 5.64842883615341 4.76666666666667 4.76666666666668 2 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MK10 2 0 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.80257553415256 4.76666666666667 4.76666666666668 2 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TYRO3 1 0 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 6.69019608002851 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LEF 1 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 4.76666666666667 4.76666666666668 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 BAZ2B 2 0 BAZ2B KIAA1476 BAZ2B_HUMAN 4.89999841719865 4.76666666666667 4.76666666666668 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 M3K5 2 0 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 6.25722468121418 4.76666666666667 4.76666666666668 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PAK5 2 0 PAK5 KIAA1264 PAK7 PAK5_HUMAN 6.06676945418511 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCE 2 0 PRKCE PKCE KPCE_HUMAN 6.18747595282456 4.76666666666667 4.76666666666668 2 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TAU 5 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.84 4.76666666666667 4.76666666666668 5 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 DCLK2 2 0 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.60639441150276 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SMN 3 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.76666666666667 4.76666666666667 4.76666666666668 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 M4K2 2 0 MAP4K2 GCK RAB8IP M4K2_HUMAN 6.13148907310259 4.76666666666667 4.76666666666668 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MET 1 0 MET MET_HUMAN 5.43195909596147 4.76666666666667 4.76666666666668 1 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KS6A5 2 0 RPS6KA5 MSK1 KS6A5_HUMAN 5.1224064000929 4.76666666666667 4.76666666666668 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 STK24 2 0 STK24 MST3 STK3 STK24_HUMAN 5.4636933297865 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RON 2 0 MST1R PTK8 RON RON_HUMAN 6.07460955632769 4.76666666666667 4.76666666666668 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TRXR1 3 0 Txnrd1 Trxr1 TRXR1_RAT 4.63254858740525 4.76666666666667 4.76666666666668 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CHK2 2 0 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.66997820872408 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ROS1 2 0 ROS1 MCF3 ROS ROS1_HUMAN 6.03274836161769 4.76666666666667 4.76666666666668 2 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FRK 2 0 FRK PTK5 RAK FRK_HUMAN 6.50965047954658 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCL 2 0 PRKCH PKCL PRKCL KPCL_HUMAN 5.89096312791004 4.76666666666667 4.76666666666668 2 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TXK 2 0 TXK PTK4 RLK TXK_HUMAN 6.39200280508144 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RAF1 2 0 RAF1 RAF RAF1_HUMAN 6.01937629449601 4.76666666666667 4.76666666666668 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 5.57383045296467 4.76666666666667 4.76666666666668 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCD 2 0 PRKCD KPCD_HUMAN 6.35231354138132 4.76666666666667 4.76666666666668 2 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 M3K9 2 0 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 5.67614313989237 4.76666666666667 4.76666666666668 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 YES 1 0 YES1 YES YES_HUMAN 5.43195909596147 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PAK3 2 0 PAK3 OPHN3 PAK3_HUMAN 5.86678661089923 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 DYRK2 2 0 DYRK2 DYRK2_HUMAN 5.62876749813663 4.76666666666667 4.76666666666668 2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TAOK1 1 0 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 5.95424250943933 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 APEX1 2 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.04999923883048 4.76666666666667 4.76666666666668 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CD5R1 4 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.97952069616055 4.76666666666667 4.76666666666668 4 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CDK5 4 0 CDK5 CDKN5 CDK5_HUMAN 5.97952069616055 4.76666666666667 4.76666666666668 4 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCD2 1 0 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.19497660321606 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SGK2 2 0 SGK2 SGK2_HUMAN 4.75281802849324 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCB 2 0 PRKCB PKCB PRKCB1 KPCB_HUMAN 6.44493086062909 4.76666666666667 4.76666666666668 2 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 NMDE1 2 0 Grin2a NMDE1_RAT 4.72 4.76666666666667 4.76666666666668 2 Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A), Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LCK 3 0 LCK LCK_HUMAN 5.92367666147666 4.76666666666667 4.76666666666668 3 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.8 4.76666666666667 4.76666666666668 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EPHA1 1 0 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.95424250943933 4.76666666666667 4.76666666666668 1 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 STK10 2 0 STK10 LOK STK10_HUMAN 6.5953058989068 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.5 4.76666666666667 4.76666666666668 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GSK3B 2 0 GSK3B GSK3B_HUMAN 6.23686510208444 4.76666666666667 4.76666666666668 2 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KGP1 3 0 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.57629429060361 4.76666666666667 4.76666666666668 3 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LYN 2 0 LYN JTK8 LYN_HUMAN 5.78147669425532 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 BLK 1 0 BLK BLK_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RUNX1 6 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.79999934327191 4.76666666666667 4.76666666666668 6 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PEBB 6 0 CBFB PEBB_HUMAN 4.79999934327191 4.76666666666667 4.76666666666668 6 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PLK1 2 0 PLK1 PLK PLK1_HUMAN 5.51912394439097 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 5.1 4.76666666666667 4.76666666666668 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCNE2 6 0 CCNE2 CCNE2_HUMAN 6.15996374897717 4.76666666666667 4.76666666666668 6 G1/S-specific cyclin-E2 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCNE1 6 0 CCNE1 CCNE CCNE1_HUMAN 6.15996374897717 4.76666666666667 4.76666666666668 6 G1/S-specific cyclin-E1 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KDM4E 2 0 KDM4E KDM4DL KDM4E_HUMAN 4.75 4.76666666666667 4.76666666666668 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KC1D 2 0 CSNK1D HCKID KC1D_HUMAN 5.71381794581987 4.76666666666667 4.76666666666668 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CLK3 1 0 CLK3 CLK3_HUMAN 5.65854134728041 4.76666666666667 4.76666666666668 1 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MARK1 2 0 MARK1 KIAA1477 MARK MARK1_HUMAN 5.80931454638058 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SGK3 1 0 SGK3 CISK SGKL SGK3_HUMAN 5.43195909596147 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 NFKB1 4 0 NFKB1 NFKB1_HUMAN 5.2 4.76666666666667 4.76666666666668 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TAOK3 1 0 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 6.00479888288177 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.70000050388302 4.76666666666667 4.76666666666668 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ERBB4 1 0 ERBB4 HER4 ERBB4_HUMAN 6.27875360095283 4.76666666666667 4.76666666666668 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 POLK 4 0 POLK DINB1 POLK_HUMAN 4.9934564506822 4.76666666666667 4.76666666666668 4 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPYM 2 0 PKM OIP3 PK2 PK3 PKM2 KPYM_HUMAN 5.1 4.76666666666667 4.76666666666668 2 Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58), Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 UBP1 1 0 USP1 UBP1_HUMAN 4.55000045168903 4.76666666666667 4.76666666666668 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PLK3 2 0 PLK3 CNK FNK PRK PLK3_HUMAN 5.89851829727201 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 BMX 2 0 BMX BMX_HUMAN 5.92453412795947 4.76666666666667 4.76666666666668 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ABL2 1 0 ABL2 ABLL ARG ABL2_HUMAN 6.06069784035361 4.76666666666667 4.76666666666668 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SGK1 2 0 SGK1 SGK SGK1_HUMAN 5.1240244310851 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAPK1 13 0 PRKAA1 AMPK1 AAPK1_HUMAN 5.40069994099944 4.76666666666667 4.76666666666668 13 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAKG1 13 0 PRKAG1 AAKG1_HUMAN 5.40069994099944 4.76666666666667 4.76666666666668 13 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAKB1 13 0 PRKAB1 AMPK AAKB1_HUMAN 5.40069994099944 4.76666666666667 4.76666666666668 13 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LOX15 1 0 ALOX15 LOG15 LOX15_HUMAN 4.9 4.76666666666667 4.76666666666668 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CDK9 2 0 CDK9 CDC2L4 TAK CDK9_HUMAN 5.41017446508905 4.76666666666667 4.76666666666668 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCNT1 2 0 CCNT1 CCNT1_HUMAN 5.41017446508905 4.76666666666667 4.76666666666668 2 Cyclin-T1 (CycT1) (Cyclin-T) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KS6A2 2 0 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 2 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KS6A3 4 0 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 5.11020534355202 4.76666666666667 4.76666666666668 4 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 UFO 2 0 AXL UFO UFO_HUMAN 5.90175824505386 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PRKX 2 0 PRKX PKX1 PRKX_HUMAN 5.78147669425532 4.76666666666667 4.76666666666668 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MTOR 1 0 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.73 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 IRAK1 2 0 IRAK1 IRAK IRAK1_HUMAN 5.87655816323275 4.76666666666667 4.76666666666668 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KAPCA 2 0 PRKACA PKACA KAPCA_HUMAN 5.48886180264443 4.76666666666667 4.76666666666668 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CDK3 3 0 CDK3 CDKN3 CDK3_HUMAN 5.62973141792582 4.76666666666667 4.76666666666668 3 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MKNK2 1 0 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.6886291709978 4.76666666666667 4.76666666666668 1 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PAK4 2 0 PAK4 KIAA1142 PAK4_HUMAN 6.00747017489647 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 NEK6 2 0 NEK6 NEK6_HUMAN 6.5953058989068 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AKT3 2 0 AKT3 PKBG AKT3_HUMAN 6.0344202063547 4.76666666666667 4.76666666666668 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KCC2B 2 0 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 6.45181625804212 4.76666666666667 4.76666666666668 2 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 WNK2 1 0 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 6.06069784035361 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 DDR2 1 0 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 BRSK1 2 0 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 6.18941262551316 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TBK1 2 0 TBK1 NAK TBK1_HUMAN 5.4636933297865 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GLCM 1 0 GBA GC GLUC GLCM_HUMAN 4.55000045168903 4.76666666666667 4.76666666666668 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PAK6 2 0 PAK6 PAK5 PAK6_HUMAN 6.0388137089895 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CBX1 1 0 CBX1 CBX CBX1_HUMAN 5 4.76666666666667 4.76666666666668 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PKN2 1 0 PKN2 PRK2 PRKCL2 PKN2_HUMAN 6.50965047954658 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EF2K 1 0 EEF2K EF2K_HUMAN 5.6886291709978 4.76666666666667 4.76666666666668 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KC1G3 1 0 CSNK1G3 KC1G3_HUMAN 6.27875360095283 4.76666666666667 4.76666666666668 1 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MK03 2 0 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.39680410072373 4.76666666666667 4.76666666666668 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ULK2 1 0 ULK2 KIAA0623 ULK2_HUMAN 5.75332766665861 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AURKC 2 0 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 6.24811877258337 4.76666666666667 4.76666666666668 2 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 M3K7 1 0 MAP3K7 TAK1 M3K7_HUMAN 6.19497660321606 4.76666666666667 4.76666666666668 1 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GEMI 3 0 GMNN GEMI_HUMAN 5.16207391742735 4.76666666666667 4.76666666666668 3 Geminin 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 DAPK1 1 0 DAPK1 DAPK DAPK1_HUMAN 6.50965047954658 4.76666666666667 4.76666666666668 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KSYK 1 0 SYK KSYK_HUMAN 5.38886035082012 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AKT2 1 0 AKT2 AKT2_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAKG2 7 0 PRKAG2 AAKG2_HUMAN 5.36797678529459 4.76666666666667 4.76666666666668 7 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAKB2 7 0 PRKAB2 AAKB2_HUMAN 5.36797678529459 4.76666666666667 4.76666666666668 7 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAPK2 7 0 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.36797678529459 4.76666666666667 4.76666666666668 7 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AAKG3 7 0 PRKAG3 AMPKG3 AAKG3_HUMAN 5.36797678529459 4.76666666666667 4.76666666666668 7 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ST17A 1 0 STK17A DRAK1 ST17A_HUMAN 5.19426522798427 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MAPK5 2 0 MAPKAPK5 PRAK MAPK5_HUMAN 5.28412131000573 4.76666666666667 4.76666666666668 2 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 IKKA 1 0 CHUK IKKA TCF16 IKKA_HUMAN 5.90799732148669 4.76666666666667 4.76666666666668 1 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 NLK 1 0 NLK LAK1 NLK_HUMAN 6.06069784035361 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MUSK 1 0 MUSK MUSK_HUMAN 5.50060235056919 4.76666666666667 4.76666666666668 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KS6B1 1 0 RPS6KB1 STK14A KS6B1_HUMAN 5.26884531229258 4.76666666666667 4.76666666666668 1 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MP2K1 1 0 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 6.69019608002851 4.76666666666667 4.76666666666668 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 NEK2 2 0 NEK2 NEK2A NLK1 NEK2_HUMAN 5.84671402693979 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KC1G1 2 0 CSNK1G1 KC1G1_HUMAN 6.06409189571072 4.76666666666667 4.76666666666668 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MP2K7 2 0 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.50799405269207 4.76666666666667 4.76666666666668 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RECQ1 1 0 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.5 4.76666666666667 4.76666666666668 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FLT3 2 0 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 6.22494678317885 4.76666666666667 4.76666666666668 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CHK1 2 0 CHEK1 CHK1 CHK1_HUMAN 6.2990967007576 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCND3 4 0 CCND3 CCND3_HUMAN 6.15918075587787 4.76666666666667 4.76666666666668 4 G1/S-specific cyclin-D3 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CDK6 4 0 CDK6 CDKN6 CDK6_HUMAN 6.15918075587787 4.76666666666667 4.76666666666668 4 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GRK7 2 0 GRK7 GPRK7 GRK7_HUMAN 6.39200280508144 4.76666666666667 4.76666666666668 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.76666666666667 4.76666666666668 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 VRK2 2 0 VRK2 VRK2_HUMAN 6.44493086062909 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KCC4 1 0 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.72015930340596 4.76666666666667 4.76666666666668 1 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MK14 1 0 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.41017446508905 4.76666666666667 4.76666666666668 1 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TPO 2 0 THPO MGDF TPO_HUMAN 6 4.76666666666667 4.76666666666668 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EPHA7 1 0 EPHA7 EHK3 HEK11 EPHA7_HUMAN 5.75332766665861 4.76666666666667 4.76666666666668 1 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PIM3 2 0 PIM3 PIM3_HUMAN 6.22176187334356 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SRPK2 2 0 SRPK2 SRPK2_HUMAN 6.53520366087006 4.76666666666667 4.76666666666668 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EHMT2 3 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.29127244302171 4.76666666666667 4.76666666666668 3 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KS6A4 4 0 RPS6KA4 MSK2 KS6A4_HUMAN 5.62131439366275 4.76666666666667 4.76666666666668 4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MEN1 8 0 MEN1 SCG2 MEN1_HUMAN 4.675 4.76666666666667 4.76666666666668 8 Menin 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MELK 2 0 MELK KIAA0175 MELK_HUMAN 5.50611722820851 4.76666666666667 4.76666666666668 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GRK5 1 0 GRK5 GPRK5 GRK5_HUMAN 6.00479888288177 4.76666666666667 4.76666666666668 1 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AURKB 1 0 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 6.50965047954658 4.76666666666667 4.76666666666668 1 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RET 1 0 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 6.99563519459755 4.76666666666667 4.76666666666668 1 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FAK1 1 0 PTK2 FAK FAK1 FAK1_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PIM1 2 0 PIM1 PIM1_HUMAN 5.41111757852737 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCT 2 0 PRKCQ PRKCT KPCT_HUMAN 6.06409189571072 4.76666666666667 4.76666666666668 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FYN 2 0 FYN FYN_HUMAN 5.99113561651978 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 STK3 1 0 STK3 KRS1 MST2 STK3_HUMAN 6.69019608002851 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TGFR1 2 0 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 6.00497132981871 4.76666666666667 4.76666666666668 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CSK2B 3 3 CSNK2B CK2N G5A CSK2B_HUMAN 6.27774875306552 4.76666666666667 4.96083333333335 6 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 0.5 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CSK22 3 3 CSNK2A2 CK2A2 CSK22_HUMAN 6.27774875306552 4.76666666666667 4.96083333333335 6 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 0.5 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CSK21 3 3 CSNK2A1 CK2A1 CSK21_HUMAN 6.27774875306552 4.76666666666667 4.96083333333335 6 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 0.5 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GRK6 2 0 GRK6 GPRK6 GRK6_HUMAN 6.45181625804212 4.76666666666667 4.76666666666668 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 AURKA 2 0 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 6.48447484049067 4.76666666666667 4.76666666666668 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MAPK2 2 0 MAPKAPK2 MAPK2_HUMAN 5.63904527790675 4.76666666666667 4.76666666666668 2 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EPHA3 1 0 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 5.78837041556533 4.76666666666667 4.76666666666668 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 POLH 1 0 POLH RAD30 RAD30A XPV POLH_HUMAN 4.94999940171424 4.76666666666667 4.76666666666668 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ULK3 1 0 ULK3 ULK3_HUMAN 5.78837041556533 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ROCK2 1 0 ROCK2 KIAA0619 ROCK2_HUMAN 5.54967192186827 4.76666666666667 4.76666666666668 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CLK2 1 0 CLK2 CLK2_HUMAN 5.60205999132796 4.76666666666667 4.76666666666668 1 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FGFR1 1 0 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 6.00479888288177 4.76666666666667 4.76666666666668 1 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MARK2 1 0 MARK2 EMK1 MARK2_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 HASP 2 0 HASPIN GSG2 HASP_HUMAN 5.32693353236929 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 HCD2 2 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.65 4.76666666666667 4.76666666666668 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CP2CJ 2 0 CYP2C19 CP2CJ_HUMAN 4.6 4.76666666666667 4.76666666666668 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PIN1 1 0 PIN1 PIN1_HUMAN 4.92098164492706 4.76666666666667 4.76666666666668 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PIM2 1 0 PIM2 PIM2_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SRC 1 0 SRC SRC1 SRC_HUMAN 5.82557590031178 4.76666666666667 4.76666666666668 1 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KCNH2 1 0 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.89999841719865 4.76666666666667 4.76666666666668 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MRCKB 2 0 CDC42BPB KIAA1124 MRCKB_HUMAN 5.7420586237961 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TEC 1 0 TEC PSCTK4 TEC_HUMAN 5.82557590031178 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase Tec (EC 2.7.10.2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 P53 1 0 TP53 P53 P53_HUMAN 4.7 4.76666666666667 4.76666666666668 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CSF1R 2 0 CSF1R FMS CSF1R_HUMAN 5.46864614037438 4.76666666666667 4.76666666666668 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LT 1 0 LT_SV40 4.8353497840657 4.76666666666667 4.76666666666668 1 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ABL1 2 0 ABL1 ABL JTK7 ABL1_HUMAN 6.59992327978754 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 NTRK1 1 0 NTRK1 MTC TRK TRKA NTRK1_HUMAN 5.2498774732166 4.76666666666667 4.76666666666668 1 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 IGF1R 2 0 IGF1R IGF1R_HUMAN 5.7737994566227 4.76666666666667 4.76666666666668 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 SRPK3 1 0 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.86530142610254 4.76666666666667 4.76666666666668 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KC1G2 2 0 CSNK1G2 CK1G2 KC1G2_HUMAN 6.48447484049067 4.76666666666667 4.76666666666668 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ACK1 2 0 TNK2 ACK1 ACK1_HUMAN 5.53895475949199 4.76666666666667 4.76666666666668 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 4.76666666666667 4.76666666666668 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 4.6 4.76666666666667 4.76666666666668 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MERTK 1 0 MERTK MER MERTK_HUMAN 6.27875360095283 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 VGFR1 2 0 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 6.20517769171724 4.76666666666667 4.76666666666668 2 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ERBB2 3 0 ERBB2 HER2 MLN19 NEU NGL ERBB2_HUMAN 4.87 4.76666666666667 4.76666666666668 3 Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Epidermal growth factor receptor-related protein) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (p185erbB2) (p185neu) (CD antigen CD340), Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340), Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (p185erbB2) (CD antigen CD340) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MP2K6 1 0 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.90799732148669 4.76666666666667 4.76666666666668 1 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MK08 1 0 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 5.90799732148669 4.76666666666667 4.76666666666668 1 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EPHB1 1 0 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 GRP78 3 0 HSPA5 GRP78 GRP78_HUMAN 4.51099973722248 4.76666666666667 4.76666666666668 3 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PFKA 1 0 pfk PFKA_TRYBB 4.87098398008989 4.76666666666667 4.76666666666668 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RIPK2 2 0 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 6.17436871365446 4.76666666666667 4.76666666666668 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FGR 1 0 FGR SRC2 FGR_HUMAN 5.65854134728041 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 DAPK2 1 0 DAPK2 DAPK2_HUMAN 6.00479888288177 4.76666666666667 4.76666666666668 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LIMK1 1 0 LIMK1 LIMK LIMK1_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 STK33 2 0 STK33 STK33_HUMAN 6.06409189571072 4.76666666666667 4.76666666666668 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ACV1B 1 0 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 6.50965047954658 4.76666666666667 4.76666666666668 1 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PLK2 1 0 PLK2 SNK PLK2_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CDK7 2 0 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 5.95424250943933 4.76666666666667 4.76666666666668 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 CCNH 2 0 CCNH CCNH_HUMAN 5.95424250943933 4.76666666666667 4.76666666666668 2 Cyclin-H (MO15-associated protein) (p34) (p37) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 POLI 2 0 POLI RAD30B POLI_HUMAN 4.62500012557179 4.76666666666667 4.76666666666668 2 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 LOX12 1 0 ALOX12 12LO LOG12 LOX12_HUMAN 4.6 4.76666666666667 4.76666666666668 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 ACM1 1 0 Chrm1 Chrm-1 ACM1_RAT 4.8 4.76666666666667 4.76666666666668 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 VGFR3 2 0 FLT4 VEGFR3 VGFR3_HUMAN 6.11649805519608 4.76666666666667 4.76666666666668 2 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 INSRR 2 0 INSRR IRR INSRR_HUMAN 5.80931454638058 4.76666666666667 4.76666666666668 2 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TSSK1 2 0 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 6.31651769404313 4.76666666666667 4.76666666666668 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TAOK2 1 0 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MINK1 1 0 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.72015930340596 4.76666666666667 4.76666666666668 1 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 JAK1 2 0 JAK1 JAK1A JAK1B JAK1_HUMAN 5.47 4.76666666666667 4.76666666666668 2 Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.73621248726524 4.76666666666667 4.76666666666668 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCI 2 0 PRKCI DXS1179E KPCI_HUMAN 5.83720090642264 4.76666666666667 4.76666666666668 2 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 WNK3 1 0 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.99563519459755 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 TSSK2 2 0 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.23928324779692 4.76666666666667 4.76666666666668 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PHKG2 1 0 PHKG2 PHKG2_HUMAN 6.12338490853968 4.76666666666667 4.76666666666668 1 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 MK09 1 0 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 FES 1 0 FES FPS FES_HUMAN 5.50060235056919 4.76666666666667 4.76666666666668 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 RGS4 1 0 RGS4 RGS4_HUMAN 4.62382285083096 4.76666666666667 4.76666666666668 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KCC1A 1 0 CAMK1 KCC1A_HUMAN 5.82557590031178 4.76666666666667 4.76666666666668 1 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KPCD1 1 0 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 6.69019608002851 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PAK2 1 0 PAK2 PAK2_HUMAN 5.75332766665861 4.76666666666667 4.76666666666668 1 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 KCC2D 1 0 CAMK2D CAMKD KCC2D_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 INSR 2 0 INSR INSR_HUMAN 5.83066249407265 4.76666666666667 4.76666666666668 2 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 PASK 1 0 PASK KIAA0135 PASK_HUMAN 5.0871501757189 4.76666666666667 4.76666666666668 1 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 DAPK3 1 0 DAPK3 ZIPK DAPK3_HUMAN 5.90799732148669 4.76666666666667 4.76666666666668 1 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87221 EPHA4 1 0 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 6.38021124171161 4.76666666666667 4.76666666666668 1 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 0 4.76666666666667 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)NCc2ccccc2)cc1O 87324 0 40 Cerebroside-sulfatase, NotRecorded 5.05800772668648 4.9 4.9 40 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 APEX1 0 4 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 6.64340973966865 4.9 4.9 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.65 4.9 4.9 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.65 4.9 4.9 4 Menin 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PGKC 0 2 PGKC_TRYBB 6.03548431892131 4.9 4.9 2 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PIN1 0 2 PIN1 PIN1_HUMAN 5.11049226683096 4.9 4.9 2 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PFKA 0 2 pfk PFKA_TRYBB 5.87096425321765 4.9 4.9 2 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.84999924507786 4.9 4.9 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 MK01 0 2 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.8 4.9 4.9 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 FEN1 0 3 FEN1 RAD2 FEN1_HUMAN 6.03256379128575 4.9 4.9 3 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 MPP8 0 2 MPHOSPH8 MPP8 MPP8_HUMAN 5.68691614051341 4.9 4.9 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 POLH 0 2 POLH RAD30 RAD30A XPV POLH_HUMAN 6.53546396651948 4.9 4.9 2 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 DPOLB 0 1 POLB DPOLB_HUMAN 7.2 4.9 4.9 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.1 4.9 4.9 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 TPO 0 2 THPO MGDF TPO_HUMAN 4.5 4.9 4.9 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 POLK 0 3 POLK DINB1 POLK_HUMAN 6.33252643205312 4.9 4.9 3 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 P53 0 1 TP53 P53 P53_HUMAN 4.5 4.9 4.9 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 6.15002808767115 4.9 4.9 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 EGFR 0 7 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 5.75098714471544 4.9 4.9 7 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 LMBL1 0 2 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 6.71189107970418 4.9 4.9 2 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 RPGF3 0 1 RAPGEF3 CGEF1 EPAC EPAC1 RPGF3_HUMAN 5.05000045714008 4.9 4.9 1 Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (Rap1 guanine-nucleotide-exchange factor directly activated by cAMP) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 5.05 4.9 4.9 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 DPO3 0 1 polC dnaF mutI BSU16580 DPO3_BACSU 4.62382285083096 4.9 4.9 1 DNA polymerase III PolC-type (PolIII) (EC 2.7.7.7) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 IGF1R 0 2 IGF1R IGF1R_HUMAN 6.43722590761558 4.9 4.9 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.59999938302362 4.9 4.9 1 Uncharacterized protein 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 5.3 4.9 4.9 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 POLI 0 3 POLI RAD30B POLI_HUMAN 6.34128473377803 4.9 4.9 3 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PPBN 0 2 ALPPL2 ALPPL PPBN_HUMAN 5.175 4.9 4.9 2 Alkaline phosphatase, placental-like (EC 3.1.3.1) (ALP-1) (Alkaline phosphatase Nagao isozyme) (Germ cell alkaline phosphatase) (GCAP) (Placental alkaline phosphatase-like) (PLAP-like), Alkaline phosphatase, placental-like (EC 3.1.3.1) (Alkaline phosphatase 5) (Embryonic alkaline phosphatase) (EAP) (Embryonic-type alkaline phosphatase) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 TYDP1 0 1 TDP1 TYDP1_HUMAN 6.65 4.9 4.9 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 RECQ1 0 2 RECQL RECQ1 RECQL1 RECQ1_HUMAN 6.175 4.9 4.9 2 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.1 4.9 4.9 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 EHMT2 0 3 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.25000085946603 4.9 4.9 3 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PPBI 0 5 ALPI, Iap Akp-3 Akp3 PPBI_HUMAN, PPBI_MOUSE 5.574 4.9 4.9 5 Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1), Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1) (Alkaline phosphatase 3) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.1 4.9 4.9 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 WRN 0 1 WRN RECQ3 RECQL2 WRN_HUMAN 6.77391588402418 4.9 4.9 1 Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.5 4.9 4.9 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 Q4GZG4 0 1 PGKC TB927.1.700 Q4GZG4_TRYB2 6.48664920119404 4.9 4.9 1 Phosphoglycerate kinase (EC 2.7.2.3) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 CBX1 0 2 CBX1 CBX CBX1_HUMAN 6.20000218756425 4.9 4.9 2 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 TRXR1 0 4 Txnrd1 Trxr1 TRXR1_RAT 4.78691095069672 4.9 4.9 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.70000050388302 4.9 4.9 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 ERBB2 0 2 ERBB2 HER2 MLN19 NEU NGL ERBB2_HUMAN 4.755 4.9 4.9 2 Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Epidermal growth factor receptor-related protein) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (p185erbB2) (p185neu) (CD antigen CD340), Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340), Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (p185erbB2) (CD antigen CD340) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 PPBT 0 2 ALPL PPBT_HUMAN 4.51 4.9 4.9 2 Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase 2) (Alkaline phosphatase liver/bone/kidney isozyme), Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 5.4 4.9 4.9 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.6 4.9 4.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.8 4.9 4.9 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 GEMI 0 2 GMNN GEMI_HUMAN 5.19311134638214 4.9 4.9 2 Geminin 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5 4.9 4.9 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 LT 0 1 LT_SV40 6.08618614761628 4.9 4.9 1 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.8 4.9 4.9 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 RGS4 0 1 RGS4 RGS4_HUMAN 4.57382231378381 4.9 4.9 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 5.65000410073714 4.9 4.9 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 UBP2 0 1 USP2 UBP41 UBP2_HUMAN 5.93 4.9 4.9 1 Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 87324 LOX12 0 1 ALOX12 12LO LOG12 LOX12_HUMAN 4.85 4.9 4.9 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 4.9 actual molregno [molregno] Oc1ccc(\C=C(/C#N)\C(=O)c2ccc(O)c(O)c2)cc1O 93231 17 1 NotRecorded 5.28681882548603 4.8 4.80069444444444 18 0.0555555555555556 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 ATAD5 1 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.83639143656895 4.8 4.8 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 ADA2C 3 0 ADRA2C ADRA2L2 ADRA2RL2 ADA2C_HUMAN 7.29 4.8 4.8 3 Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 ADA2A 3 0 ADRA2A ADRA2R ADRAR ADA2A_HUMAN 7.29 4.8 4.8 3 Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor) (CA2-47) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 ADA2B 3 0 ADRA2B ADRA2L1 ADRA2RL1 ADA2B_HUMAN 7.29 4.8 4.8 3 Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR), Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.12383991517437 4.8 4.8 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 GEMI 2 0 GMNN GEMI_HUMAN 4.92497888965209 4.8 4.8 2 Geminin 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 ANDR 2 0 AR DHTR NR3C4 ANDR_HUMAN 4.6713394100923 4.8 4.8 2 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 DRD1 1 0 DRD1 DRD1_HUMAN 5.63623764113062 4.8 4.8 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 NISCH 3 0 NISCH IRAS KIAA0975 NISCH_HUMAN 7.23333333333333 4.8 4.8 3 Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein), Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline-1 receptor) (I1R) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93231 RGS4 1 0 RGS4 RGS4_HUMAN 6.37386502136461 4.8 4.8 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.8 actual molregno [molregno] CCC1(Cc2ccccc2O1)C3=NCCN3 93895 SMN 0 6 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.90833333333333 4.86 4.86 6 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 PYRD 1 6 DHODH, Dhodh PYRD_HUMAN, PYRD_MOUSE, PYRD_RAT 5.46571428571429 4.86 4.84892857142857 7 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Dihydroorotate dehydrogenase (fumarate) (DHOD) (DHODase) (DHOdehase) (EC 1.3.98.1) (Dihydroorotate oxidase), Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) 0.857142857142857 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 LUCI 0 4 LUCI_PHOPY 5.5267890814424 4.86 4.865 4 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 P53 0 4 TP53 P53 P53_HUMAN 4.81250006278589 4.86 4.86 4 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 6.67 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 PMP22 1 2 PMP22 GAS3, Pmp22 Cd25 Pmp-22 PMP22_HUMAN, PMP22_RAT 5.40073442458312 4.86 4.83416666666667 3 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0.666666666666667 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 GEMI 0 2 GMNN GEMI_HUMAN 5.86809888796271 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Geminin 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 NF2L2 0 4 NFE2L2 NRF2 NF2L2_HUMAN 5.15281817396549 4.86 4.86 4 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.836212690038 4.86 4.86 1 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 ATAD5 1 3 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.27380378494339 4.86 4.840625 4 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0.75 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 SC6A3 0 2 SLC6A3 DAT1 SC6A3_HUMAN 5.59 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 NPC1 0 2 NPC1 NPC1_HUMAN 5.995 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Niemann-Pick C1 protein 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 SC6A2 0 2 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.335 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.84999924507786 4.86 4.86 1 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.55 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 RAB9A 1 1 RAB9A RAB9 RAB9A_HUMAN 5.995 4.86 4.82275 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Ras-related protein Rab-9A 0.5 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 POLI 0 1 POLI RAD30B POLI_HUMAN 4.59999938302362 4.86 4.86 1 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 TPO 0 2 THPO MGDF TPO_HUMAN 5.1 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 6.19997064075587 4.86 4.86 1 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 6.75 4.86 4.86 2 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 7.1 4.86 4.145 1 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 93895 AOFA 0 1 MAOA AOFA_HUMAN 4.68 4.86 4.86 1 LEFLUNOMIDE CHRONIC CHILDHOOD ARTHRITIS, IMMUNE SYSTEM DISEASE, MULTIPLE MYELOMA, MYASTHENIA GRAVIS, RHEUMATOID ARTHRITIS Dihydroorotate dehydrogenase inhibitor INHIBITOR 4 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.86 actual drug [drugName] Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 94815 GBRG3 0 32 Gabrg3 GBRG3_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRA4 0 32 Gabra4 GBRA4_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRG1 0 32 Gabrg1 GBRG1_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRB1 0 32 Gabrb1 Gabrb-1 GBRB1_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRB3 0 32 Gabrb3 Gabrb-3 GBRB3_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRP 0 32 Gabrp GBRP_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRA6 0 32 Gabra6 Gabra-6 GBRA6_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 Q91ZM7 0 32 Gabrq Q91ZM7_RAT 6.125 7.1 7.1 32 GABA theta subunit 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRG2 0 32 Gabrg2 GBRG2_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRA1 0 32 Gabra1 Gabra-1 GBRA1_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRA3 0 32 Gabra3 Gabra-3 GBRA3_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRA5 0 32 Gabra5 Gabra-5 GBRA5_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRA2 0 32 Gabra2 Gabra-2 GBRA2_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRB2 0 32 Gabrb2 Gabrb-2 GBRB2_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRE 0 32 Gabre GBRE_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GBRD 0 32 Gabrd GBRD_RAT 6.125 7.1 7.1 32 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.65 7.1 5.825 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 0 4 NotRecorded 5.3548029319817 7.1 7.1 4 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.1 7.1 5.94 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.7862167006647 7.1 7.215 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 94815 GLHA 0 1 CGA GLHA_HUMAN 5 7.1 7.1 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 7.1 actual molregno [molregno] CCO\C(=C\1/C(=O)CCn2c1nc3ccccc23)\O 59311 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.2 4.95 4.95 4 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 17 16 NotRecorded, Rhodesain 5.1182709516386 4.95 4.74241695804196 33 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 0.484848484848485 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 5.75 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 APEX1 0 4 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.82500016814062 4.95 4.95 4 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 NFKB1 0 4 NFKB1 NFKB1_HUMAN 6.45 4.95 4.95 4 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 SIR2 0 2 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5.92 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 CYSP 0 2 CYSP_TRYCR 4.75 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 5.8 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.2 4.95 4.95 3 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.9 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 RECQ1 0 3 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.53333333333333 4.95 4.95 3 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 POLK 0 1 POLK DINB1 POLK_HUMAN 7 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 TPO 0 2 THPO MGDF TPO_HUMAN 5.4 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 5.35000349253396 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 PEBB 0 2 CBFB PEBB_HUMAN 5.35000349253396 4.95 4.95 2 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 TYDP1 0 4 TDP1 TYDP1_HUMAN 5.37500244747424 4.95 4.95 4 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 LX15B 0 1 ALOX15B LX15B_HUMAN 5.49999693194831 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.90000876645532 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 5.05000045714008 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 GALK1 0 1 GALK1 GALK GALK1_HUMAN 4.74999985591871 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Galactokinase (EC 2.7.1.6) (Galactose kinase) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 5.02382432408324 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 DPOLB 0 1 POLB DPOLB_HUMAN 6.05 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 SIR1 0 1 SIRT1 SIR2L1 SIR1_HUMAN 6.52 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)] 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 TAU 0 4 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.775 4.95 4.95 4 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 POLI 0 1 POLI RAD30B POLI_HUMAN 5.85001154350852 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 END4 0 1 nfo b2159 JW2146 END4_ECOLI 5.35 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 59311 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 6.64994590642097 4.95 4.95 1 SURAMIN HEXASODIUM AUTISM SPECTRUM DISORDER, LEISHMANIASIS, PROSTATE CARCINOMA, TRYPANOSOMIASIS 3 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.95 actual drug [drugName] [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-] 100257 0 57 NotRecorded 5.26006615551774 4.9 4.8728593598524 57 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 GRM5 0 47 GRM5 GPRC1E MGLUR5, Grm5 Gprc1e Mglur5 GRM5_HUMAN, GRM5_RAT 7.76944288012724 4.9 4.9 47 Metabotropic glutamate receptor 5 (mGluR5) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 TPO 0 2 THPO MGDF TPO_HUMAN 6 4.9 4.854375 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.3 4.9 4.82416666666667 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 P53 0 4 TP53 P53 P53_HUMAN 4.85 4.9 4.9 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 GRM6 0 2 GRM6 GPRC1F MGLUR6 GRM6_HUMAN 5.1839883926473 4.9 4.9 2 Metabotropic glutamate receptor 6 (mGluR6) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 ACM1 0 2 Chrm1 Chrm-1 ACM1_RAT 4.9 4.9 4.9 2 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.65 4.9 4.9 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 5 4.9 4.9 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 Q4Q090 0 1 PGAM LMJF_36_6650 Q4Q090_LEIMA 4.62098289875995 4.9 4.9 1 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.1) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 5.1 4.9 4.9 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 GRM1 0 6 GRM1 GPRC1A MGLUR1, Grm1 Gprc1a Mglur1 GRM1_HUMAN, GRM1_RAT 5.06228904597588 4.9 4.9 6 Metabotropic glutamate receptor 1 (mGluR1) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.08639275144419 4.9 4.78666666666667 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 NMDE2 0 1 GRIN2B NMDAR2B NMDE2_HUMAN 4.74 4.9 4.9 1 Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B), Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.836212690038 4.9 4.87916666666667 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 Q94696 0 1 luc Q94696_PHOPE 4.9 4.9 4.87916666666667 1 Luciferase 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 4.9 4.8375 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 PIN1 0 1 PIN1 PIN1_HUMAN 4.72098361611599 4.9 4.9 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.9 4.9 4.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 NPC1 0 1 NPC1 NPC1_HUMAN 5.24 4.9 4.82416666666667 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 ADRB2 0 1 ADRB2 ADRB2R B2AR ADRB2_HUMAN 4.73621248726524 4.9 4.9 1 Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 LUCI 0 2 LUCI_PHOPY 4.75 4.9 4.9 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.59999765407204 4.9 4.873125 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 AOFA 0 1 Maoa AOFA_MOUSE 5.1 4.9 4.9 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 PFKA 0 1 pfk PFKA_TRYBB 4.82098278885978 4.9 4.9 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 100257 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.70000050388302 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] Cc1cccc(n1)C#Cc2ccccc2 99706 0 7 NotRecorded 4.85349122134096 5.45 5.45 7 1 5.45 actual molregno [molregno] Cc1ncc[nH]1 99706 GLSK 0 1 GLS GLS1 KIAA0838 GLSK_HUMAN 4.89999841719865 5.45 5.45 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 1 5.45 actual molregno [molregno] Cc1ncc[nH]1 99706 GCR 0 1 NR3C1 GRL GCR_HUMAN 5.09999903484653 5.45 5.45 1 Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) 1 5.45 actual molregno [molregno] Cc1ncc[nH]1 99706 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] Cc1ncc[nH]1 99706 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.91079456005242 5.45 5.45 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.45 actual molregno [molregno] Cc1ncc[nH]1 102367 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.75 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 AOFA 1 0 Maoa AOFA_RAT 6.8 4.9 4.175 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 LUCI 0 1 LUCI_PHOPY 5.32098115059902 4.9 4.8875 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.2 4.9 4.9 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.18621304294598 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 POLI 0 1 POLI RAD30B POLI_HUMAN 4.74999985591871 4.9 4.8875 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 AOFB 0 1 Maob AOFB_RAT 5.46 4.9 4.8875 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.39999691337226 4.9 4.9 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.7862167006647 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.7499949715131 4.9 4.9 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.45 4.9 4.934375 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.15 4.9 5.11875 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 NPC1 0 1 NPC1 NPC1_HUMAN 5.8 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.90000876645532 4.9 4.369375 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 102367 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5.69999179744619 4.9 4.928125 1 TAR DNA-binding protein 43 (TDP-43) 1 4.9 actual molregno [molregno] CC(=O)Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 103658 Q8I2J3 0 1 PF3D7_0932300 Q8I2J3_PLAF7 5.65 4.8125 4.8075 1 M18 aspartyl aminopeptidase (EC 3.4.11.21) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 A4 0 13 APP A4 AD1 A4_HUMAN 5.23362100653973 4.8125 4.81758077520306 13 Amyloid-beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31] 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 AOFA 0 2 MAOA AOFA_HUMAN 5.555 4.8125 4.81342810382553 2 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PGDH 0 5 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.71 4.8125 4.82110764547755 5 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 Q9JKS8 0 3 Akp3 Alpi2 IAP-II Q9JKS8_RAT 5 4.8125 4.81354099025974 3 Alkaline phosphatase (EC 3.1.3.1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 SRC 0 3 Src SRC_MOUSE 5 4.8125 4.81354099025974 3 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 FOXO3 0 5 FOXO3 FKHRL1 FOXO3A FOXO3_HUMAN 5 4.8125 4.81290178571429 5 Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 NFKB1 0 10 NFKB1 NFKB1_HUMAN 5.44 4.8125 4.81296875 10 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 TF65 0 11 RELA NFKB3 TF65_HUMAN 5.37272727272727 4.8125 4.81292613636364 11 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 NFKB2 0 10 NFKB2 LYT10 NFKB2_HUMAN 5.44 4.8125 4.81296875 10 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CP19A 0 8 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 4.67275358481809 4.8125 4.81439147639046 8 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 TAU 0 12 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.95 4.8125 4.81578369059098 12 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PGH2 0 11 PTGS2 COX2 PGH2_HUMAN, PGH2_SHEEP 4.75586294560469 4.8125 4.81421264673319 11 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 NQO2 1 6 NQO2 NMOR2 NQO2_HUMAN 6.31857142857143 4.8125 4.81200617462894 7 Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2) 0.857142857142857 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PK3CA 0 1 PIK3CA PK3CA_HUMAN 6.6 4.8125 4.81316964285714 1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PGH1 0 15 PTGS1 COX1 PGH1_HUMAN, PGH1_SHEEP 5.1892294257579 4.8125 4.81447575047235 15 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 ANDR 0 14 AR DHTR NR3C4, Ar Nr3c4 ANDR_HUMAN, ANDR_RAT 4.70668598073726 4.8125 4.81418165377969 14 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 NQO1 0 11 Nqo1 Dia4 Nmo1 Nmor1 NQO1_MOUSE 4.92575992322366 4.8125 4.81588477033713 11 NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 6.40803196649977 4.8125 4.82259615384616 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH7 0 1 CA7 CAH7_HUMAN 5.36 4.8125 4.81354099025974 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH5B 0 1 CA5B CAH5B_HUMAN 5.33 4.8125 4.81354099025974 1 Carbonic anhydrase 5B, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VB) (Carbonic anhydrase VB) (CA-VB) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 RORG 0 11 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.20227894963835 4.8125 4.81699608799644 11 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH6 0 1 CA6 CAH6_HUMAN 5.09 4.8125 4.81354099025974 1 Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 DCOR 0 1 ODC1 DCOR_HUMAN 4.72 4.8125 4.81435620765105 1 Ornithine decarboxylase (ODC) (EC 4.1.1.17) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.82499932430368 4.8125 4.81397429435484 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PFKA 0 1 pfk PFKA_TRYBB 5.02098457748104 4.8125 4.821875 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 AOFB 0 1 MAOB AOFB_HUMAN 4.53 4.8125 4.81435620765105 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 RPGF4 0 1 RAPGEF4 CGEF2 EPAC2 RPGF4_HUMAN 4.70000050388302 4.8125 4.81310483870968 1 Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-dependent Rap1 guanine-nucleotide exchange factor) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII), Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH12 0 1 CA12 CAH12_HUMAN 6.02 4.8125 4.81375558035714 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PPARD 0 4 PPARD NR1C2 PPARB PPARD_HUMAN 4.50878759782269 4.8125 4.81310483870968 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 4.8125 4.81388608870968 1 Geminin 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PK3CB 0 1 PIK3CB PIK3C1 PK3CB_HUMAN 6.3 4.8125 4.81316964285714 1 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH9 0 1 CA9 G250 MN CAH9_HUMAN 6.09 4.8125 4.81375558035714 1 Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 NF2L2 0 8 NFE2L2 NRF2 NF2L2_HUMAN 4.89530589738994 4.8125 4.81434286794355 8 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 NPC1 0 2 NPC1 NPC1_HUMAN 4.995 4.8125 4.81670866935484 2 Niemann-Pick C1 protein 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 SC6A2 0 2 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.64 4.8125 4.871875 2 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 TYRO 0 1 TYR TYRO_HUMAN 4.753887891812 4.8125 4.8125 1 Tyrosinase (EC 1.14.18.1) (Albino locus protein) (Monophenol monooxygenase), Tyrosinase (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH13 0 1 CA13 CAH13_HUMAN 5.39 4.8125 4.81354099025974 1 Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 Q9EQ79 0 3 Q9EQ79_MOUSE 5 4.8125 4.81354099025974 3 Alkaline phosphatase (EC 3.1.3.1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 SMN 0 4 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8125 4.8125 4.81775033602151 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 ATAD5 0 4 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.23630167408546 4.8125 4.8159414741005 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 RAB9A 0 2 RAB9A RAB9 RAB9A_HUMAN 4.97 4.8125 4.81514616935484 2 Ras-related protein Rab-9A 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 P53 0 4 TP53 P53 P53_HUMAN 4.87500005061136 4.8125 4.81860249644212 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 RGS4 0 1 RGS4 RGS4_HUMAN 4.82382189073267 4.8125 4.81310483870968 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 AKT1 0 3 AKT1 PKB RAC AKT1_HUMAN 5 4.8125 4.81354099025974 3 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH5A 0 1 CA5A CA5 CAH5A_HUMAN 5.32 4.8125 4.81354099025974 1 Carbonic anhydrase 5A, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VA) (Carbonic anhydrase VA) (CA-VA) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999903484653 4.8125 4.81666666666667 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.52 4.8125 4.8130859375 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 KDM4E 0 4 KDM4E KDM4DL KDM4E_HUMAN 4.5375 4.8125 4.81427671370968 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 HD 0 1 HTT HD IT15 HD_HUMAN 5.65 4.8125 4.81394230769231 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.89999841719865 4.8125 4.81785851518027 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 TRXR1 0 3 Txnrd1 Trxr1 TRXR1_RAT 4.69048976579955 4.8125 4.81685851518027 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH1 0 1 CA1 CAH1_HUMAN 5.66 4.8125 4.8130859375 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PPARG 0 3 PPARG NR1C3 PPARG_HUMAN 4.5666666703337 4.8125 4.81310483870968 3 Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 LUCI 0 7 LUCI_AQULA, LUCI_PHOPY 5.64432350597504 4.8125 4.82946233454046 7 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 LMNA 0 3 LMNA LMN1 LMNA_HUMAN 5.88333333333333 4.8125 4.82238911290323 3 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 GTR1 0 2 Slc2a1 Glut-1 Glut1 GTR1_RAT 5 4.8125 4.81290178571429 2 Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1), Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH14 0 1 CA14 UNQ690/PRO1335 CAH14_HUMAN 6.08 4.8125 4.81375558035714 1 Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH4 0 1 CA4 CAH4_HUMAN 5.35 4.8125 4.81354099025974 1 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.55000045168903 4.8125 4.8125 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PEBB 0 2 CBFB PEBB_HUMAN 4.55000045168903 4.8125 4.8125 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 LT 0 1 LT_SV40 4.58169870868025 4.8125 4.81448351518027 1 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CBX1 0 1 CBX1 CBX CBX1_HUMAN 10.3738650213646 4.8125 4.84 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 5.15 4.8125 4.81313920454546 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 5.52 4.8125 4.8130859375 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH3 0 1 CA3 CAH3_HUMAN 5.04 4.8125 4.81354099025974 1 Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.55000045168903 4.8125 4.81310483870968 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.39999691337226 4.8125 4.8140625 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.8125 4.81675857843137 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 LX15B 0 1 ALOX15B LX15B_HUMAN 4.70000050388302 4.8125 4.81785851518027 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 MTOR 0 2 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.08 4.8125 4.82129384092347 2 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 ALR 0 1 GFER ALR HERV1 HPO ALR_HUMAN 5.4 4.8125 4.821875 1 Alanine racemase (EC 5.1.1.1), FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 CAH15 0 1 Ca15 Car15 CAH15_MOUSE 5.03 4.8125 4.81354099025974 1 Carbonic anhydrase 15 (EC 4.2.1.1) (Carbonate dehydratase XV) (Carbonic anhydrase XV) (CA-XV) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 GTR3 0 2 SLC2A3 GLUT3 GTR3_HUMAN 5 4.8125 4.81290178571429 2 Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 MRP2 0 1 ABCC2 CMOAT CMOAT1 CMRP MRP2 MRP2_HUMAN 5.47712125471966 4.8125 4.82227678571429 1 Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2), Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 POLK 0 1 POLK DINB1 POLK_HUMAN 4.84999924507786 4.8125 4.81635851518027 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 6.79997073344623 4.8125 4.81875 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 103658 FOXO1 0 1 FOXO1 FKHR FOXO1A FOXO1_HUMAN 4.82390874094432 4.8125 4.81371700310559 1 Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma) 1 4.8125 actual molregno [molregno] Oc1ccc(\C=C\c2cc(O)cc(O)c2)cc1 105093 1 5 NotRecorded 4.86207351048168 4.95 4.871875 6 0.833333333333333 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 P53 0 2 TP53 P53 P53_HUMAN 4.9 4.95 4.9425 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.7 4.95 4.9425 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 4.95 4.9425 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 4.95 4.9425 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 4.95 4.9425 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 7.26495567385599 4.95 4.9375 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.9 4.95 4.9375 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 105093 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.9425 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccccc3 106627 IMPA1 0 1 Impa1 Imp IMPA1_RAT 5.2 5 5 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 2 6 ATP-dependent Clp protease proteolytic subunit, NotRecorded 5.10273038584204 5 4.8 8 0.75 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 LUCI 0 1 LUCI_PHOPY 4.62098289875995 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.65000022087346 5 5 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.94999940171424 5 5 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.66121305452969 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 5 5 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 106627 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.7 5 5 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5 actual molregno [molregno] COc1ccc(\C=C\c2ccncc2)cc1OC 109185 FGFR4 1 0 FGFR4 JTK2 TKF FGFR4_HUMAN 6.69019608002851 4.675 4.675 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CCND3 2 0 CCND3 CCND3_HUMAN 5.90799732148669 4.675 4.675 2 G1/S-specific cyclin-D3 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CDK6 2 0 CDK6 CDKN6 CDK6_HUMAN 5.90799732148669 4.675 4.675 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 9 0 NotRecorded 4.74210786688519 4.675 4.6525 9 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CDK7 4 0 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 6.1417762419173 4.675 4.675 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CCNH 4 0 CCNH CCNH_HUMAN 6.1417762419173 4.675 4.675 4 Cyclin-H (MO15-associated protein) (p34) (p37) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CHK1 2 0 CHEK1 CHK1 CHK1_HUMAN 5.7519572156538 4.675 4.675 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 M3K7 2 0 MAP3K7 TAK1 M3K7_HUMAN 6.17436871365446 4.675 4.675 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MP2K7 2 0 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.95424250943933 4.675 4.675 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PGFRB 4 0 PDGFRB PDGFR PDGFR1, Pdgfrb Pdgfr Pdgfr1 PGFRB_HUMAN, PGFRB_MOUSE 6.03540239387701 4.675 4.673125 4 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AURKB 2 0 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.3443145854989 4.675 4.675 2 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 GRK7 1 0 GRK7 GPRK7 GRK7_HUMAN 6.12338490853968 4.675 4.675 1 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KS6A6 4 0 RPS6KA6 RSK4 KS6A6_HUMAN 6.12783722178483 4.675 4.675 4 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 VGFR2 1 0 KDR FLK1 VEGFR2 VGFR2_HUMAN 5.2498774732166 4.675 4.675 1 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 GRK5 1 0 GRK5 GPRK5 GRK5_HUMAN 6.99563519459755 4.675 4.675 1 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ACK1 2 0 TNK2 ACK1 ACK1_HUMAN 5.74247329611581 4.675 4.675 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 BRSK2 2 0 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 5.45481042707545 4.675 4.675 2 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PASK 2 0 PASK KIAA0135 PASK_HUMAN 6.0388137089895 4.675 4.675 2 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SRPK2 1 0 SRPK2 SRPK2_HUMAN 5.95424250943933 4.675 4.675 1 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PAK4 1 0 PAK4 KIAA1142 PAK4_HUMAN 6.12338490853968 4.675 4.675 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AKT3 1 0 AKT3 PKBG AKT3_HUMAN 6.69019608002851 4.675 4.675 1 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHB3 1 0 EPHB3 ETK2 HEK2 TYRO6 EPHB3_HUMAN 5.95424250943933 4.675 4.675 1 Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PIM1 2 0 PIM1 PIM1_HUMAN 5.64413638260312 4.675 4.675 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CHK2 2 0 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.82683592083393 4.675 4.675 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 LCK 3 0 LCK LCK_HUMAN 5.62251722053765 4.675 4.675 3 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCD2 2 0 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.68792321815458 4.675 4.675 2 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FLT3 2 0 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 4.70112354834347 4.675 4.675 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 VGFR1 2 0 FLT1 FLT FRT VEGFR1 VGFR1_HUMAN 5.79315723188788 4.675 4.675 2 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MK14 2 0 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.96299963322807 4.675 4.675 2 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCI 2 0 PRKCI DXS1179E KPCI_HUMAN 5.49295014083337 4.675 4.675 2 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHA1 2 0 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 6.07460955632769 4.675 4.675 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KIT 2 0 KIT SCFR KIT_HUMAN 5.10977847641839 4.675 4.675 2 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MINK1 2 0 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.63665296661753 4.675 4.675 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MELK 2 0 MELK KIAA0175 MELK_HUMAN 5.26178932797933 4.675 4.675 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KS6A2 2 0 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 5.32735893438633 4.675 4.675 2 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PGFRA 4 0 PDGFRA PDGFR2 RHEPDGFRA, Pdgfra PGFRA_HUMAN, PGFRA_MOUSE 5.62205005186112 4.675 4.673125 4 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DAPK1 2 0 DAPK1 DAPK DAPK1_HUMAN 5.68762391109003 4.675 4.675 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MK08 1 0 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.50965047954658 4.675 4.675 1 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CLK2 1 0 CLK2 CLK2_HUMAN 6.19497660321606 4.675 4.675 1 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TEC 2 0 TEC PSCTK4 TEC_HUMAN 5.8056750335491 4.675 4.675 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CD5R1 6 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.54289019422794 4.675 4.675 6 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CDK5 6 0 CDK5 CDKN5 CDK5_HUMAN 6.54289019422794 4.675 4.675 6 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MARK1 2 0 MARK1 KIAA1477 MARK MARK1_HUMAN 5.77815125038364 4.675 4.675 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 RET 2 0 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 6.12783722178484 4.675 4.675 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 HASP 2 0 HASPIN GSG2 HASP_HUMAN 5.3752399118929 4.675 4.675 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCB 2 0 PRKCB PKCB PRKCB1 KPCB_HUMAN 6.44493086062909 4.675 4.675 2 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PLK1 2 0 PLK1 PLK PLK1_HUMAN 5.6712113404111 4.675 4.675 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCE 1 0 PRKCE PKCE KPCE_HUMAN 6.69019608002851 4.675 4.675 1 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.575 4.675 4.675 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 M3K5 2 0 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 5.60669603007634 4.675 4.675 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCD1 1 0 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 6.38021124171161 4.675 4.675 1 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FER 1 0 FER TYK3 FER_HUMAN 6.99563519459755 4.675 4.675 1 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 STK24 2 0 STK24 MST3 STK3 STK24_HUMAN 5.32885283155635 4.675 4.675 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KS6A1 2 0 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.1224064000929 4.675 4.675 2 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TSSK1 1 0 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 6.06069784035361 4.675 4.675 1 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DCLK2 2 0 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.61486935473764 4.675 4.675 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 M4K2 2 0 MAP4K2 GCK RAB8IP M4K2_HUMAN 6.16722687557547 4.675 4.675 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SRC 2 0 SRC SRC1 SRC_HUMAN 6.07202751352768 4.675 4.675 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHA8 1 0 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.69019608002851 4.675 4.675 1 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 BTK 1 0 BTK AGMX1 ATK BPK BTK_HUMAN 6.38021124171161 4.675 4.675 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NUAK1 1 0 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 5.52476288915489 4.675 4.675 1 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KCC4 1 0 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.17609125905568 4.675 4.675 1 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KGP1 2 0 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.23514091509468 4.675 4.675 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TAOK1 1 0 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 6.00479888288177 4.675 4.675 1 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NLK 1 0 NLK LAK1 NLK_HUMAN 6.12338490853968 4.675 4.675 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TBK1 2 0 TBK1 NAK TBK1_HUMAN 5.75270061672548 4.675 4.675 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TAOK3 1 0 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 6.50965047954658 4.675 4.675 1 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NEK11 1 0 NEK11 NEK11_HUMAN 5.82557590031178 4.675 4.675 1 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MK03 2 0 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.76886436970625 4.675 4.675 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SRPK3 1 0 SRPK3 MSSK1 STK23 SRPK3_HUMAN 6.06069784035361 4.675 4.675 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHA3 1 0 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 5.75332766665861 4.675 4.675 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KCC2D 1 0 CAMK2D CAMKD KCC2D_HUMAN 5.60205999132796 4.675 4.675 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 JAK2 6 0 JAK2 JAK2_HUMAN 4.98567697553561 4.675 4.66927083333333 6 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MKNK2 1 0 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.52476288915489 4.675 4.675 1 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KC1D 2 0 CSNK1D HCKID KC1D_HUMAN 5.10795461855239 4.675 4.675 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PAK6 2 0 PAK6 PAK5 PAK6_HUMAN 5.75747810605688 4.675 4.675 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MP2K6 2 0 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 6.06069784035361 4.675 4.675 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TSSK2 2 0 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 5.61038082698757 4.675 4.675 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ERBB4 2 0 ERBB4 HER4 ERBB4_HUMAN 5.80931454638058 4.675 4.675 2 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KCC2B 1 0 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.65854134728041 4.675 4.675 1 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NTRK1 1 0 NTRK1 MTC TRK TRKA NTRK1_HUMAN 4.80573477201573 4.675 4.675 1 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ROCK2 1 0 ROCK2 KIAA0619 ROCK2_HUMAN 6.12338490853968 4.675 4.675 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TYRO3 2 0 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 6.53520366087006 4.675 4.675 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KS6B1 2 0 RPS6KB1 STK14A KS6B1_HUMAN 5.08948040686076 4.675 4.675 2 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CDK3 6 0 CDK3 CDKN3 CDK3_HUMAN 6.19250506229669 4.675 4.675 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CCNE1 9 0 CCNE1 CCNE CCNE1_HUMAN 6.29822020137999 4.675 4.675 9 G1/S-specific cyclin-E1 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CCNE2 9 0 CCNE2 CCNE2_HUMAN 6.29822020137999 4.675 4.675 9 G1/S-specific cyclin-E2 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PRKX 2 0 PRKX PKX1 PRKX_HUMAN 5.68295188833586 4.675 4.675 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KC1G1 2 0 CSNK1G1 KC1G1_HUMAN 5.7519572156538 4.675 4.675 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KS6A4 4 0 RPS6KA4 MSK2 KS6A4_HUMAN 5.77696529855017 4.675 4.675 4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EF2K 1 0 EEF2K EF2K_HUMAN 5.65854134728041 4.675 4.675 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.675 4.675 4.675 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 BRSK1 2 0 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 6.08429082863847 4.675 4.675 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCD 1 0 PRKCD KPCD_HUMAN 6.50965047954658 4.675 4.675 1 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 HIPK1 1 0 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.99563519459755 4.675 4.675 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FAK2 1 0 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 5.50060235056919 4.675 4.675 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ULK2 1 0 ULK2 KIAA0623 ULK2_HUMAN 6.99563519459755 4.675 4.675 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TXK 2 0 TXK PTK4 RLK TXK_HUMAN 5.90608516883654 4.675 4.675 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 M3K9 2 0 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 5.68553393113587 4.675 4.675 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 IKKB 2 0 IKBKB IKKB IKKB_HUMAN 6.27875360095283 4.675 4.675 2 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PIM3 2 0 PIM3 PIM3_HUMAN 6.63719439777519 4.675 4.675 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 JAK3 4 0 JAK3 JAK3_HUMAN 5.60043827175932 4.675 4.675 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ABL2 2 0 ABL2 ABLL ARG ABL2_HUMAN 6.35789724900175 4.675 4.675 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TAOK2 1 0 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 6.12338490853968 4.675 4.675 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 6.69019608002851 4.675 4.675 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CDK2 3 0 CDK2 CDKN2 CDK2_HUMAN 6.50965047954658 4.675 4.675 3 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MRCKB 2 0 CDC42BPB KIAA1124 MRCKB_HUMAN 6.13280193829251 4.675 4.675 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FGFR2 1 0 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 6.12338490853968 4.675 4.675 1 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCL 1 0 PRKCH PKCL PRKCL KPCL_HUMAN 5.62973141792582 4.675 4.675 1 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CLK3 2 0 CLK3 CLK3_HUMAN 5.84521462913971 4.675 4.675 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KC1G2 2 0 CSNK1G2 CK1G2 KC1G2_HUMAN 5.3118896205106 4.675 4.675 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MAPK3 1 0 MAPKAPK3 MAPK3_HUMAN 6.69019608002851 4.675 4.675 1 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ULK3 1 0 ULK3 ULK3_HUMAN 5.78837041556533 4.675 4.675 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 RON 2 0 MST1R PTK8 RON RON_HUMAN 6.37544696019106 4.675 4.675 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAKG2 7 0 PRKAG2 AAKG2_HUMAN 5.47712125471966 4.675 4.675 7 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAKB2 7 0 PRKAB2 AAKB2_HUMAN 5.47712125471966 4.675 4.675 7 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAPK1 13 0 PRKAA1 AMPK1 AAPK1_HUMAN 5.59081415935191 4.675 4.675 13 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAPK2 7 0 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.47712125471966 4.675 4.675 7 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAKB1 13 0 PRKAB1 AMPK AAKB1_HUMAN 5.59081415935191 4.675 4.675 13 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAKG1 13 0 PRKAG1 AAKG1_HUMAN 5.59081415935191 4.675 4.675 13 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AAKG3 7 0 PRKAG3 AMPKG3 AAKG3_HUMAN 5.47712125471966 4.675 4.675 7 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 GLCM 2 0 GBA GC GLUC GLCM_HUMAN 4.70000012891341 4.675 4.675 2 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MARK2 1 0 MARK2 EMK1 MARK2_HUMAN 6.27875360095283 4.675 4.675 1 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 INSRR 1 0 INSRR IRR INSRR_HUMAN 5.60205999132796 4.675 4.675 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FAK1 1 0 PTK2 FAK FAK1 FAK1_HUMAN 6.27875360095283 4.675 4.675 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NEK3 1 0 NEK3 NEK3_HUMAN 5.75332766665861 4.675 4.675 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 HIPK2 2 0 HIPK2 HIPK2_HUMAN 6.44493086062909 4.675 4.675 2 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PLK2 1 0 PLK2 SNK PLK2_HUMAN 6.12338490853968 4.675 4.675 1 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AL1A1 2 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.45 4.675 4.675 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MP2K1 1 0 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 6.06069784035361 4.675 4.675 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SGK2 2 0 SGK2 SGK2_HUMAN 5.9404067961404 4.675 4.675 2 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FRK 2 0 FRK PTK5 RAK FRK_HUMAN 5.95424250943933 4.675 4.675 2 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FYN 1 0 FYN FYN_HUMAN 5.72015930340596 4.675 4.675 1 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 STK10 2 0 STK10 LOK STK10_HUMAN 5.90977196777093 4.675 4.675 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 LYN 2 0 LYN JTK8 LYN_HUMAN 5.22386978299399 4.675 4.675 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KAPCA 2 0 PRKACA PKACA KAPCA_HUMAN 6.22494678317885 4.675 4.675 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DMPK 1 0 DMPK DM1PK MDPK DMPK_HUMAN 6.99563519459755 4.675 4.675 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 UFO 2 0 AXL UFO UFO_HUMAN 6.05018527255879 4.675 4.675 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DYRK2 2 0 DYRK2 DYRK2_HUMAN 6.55951005156861 4.675 4.675 2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KS6A3 4 0 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 4.79625733671087 4.675 4.675 4 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHA7 1 0 EPHA7 EHK3 HEK11 EPHA7_HUMAN 6.19497660321606 4.675 4.675 1 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PAK5 1 0 PAK5 KIAA1264 PAK7 PAK5_HUMAN 5.52476288915489 4.675 4.675 1 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AURKC 1 0 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.82557590031178 4.675 4.675 1 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 STK11 1 0 STK11 LKB1 PJS STK11_HUMAN 6.50965047954658 4.675 4.675 1 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PLK3 2 0 PLK3 CNK FNK PRK PLK3_HUMAN 6.20106925474625 4.675 4.675 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 GSK3B 1 0 GSK3B GSK3B_HUMAN 6.12338490853968 4.675 4.675 1 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 WNK2 1 0 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 6.19497660321606 4.675 4.675 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ALK 1 0 ALK ALK_HUMAN 5.65854134728041 4.675 4.675 1 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 WNK3 1 0 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.27875360095283 4.675 4.675 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 ABL1 2 0 ABL1 ABL JTK7 ABL1_HUMAN 6.0344202063547 4.675 4.675 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 YES 1 0 YES1 YES YES_HUMAN 6.27875360095283 4.675 4.675 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KC1G3 2 0 CSNK1G3 KC1G3_HUMAN 5.88453579626587 4.675 4.675 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHA2 1 0 EPHA2 ECK EPHA2_HUMAN 6.12338490853968 4.675 4.675 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MET 2 0 MET MET_HUMAN 5.69402838736997 4.675 4.675 2 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NTRK2 2 0 NTRK2 TRKB NTRK2_HUMAN 4.9192485513774 4.675 4.675 2 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MAPK5 1 0 MAPKAPK5 PRAK MAPK5_HUMAN 5.75332766665861 4.675 4.675 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 GRK6 1 0 GRK6 GPRK6 GRK6_HUMAN 6.00479888288177 4.675 4.675 1 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 VGFR3 2 0 FLT4 VEGFR3 VGFR3_HUMAN 4.85011558991116 4.675 4.675 2 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 EPHA5 1 0 EPHA5 BSK EHK1 HEK7 TYRO4 EPHA5_HUMAN 6.99563519459755 4.675 4.675 1 Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FES 1 0 FES FPS FES_HUMAN 5.82557590031178 4.675 4.675 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SGK1 2 0 SGK1 SGK SGK1_HUMAN 6.48447484049067 4.675 4.675 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NEK6 2 0 NEK6 NEK6_HUMAN 5.75502865640732 4.675 4.675 2 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AURKA 2 0 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 6.18941262551316 4.675 4.675 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 TIE2 1 0 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 5.60205999132796 4.675 4.675 1 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 SIK1 1 0 SIK1 SIK SNF1LK SIK1_HUMAN 5.45425837176016 4.675 4.675 1 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 RAF1 2 0 RAF1 RAF RAF1_HUMAN 6.39200280508144 4.675 4.675 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 INSR 2 0 INSR INSR_HUMAN 6.2851741599501 4.675 4.675 2 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 HCK 3 0 HCK HCK_HUMAN 5.4018501380272 4.675 4.675 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 NEK2 1 0 NEK2 NEK2A NLK1 NEK2_HUMAN 6.19497660321606 4.675 4.675 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KPCA 1 0 PRKCA PKCA PRKACA KPCA_HUMAN 6.99563519459755 4.675 4.675 1 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 PHKG2 1 0 PHKG2 PHKG2_HUMAN 6.38021124171161 4.675 4.675 1 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DDR2 1 0 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.06069784035361 4.675 4.675 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FGFR1 1 0 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 5.86530142610254 4.675 4.675 1 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 VRK2 1 0 VRK2 VRK2_HUMAN 5.78837041556533 4.675 4.675 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DAPK2 1 0 DAPK2 DAPK2_HUMAN 5.6886291709978 4.675 4.675 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 IRAK1 1 0 IRAK1 IRAK IRAK1_HUMAN 6.19497660321606 4.675 4.675 1 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MUSK 1 0 MUSK MUSK_HUMAN 5.47712125471966 4.675 4.675 1 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 FKB1A 2 0 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 6.12338490853968 4.675 4.675 2 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MTOR 2 0 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 6.12338490853968 4.675 4.675 2 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 IRAK4 1 0 IRAK4 IRAK4_HUMAN 5.28806501849961 4.675 4.675 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KCC1A 1 0 CAMK1 KCC1A_HUMAN 5.60205999132796 4.675 4.675 1 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 RIPK2 1 0 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.14017870316504 4.675 4.675 1 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MYLK 2 0 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.6690211687168 4.675 4.675 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 AKT2 1 0 AKT2 AKT2_HUMAN 5.6886291709978 4.675 4.675 1 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MAPK2 1 0 MAPKAPK2 MAPK2_HUMAN 5.60205999132796 4.675 4.675 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MERTK 1 0 MERTK MER MERTK_HUMAN 5.21260809288144 4.675 4.675 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MRCKA 1 0 CDC42BPA KIAA0451 MRCKA_HUMAN 6.12338490853968 4.675 4.675 1 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 DAPK3 1 0 DAPK3 ZIPK DAPK3_HUMAN 6.38021124171161 4.675 4.675 1 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 BLK 1 0 BLK BLK_HUMAN 6.06069784035361 4.675 4.675 1 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 KCC2G 1 0 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 5.54967192186827 4.675 4.675 1 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 CSK 1 0 CSK CSK_HUMAN 6.19497660321606 4.675 4.675 1 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 LIMK1 1 0 LIMK1 LIMK LIMK1_HUMAN 6.27875360095283 4.675 4.675 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109185 MK10 2 0 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 6.28552149557703 4.675 4.675 2 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 0 4.675 actual molregno [molregno] COc1cc2ncc(nc2cc1OC)c3ccccc3 109093 DPOLB 0 1 POLB DPOLB_HUMAN 5.42 9.09691001300806 9.09691001300806 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 CP2C9 0 2 CYP2C9 CYP2C10 CP2C9_HUMAN 4.5 9.09691001300806 9.09691001300806 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 DPO3 0 1 polC dnaF mutI BSU16580 DPO3_BACSU 4.67382190675771 9.09691001300806 9.09691001300806 1 DNA polymerase III PolC-type (PolIII) (EC 2.7.7.7) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.9 9.09691001300806 9.09691001300806 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 CP2CJ 0 2 CYP2C19 CP2CJ_HUMAN 4.5 9.09691001300806 9.09691001300806 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 RECQ1 0 2 RECQL RECQ1 RECQL1 RECQ1_HUMAN 5 9.09691001300806 9.09691001300806 2 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 PTK6 0 2 PTK6 BRK PTK6_HUMAN 4.95 9.09691001300806 9.09691001300806 2 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.77500036536096 9.09691001300806 9.09691001300806 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 MTOR 0 1 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.73 9.09691001300806 9.09691001300806 1 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 6.6 9.09691001300806 9.09691001300806 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.85 9.09691001300806 9.09691001300806 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.45 9.09691001300806 9.09691001300806 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.9 9.09691001300806 9.09691001300806 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 LOX12 0 1 ALOX12 12LO LOG12 LOX12_HUMAN 5.4 9.09691001300806 9.09691001300806 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 NFKB1 0 4 NFKB1 NFKB1_HUMAN 4.95 9.09691001300806 9.09691001300806 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.9 9.09691001300806 9.09691001300806 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.8 9.09691001300806 9.09691001300806 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.8 9.09691001300806 9.09691001300806 4 Menin 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 MPP8 0 2 MPHOSPH8 MPP8 MPP8_HUMAN 5.23690957969244 9.09691001300806 9.09691001300806 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 FRIL 0 1 FTL FRIL_HORSE 4.75 9.09691001300806 9.09691001300806 1 Ferritin light chain (Ferritin L subunit) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68639005935126 9.09691001300806 9.09691001300806 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 UBP2 0 1 USP2 UBP41 UBP2_HUMAN 4.5 9.09691001300806 9.09691001300806 1 Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 P53 0 2 TP53 P53 P53_HUMAN 4.95 9.09691001300806 9.09691001300806 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 5.42382636078642 9.09691001300806 9.09691001300806 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.75 9.09691001300806 9.09691001300806 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.95 9.09691001300806 9.09691001300806 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 9.09691001300806 9.09691001300806 1 Geminin 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 TPO 0 2 THPO MGDF TPO_HUMAN 5.5 9.09691001300806 9.09691001300806 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 PGFRB 0 2 Pdgfrb Pdgfr Pdgfr1 PGFRB_MOUSE 6 9.09691001300806 9.09691001300806 2 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 PGFRA 0 2 Pdgfra PGFRA_MOUSE 6 9.09691001300806 9.09691001300806 2 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 4.55 9.09691001300806 9.09691001300806 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 5.85001154350852 9.09691001300806 9.09691001300806 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.65 9.09691001300806 9.09691001300806 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 PIN1 0 1 PIN1 PIN1_HUMAN 5.32098115059902 9.09691001300806 9.09691001300806 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.45000414846935 9.09691001300806 9.09691001300806 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 9.09691001300806 9.09691001300806 9.09691001300806 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 PFKA 0 1 pfk PFKA_TRYBB 4.67098267640138 9.09691001300806 9.09691001300806 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 CP2D6 0 2 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.6 9.09691001300806 9.09691001300806 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 RGS4 0 1 RGS4 RGS4_HUMAN 4.92382212781084 9.09691001300806 9.09691001300806 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 POLK 0 1 POLK DINB1 POLK_HUMAN 5.22382202741777 9.09691001300806 9.09691001300806 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 POLI 0 1 POLI RAD30B POLI_HUMAN 5.09999903484653 9.09691001300806 9.09691001300806 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.89999841719865 9.09691001300806 9.09691001300806 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109093 EGFR 0 1 Egfr EGFR_MOUSE 4.52 9.09691001300806 9.09691001300806 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 9.09691001300806 actual molregno [molregno] Oc1ccc(cc1O)C(=O)\C(=C\c2c[nH]c3ccccc23)\C#N 109006 NMD3A 0 21 GRIN3A KIAA1973, Grin3a NMD3A_HUMAN, NMD3A_RAT 5.77666666666667 6.95 6.95 21 Glutamate receptor ionotropic, NMDA 3A (GluN3A) (Glutamate receptor chi-1) (N-methyl-D-aspartate receptor) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) (NMDAR-L1), Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 NMDE3 0 23 GRIN2C NMDAR2C, Grin2c NMDE3_HUMAN, NMDE3_RAT 5.72565217391305 6.95 6.95 23 Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 NMDE1 0 23 GRIN2A NMDAR2A, Grin2a NMDE1_HUMAN, NMDE1_RAT 5.82304347826087 6.95 6.95 23 Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A), Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 NMDE4 0 21 GRIN2D GluN2D NMDAR2D, Grin2d GluN2D NMDE4_HUMAN, NMDE4_RAT 5.77666666666667 6.95 6.95 21 Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D), Glutamate receptor ionotropic, NMDA 2D (GluN2D) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 NMDE2 0 23 GRIN2B NMDAR2B, Grin2b NMDE2_HUMAN, NMDE2_RAT 5.74217391304348 6.95 6.95 23 Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B), Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 NMDZ1 0 27 GRIN1 NMDAR1, Grin1 Nmdar1 NMDZ1_HUMAN, NMDZ1_RAT 5.74333333333333 6.95 6.95 27 Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1), Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 NMD3B 0 21 GRIN3B, Grin3b NMD3B_HUMAN, NMD3B_RAT 5.77666666666667 6.95 6.95 21 Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 TSHR 0 6 TSHR LGR3 TSHR_HUMAN 6.13333333333333 6.95 6.95 6 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 0 13 NotRecorded 4.96653554440852 6.95 6.95 13 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.95 6.95 6.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 7.75 6.95 6.95 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 END4 0 1 nfo b2159 JW2146 END4_ECOLI 4.9 6.95 5.7125 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 6 6.95 6.95 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 109006 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 6.95 6.95 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 6.95 actual molregno [molregno] N[C@H](CCCCCP(=O)(O)O)C(=O)O 108981 KMT2A 8 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.975 4.63333333333333 4.63333333333333 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 MEN1 8 0 MEN1 SCG2 MEN1_HUMAN 4.975 4.63333333333333 4.63333333333333 8 Menin 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 GLCM 1 0 GBA GC GLUC GLCM_HUMAN 4.70000050388302 4.63333333333333 4.63333333333333 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 TAU 8 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.16875 4.63333333333333 4.633125 8 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 GRP78 2 0 HSPA5 GRP78 GRP78_HUMAN 6.93292914395463 4.63333333333333 4.63333333333333 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 PFKA 2 0 pfk PFKA_TRYBB 5.24598385467467 4.63333333333333 4.63333333333333 2 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 POLK 5 0 POLK DINB1 POLK_HUMAN 4.96476381671516 4.63333333333333 4.63333333333333 5 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 KSYK 6 0 SYK KSYK_HUMAN 4.85659065592364 4.63333333333333 4.63333333333333 6 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.65 4.63333333333333 4.63333333333333 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 EHMT2 6 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.93730595505773 4.63333333333333 4.63222222222222 6 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 MYLK 2 0 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 4.92 4.63333333333333 4.63333333333333 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 PGKC 2 0 PGKC_TRYBB 4.63549155981671 4.63333333333333 4.63333333333333 2 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 PGDH 2 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.025 4.63333333333333 4.63333333333333 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 4.6 4.63333333333333 4.63333333333333 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 ALR 1 0 GFER ALR HERV1 HPO ALR_HUMAN 6.16 4.63333333333333 4.63333333333333 1 Alanine racemase (EC 5.1.1.1), FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 LMBL1 1 0 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 4.5 4.63333333333333 4.63333333333333 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 MPP8 2 0 MPHOSPH8 MPP8 MPP8_HUMAN 4.53691104640714 4.63333333333333 4.63333333333333 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 DPOLB 1 0 POLB DPOLB_HUMAN 5.1 4.63333333333333 4.63333333333333 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 DYR1A 1 0 Dyrk1a Dyrk DYR1A_RAT 5.12 4.63333333333333 4.63333333333333 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 ATX2 3 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.88333227715961 4.63333333333333 4.63333333333333 3 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 GEMI 2 0 GMNN GEMI_HUMAN 5.01810649291336 4.63333333333333 4.6325 2 Geminin 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 LX15B 1 0 ALOX15B LX15B_HUMAN 5.35000349253396 4.63333333333333 4.63333333333333 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 CBX1 2 0 CBX1 CBX CBX1_HUMAN 4.57500023913317 4.63333333333333 4.63333333333333 2 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 Q94696 1 0 luc Q94696_PHOPE 4.9 4.63333333333333 4.63333333333333 1 Luciferase 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 LUCI 1 0 LUCI_PHOPY 5.02098457748104 4.63333333333333 4.63333333333333 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 MTOR 2 0 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.63 4.63333333333333 4.63333333333333 2 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 ATAD5 4 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.38979566534114 4.63333333333333 4.63291666666666 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.63621320946427 4.63333333333333 4.63333333333333 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 APEX1 4 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.08750434725165 4.63333333333333 4.63333333333333 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 O97447 1 0 ald O97447_GIAIN 4.8 4.63333333333333 4.63333333333333 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 SMN 3 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.63333333333333 4.63333333333333 4.63333333333333 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 P53 1 0 TP53 P53 P53_HUMAN 5 4.63333333333333 4.63333333333333 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 SRC 1 0 SRC SRC1 SRC_HUMAN 4.84193184507759 4.63333333333333 4.63333333333333 1 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 LMNA 2 0 LMNA LMN1 LMNA_HUMAN 6.05 4.63333333333333 4.63333333333333 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 RGS4 3 0 RGS4 RGS4_HUMAN 5.95713867235295 4.63333333333333 4.63333333333333 3 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 AL1A1 4 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6625 4.63333333333333 4.63333333333333 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 DRD1 1 0 DRD1 DRD1_HUMAN 6.2362725962343 4.63333333333333 4.63333333333333 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.63621398618501 4.63333333333333 4.63333333333333 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 TRXR1 3 0 Txnrd1 Trxr1 TRXR1_RAT 4.98254855971972 4.63333333333333 4.63333333333333 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 FEN1 2 0 FEN1 RAD2 FEN1_HUMAN 6.07381195089279 4.63333333333333 4.63333333333333 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 RUNX1 2 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.8000008748032 4.63333333333333 4.63333333333333 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 PEBB 2 0 CBFB PEBB_HUMAN 4.8000008748032 4.63333333333333 4.63333333333333 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 LOX12 1 0 ALOX12 12LO LOG12 LOX12_HUMAN 5.35 4.63333333333333 4.63333333333333 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 MBNL1 1 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.74999985591871 4.63333333333333 4.63333333333333 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 PTH1R 2 0 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.25000102344165 4.63333333333333 4.63333333333333 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 LT 1 0 LT_SV40 4.78648224300369 4.63333333333333 4.63333333333333 1 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 Q57TT1 1 0 Tb927.8.6820 Q57TT1_TRYB2 4.89999841719865 4.63333333333333 4.63333333333333 1 Uncharacterized protein 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 PMP22 1 0 PMP22 GAS3 PMP22_HUMAN 4.52 4.63333333333333 4.63333333333333 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 TYDP1 1 0 TDP1 TYDP1_HUMAN 5.55 4.63333333333333 4.63333333333333 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 Q962Y6 1 0 TGR Q962Y6_SCHMA 4.65 4.63333333333333 4.63333333333333 1 Thioredoxin glutathione reductase (EC 1.6.4.5) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 POLH 1 0 POLH RAD30 RAD30A XPV POLH_HUMAN 4.74999985591871 4.63333333333333 4.63333333333333 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 NPC1 1 0 NPC1 NPC1_HUMAN 5.19 4.63333333333333 4.63333333333333 1 Niemann-Pick C1 protein 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.74999985591871 4.63333333333333 4.63333333333333 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 ASM 1 0 SMPD1 ASM ASM_HUMAN 4.59999938302362 4.63333333333333 4.63333333333333 1 Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 108981 SIR2 1 0 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5.17609125905568 4.63333333333333 4.63333333333333 1 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 0 4.63333333333333 actual molregno [molregno] Oc1cc(O)cc(\C=C\c2ccc(O)c(O)c2)c1 110802 DYR1A 0 1 Dyrk1a Dyrk DYR1A_RAT 5.06 4.85 4.85 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 CAH12 0 1 CA12 CAH12_HUMAN 4.59 4.85 4.85 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 4.85 4.85 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.78649508309594 4.85 4.85 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 CAH7 0 1 CA7 CAH7_HUMAN 5.04 4.85 4.85 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 P53 0 2 TP53 P53 P53_HUMAN 4.75 4.85 4.85 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.63638990017462 4.85 4.85 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.3 4.85 4.85 1 Ras-related protein Rab-9A 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 4.85 4.85 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.85 4.85 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 5.25000102344165 4.85 4.85 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.525 4.85 4.85 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.82382189073267 4.85 4.85 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.48956452844795 4.85 4.85 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 ALF 0 1 fba Rv0363c MTCY13E10.25c ALF_MYCTU 5.95428594105913 4.85 4.85 1 Fructose-bisphosphate aldolase (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase), Fructose-bisphosphate aldolase class 2 (FBP aldolase) (FBPA) (EC 4.1.2.13) (Fructose-1,6-bisphosphate aldolase) (Fructose-bisphosphate aldolase class II), Fructose-bisphosphate aldolase, glycosomal (EC 4.1.2.13) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.94999940171424 4.85 4.85 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 LUCI 0 1 LUCI_PHOPY 4.97098167045352 4.85 4.85 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 CAH13 0 1 CA13 CAH13_HUMAN 5.08 4.85 4.85 1 Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 CAH1 0 1 CA1 CAH1_HUMAN 4.67 4.85 4.85 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.73621248726524 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 110802 CAH9 0 1 CA9 G250 MN CAH9_HUMAN 5.12 4.85 4.85 1 Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1) 1 4.85 actual molregno [molregno] CC1(C)Oc2cc3OC(=O)C=Cc3cc2C=C1 111490 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 6.72514967998334 4.95 4.95 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 4.97133178334578 4.95 4.95 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 ANDR 0 5 AR DHTR NR3C4 ANDR_HUMAN 4.78953961236478 4.95 4.95 5 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.84999924507786 4.95 4.89 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 PEBB 0 2 CBFB PEBB_HUMAN 4.84999924507786 4.95 4.89 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 CASP7 0 1 CASP7 MCH3 CASP7_HUMAN 4.5 4.95 4.95 1 Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 HSPB1 0 1 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.61010420523426 4.95 4.95 1 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 4.89999841719865 4.95 4.95 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 LUCI 0 1 LUCI_PHOPY 5.57936774166588 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Nc1ccccc1N 111490 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.5 4.95 4.95 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.95 actual molregno [molregno] Nc1ccccc1N 114697 GLSK 0 1 GLS GLS1 KIAA0838 GLSK_HUMAN 4.8000008748032 8.49 8.49 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 0 5 NotRecorded 4.71091440828601 8.49 8.44575 5 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 Q72547 0 2 pol Q72547_9HIV1 5.22516403906586 8.49 8.49 2 Reverse transcriptase/RNaseH (Fragment) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 8.49 8.49 8.49 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.6862171168448 8.49 8.49 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.65 8.49 8.49 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.49999693194831 8.49 8.49 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.03621217265444 8.49 8.49 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 114697 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.2 8.49 8.49 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 8.49 actual molregno [molregno] O=C1Nc2ccccc2Nc3ncccc13 115840 LUCI 0 1 LUCI_PHOPY 4.92098164492706 5.5 5.5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 0 42 ATP-dependent Clp protease proteolytic subunit, Nonstructural protein 1, NotRecorded 4.78224916457142 5.5 5.48230282738095 42 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 NPC1 0 1 NPC1 NPC1_HUMAN 5.4 5.5 5.5 1 Niemann-Pick C1 protein 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.84999924507786 5.5 5.5 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 GEMI 0 2 GMNN GEMI_HUMAN 4.93621247076273 5.5 5.5 2 Geminin 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 7.3 5.5 5.5 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.225 5.5 5.5 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 5.5 5.5 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 Q94696 0 1 luc Q94696_PHOPE 5.1 5.5 5.5 1 Luciferase 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.13621245580523 5.5 5.5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.5 5.5 5.5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 MAP11 0 2 METAP1 KIAA0094 MAP11_HUMAN 4.68695437047216 5.5 5.5 2 Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 FFP 1 0 ffp sfp FFP_BACIU 5.5 5.5 4.625 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 0 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.55000045168903 5.5 5.5 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.54999736982681 5.5 5.5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 MAP2 0 2 METAP2 MNPEP P67EIF2 MAP2_HUMAN 5.04630404644072 5.5 5.5 2 Methionine aminopeptidase (MAP) (MetAP) (EC 3.4.11.18) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M) 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 115840 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.55 5.5 5.5 1 Ras-related protein Rab-9A 1 5.5 actual molregno [molregno] c1ccc(nc1)c2nc3ccccc3[nH]2 114365 GNAS2 2 0 GNAS GNAS1 GSP GNAS2_HUMAN 4.74999992670164 4.8 4.8 2 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.8 4.8 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 8 0 NotRecorded 4.89170639822501 4.8 4.3625 8 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.85 4.8 4.8 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 AA1R 0 1 Adora1 AA1R_RAT 6.07 4.8 5.73125 1 Adenosine receptor A1 1 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 RORG 1 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 4.8 4.8 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 ATAD5 1 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.23621273895602 4.8 4.8 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 114365 GLP1R 1 0 GLP1R GLP1R_HUMAN 4.55000045168903 4.8 4.8 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.8 actual molregno [molregno] CC(C)Nc1nc2ccccc2n3c(C)nnc13 122714 0 14 NotRecorded 4.51301570111548 4.9 4.9 14 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 4.75 4.9 4.9 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 4.94999940171424 4.9 4.9 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.5 4.9 4.9 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 NFKB1 0 4 NFKB1 NFKB1_HUMAN 5.5 4.9 4.9 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 4.9 4.9 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.2 4.9 4.9 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 4.9 4.9 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.6 4.9 4.9 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 LX15B 0 1 ALOX15B LX15B_HUMAN 5.19999817218203 4.9 4.9 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 CP2C9 0 2 CYP2C9 CYP2C10 CP2C9_HUMAN 5.6 4.9 4.9 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 EGFR 0 2 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 5.44 4.9 4.9 2 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.9 4.9 4.9 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.95 4.9 4.9 4 Menin 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.8 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 GEMI 0 1 GMNN GEMI_HUMAN 4.7 4.9 4.9 1 Geminin 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.59999765407204 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 UBP2 0 1 USP2 UBP41 UBP2_HUMAN 4.8 4.9 4.9 1 Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 POLI 0 1 POLI RAD30B POLI_HUMAN 4.59999938302362 4.9 4.9 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.95 4.9 4.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122714 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.55 4.9 4.9 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] COc1cc(C=C(C#N)C#N)cc(O)c1O 122795 TAU 0 4 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.0375 4.925 4.925 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 TPO 0 2 THPO MGDF TPO_HUMAN 4.9 4.925 4.925 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 AL1A1 0 3 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.86666666666667 4.925 4.925 3 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.6 4.925 4.925 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 PFKA 0 3 pfk PFKA_TRYBB 4.730655825931 4.925 4.925 3 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 LMBL1 0 1 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 4.65 4.925 4.925 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 JAK2 0 6 JAK2 JAK2_HUMAN 5.13855625854416 4.925 4.925 6 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5 4.925 4.925 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 LOX12 0 1 ALOX12 12LO LOG12 LOX12_HUMAN 4.8 4.925 4.925 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 TRXR1 0 5 Txnrd1 Trxr1 TRXR1_RAT 4.53952919381243 4.925 4.925 5 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.7 4.925 4.925 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 NFKB1 0 4 NFKB1 NFKB1_HUMAN 4.95 4.925 4.925 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 GEMI 0 2 GMNN GEMI_HUMAN 7.1419983281826 4.925 4.925 2 Geminin 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 4.72382322328385 4.925 4.925 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 EHMT2 0 4 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.13095758066447 4.925 4.925 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 6.79 4.925 4.925 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 PPBI 0 2 ALPI, Iap Akp-3 Akp3 PPBI_HUMAN, PPBI_MOUSE 4.685 4.925 4.925 2 Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1), Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1) (Alkaline phosphatase 3) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.975 4.925 4.925 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.975 4.925 4.925 8 Menin 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 ALDR 0 1 Akr1b1 Akr1b4 Aldr1 ALDR_RAT 6.69 4.925 4.925 1 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 POLK 0 4 POLK DINB1 POLK_HUMAN 5.10595566925687 4.925 4.925 4 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 5.39999691337226 4.925 4.925 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 CCNE1 0 2 CCNE1 CCNE CCNE1_HUMAN 6.21 4.925 4.925 2 G1/S-specific cyclin-E1 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 CDK2 0 2 CDK2 CDKN2 CDK2_HUMAN 6.21 4.925 4.925 2 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.925 4.925 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 Q962Y6 0 1 TGR Q962Y6_SCHMA 5.85 4.925 4.925 1 Thioredoxin glutathione reductase (EC 1.6.4.5) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 5.4 4.925 4.925 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 PPBT 0 1 ALPL PPBT_HUMAN 5 4.925 4.925 1 Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase 2) (Alkaline phosphatase liver/bone/kidney isozyme), Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.925 4.925 4.925 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 GLSK 0 1 GLS GLS1 KIAA0838 GLSK_HUMAN 5.09999903484653 4.925 4.925 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 KDM4C 0 3 KDM4C GASC1 JHDM3C JMJD2C KIAA0780 KDM4C_HUMAN 4.97 4.925 4.925 3 Lysine-specific demethylase 4C (EC 1.14.11.-) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 RORG 0 3 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.925 4.925 3 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 LX15B 0 1 ALOX15B LX15B_HUMAN 4.89999841719865 4.925 4.925 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 P53 0 1 TP53 P53 P53_HUMAN 4.8 4.925 4.925 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 CBX1 0 1 CBX1 CBX CBX1_HUMAN 4.65000022087346 4.925 4.925 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 RGS4 0 1 RGS4 RGS4_HUMAN 4.72382322328385 4.925 4.925 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 5.09999903484653 4.925 4.925 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.57510040419402 4.925 4.925 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.70000050388302 4.925 4.925 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 122795 O97447 0 1 ald O97447_GIAIN 4.85 4.925 4.925 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.925 actual molregno [molregno] Oc1ccc(C=C(C#N)C#N)cc1O 124240 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.65 4.9 4.9 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 5.65 4.9 4.9 4 Menin 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.836212690038 4.9 4.9 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 NF2L2 0 4 NFE2L2 NRF2 NF2L2_HUMAN 5.39835564693777 4.9 4.9 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.65000022087346 4.9 4.9175 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 GEMI 0 1 GMNN GEMI_HUMAN 4.98621510845326 4.9 4.9 1 Geminin 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.70000050388302 4.9 4.9 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.275 4.9 4.9 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 LUCI 0 1 LUCI_PHOPY 5.62098471330652 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 124240 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 7.9 4.9 4.9 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 4.9 actual molregno [molregno] COC(=O)c1sccc1NC(=O)Nc2ccc(Cl)c(Cl)c2 131879 LUCI 1 0 LUCI_PHOPY 4.87098398008989 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 5 4 Human herpesvirus 1 protease, NotRecorded 4.67108205655996 4.7 4.88078703703704 9 0.444444444444444 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.84999924507786 4.7 4.7 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.65 4.7 4.7 1 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68621284836475 4.7 4.7 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 4.7 4.7 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 NPC1 1 0 NPC1 NPC1_HUMAN 5.65 4.7 4.7 1 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 131879 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.69999179744619 4.7 4.6975 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.7 actual molregno [molregno] Fc1cccc(NC2=Nc3ccccc3C(=O)O2)c1 130689 2 56 Aberrant vpr protein, Nonstructural protein 1, NotRecorded 4.93015131210068 4.9 4.88669181034483 58 0.96551724137931 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 MITF 0 10 MITF BHLHE32 MITF_HUMAN 6.46404637688739 4.9 4.9 10 Microphthalmia-associated transcription factor, Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.89999841719865 4.9 4.9 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.65000410073714 4.9 4.9 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 EYA2 0 1 EYA2 EAB1 EYA2_HUMAN 5.2209087961545 4.9 4.9 1 Eyes absent homolog 2 (EC 3.1.3.48) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6 4.9 4.91458333333333 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.6 4.9 4.9 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 5.45000414846935 4.9 4.9125 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 PEBB 0 2 CBFB PEBB_HUMAN 5.45000414846935 4.9 4.9125 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 NFKB1 0 5 NFKB1 NFKB1_HUMAN 5.87 4.9 4.9 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 TF65 0 5 RELA NFKB3 TF65_HUMAN 5.87 4.9 4.9 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 5.87 4.9 4.9 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 LMBL1 0 1 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 5.6 4.9 4.96666666666667 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.84999924507786 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 5.09999903484653 4.9 4.9 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.15 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.836212690038 4.9 4.9 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 7.75 4.9 4.86666666666667 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.02382432408324 4.9 4.9 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6 4.9 4.86979166666667 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 5.5 4.9 4.17916666666667 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 CBX1 0 1 CBX1 CBX CBX1_HUMAN 4.89999841719865 4.9 4.9 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 SMAD3 0 3 SMAD3 MADH3 SMAD3_HUMAN 5.09080735557571 4.9 4.9 3 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 LUCI 0 1 LUCI_PHOPY 5.47098052029176 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.39999691337226 4.9 4.91875 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.73621248726524 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 HD 0 1 HTT HD IT15 HD_HUMAN 4.95 4.9 4.9 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 O97447 0 1 ald O97447_GIAIN 5.45 4.9 4.9 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.53639066359653 4.9 4.86666666666667 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 UBP1 0 1 USP1 UBP1_HUMAN 4.74999985591871 4.9 4.9 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 HSF1 0 1 Hsf1 HSF1_MOUSE 5.9 4.9 4.86979166666667 1 Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1) 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 130689 NPC1 0 1 NPC1 NPC1_HUMAN 5.75 4.9 4.93666666666667 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] O=C1C=C(Nc2ccccc2)C(=O)c3ccccc13 131097 GEMI 0 1 GMNN GEMI_HUMAN 8.33724216831843 8.55 8.29479166666667 1 Geminin 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 131097 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.6 8.55 8.059375 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 131097 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.89999841719865 8.55 6.35625 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 131097 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.14999741390754 8.55 8.059375 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 131097 0 1 NotRecorded 5.69999179744619 8.55 7.296875 1 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 131097 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 8.55 8.55 8.29479166666667 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 131097 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 6.15 8.55 8.059375 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 8.55 actual molregno [molregno] OCCNC(=O)c1ccc2C(=O)c3ccccc3S(=O)(=O)c2c1 132945 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.86121319014009 4.85 4.85 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.73621248726524 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 LUCI 0 1 LUCI_PHOPY 4.57098292927852 4.85 4.85 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 8.49485002168009 4.85 4.415 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 4.65000022087346 4.85 4.85 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 6.15 4.85 4.4775 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.1375 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 132945 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.5 4.85 4.8625 1 Ras-related protein Rab-9A 1 4.85 actual molregno [molregno] O=C(NCCc1ccccc1)c2cccnc2 133128 RXRA 0 2 RXRA NR2B1 RXRA_HUMAN 4.69999984838345 4.85 4.85 2 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.65000022087346 4.85 4.85 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 NF2L2 2 2 NFE2L2 NRF2 NF2L2_HUMAN 5.65689896659468 4.85 4.80078125 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0.5 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 GCR 0 3 NR3C1 GRL GCR_HUMAN 4.91666659650658 4.85 4.85104166666667 3 Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 P53 0 1 TP53 P53 P53_HUMAN 4.8 4.85 4.85 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.8 4.85 4.85 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.8 4.85 4.85 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 NR1I2 0 2 Nr1i2 Pxr NR1I2_RAT 4.72499954018565 4.85 4.85 2 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR), Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 ESR1 0 3 ESR1 ESR NR3A1 ESR1_HUMAN 4.96666582139463 4.85 4.85 3 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.89999841719865 4.85 4.85 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 133128 PEBB 0 2 CBFB PEBB_HUMAN 4.89999841719865 4.85 4.85 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.85 actual molregno [molregno] Cc1ccccc1N=Nc2ccc(N)c(C)c2 132927 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 4.85 4.85 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 6.175 4.85 4.85 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 ANDR 0 3 AR DHTR NR3C4 ANDR_HUMAN 4.79843264736841 4.85 4.85 3 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.74999985591871 4.85 4.85 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.89999841719865 4.85 4.85 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.98621510845326 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.45 4.85 4.85 1 Ras-related protein Rab-9A 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 6.2500319164906 4.85 4.85 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 LT 0 1 LT_SV40 5.45345733652187 4.85 4.85 1 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 NPC1 0 1 NPC1 NPC1_HUMAN 5.4 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.7 4.85 4.85 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93621268968233 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 132927 LUCI 0 1 LUCI_PHOPY 4.62098289875995 4.85 4.85 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] Nc1ccc2c(Cc3ccccc23)c1 136386 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.1 5.1 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 ATAD5 0 4 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.48979444848112 5.1 5.1 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 PGH1 0 2 PTGS1 COX1 PGH1_HUMAN 5.06 5.1 5.1 2 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.675 5.1 5.1 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.9499938184926 5.1 5.1 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 PGH2 0 2 PTGS2 COX2 PGH2_HUMAN 6.535 5.1 5.1 2 Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (Glucocorticoid-regulated inflammatory cyclooxygenase) (Gripghs) (Macrophage activation-associated marker protein P71/73) (PES-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) (TIS10 protein), Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 P53 0 3 TP53 P53 P53_HUMAN 5.13333255135735 5.1 5.1 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 5.1 5.1 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 LUCI 0 1 LUCI_PHOPY 6.02099825152528 5.1 5.1 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6.19997064075587 5.1 5.1 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 6.18620852521751 5.1 5.1 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 NPC1 0 2 NPC1 NPC1_HUMAN 5.395 5.1 5.1 2 Niemann-Pick C1 protein 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 7.08 5.1 5.1 2 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 MTOR 0 1 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.73 5.1 5.1 1 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.2 5.1 5.1 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.7 5.1 5.1 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 RAB9A 0 2 RAB9A RAB9 RAB9A_HUMAN 5.645 5.1 5.1 2 Ras-related protein Rab-9A 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 4.75 5.1 5.1 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 CP1A1 0 1 CYP1A1 CP1A1_HUMAN 6.59 5.1 5.1 1 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 4.74999985591871 5.1 5.1 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 POLI 0 1 POLI RAD30B POLI_HUMAN 7.64975198166584 5.1 5.1 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.8 5.1 5.1 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 Q4Q090 0 1 PGAM LMJF_36_6650 Q4Q090_LEIMA 4.62098289875995 5.1 5.1 1 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.1) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 TPO 0 2 THPO MGDF TPO_HUMAN 6.5 5.1 5.1 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 5.1 5.1 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 4.9 5.1 5.1 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 6.58302682739696 5.1 5.1 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 MMP9 0 1 MMP9 CLG4B MMP9_HUMAN 4.61814681122142 5.1 5.1 1 Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB), Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9] 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5.45000414846935 5.1 5.1 1 TAR DNA-binding protein 43 (TDP-43) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.1 5.1 5.1 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.15 5.1 5.1 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 136386 CP1B1 0 1 CYP1B1 CP1B1_HUMAN 7.26 5.1 5.1 1 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 1 5.1 actual molregno [molregno] O=C1N2CCc3c([nH]c4ccccc34)C2=Nc5ccccc15 135448 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.73622195097738 5.8 5.8 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 ASM 0 1 SMPD1 ASM ASM_HUMAN 5.39999691337226 5.8 5.8 1 Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 LUCI 0 2 LUCI_PHOPY 6.26051331204012 5.8 5.8 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 NFKB1 0 5 NFKB1 NFKB1_HUMAN 6.73 5.8 5.7775 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 TF65 0 5 RELA NFKB3 TF65_HUMAN 6.73 5.8 5.7775 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 6.73 5.8 5.7775 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.85 5.8 5.8 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 STAT1 0 2 STAT1 STAT1_HUMAN 7.83369998609746 5.8 5.74375 2 Signal transducer and activator of transcription 1, Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 ESR1 0 1 ESR1 ESR NR3A1 ESR1_HUMAN 4.76 5.8 5.8 1 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.36812395313314 5.8 5.8 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 5.8 5.8 1 Geminin 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 P53 0 2 TP53 P53 P53_HUMAN 4.62500012557179 5.8 5.8 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 5.8 5.8 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.6 5.8 5.8 1 Ras-related protein Rab-9A 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.8 5.8 5.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.45 5.8 5.8 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.75 5.8 5.8 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 6.19997064075587 5.8 5.8 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 CP1A1 0 1 CYP1A1 CP1A1_HUMAN 5.75 5.8 5.8 1 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.53 5.8 5.8 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 NPC1 0 1 NPC1 NPC1_HUMAN 6.7 5.8 5.8 1 Niemann-Pick C1 protein 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 135448 CP1B1 0 1 CYP1B1 CP1B1_HUMAN 7.08 5.8 5.8 1 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 1 5.8 actual molregno [molregno] COc1ccc2[nH]c3C4=Nc5ccccc5C(=O)N4CCc3c2c1 137009 CP2CJ 0 4 CYP2C19 CP2CJ_HUMAN 5.925 4.85 4.83639521059783 4 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 LUCI 0 4 LUCI_PHOPY 5.36511256978988 4.85 4.83795823317308 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.85 4.85 4.81516873340764 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.9 4.85 4.83212890625 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.9 4.85 4.83212890625 8 Menin 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 HCD2 0 6 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.86666666666667 4.85 4.83695211364116 6 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 P53 0 4 TP53 P53 P53_HUMAN 5.175 4.85 4.82457107843137 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 6.45 4.85 4.825390625 2 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 KAT2A 0 2 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 7.1001794975729 4.85 4.840625 2 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 TPO 0 2 THPO MGDF TPO_HUMAN 4.9 4.85 4.82265625 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.725 4.85 4.82832509092347 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 NQO1 0 4 Nqo1 Dia4 Nmo1 Nmor1 NQO1_MOUSE 5.01769197766826 4.85 4.81904473328981 4 NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 HIF1A 0 4 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.2 4.85 4.83264210972851 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 5.16045282297171 4.85 4.8140625 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 RORG 0 4 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.175 4.85 4.82676164215687 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.35 4.85 4.81953125 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 CP19A 0 2 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 4.60342754482384 4.85 4.81716870765105 2 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 UBP2 0 1 USP2 UBP41 UBP2_HUMAN 5 4.85 4.83410416666667 1 Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 4.85 4.84765625 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.625 4.85 4.81785851518027 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.725 4.85 4.81748991935484 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.7 4.85 4.81785851518027 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.81310483870968 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 137009 POLK 0 1 POLK DINB1 POLK_HUMAN 4.84999924507786 4.85 4.81635851518027 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.85 actual molregno [molregno] Oc1ccc(\C=C/c2cc(O)cc(O)c2)cc1 139210 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 5.15 4.925 4.19375 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.925 4.925 3.76875 2 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 7.69897000433602 4.925 4.46875 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 5.45000414846935 4.925 4.9075 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 POLI 0 1 POLI RAD30B POLI_HUMAN 6.2500319164906 4.925 4.92625 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 RPGF4 0 1 RAPGEF4 CGEF2 EPAC2 RPGF4_HUMAN 4.55000045168903 4.925 4.89375 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-dependent Rap1 guanine-nucleotide exchange factor) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII), Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.25 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 LUCI 0 2 LUCI_PHOPY 4.79071895801673 4.925 4.925 2 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 P53 0 2 TP53 P53 P53_HUMAN 4.8 4.925 4.925 2 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 5.85 4.925 4.916875 2 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.55 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Ras-related protein Rab-9A 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 GEMI 0 1 GMNN GEMI_HUMAN 5.33621429654423 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Geminin 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.7306570472181 4.925 4.909375 2 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 NPC1 0 1 NPC1 NPC1_HUMAN 5.55 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Niemann-Pick C1 protein 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 6.36041391332657 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.9 4.925 4.925 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 SC6A2 0 2 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.73 4.925 4.925 2 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 AOFA 0 1 MAOA AOFA_HUMAN 6 4.925 4.9075 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 139210 PPARD 0 1 PPARD NR1C2 PPARB PPARD_HUMAN 5.87510469501151 4.925 4.9075 1 NABUMETONE OSTEOARTHRITIS, KNEE, RHEUMATIC DISEASE Cyclooxygenase-2 inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.925 actual drug [drugName] COc1ccc2cc(CCC(=O)C)ccc2c1 140545 15 0 NotRecorded 4.62380521502058 4.6 4.56458333333333 15 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 CP2C9 1 0 CYP2C9 CYP2C10 CP2C9_HUMAN 4.65 4.6 4.6 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.75 4.6 4.6 1 Ras-related protein Rab-9A 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 P53 2 0 TP53 P53 P53_HUMAN 4.95 4.6 4.6 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 4.9 4.6 4.6 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 CP2D6 1 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.15 4.6 4.6 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.21121280869158 4.6 4.6 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.14999741390754 4.6 4.6 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.95 4.6 4.6 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 4.95 4.6 4.6 4 Menin 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 CP2CJ 1 0 CYP2C19 CP2CJ_HUMAN 5.6 4.6 4.6 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 LUCI 2 0 LUCI_PHOPY 5.36049057529951 4.6 4.6 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.09999903484653 4.6 4.6 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 CBX1 1 0 CBX1 CBX CBX1_HUMAN 5 4.6 4.6 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 CP3A4 1 0 CYP3A4 CYP3A3 CP3A4_HUMAN 4.85 4.6 4.6 1 Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.58621423228026 4.6 4.6 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.59999765407204 4.6 4.6 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 140545 NPC1 1 0 NPC1 NPC1_HUMAN 5.7 4.6 4.6 1 Niemann-Pick C1 protein 0 4.6 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2cc(OC)cc(OC)c2 141768 KPCD1 0 2 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 6.00497132981871 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 0 71 NotRecorded 4.83299987552197 5.13333333333333 5.12762715179968 71 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PAK5 0 2 PAK5 KIAA1264 PAK7 PAK5_HUMAN 5.90175824505386 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 M3K5 0 2 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 6.52816651747558 5.13333333333333 5.13333333333333 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 5.10575395813907 5.13333333333333 5.13333333333333 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SRPK1 0 1 SRPK1 SRPK1_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RUNX1 0 6 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.70000039413698 5.13333333333333 5.13333333333333 6 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PEBB 0 6 CBFB PEBB_HUMAN 4.70000039413698 5.13333333333333 5.13333333333333 6 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 LCK 0 3 LCK LCK_HUMAN 5.38821323251227 5.13333333333333 5.13333333333333 3 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SRC 0 2 SRC SRC1 SRC_HUMAN 5.78945178348519 5.13333333333333 5.13333333333333 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PASK 0 2 PASK KIAA0135 PASK_HUMAN 5.13180376320522 5.13333333333333 5.13333333333333 2 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TAU 0 9 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.52555555555556 5.13333333333333 5.13333333333333 9 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 HIPK2 0 2 HIPK2 HIPK2_HUMAN 6.09913982527219 5.13333333333333 5.13333333333333 2 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAPK1 0 20 PRKAA1 AMPK1 AAPK1_HUMAN 5.72413971657635 5.13333333333333 5.13333333333333 20 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAKG1 0 20 PRKAG1 AAKG1_HUMAN 5.72413971657635 5.13333333333333 5.13333333333333 20 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAKB1 0 20 PRKAB1 AMPK AAKB1_HUMAN 5.72413971657635 5.13333333333333 5.13333333333333 20 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MTOR 0 7 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.91071577265403 5.13333333333333 5.13333333333333 7 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 5.68220848726419 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FGFR2 0 2 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 5.49118425516731 5.13333333333333 5.13333333333333 2 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.57646741734906 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6A4 0 4 RPS6KA4 MSK2 KS6A4_HUMAN 5.47399115020234 5.13333333333333 5.13333333333333 4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAKG2 0 14 PRKAG2 AAKG2_HUMAN 5.8071929150333 5.13333333333333 5.13333333333333 14 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAKB2 0 14 PRKAB2 AAKB2_HUMAN 5.8071929150333 5.13333333333333 5.13333333333333 14 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAPK2 0 14 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.8071929150333 5.13333333333333 5.13333333333333 14 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AAKG3 0 14 PRKAG3 AMPKG3 AAKG3_HUMAN 5.8071929150333 5.13333333333333 5.13333333333333 14 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ERBB4 0 1 ERBB4 HER4 ERBB4_HUMAN 5.65854134728041 5.13333333333333 5.13333333333333 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DCLK2 0 1 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.86530142610254 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EPHA7 0 1 EPHA7 EHK3 HEK11 EPHA7_HUMAN 5.90799732148669 5.13333333333333 5.13333333333333 1 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TRXR1 0 5 Txnrd1 Trxr1 TRXR1_RAT 4.61952882524145 5.13333333333333 5.13333333333333 5 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EPHA8 0 1 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.69019608002851 5.13333333333333 5.13333333333333 1 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 WNK3 0 1 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 5.95424250943933 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MELK 0 2 MELK KIAA0175 MELK_HUMAN 4.76418376608521 5.13333333333333 5.13333333333333 2 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TGFR1 0 2 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 6.4067904942841 5.13333333333333 5.13333333333333 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SGK3 0 1 SGK3 CISK SGKL SGK3_HUMAN 5.62973141792582 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CLK3 0 2 CLK3 CLK3_HUMAN 4.84959349442155 5.13333333333333 5.13333333333333 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PIM2 0 1 PIM2 PIM2_HUMAN 6.06069784035361 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PGFRB 0 8 PDGFRB PDGFR PDGFR1 PGFRB_HUMAN 5.24025290183818 5.13333333333333 5.13333333333333 8 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 STK4 0 2 STK4 KRS2 MST1 STK4_HUMAN 5.8665059863565 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AURKC 0 2 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.33551809905913 5.13333333333333 5.13333333333333 2 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ACK1 0 2 TNK2 ACK1 ACK1_HUMAN 5.56030270718406 5.13333333333333 5.13333333333333 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FAK1 0 2 PTK2 FAK FAK1 FAK1_HUMAN 5.43557472008093 5.13333333333333 5.13333333333333 2 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6A6 0 4 RPS6KA6 RSK4 KS6A6_HUMAN 5.41435381191305 5.13333333333333 5.13333333333333 4 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FRK 0 2 FRK PTK5 RAK FRK_HUMAN 6.00512641505789 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 STK3 0 1 STK3 KRS1 MST2 STK3_HUMAN 5.17609125905568 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 GRK5 0 2 GRK5 GPRK5 GRK5_HUMAN 5.89658464922355 5.13333333333333 5.13333333333333 2 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.95639810218423 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RGS4 0 3 RGS4 RGS4_HUMAN 5.30714657642369 5.13333333333333 5.15833333333333 3 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TIE2 0 2 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 5.5283029781462 5.13333333333333 5.13333333333333 2 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6A2 0 4 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 4.98856855852025 5.13333333333333 5.13333333333333 4 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.99563519459755 5.13333333333333 5.13333333333333 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RET 0 3 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 4.65356869470443 5.13333333333333 5.13333333333333 3 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6A1 0 4 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5 5.13333333333333 5.13333333333333 4 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PLK1 0 2 PLK1 PLK PLK1_HUMAN 5.68295188833586 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KC1G1 0 2 CSNK1G1 KC1G1_HUMAN 5.72952862732097 5.13333333333333 5.13333333333333 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PRKX 0 2 PRKX PKX1 PRKX_HUMAN 5.67438142942661 5.13333333333333 5.13333333333333 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 BRSK1 0 2 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.51805828395039 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 5.33562753746419 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 HASP 0 2 HASPIN GSG2 HASP_HUMAN 5.3094966214282 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PAK2 0 1 PAK2 PAK2_HUMAN 6.38021124171161 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.27129062110346 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK7 0 4 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 5.73368070871525 5.13333333333333 5.13333333333333 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNH 0 4 CCNH CCNH_HUMAN 5.73368070871525 5.13333333333333 5.13333333333333 4 Cyclin-H (MO15-associated protein) (p34) (p37) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 BMX 0 2 BMX BMX_HUMAN 5.80342943710487 5.13333333333333 5.13333333333333 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ALK 0 2 ALK ALK_HUMAN 5.08505044768325 5.13333333333333 5.13333333333333 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NPC1 0 1 NPC1 NPC1_HUMAN 5.84 5.13333333333333 5.13333333333333 1 Niemann-Pick C1 protein 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 HIPK1 0 1 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.38021124171161 5.13333333333333 5.13333333333333 1 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AL1A1 0 4 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.8375 5.13333333333333 5.13333333333333 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MPP8 0 2 MPHOSPH8 MPP8 MPP8_HUMAN 4.7619113879862 5.13333333333333 5.13333333333333 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KPCB 0 2 PRKCB PKCB PRKCB1 KPCB_HUMAN 6.44258634162228 5.13333333333333 5.13333333333333 2 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 HCK 0 3 HCK HCK_HUMAN 5.23266876844592 5.13333333333333 5.13333333333333 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EHMT2 0 5 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.04476431498982 5.13333333333333 5.13333333333333 5 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 JAK3 0 4 JAK3 JAK3_HUMAN 5.2305057405895 5.13333333333333 5.13333333333333 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 6.2851741599501 5.13333333333333 5.13333333333333 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 5.60205999132796 5.13333333333333 5.13333333333333 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 6.19497660321606 5.13333333333333 5.13333333333333 1 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 5.6886291709978 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5 5.13333333333333 5.13333333333333 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.91139282480093 5.13333333333333 5.13333333333333 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RON 0 2 MST1R PTK8 RON RON_HUMAN 6.03274836161769 5.13333333333333 5.13333333333333 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KCC2G 0 2 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 5.49553095610611 5.13333333333333 5.13333333333333 2 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 5.1353454612151 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KCC4 0 2 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.86678661089923 5.13333333333333 5.13333333333333 2 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6B1 0 2 RPS6KB1 STK14A KS6B1_HUMAN 4.97931352304143 5.13333333333333 5.13333333333333 2 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SGK2 0 2 SGK2 SGK2_HUMAN 5.4598839981922 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EPHA3 0 1 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 6.99563519459755 5.13333333333333 5.13333333333333 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FRIL 0 4 FTL FRIL_HORSE 4.8125 5.13333333333333 5.13333333333333 4 Ferritin light chain (Ferritin L subunit) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AKT2 0 1 AKT2 AKT2_HUMAN 5.86530142610254 5.13333333333333 5.13333333333333 1 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.13333333333333 5.13333333333333 5.08611111111111 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 YES 0 2 YES1 YES YES_HUMAN 5.97003677662256 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MAPK5 0 1 MAPKAPK5 PRAK MAPK5_HUMAN 5.26884531229258 5.13333333333333 5.13333333333333 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KAPCA 0 2 PRKACA PKACA KAPCA_HUMAN 5.84818386852601 5.13333333333333 5.13333333333333 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KCC2B 0 1 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.50060235056919 5.13333333333333 5.13333333333333 1 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 GEMI 0 1 GMNN GEMI_HUMAN 4.65 5.13333333333333 5.13333333333333 1 Geminin 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MKNK2 0 1 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 6.27875360095283 5.13333333333333 5.13333333333333 1 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RIPK2 0 1 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.6886291709978 5.13333333333333 5.13333333333333 1 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MARK2 0 2 MARK2 EMK1 MARK2_HUMAN 5.47330318289001 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MK11 0 1 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.99563519459755 5.13333333333333 5.13333333333333 1 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NUAK1 0 2 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 5.86272244993382 5.13333333333333 5.13333333333333 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PLK3 0 2 PLK3 CNK FNK PRK PLK3_HUMAN 6.0301390146593 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SIK1 0 2 SIK1 SIK SNF1LK SIK1_HUMAN 5.86530142610254 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 M3K9 0 2 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 4.54278773430489 5.13333333333333 5.13333333333333 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MK03 0 2 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.67614313989237 5.13333333333333 5.13333333333333 2 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PTK6 0 1 PTK6 BRK PTK6_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 1 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.4114817974 5.13333333333333 5.13333333333333 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MERTK 0 2 MERTK MER MERTK_HUMAN 4.88374831142641 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RAF1 0 2 RAF1 RAF RAF1_HUMAN 5.97415213493733 5.13333333333333 5.13333333333333 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TAOK1 0 1 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 5.95424250943933 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 5.36797678529459 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.72883462167748 5.13333333333333 5.13333333333333 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 GSK3B 0 2 GSK3B GSK3B_HUMAN 6.2851741599501 5.13333333333333 5.13333333333333 2 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KCC2D 0 2 CAMK2D CAMKD KCC2D_HUMAN 5.31957600459705 5.13333333333333 5.13333333333333 2 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TLK2 0 2 TLK2 TLK2_HUMAN 6.59992327978754 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AURKA 0 2 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 4.82523848937993 5.13333333333333 5.13333333333333 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ABL2 0 1 ABL2 ABLL ARG ABL2_HUMAN 5.90799732148669 5.13333333333333 5.13333333333333 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DAPK2 0 1 DAPK2 DAPK2_HUMAN 5.86530142610254 5.13333333333333 5.13333333333333 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 JAK2 0 2 JAK2 JAK2_HUMAN 5.6886291709978 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK2 0 3 CDK2 CDKN2 CDK2_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 3 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNA1 0 3 CCNA1 CCNA1_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 3 Cyclin-A1 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNA2 0 3 CCNA2 CCN1 CCNA CCNA2_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 3 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MUSK 0 2 MUSK MUSK_HUMAN 5.3589276742482 5.13333333333333 5.13333333333333 2 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PHKG2 0 2 PHKG2 PHKG2_HUMAN 6.22176187334356 5.13333333333333 5.13333333333333 2 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.42499186309261 5.13333333333333 5.17083333333333 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 6.19497660321606 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NEK11 0 2 NEK11 NEK11_HUMAN 5.95424250943933 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5.60669603007634 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NEK2 0 1 NEK2 NEK2A NLK1 NEK2_HUMAN 6.19497660321606 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MK08 0 1 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.12338490853968 5.13333333333333 5.13333333333333 1 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.65 5.13333333333333 5.13333333333333 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PLK2 0 1 PLK2 SNK PLK2_HUMAN 6.69019608002851 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TXK 0 1 TXK PTK4 RLK TXK_HUMAN 5.34748739690298 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 INSR 0 4 INSR INSR_HUMAN 5.94418144156248 5.13333333333333 5.13333333333333 4 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FGR 0 2 FGR SRC2 FGR_HUMAN 5.42475357945966 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SRPK2 0 1 SRPK2 SRPK2_HUMAN 5.75332766665861 5.13333333333333 5.13333333333333 1 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DYRK2 0 2 DYRK2 DYRK2_HUMAN 6.69019608002851 5.13333333333333 5.13333333333333 2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 6.23194649449295 5.13333333333333 5.13333333333333 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ULK3 0 1 ULK3 ULK3_HUMAN 4.98262590393058 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 LIMK1 0 1 LIMK1 LIMK LIMK1_HUMAN 5.90799732148669 5.13333333333333 5.13333333333333 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EF2K 0 2 EEF2K EF2K_HUMAN 6.16722687557547 5.13333333333333 5.13333333333333 2 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EPHB1 0 1 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 5.60205999132796 5.13333333333333 5.13333333333333 1 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MP2K6 0 2 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 6.25722468121418 5.13333333333333 5.13333333333333 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6A5 0 2 RPS6KA5 MSK1 KS6A5_HUMAN 5.57540779655652 5.13333333333333 5.13333333333333 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SYUA 0 2 SNCA NACP PARK1 SYUA_HUMAN 5.76000023821267 5.13333333333333 5.13333333333333 2 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.09104081137244 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 WNK2 0 1 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.50060235056919 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KC1G2 0 2 CSNK1G2 CK1G2 KC1G2_HUMAN 5.40275283916184 5.13333333333333 5.13333333333333 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNB3 0 4 CCNB3 CYCB3 CCNB3_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 4 G2/mitotic-specific cyclin-B3 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK1 0 4 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 4 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNB1 0 4 CCNB1 CCNB CCNB1_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 4 G2/mitotic-specific cyclin-B1 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNB2 0 4 CCNB2 CCNB2_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 4 G2/mitotic-specific cyclin-B2 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 VGFR1 0 3 FLT1 FLT FRT VEGFR1, Flt1 Emrk2 Flt Vegfr1 VGFR1_HUMAN, VGFR1_MOUSE 4.54047783480205 5.13333333333333 5.11805555555555 3 Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Embryonic receptor kinase 2) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase receptor FLT), Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FER 0 1 FER TYK3 FER_HUMAN 5.65854134728041 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DRD1 0 1 DRD1 DRD1_HUMAN 7.23657200643706 5.13333333333333 5.13333333333333 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CSK2B 0 3 CSNK2B CK2N G5A CSK2B_HUMAN 5.82557590031178 5.13333333333333 5.13333333333333 3 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CSK22 0 4 CSNK2A2 CK2A2 CSK22_HUMAN 5.96423473566174 5.13333333333333 5.13333333333333 4 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CSK21 0 3 CSNK2A1 CK2A1 CSK21_HUMAN 5.82557590031178 5.13333333333333 5.13333333333333 3 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 M3K7 0 1 MAP3K7 TAK1 M3K7_HUMAN 5.62973141792582 5.13333333333333 5.13333333333333 1 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 7.28316227670048 5.13333333333333 5.45 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.84999924507786 5.13333333333333 5.13333333333333 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.86247909314386 5.13333333333333 5.13333333333333 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MK09 0 1 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.69019608002851 5.13333333333333 5.13333333333333 1 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PGFRA 0 2 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 4.8935186904956 5.13333333333333 5.13333333333333 2 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FYN 0 2 FYN FYN_HUMAN 5.3966822607589 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CLK2 0 2 CLK2 CLK2_HUMAN 5.37680415465306 5.13333333333333 5.13333333333333 2 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PIM1 0 2 PIM1 PIM1_HUMAN 5.82407389884728 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 6.05018527255879 5.13333333333333 5.13333333333333 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PDPK1 0 1 PDPK1 PDK1 PDPK1_HUMAN 6.06069784035361 5.13333333333333 5.13333333333333 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PFKA 0 1 pfk PFKA_TRYBB 5.12098444659037 5.13333333333333 5.13333333333333 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 END4 0 1 nfo b2159 JW2146 END4_ECOLI 4.85 5.13333333333333 5.13333333333333 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MYLK 0 2 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.31474911983745 5.13333333333333 5.13333333333333 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TAOK3 0 1 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NLK 0 1 NLK LAK1 NLK_HUMAN 5.86530142610254 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KPCI 0 2 PRKCI DXS1179E KPCI_HUMAN 5.80518488111094 5.13333333333333 5.13333333333333 2 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EPHB4 0 1 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 1 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK3 0 3 CDK3 CDKN3 CDK3_HUMAN 5.90799732148669 5.13333333333333 5.13333333333333 3 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNE1 0 3 CCNE1 CCNE CCNE1_HUMAN 5.90799732148669 5.13333333333333 5.13333333333333 3 G1/S-specific cyclin-E1 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNE2 0 3 CCNE2 CCNE2_HUMAN 5.90799732148669 5.13333333333333 5.13333333333333 3 G1/S-specific cyclin-E2 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KGP1 0 2 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.49450230784927 5.13333333333333 5.13333333333333 2 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 EGFR 0 2 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 4.58804562952784 5.13333333333333 5.13333333333333 2 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ROCK2 0 1 ROCK2 KIAA0619 ROCK2_HUMAN 4.78739190711856 5.13333333333333 5.13333333333333 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 4.75 5.13333333333333 5.13333333333333 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.44 5.13333333333333 5.13333333333333 1 Ras-related protein Rab-9A 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 UFO 0 2 AXL UFO UFO_HUMAN 5.26614891289942 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 BRSK2 0 2 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 5.5742538687118 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 BLK 0 2 BLK BLK_HUMAN 5.51909199659661 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FGFR1 0 2 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 4.62001135927247 5.13333333333333 5.13333333333333 2 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CD5R1 0 4 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.10289357101169 5.13333333333333 5.13333333333333 4 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK5 0 4 CDK5 CDKN5 CDK5_HUMAN 6.10289357101169 5.13333333333333 5.13333333333333 4 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KS6A3 0 4 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 4.61383134246448 5.13333333333333 5.13333333333333 4 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 IRAK4 0 2 IRAK4 IRAK4_HUMAN 5.49553095610611 5.13333333333333 5.13333333333333 2 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TAOK2 0 2 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 6.45181625804212 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.836212690038 5.13333333333333 5.13333333333333 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KPCT 0 1 PRKCQ PRKCT KPCT_HUMAN 5.75332766665861 5.13333333333333 5.13333333333333 1 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 DAPK3 0 1 DAPK3 ZIPK DAPK3_HUMAN 6.50965047954658 5.13333333333333 5.13333333333333 1 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 LYN 0 2 LYN JTK8 LYN_HUMAN 5.50975462047596 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.14528228099291 5.13333333333333 5.13333333333333 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ABL1 0 1 ABL1 ABL JTK7 ABL1_HUMAN 5.82557590031178 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 STK10 0 1 STK10 LOK STK10_HUMAN 5.52476288915489 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 STK33 0 2 STK33 STK33_HUMAN 5.91421276141055 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 ITK 0 2 ITK EMT LYK ITK_HUMAN 5.97952069616055 5.13333333333333 5.13333333333333 2 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 HIPK3 0 1 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 6.19497660321606 5.13333333333333 5.13333333333333 1 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CBX1 0 1 CBX1 CBX CBX1_HUMAN 4.55000045168903 5.13333333333333 5.13333333333333 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 PIM3 0 1 PIM3 PIM3_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 A4 0 1 APP A4 AD1 A4_HUMAN 7.04 5.13333333333333 5.13333333333333 1 Amyloid-beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FGFR3 0 2 FGFR3 JTK4 FGFR3_HUMAN 5.57893739735164 5.13333333333333 5.13333333333333 2 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCND3 0 2 CCND3 CCND3_HUMAN 5 5.13333333333333 5.0475 2 G1/S-specific cyclin-D3 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 5 5.13333333333333 5.0475 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SGK1 0 2 SGK1 SGK SGK1_HUMAN 5.90608516883654 5.13333333333333 5.13333333333333 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KC1D 0 2 CSNK1D HCKID KC1D_HUMAN 4.76466377698175 5.13333333333333 5.13333333333333 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 BTK 0 1 BTK AGMX1 ATK BPK BTK_HUMAN 5.78837041556533 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MK12 0 1 MAPK12 ERK6 SAPK3 MK12_HUMAN 5.6886291709978 5.13333333333333 5.13333333333333 1 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5 5.13333333333333 5.0875 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 NEK3 0 1 NEK3 NEK3_HUMAN 5.47712125471966 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 6.12338490853968 5.13333333333333 5.13333333333333 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.60205999132796 5.13333333333333 5.13333333333333 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 AKT3 0 1 AKT3 PKBG AKT3_HUMAN 6.38021124171161 5.13333333333333 5.13333333333333 1 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MAPK2 0 1 MAPKAPK2 MAPK2_HUMAN 6.12338490853968 5.13333333333333 5.13333333333333 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KSYK 0 1 SYK KSYK_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FES 0 1 FES FPS FES_HUMAN 5.57540779655652 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 4.94782198833493 5.13333333333333 5.13333333333333 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 6.12338490853968 5.13333333333333 5.13333333333333 1 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 VRK2 0 1 VRK2 VRK2_HUMAN 5.82557590031178 5.13333333333333 5.13333333333333 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CDK9 0 2 CDK9 CDC2L4 TAK CDK9_HUMAN 6.12338490853968 5.13333333333333 5.13333333333333 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 CCNT1 0 2 CCNT1 CCNT1_HUMAN 6.12338490853968 5.13333333333333 5.13333333333333 2 Cyclin-T1 (CycT1) (Cyclin-T) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 IRAK1 0 1 IRAK1 IRAK IRAK1_HUMAN 6.00479888288177 5.13333333333333 5.13333333333333 1 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 MP2K1 0 1 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.43195909596147 5.13333333333333 5.13333333333333 1 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 KPCD 0 1 PRKCD KPCD_HUMAN 5.86530142610254 5.13333333333333 5.13333333333333 1 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 141768 TYRO3 0 1 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 6.99563519459755 5.13333333333333 5.13333333333333 1 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 5.13333333333333 actual molregno [molregno] CN(C)c1ccc(\C=C\2/C(=O)Nc3ccccc23)cc1 142154 RORG 2 0 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.41253695143802 4.8 4.8 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 ANDR 5 0 AR DHTR NR3C4 ANDR_HUMAN 5.40347003079171 4.8 4.8 5 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 64 0 NotRecorded 5.0859555243514 4.8 4.8 64 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 NR1I2 2 0 Nr1i2 Pxr NR1I2_RAT 5.475000573303 4.8 4.8 2 Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR), Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PXR) (Pregnane X receptor) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 NPC1 1 0 NPC1 NPC1_HUMAN 5.45 4.8 4.8 1 Niemann-Pick C1 protein 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 LUCI 1 0 LUCI_PHOPY 4.87098398008989 4.8 4.8 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 NF2L2 7 0 NFE2L2 NRF2 NF2L2_HUMAN 5.19989993291263 4.8 4.8 7 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.6 4.8 4.8 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 THB 1 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 7.34969247686806 4.8 4.8 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 NFKB1 4 0 NFKB1 NFKB1_HUMAN 5.46418875795194 4.8 4.8 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.54999736982681 4.8 4.8 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93639101807974 4.8 4.8 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 AHR 2 0 AHR BHLHE76 AHR_HUMAN 4.59999942427051 4.8 4.8 2 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 ABC3F 1 0 APOBEC3F ABC3F_HUMAN 4.84999924507786 4.8 4.8 1 DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 P53 2 0 TP53 P53 P53_HUMAN 4.55000011855468 4.8 4.8 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.2 4.8 4.8 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.4 4.8 4.8 1 Ras-related protein Rab-9A 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 142154 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.8 4.8 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.8 actual molregno [molregno] Nc1ccc2C(=O)c3ccccc3C(=O)c2c1 143618 MAP1 8 0 MAP1 YLR244C L9672.12, map b0168 JW0163 MAP1_ECOLI, MAP1_YEAST 5.225 4.75 4.75 8 Methionine aminopeptidase (MAP) (MetAP) (EC 3.4.11.18) (Peptidase M), Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.86139114274796 4.75 4.75 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 NPC1 1 0 NPC1 NPC1_HUMAN 5.45 4.75 4.75 1 Niemann-Pick C1 protein 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 21 0 NotRecorded 5.02580341666399 4.75 4.74820436507937 21 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.90000876645532 4.75 4.0625 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 MAP2 2 0 METAP2 MNPEP P67EIF2 MAP2_HUMAN 4.77761894687039 4.75 4.75 2 Methionine aminopeptidase (MAP) (MetAP) (EC 3.4.11.18) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.5 4.75 4.740625 1 Ras-related protein Rab-9A 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.09999903484653 4.75 4.75 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 PTH1R 2 0 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.09999903484653 4.75 4.75 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.25 4.75 4.7453125 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 MAP11 2 0 METAP1 KIAA0094 MAP11_HUMAN 5.49899866074334 4.75 4.7453125 2 Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.75 4.75 4.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 LUCI 1 0 LUCI_PHOPY 4.62098289875995 4.75 4.75 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 GEMI 1 0 GMNN GEMI_HUMAN 4.53621298582672 4.75 4.75 1 Geminin 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.78621404606106 4.75 4.75 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143618 GLP1R 1 0 GLP1R GLP1R_HUMAN 4.55000045168903 4.75 4.75 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.75 actual molregno [molregno] O=C(Nc1nccs1)c2ccccn2 143131 24 0 Cerebroside-sulfatase, NotRecorded 4.83397557864456 4.8 4.8 24 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 4.95 4.8 4.8 1 Ras-related protein Rab-9A 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5 4.8 4.8 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 PIN1 1 0 PIN1 PIN1_HUMAN 4.77098149412752 4.8 4.8 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 Q94696 1 0 luc Q94696_PHOPE 5 4.8 4.8 1 Luciferase 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 GRM5 5 0 GRM5 GPRC1E MGLUR5, Grm5 Gprc1e Mglur5 GRM5_HUMAN, GRM5_RAT 6.106 4.8 4.8 5 Metabotropic glutamate receptor 5 (mGluR5) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 GRM4 1 0 GRM4 GPRC1D MGLUR4 GRM4_HUMAN 4.59 4.8 4.8 1 Metabotropic glutamate receptor 4 (mGluR4) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.45000414846935 4.8 4.8 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.63621320946427 4.8 4.8 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 DRD1 1 0 DRD1 DRD1_HUMAN 8.03621217265444 4.8 4.1 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.55000045168903 4.8 4.8 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 PGKC 1 0 PGKC_TRYBB 4.52098213050232 4.8 4.8 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 Q4Q090 1 0 PGAM LMJF_36_6650 Q4Q090_LEIMA 4.62098289875995 4.8 4.8 1 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.1) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 NPC1 1 0 NPC1 NPC1_HUMAN 4.89 4.8 4.8 1 Niemann-Pick C1 protein 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 PFKA 1 0 pfk PFKA_TRYBB 4.82098278885978 4.8 4.8 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 FRIL 1 0 FTL FRIL_HORSE 4.6 4.8 4.8 1 Ferritin light chain (Ferritin L subunit) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143131 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.08638999707259 4.8 4.8 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.8 actual molregno [molregno] Cc1cccc(\C=C\c2ccccc2)n1 143808 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 5.075 5.025 5.025 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.68640053886184 5.025 5.025 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 Q4Q090 0 1 PGAM LMJF_36_6650 Q4Q090_LEIMA 4.97098167045352 5.025 5.025 1 2,3-bisphosphoglycerate-independent phosphoglycerate mutase (EC 5.4.2.1) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 2 37 Cerebroside-sulfatase, Nonstructural protein 1, NotRecorded 4.97570316290463 5.025 4.9991452991453 39 0.948717948717949 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.025 5.025 5.025 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 4.88300063791642 5.025 5.025 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 FRIL 0 3 FTL FRIL_HORSE 4.58333340695782 5.025 5.025 3 Ferritin light chain (Ferritin L subunit) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 4.98621510845326 5.025 5.025 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 GRM5 0 3 GRM5 GPRC1E MGLUR5, Grm5 Gprc1e Mglur5 GRM5_HUMAN, GRM5_RAT 6.26333333333333 5.025 5.025 3 Metabotropic glutamate receptor 5 (mGluR5) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 PGKC 0 1 PGKC_TRYBB 4.97098167045352 5.025 5.025 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.52500020346502 5.025 5.025 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.53621298582672 5.025 5.025 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.85 5.025 5.025 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 KMT2A 0 3 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.6 5.025 5.025 3 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.87500013825872 5.025 5.025 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 PFKA 0 1 pfk PFKA_TRYBB 4.82098278885978 5.025 5.025 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 UBP1 0 1 USP1 UBP1_HUMAN 5.65000410073714 5.025 5.025 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 END4 1 0 nfo b2159 JW2146 END4_ECOLI 5.1 5.025 4.26875 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 0 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 TRXR1 0 3 Txnrd1 Trxr1 TRXR1_RAT 5.29921467753631 5.025 5.025 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 LUCI 0 1 LUCI_PHOPY 7.30102999566398 5.025 5.025 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 4.69 5.025 5.025 1 Ras-related protein Rab-9A 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 GALK1 0 1 GALK1 GALK GALK1_HUMAN 4.84999924507786 5.025 5.025 1 Galactokinase (EC 2.7.1.6) (Galactose kinase) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 NPC1 0 1 NPC1 NPC1_HUMAN 4.74 5.025 5.025 1 Niemann-Pick C1 protein 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.89999841719865 5.025 5.025 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 143808 Q94696 0 1 luc Q94696_PHOPE 5.55 5.025 5.025 1 Luciferase 1 5.025 actual molregno [molregno] Cc1ccc(O)c(N=Nc2ccccc2)n1 146591 MDR1 0 1 ABCB1 MDR1 PGY1 MDR1_HUMAN 5.92 5 5.015625 1 Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 0 10 NotRecorded 4.57090803381789 5 5.0811875 10 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.8 5 5 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 5.35 5 5.2625 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5.2625 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 O97447 0 2 ald O97447_GIAIN 4.775 5 5 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.35 5 5.2625 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.9 5 5.2625 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.8 5 5 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 5 5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.45 5 5.2625 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146591 AGAL 0 1 GLA AGAL_HUMAN 4.5 5 5 1 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 5 actual molregno [molregno] COc1ccc(cc1OC)C2=CC(=O)c3ccccc3O2 146166 TNKS1 2 0 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 6.1 4.9 4.7875 2 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 0 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 TYDP1 0 1 TDP1 TYDP1_HUMAN 4.55 4.9 4.9 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.795 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 LOX5 0 1 ALOX5 LOG5 LOX5_HUMAN 4.79475051220311 4.9 4.9 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71139001277257 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 DPOLB 0 1 POLB DPOLB_HUMAN 4.55 4.9 4.9 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.59999765407204 4.9 4.6875 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 LUCI 0 1 LUCI_PHOPY 4.97098167045352 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 5 4.9 4.175 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.25 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 146166 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.05000045714008 4.9 4.795 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.9 actual molregno [molregno] Oc1ccc(cc1)C2=CC(=O)c3ccccc3O2 147540 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.55 8.05 8.05 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 147540 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.55 8.05 8.05 4 Menin 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 147540 0 4 NotRecorded 5.07810888613794 8.05 7.853125 4 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 147540 PFKA 0 1 pfk PFKA_TRYBB 5.17097941513958 8.05 8.05 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 147540 CYSP 0 1 CYSP_TRYCR 5 8.05 8.05 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 147540 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 8.05 8.05 8.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 147540 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.55000045168903 8.05 8.05 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 8.05 actual molregno [molregno] C\C(=N/NC(=O)N)\c1cccc(Cl)c1 148018 NPC1 0 1 NPC1 NPC1_HUMAN 4.99 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 CP2D6 0 5 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.52 4.9 4.9 5 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 4.85 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.72382322328385 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.84999924507786 4.9 4.9 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.8 4.9 4.9 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 KDM1A 0 2 KDM1A AOF2 KDM1 KIAA0601 LSD1 KDM1A_HUMAN 4.745 4.9 4.90000000000001 2 Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.53621298582672 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 AOFB 0 3 MAOB, Maob AOFB_HUMAN, AOFB_RAT 5.38333333333333 4.9 4.90000000000001 3 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 CP2C9 0 5 CYP2C9 CYP2C10 CP2C9_HUMAN 5.8 4.9 4.9 5 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 NFKB1 0 4 NFKB1 NFKB1_HUMAN 8 4.9 4.9 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 AOFA 0 4 MAOA, Maoa AOFA_HUMAN, AOFA_MOUSE, AOFA_RAT 5.65968840023821 4.9 4.90000000000001 4 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.91138990523561 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 CP2C8 0 2 CYP2C8 CP2C8_HUMAN 5.095 4.9 4.9 2 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 GABT 0 2 Abat Gabat GABT_RAT 5.34486467380055 4.9 4.90000000000001 2 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT), 4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT) [Cleaved into: 4-aminobutyrate aminotransferase, brain isoform; 4-aminobutyrate aminotransferase, liver isoform] 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 MPP8 0 1 MPHOSPH8 MPP8 MPP8_HUMAN 4.72382322328385 4.9 4.9 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 CP2CJ 0 5 CYP2C19 CP2CJ_HUMAN 6.26 4.9 4.9 5 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 LUCI 0 1 LUCI_PHOPY 4.91045518461584 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 RGS4 0 1 RGS4 RGS4_HUMAN 4.62382285083096 4.9 4.9 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 6.9 4.9 4.9 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.3 4.9 4.9 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 AOC3 0 1 AOC3 VAP1 AOC3_HUMAN 7.7 4.9 4.90000000000001 1 Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1), Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (Semicarbazide-sensitive amine oxidase) (SSAO) (VP97) (Vascular adhesion protein 1) (VAP-1), Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 148018 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 4.81045635024068 4.9 4.9 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.9 actual molregno [molregno] NNCCc1ccccc1 150451 0 86 Cerebroside-sulfatase, NotRecorded 4.76316245612761 7.4 7.26511627906976 86 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 6.1 7.4 7.4 1 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 CP2D6 0 3 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.73333333333333 7.4 7.4 3 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.53621298582672 7.4 7.4 1 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 KPYM 0 2 PKM OIP3 PK2 PK3 PKM2 KPYM_HUMAN 5 7.4 6.725 2 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58), Pyruvate kinase PKM (EC 2.7.1.40) (Pyruvate kinase muscle isozyme) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 CP1A2 0 2 CYP1A2 CP1A2_HUMAN 4.7 7.4 7.4 2 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 6.5 7.4 7.4 1 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.03678712134482 7.4 7.4 2 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.4 7.4 7.4 1 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 5.25000102344165 7.4 7.4 1 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 NMDE2 0 1 GRIN2B NMDAR2B NMDE2_HUMAN 5.32735893438633 7.4 7.4 1 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B), Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 150451 GEMI 0 2 GMNN GEMI_HUMAN 6.96861991119524 7.4 7.4 2 FELBAMATE EPILEPSY Glutamate [NMDA] receptor antagonist ANTAGONIST 4 Geminin 1 7.4 actual drug [drugName] NC(=O)OCC(COC(=O)N)c1ccccc1 153148 0 41 Nonstructural protein 1, NotRecorded 5.1970196598599 5 4.99832317073171 41 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 TAU 0 5 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.04 5 5 5 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.875 5 5 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.875 5 5 8 Menin 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 6 5 5 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 CP2C9 0 2 CYP2C9 CYP2C10 CP2C9_HUMAN 5.6 5 5 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5 5 5 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 BLM 0 3 BLM RECQ2 RECQL3 BLM_HUMAN 4.58333333333333 5 5 3 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 END4 0 1 nfo b2159 JW2146 END4_ECOLI 4.65 5 5 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93639134914326 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7 5 5 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 5.23300006248992 5 5 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 5HT2C 0 2 HTR2C HTR1C, Htr2c 5ht1c Htr1c 5HT2C_HUMAN, 5HT2C_MOUSE 5.82 5 5 2 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 LUCI 0 1 LUCI_PHOPY 4.5 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.52487444751905 5 5 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 CP2CJ 0 2 CYP2C19 CP2CJ_HUMAN 5.5 5 5 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 FGF22 0 2 FGF22 UNQ2500/PRO5800 FGF22_HUMAN 5.03646271376354 5 5 2 Fibroblast growth factor 22 (FGF-22) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 4.8 5 5 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 6.55 5 5 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.2 5 5 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.5 5 5 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.19 5 5 1 Ras-related protein Rab-9A 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 5HT2B 0 1 Htr2b Srl 5HT2B_RAT 7.95 5 5 1 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 protein) (Serotonin receptor 2B), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (Serotonin receptor 2B) (Stomach fundus serotonin receptor), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 P53 0 2 TP53 P53 P53_HUMAN 4.8 5 5 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.4362105089299 5 5 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 NPC1 0 1 NPC1 NPC1_HUMAN 5.14 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 TPO 0 2 THPO MGDF TPO_HUMAN 5.8 5 5 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.9 5 5 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 DRD1 0 2 DRD1 DRD1_HUMAN 5.21811511352685 5 5 2 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.3 5 5 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 153148 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.6 5 5 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5 actual molregno [molregno] Cc1cc(NC(=O)Nc2ccc3c(ccn3C)c2)sn1 157152 MK14 0 5 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 4.58463843808413 5.05 5.05 5 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 JAK3 0 4 JAK3 JAK3_HUMAN 5.92453412795947 5.05 5.05 4 Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3), Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK2 0 12 CDK2 CDKN2 CDK2_HUMAN 5.65837492641873 5.05 5.05 12 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCNA1 0 6 CCNA1 CCNA1_HUMAN 5.57724715354035 5.05 5.05 6 Cyclin-A1 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCNA2 0 6 CCNA2 CCN1 CCNA CCNA2_HUMAN 5.57724715354035 5.05 5.05 6 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MAPK3 0 2 MAPKAPK3 MAPK3_HUMAN 5.86530142610254 5.05 5.05 2 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PK3CB 0 12 PIK3CB PIK3C1 PK3CB_HUMAN 6.06865906174536 5.05 5.05 12 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MP2K1 0 2 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.70905091674558 5.05 5.05 2 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAPK1 0 20 PRKAA1 AMPK1 AAPK1_HUMAN 5.64589100125314 5.05 5.05 20 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAKG1 0 20 PRKAG1 AAKG1_HUMAN 5.64589100125314 5.05 5.05 20 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAKB1 0 20 PRKAB1 AMPK AAKB1_HUMAN 5.64589100125314 5.05 5.05 20 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 IRAK1 0 2 IRAK1 IRAK IRAK1_HUMAN 5.5795718489248 5.05 5.05 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA8 0 1 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.12338490853968 5.05 5.05 1 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KS6A5 0 4 RPS6KA5 MSK1 KS6A5_HUMAN 5.75710253565479 5.05 5.05 4 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KC1D 0 3 CSNK1D HCKID KC1D_HUMAN 5.45095177382372 5.05 5.05 3 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PKN2 0 3 PKN2 PRK2 PRKCL2 PKN2_HUMAN 6.01743636654911 5.05 5.05 3 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PIM1 0 6 PIM1 PIM1_HUMAN 5.02917735944223 5.05 5.05 6 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PK3CA 0 29 PIK3CA, Pik3ca PK3CA_BOVIN, PK3CA_HUMAN, PK3CA_MOUSE 5.67132182209078 5.05 5.05 29 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ALK 0 2 ALK ALK_HUMAN 5.24206855381327 5.05 5.05 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MTOR 0 23 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1, Mtor Frap1 Raft1 MTOR_HUMAN, MTOR_RAT 5.33604896648604 5.05 5.04755434782609 23 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FGFR2 0 1 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 5.95424250943933 5.05 5.05 1 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 IKKB 0 2 IKBKB IKKB IKKB_HUMAN 5.7611677688012 5.05 5.05 2 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EF2K 0 3 EEF2K EF2K_HUMAN 5.94422806601772 5.05 5.05 3 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TIE2 0 2 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 5.31936891201836 5.05 5.05 2 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PAK5 0 3 PAK5 KIAA1264 PAK7 PAK5_HUMAN 5.83115268366506 5.05 5.05 3 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 YES 0 1 YES1 YES YES_HUMAN 5.95424250943933 5.05 5.05 1 Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 GSK3B 0 5 GSK3B GSK3B_HUMAN 5.25923155249697 5.05 5.05 5 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 5.5132590662875 5.05 5.05 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 M3K9 0 2 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 6.18747595282456 5.05 5.05 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PK3CD 0 9 PIK3CD PK3CD_HUMAN 5.8937676378827 5.05 5.05 9 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ABL2 0 1 ABL2 ABLL ARG ABL2_HUMAN 5.6886291709978 5.05 5.05 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MKNK2 0 2 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 6.3942020402497 5.05 5.05 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 RON 0 2 MST1R PTK8 RON RON_HUMAN 5.25936139275459 5.05 5.05 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KPCL 0 1 PRKCH PKCL PRKCL KPCL_HUMAN 5.28806501849961 5.05 5.05 1 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SGK3 0 2 SGK3 CISK SGKL SGK3_HUMAN 5.91723480673588 5.05 5.05 2 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NEK6 0 1 NEK6 NEK6_HUMAN 6.19497660321606 5.05 5.05 1 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PRKX 0 1 PRKX PKX1 PRKX_HUMAN 5.72015930340596 5.05 5.05 1 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 HIPK1 0 2 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 6.28759392246383 5.05 5.05 2 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.13362578464301 5.05 5.05 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 M3K5 0 2 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 6.59992327978754 5.05 5.05 2 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 6.22176187334356 5.05 5.05 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 4.9751048951049 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 RGS4 0 1 RGS4 RGS4_HUMAN 4.72382322328385 5.05 4.99375 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PK3CG 0 13 PIK3CG PK3CG_HUMAN 5.53 5.05 5.05 13 Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PRKDC 0 14 PRKDC HYRC HYRC1 PRKDC_HUMAN 5.71571428571428 5.05 5.05 14 DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460), DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (p460) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FKB1A 0 4 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.46470946285714 5.05 5.05 4 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 5.50799405269207 5.05 5.05 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FAK1 0 1 PTK2 FAK FAK1 FAK1_HUMAN 5.6886291709978 5.05 5.05 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AKT2 0 2 AKT2 AKT2_HUMAN 5.61589570462689 5.05 5.05 2 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PGFRB 0 2 PDGFRB PDGFR PDGFR1 PGFRB_HUMAN 5.80639192835987 5.05 5.05 2 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 5.59269066741296 5.05 5.05 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SRC 0 2 SRC SRC1 SRC_HUMAN 5.9558776620525 5.05 5.05 2 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KS6A4 0 4 RPS6KA4 MSK2 KS6A4_HUMAN 6.25722468121418 5.05 5.05 4 Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 INSRR 0 1 INSRR IRR INSRR_HUMAN 5.47712125471966 5.05 5.05 1 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DCLK2 0 2 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.75270061672548 5.05 5.05 2 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAKG2 0 14 PRKAG2 AAKG2_HUMAN 5.66110964736696 5.05 5.05 14 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAKB2 0 14 PRKAB2 AAKB2_HUMAN 5.66110964736696 5.05 5.05 14 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAPK2 0 14 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 5.66110964736696 5.05 5.05 14 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AAKG3 0 14 PRKAG3 AMPKG3 AAKG3_HUMAN 5.66110964736696 5.05 5.05 14 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NEK2 0 3 NEK2 NEK2A NLK1 NEK2_HUMAN 5.89840938038707 5.05 5.05 3 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MAPK5 0 4 MAPKAPK5 PRAK MAPK5_HUMAN 5.66103618256919 5.05 5.05 4 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 STK4 0 2 STK4 KRS2 MST1 STK4_HUMAN 5.91518739159678 5.05 5.05 2 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 STK33 0 2 STK33 STK33_HUMAN 6.27265355823291 5.05 5.05 2 Serine/threonine-protein kinase 33 (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KS6A1 0 4 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 6.52816651747558 5.05 5.05 4 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 6.27875360095283 5.05 5.05 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK7 0 4 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 5.98369138597531 5.05 5.05 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCNH 0 4 CCNH CCNH_HUMAN 5.98369138597531 5.05 5.05 4 Cyclin-H (MO15-associated protein) (p34) (p37) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.7074866739854 5.05 5.05 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 LCK 0 7 LCK, Lck Lsk-t LCK_HUMAN, LCK_MOUSE 4.80255531864823 5.05 5.05 7 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CLK3 0 2 CLK3 CLK3_HUMAN 5.75502865640732 5.05 5.05 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PAK2 0 2 PAK2 PAK2_HUMAN 5.72742243000426 5.05 5.05 2 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PIM2 0 3 PIM2 PIM2_HUMAN 5.52203527811886 5.05 5.05 3 Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NFKB1 0 4 NFKB1 NFKB1_HUMAN 5.15 5.05 5.05 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK8 0 1 CDK8 CDK8_HUMAN 5.5 5.05 5.05 1 Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 VGFR2 0 2 KDR FLK1 VEGFR2 VGFR2_HUMAN 6.05018527255879 5.05 5.05 2 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DYRK3 0 1 DYRK3 DYRK3_HUMAN 5.54967192186827 5.05 5.05 1 Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 5.12260916532066 5.05 5.05 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK11 0 3 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.42179464165206 5.05 5.05 3 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PIM3 0 4 PIM3 PIM3_HUMAN 5.30449419632365 5.05 5.05 4 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK08 0 3 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.04858537215224 5.05 5.05 3 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 BRSK1 0 2 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.70905091674558 5.05 5.05 2 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SGK1 0 3 SGK1 SGK SGK1_HUMAN 5.96097697146875 5.05 5.05 3 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 HIPK3 0 3 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 5.57744964252455 5.05 5.05 3 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 LX15B 0 1 ALOX15B LX15B_HUMAN 4.59999938302362 5.05 5.05 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ABL1 0 2 ABL1 ABL JTK7 ABL1_HUMAN 5.93111991546301 5.05 5.05 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5.95248706543325 5.05 5.05 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 HIPK2 0 3 HIPK2 HIPK2_HUMAN 5.28212325569263 5.05 5.05 3 Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ROS1 0 2 ROS1 MCF3 ROS ROS1_HUMAN 6.12338490853968 5.05 5.05 2 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PLK1 0 5 PLK1 PLK PLK1_HUMAN 5.05094108602431 5.05 5.05 5 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA7 0 2 EPHA7 EHK3 HEK11 EPHA7_HUMAN 5.79010333971915 5.05 5.05 2 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SGK2 0 2 SGK2 SGK2_HUMAN 5.50992056414803 5.05 5.05 2 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KC1G1 0 2 CSNK1G1 KC1G1_HUMAN 5.83720090642264 5.05 5.05 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 BMX 0 2 BMX BMX_HUMAN 5.73849979328156 5.05 5.05 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KAPCA 0 3 PRKACA PKACA KAPCA_HUMAN 5.83185025373777 5.05 5.05 3 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NUAK1 0 2 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 6.0840959134135 5.05 5.05 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA3 0 2 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 6.26019904187622 5.05 5.05 2 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 P3C2A 0 1 PIK3C2A P3C2A_HUMAN 4.57 5.05 5.05 1 Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 5.50301437209169 5.05 5.05 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MARK1 0 2 MARK1 KIAA1477 MARK MARK1_HUMAN 5.7209784188282 5.05 5.05 2 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 5HT2B 0 2 HTR2B 5HT2B_HUMAN 4.535 5.05 5.05 2 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (NP75 protein) (Serotonin receptor 2B), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (5-HT-2F) (Serotonin receptor 2B) (Stomach fundus serotonin receptor), 5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 6.99563519459755 5.05 5.05 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KPCT 0 2 PRKCQ PRKCT KPCT_HUMAN 6.2851741599501 5.05 5.05 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KCC1A 0 2 CAMK1 KCC1A_HUMAN 5.45636303801534 5.05 5.05 2 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CHK1 0 4 CHEK1 CHK1 CHK1_HUMAN 5.79715172103872 5.05 5.05 4 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SIK1 0 2 SIK1 SIK SNF1LK SIK1_HUMAN 4.8923062064735 5.05 5.05 2 Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CD5R1 0 8 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.93589035736078 5.05 5.05 8 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK5 0 8 CDK5 CDKN5 CDK5_HUMAN 5.93589035736078 5.05 5.05 8 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MRCKA 0 2 CDC42BPA KIAA0451 MRCKA_HUMAN 5.73674348503229 5.05 5.05 2 Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AURKB 0 3 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 5.65486775925969 5.05 5.05 3 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK9 0 4 CDK9 CDC2L4 TAK CDK9_HUMAN 5.70425044059974 5.05 5.01229166666667 4 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCNT1 0 4 CCNT1 CCNT1_HUMAN 5.70425044059974 5.05 5.01229166666667 4 Cyclin-T1 (CycT1) (Cyclin-T) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CSK2B 0 9 CSNK2B CK2N G5A CSK2B_HUMAN 4.55985720429465 5.05 5.05 9 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CSK22 0 10 CSNK2A2 CK2A2 CSK22_HUMAN 4.58985361354868 5.05 5.05 10 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CSK21 0 9 CSNK2A1 CK2A1 CSK21_HUMAN 4.55985720429465 5.05 5.05 9 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NEK11 0 1 NEK11 NEK11_HUMAN 6.99563519459755 5.05 5.05 1 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 5.36797678529459 5.05 5.05 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.84818386852601 5.05 5.05 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MARK3 0 1 MARK3 CTAK1 EMK2 MARK3_HUMAN 5.57540779655652 5.05 5.05 1 MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KCC2B 0 2 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.8493963525481 5.05 5.05 2 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 HCK 0 3 HCK HCK_HUMAN 5.40553804574333 5.05 5.05 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PDE2A 0 2 PDE2A PDE2A_HUMAN 4.73481796407069 5.05 5.05 2 cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ACK1 0 2 TNK2 ACK1 ACK1_HUMAN 5.32039052686712 5.05 5.05 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KKCC1 0 1 CAMKK1 CAMKKA KKCC1_HUMAN 5.38886035082012 5.05 5.05 1 Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 5.7420586237961 5.05 5.05 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CP1A2 0 3 CYP1A2 CP1A2_HUMAN 6.16666666666667 5.05 5.05 3 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NEK7 0 3 NEK7 NEK7_HUMAN 6.1611217928252 5.05 5.05 3 Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK10 0 3 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 5.88866589346883 5.05 5.05 3 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KS6A2 0 4 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 6.45181625804212 5.05 5.05 4 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TSSK1 0 2 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 6.18747595282456 5.05 5.05 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ITK 0 1 ITK EMT LYK ITK_HUMAN 6.00479888288177 5.05 5.05 1 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KCC2D 0 1 CAMK2D CAMKD KCC2D_HUMAN 5.6886291709978 5.05 5.05 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FRK 0 2 FRK PTK5 RAK FRK_HUMAN 6.31651769404313 5.05 5.05 2 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 BLK 0 1 BLK BLK_HUMAN 5.95424250943933 5.05 5.05 1 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CAC1C 0 2 CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 CAC1C_RABIT 4.92 5.05 5.05 2 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TAOK1 0 2 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 6.01937629449601 5.05 5.05 2 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DAPK2 0 2 DAPK2 DAPK2_HUMAN 6.03274836161769 5.05 5.05 2 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KPCE 0 2 PRKCE PKCE KPCE_HUMAN 6.12783722178484 5.05 5.05 2 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK12 0 4 MAPK12 ERK6 SAPK3 MK12_HUMAN 6.48073336879435 5.05 5.05 4 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KS6B1 0 4 RPS6KB1 STK14A KS6B1_HUMAN 5.96532608019793 5.05 5.05 4 Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (S6K) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA), Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AKT3 0 2 AKT3 PKBG AKT3_HUMAN 6.16722687557547 5.05 5.05 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AKT1 0 3 AKT1 PKB RAC AKT1_HUMAN 5.4849482866695 5.05 5.05 3 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KS6A3 0 4 RPS6KA3 ISPK1 MAPKAPK1B RSK2 KS6A3_HUMAN 5.21731878631094 5.05 5.05 4 Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2), Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MRCKB 0 2 CDC42BPB KIAA1124 MRCKB_HUMAN 5.73191095775432 5.05 5.05 2 Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK15 0 1 MAPK15 ERK7 ERK8 MK15_HUMAN 5.36797678529459 5.05 5.05 1 Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 VRK2 0 1 VRK2 VRK2_HUMAN 5.86530142610254 5.05 5.05 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FLT3 0 2 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.57109400873937 5.05 5.05 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PAK4 0 3 PAK4 KIAA1142 PAK4_HUMAN 5.84579021525849 5.05 5.05 3 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MUSK 0 2 MUSK MUSK_HUMAN 5.6712113404111 5.05 5.05 2 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.1 5.05 5.05 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AURKC 0 2 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 6.35789724900175 5.05 5.05 2 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MYLK 0 3 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.77338209537035 5.05 5.05 3 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 5.79273036475425 5.05 5.05 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 IKKA 0 1 CHUK IKKA TCF16 IKKA_HUMAN 6.38021124171161 5.05 5.05 1 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MAPK2 0 3 MAPKAPK2 MAPK2_HUMAN 5.62204246189973 5.05 5.05 3 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NTRK1 0 2 NTRK1 MTC TRK TRKA NTRK1_HUMAN 5.48213407368832 5.05 5.05 2 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 RET 0 1 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 6.06069784035361 5.05 5.05 1 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SRPK2 0 2 SRPK2 SRPK2_HUMAN 5.99945645217939 5.05 5.05 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PASK 0 1 PASK KIAA0135 PASK_HUMAN 5.15806815492241 5.05 5.05 1 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KPCD1 0 1 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 6.06069784035361 5.05 5.05 1 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CSK 0 1 CSK CSK_HUMAN 6.27875360095283 5.05 5.05 1 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 WNK2 0 1 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.47712125471966 5.05 5.05 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ERBB4 0 2 ERBB4 HER4 ERBB4_HUMAN 5.42212655442455 5.05 5.05 2 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 P3C2B 0 4 PIK3C2B P3C2B_HUMAN 5.505 5.05 5.05 4 Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCND3 0 4 CCND3 CCND3_HUMAN 5.77084904111197 5.05 5.05 4 G1/S-specific cyclin-D3 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK6 0 4 CDK6 CDKN6 CDK6_HUMAN 5.77084904111197 5.05 5.05 4 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 5.60410663457434 5.05 5.05 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MELK 0 3 MELK KIAA0175 MELK_HUMAN 5.73444792117872 5.05 5.05 3 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TPO 0 2 THPO MGDF TPO_HUMAN 5 5.05 4.95703671328671 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TLK2 0 2 TLK2 TLK2_HUMAN 6.27774875306553 5.05 5.05 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TGFR1 0 2 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5.6886291709978 5.05 5.05 2 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KKCC2 0 1 CAMKK2 CAMKKB KIAA0787 KKCC2_HUMAN 5.38886035082012 5.05 5.05 1 Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MARK2 0 2 MARK2 EMK1 MARK2_HUMAN 6.3942020402497 5.05 5.05 2 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KCC2G 0 1 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 5.78837041556533 5.05 5.05 1 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KPCB 0 3 PRKCB PKCB PRKCB1 KPCB_HUMAN 6.03276584549823 5.05 5.05 3 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 GRK5 0 2 GRK5 GPRK5 GRK5_HUMAN 6.59992327978754 5.05 5.05 2 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 5HT2C 0 2 HTR2C HTR1C 5HT2C_HUMAN 6.14 5.05 5.05 2 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C), 5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (Serotonin receptor 2C) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MP2K6 0 2 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.80257553415256 5.05 5.05 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 HASP 0 2 HASPIN GSG2 HASP_HUMAN 5.87991600408495 5.05 5.05 2 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 M3K7 0 2 MAP3K7 TAK1 M3K7_HUMAN 5.88664937379462 5.05 5.05 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PHKG2 0 1 PHKG2 PHKG2_HUMAN 6.50965047954658 5.05 5.05 1 Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 UFO 0 2 AXL UFO UFO_HUMAN 5.63030066930419 5.05 5.05 2 Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 LYN 0 2 LYN JTK8 LYN_HUMAN 5.8665059863565 5.05 5.05 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 RIPK2 0 2 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 5.8665059863565 5.05 5.05 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCNE2 0 12 CCNE2 CCNE2_HUMAN 5.94281536748767 5.05 5.05 12 G1/S-specific cyclin-E2 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CCNE1 0 12 CCNE1 CCNE CCNE1_HUMAN 5.94281536748767 5.05 5.05 12 G1/S-specific cyclin-E1 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KGP1 0 3 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.74553009737852 5.05 5.05 3 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.20725455505262 5.05 5.05 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK13 0 2 MAPK13 PRKM13 SAPK4 MK13_HUMAN 5.79191847701809 5.05 5.05 2 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 6.38021124171161 5.05 5.05 1 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TAOK3 0 2 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 5.89096312791004 5.05 5.05 2 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 6.00497132981871 5.05 5.05 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FEN1 0 1 FEN1 RAD2 FEN1_HUMAN 4.67382190675771 5.05 5.05 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 WNK3 0 1 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.12338490853968 5.05 5.05 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 VGFR3 0 2 FLT4 VEGFR3 VGFR3_HUMAN 5.58175106587383 5.05 5.05 2 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 IRAK4 0 2 IRAK4 IRAK4_HUMAN 5.98434758092015 5.05 5.05 2 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.75270061672548 5.05 5.05 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 4.8 5.05 4.98942307692308 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PDE5A 0 1 PDE5A PDE5 PDE5A_HUMAN 5.02 5.05 5.05 1 cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CLK2 0 1 CLK2 CLK2_HUMAN 5.82557590031178 5.05 5.05 1 Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 5HT2A 0 2 HTR2A HTR2 5HT2A_HUMAN 5.825 5.05 5.05 2 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-HT2A) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (5-hydroxytryptamine receptor) (Serotonin receptor 2A), 5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 RAF1 0 2 RAF1 RAF RAF1_HUMAN 5.33742316564465 5.05 5.05 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CHK2 0 3 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.80367887660676 5.05 5.05 3 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FGR 0 1 FGR SRC2 FGR_HUMAN 6.50965047954658 5.05 5.05 1 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 AURKA 0 2 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 5.63491561263711 5.05 5.05 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KCC1D 0 2 CAMK1D CAMKID KCC1D_HUMAN 5.90600703976874 5.05 5.05 2 Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA4 0 1 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 6.50965047954658 5.05 5.05 1 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DYR1A 0 1 DYRK1A DYRK MNB MNBH DYR1A_HUMAN 5.50060235056919 5.05 5.05 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PFKA 0 1 pfk PFKA_TRYBB 7.92081875395237 5.05 5.05 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SRPK1 0 1 SRPK1 SRPK1_HUMAN 6.12338490853968 5.05 5.05 1 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.83639143656895 5.05 4.95703671328671 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KC1G2 0 2 CSNK1G2 CK1G2 KC1G2_HUMAN 5.53084525694364 5.05 5.05 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CDK3 0 6 CDK3 CDKN3 CDK3_HUMAN 6.14612803567823 5.05 5.05 6 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PGFRA 0 1 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 5.95424250943933 5.05 5.05 1 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FES 0 1 FES FPS FES_HUMAN 5.78837041556533 5.05 5.05 1 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DYRK2 0 3 DYRK2 DYRK2_HUMAN 6.10772013154584 5.05 5.05 3 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NLK 0 2 NLK LAK1 NLK_HUMAN 5.73543615272133 5.05 5.05 2 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KIT 0 1 KIT SCFR KIT_HUMAN 6.00479888288177 5.05 5.05 1 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FER 0 1 FER TYK3 FER_HUMAN 6.12338490853968 5.05 5.05 1 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 INSR 0 5 INSR, Insr INSR_HUMAN, INSR_RAT 4.5688208461395 5.05 5.05 5 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TYRO3 0 2 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 6.01569111501319 5.05 5.05 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CYSP 0 1 CYSP_TRYCR 4.55 5.05 5.05 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHB4 0 1 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 6.06069784035361 5.05 5.05 1 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KCC4 0 1 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 5.78837041556533 5.05 5.05 1 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ZAP70 0 1 ZAP70 SRK ZAP70_HUMAN 6.69019608002851 5.05 5.05 1 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PDK1 0 1 PDK1 PDHK1 PDK1_HUMAN 5.50060235056919 5.05 5.05 1 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (PDK p48) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1), [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 TAOK2 0 1 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 5.65854134728041 5.05 5.05 1 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CSF1R 0 2 CSF1R FMS CSF1R_HUMAN 5.25033655569053 5.05 5.05 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 BRSK2 0 1 BRSK2 C11orf7 PEN11B SADA STK29 HUSSY-12 BRSK2_HUMAN 6.50965047954658 5.05 5.05 1 Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ST17A 0 1 STK17A DRAK1 ST17A_HUMAN 6.19497660321606 5.05 5.05 1 Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FGFR1 0 1 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 5.62973141792582 5.05 5.05 1 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NTRK2 0 1 NTRK2 TRKB NTRK2_HUMAN 6.99563519459755 5.05 5.05 1 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 STK10 0 2 STK10 LOK STK10_HUMAN 5.83066249407265 5.05 5.05 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 LIMK1 0 1 LIMK1 LIMK LIMK1_HUMAN 5.60205999132796 5.05 5.05 1 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 IGF1R 0 2 IGF1R IGF1R_HUMAN 6.37448143062808 5.05 5.05 2 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 EPHA5 0 1 EPHA5 BSK EHK1 HEK7 TYRO4 EPHA5_HUMAN 6.12338490853968 5.05 5.05 1 Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MK09 0 2 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.3942020402497 5.05 5.05 2 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PLK3 0 4 PLK3 CNK FNK PRK PLK3_HUMAN 5.11566888054299 5.05 5.05 4 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ULK3 0 1 ULK3 ULK3_HUMAN 5.86530142610254 5.05 5.05 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 DAPK3 0 2 DAPK3 ZIPK DAPK3_HUMAN 6.09988774304892 5.05 5.05 2 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 P85A 0 1 PIK3R1 GRB1 P85A_HUMAN 5.85 5.05 5.05 1 Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MKNK1 0 1 MKNK1 MNK1 MKNK1_HUMAN 5.52476288915489 5.05 5.05 1 MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 ROCK2 0 2 ROCK2 KIAA0619 ROCK2_HUMAN 5.6931008027004 5.05 5.05 2 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.03621217265444 5.05 4.97067307692308 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 GSK3A 0 1 GSK3A GSK3A_HUMAN 5.86530142610254 5.05 5.05 1 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PDPK1 0 1 PDPK1 PDK1 PDPK1_HUMAN 5.90799732148669 5.05 5.05 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 NEK3 0 1 NEK3 NEK3_HUMAN 6.00479888288177 5.05 5.05 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 CBX1 0 1 CBX1 CBX CBX1_HUMAN 4.57382231378381 5.05 4.96828671328671 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 MERTK 0 1 MERTK MER MERTK_HUMAN 5.78837041556533 5.05 5.05 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 KPCI 0 2 PRKCI DXS1179E KPCI_HUMAN 5.6459183328701 5.05 5.05 2 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FGFR3 0 1 FGFR3 JTK4 FGFR3_HUMAN 5.43195909596147 5.05 5.05 1 Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333), Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (Heparin-binding growth factor receptor) (CD antigen CD333) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 FAK2 0 1 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 6.19497660321606 5.05 5.05 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.86530142610254 5.05 5.05 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 157152 PLK2 0 1 PLK2 SNK PLK2_HUMAN 5.65854134728041 5.05 5.05 1 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 1 5.05 actual molregno [molregno] O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4 156627 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.7 4.7 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 4.74999985591871 4.7 4.7 1 TAR DNA-binding protein 43 (TDP-43) 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.45 4.7 4.025 1 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71139001277257 4.7 4.7 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 NPC1 1 0 NPC1 NPC1_HUMAN 5.65 4.7 4.025 1 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 LUCI 1 0 LUCI_PHOPY 4.97098167045352 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 GEMI 1 0 GMNN GEMI_HUMAN 5.13621334693594 4.7 4.025 1 Geminin 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156627 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] CCc1ccc2nc(N)sc2c1 156951 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93638896154424 4.9 4.9 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.7 4.9 4.8325 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 LUCI 0 1 LUCI_PHOPY 5.17097941513958 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.3 4.9 4.9 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 1 12 NotRecorded 4.78586088217719 4.9 4.84433092948718 13 0.923076923076923 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 NPC1 0 1 NPC1 NPC1_HUMAN 5.8 4.9 4.8325 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 156951 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.65000410073714 4.9 4.9 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] CC(C)c1ccc2nc(N)sc2c1 158019 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.62382285083096 5.45 5.45 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.45 actual molregno [molregno] NC(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 158019 FRIL 1 1 FTL FRIL_HORSE 5.17499870695377 5.45 5.01875 2 Ferritin light chain (Ferritin L subunit) 0.5 5.45 actual molregno [molregno] NC(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 158019 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5.54999736982681 5.45 5.45 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 5.45 actual molregno [molregno] NC(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 158019 IMPA1 0 1 Impa1 Imp IMPA1_RAT 5.5 5.45 5.45 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5.45 actual molregno [molregno] NC(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 158019 0 3 NotRecorded 4.67407294805589 5.45 5.45 3 1 5.45 actual molregno [molregno] NC(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 158019 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] NC(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 240123 SO1B3 0 3 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 4.94918695427431 5.4 5.4 3 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 0 42 NotRecorded 5.32783311957384 5.4 5.4 42 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 IMPA1 0 1 Impa1 Imp IMPA1_RAT 4.9 5.4 5.4 1 Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 BLM 0 1 BLM RECQ2 RECQL3 BLM_HUMAN 4.6 5.4 5.4 1 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.4 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 RECQ1 0 3 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.90000034114722 5.4 5.4 3 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.975 5.4 5.4 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.975 5.4 5.4 8 Menin 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 FFP 0 1 ffp sfp FFP_BACIU 5.1 5.4 5.4 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 POLK 0 2 POLK DINB1 POLK_HUMAN 6.36193196195784 5.4 5.4 2 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 AGAL 0 2 GLA AGAL_HUMAN 4.575 5.4 5.4 2 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 APEX1 0 2 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.57499991735633 5.4 5.4 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.15 5.4 5.4 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.275 5.4 5.4 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 KAT2A 0 4 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 4.74999992670164 5.4 5.4 4 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 SO1B1 0 3 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 4.80899257284179 5.4 5.4 3 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.89999841719865 5.4 5.4 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.84999924507786 5.4 5.4 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 PEBB 0 2 CBFB PEBB_HUMAN 4.84999924507786 5.4 5.4 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 TOP2B 0 1 TOP2B TOP2B_HUMAN 6.54668165995296 5.4 5.4 1 DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.9 5.4 5.4 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 240123 MRP2 0 1 ABCC2 CMOAT CMOAT1 CMRP MRP2 MRP2_HUMAN 5.36797678529459 5.4 5.4 1 Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2), Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) 1 5.4 actual molregno [molregno] CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 160850 0 6 NotRecorded 6.03410315204401 6.45 6.45 6 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.45 6.45 6.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 P53 0 2 TP53 P53 P53_HUMAN 5 6.45 6.45 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.19999817218203 6.45 6.45 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 5.2 6.45 6.45 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 DNAB 0 2 dnaB Rv0058 MTCY21D4.21 DNAB_MYCTU 5 6.45 6.45 2 Replicative DNA helicase (EC 3.6.4.12) [Cleaved into: Endonuclease PI-MtuHIP (EC 3.1.-.-) (Mtu dnaB intein)] 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.74999985591871 6.45 6.45 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 POLG 0 1 POLG_HCVBK 7 6.45 6.45 1 Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Non-structural protein 2A-alpha (NS2A-alpha); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)], Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)], Genome polyprotein [Cleaved into: Core protein p21 (Capsid protein C) (p21); Core protein p19; Envelope glycoprotein E1 (gp32) (gp35); Envelope glycoprotein E2 (NS1) (gp68) (gp70); p7; Protease NS2-3 (p23) (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P) (p70); Non-structural protein 4A (NS4A) (p8); Non-structural protein 4B (NS4B) (p27); Non-structural protein 5A (NS5A) (p56); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B) (p68)], Genome polyprotein [Cleaved into: Core protein; Envelope glycoprotein E1; Envelope glycoprotein E2 (NS1); p13; p6; p7; Protease NS2-3 (EC 3.4.22.-); Serine protease NS3 (EC 3.4.21.98) (EC 3.6.1.15) (EC 3.6.4.13) (Hepacivirin) (NS3P); Non-structural protein 4A (NS4A); Non-structural protein 4B (NS4B); Non-structural protein 5A (NS5A); RNA-directed RNA polymerase (EC 2.7.7.48) (NS5B)], Genome polyprotein [Cleaved into: P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); P2; Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); P3; Protein 3AB; Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)], Genome polyprotein [Cleaved into: P3; Protein 3AB; P2; P1; Capsid protein VP0 (VP4-VP2); Capsid protein VP4 (P1A) (Virion protein 4); Capsid protein VP2 (P1B) (Virion protein 2); Capsid protein VP3 (P1C) (Virion protein 3); Capsid protein VP1 (P1D) (Virion protein 1); Protease 2A (P2A) (EC 3.4.22.29) (Picornain 2A) (Protein 2A); Protein 2B (P2B); Protein 2C (P2C) (EC 3.6.1.15); Protein 3A (P3A); Viral protein genome-linked (VPg) (Protein 3B) (P3B); Protein 3CD (EC 3.4.22.28); Protease 3C (P3C) (EC 3.4.22.28); RNA-directed RNA polymerase (RdRp) (EC 2.7.7.48) (3D polymerase) (3Dpol) (Protein 3D) (3D)], Genome polyprotein [Cleaved into: Peptide 2k; Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (NS5)] 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.175 6.45 6.45 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 RECA 0 1 recA Rv2737c MTV002.02c RECA_MYCTU 5.23 6.45 6.45 1 Protein RecA (Recombinase A) [Cleaved into: Endonuclease PI-MtuI (EC 3.1.-.-) (Mtu RecA intein)] 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.58621423228026 6.45 6.45 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.7 6.45 6.45 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 O97447 0 1 ald O97447_GIAIN 5.65 6.45 6.45 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 UBP1 0 1 USP1 UBP1_HUMAN 5 6.45 6.45 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 CASP1 0 1 CASP1 IL1BC IL1BCE CASP1_HUMAN 4.6 6.45 6.45 1 Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.8 6.45 6.45 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 ATM 0 1 ATM ATM_HUMAN 5.5 6.45 6.45 1 Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 160850 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 6.45 6.45 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 6.45 actual molregno [molregno] Nc1ccc2ncccc2c1 419837 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.8 4.6 4.6 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 8 0 NotRecorded 4.65030280025815 4.6 4.6134375 8 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 Q72547 4 0 pol Q72547_9HIV1 6.14990393945541 4.6 4.6 4 Reverse transcriptase/RNaseH (Fragment) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.21139233151855 4.6 4.6 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 ABC3F 1 0 APOBEC3F ABC3F_HUMAN 5.09999903484653 4.6 4.6 1 DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.7999981345934 4.6 4.6 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 5.25 4.6 4.6 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 LUCI 1 0 LUCI_PHOPY 4.77098149412752 4.6 4.6 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.25 4.6 4.6 1 Ras-related protein Rab-9A 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 GLP1R 2 0 GLP1R GLP1R_HUMAN 5.19999767457348 4.6 4.6 2 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5 4.6 4.6 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 419837 ATX2 1 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6.50003813440381 4.6 4.6 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.6 actual molregno [molregno] Cc1ccc(NC(=S)NCCc2ccccc2)nc1 167875 3 26 NotRecorded 5.17057245341371 5.45 5.36336206896552 29 0.896551724137931 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 167875 ACES 0 14 ACHE ACES_BOVIN, ACES_HUMAN 6.01 5.45 5.45 14 Acetylcholinesterase (AChE) (EC 3.1.1.7), Acetylcholinesterase (AChE) (EC 3.1.1.7) [Cleaved into: Acetylcholinesterase 16 kDa subunit; Acetylcholinesterase 55 kDa subunit] 1 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 167875 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.14999741390754 5.45 5.45 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 167875 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.58694028098665 5.45 5.45 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 167875 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 167875 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.12886841137876 5.45 5.45 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 167875 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 8.6 5.45 5.45 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.45 actual molregno [molregno] [Cl-].CC[N+](C)(C)c1cccc(O)c1 169652 0 48 NotRecorded 4.83547667309036 5.5 5.50260416666667 48 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 GEMI 0 2 GMNN GEMI_HUMAN 4.83059530242934 5.5 5.5 2 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Geminin 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.525 5.5 5.5 2 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 KAT2A 0 4 KAT2A GCN5 GCN5L2 HGCN5 KAT2A_HUMAN 4.62499980194854 5.5 5.5 4 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.5 5.5 5.5 1 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.84999924507786 5.5 5.5 2 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 EYA2 0 1 EYA2 EAB1 EYA2_HUMAN 4.67090938840579 5.5 5.5 1 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Eyes absent homolog 2 (EC 3.1.3.48) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 RPGF4 0 1 RAPGEF4 CGEF2 EPAC2 RPGF4_HUMAN 5 5.5 5.5 1 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-dependent Rap1 guanine-nucleotide exchange factor) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII), Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 ANDR 0 2 AR DHTR NR3C4 ANDR_HUMAN 5.29634000906215 5.5 5.5 2 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 ABCBB 0 2 ABCB11 BSEP, Abcb11 Bsep Spgp ABCBB_HUMAN, ABCBB_RAT 4.725 5.5 5.5 2 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Bile salt export pump (ATP-binding cassette sub-family B member 11), Bile salt export pump (ATP-binding cassette sub-family B member 11) (Sister of P-glycoprotein) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 6.24222450898807 5.5 4.875 1 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 169652 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.52382218831237 5.5 5.5 1 ACITRETIN PSORIASIS Retinoid receptor agonist AGONIST 4 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.5 actual drug [drugName] COc1cc(C)c(\C=C\C(=C\C=C\C(=C\C(=O)O)\C)\C)c(C)c1C 171563 SC6A2 2 0 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.425 4.78333333333333 4.78333333333333 2 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 SYUA 2 0 SNCA NACP PARK1 SYUA_HUMAN 5.39310623926262 4.78333333333333 4.78333333333333 2 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 GRP78 6 0 HSPA5 GRP78 GRP78_HUMAN 5.02766571686536 4.78333333333333 4.78333333333333 6 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 LIPP 2 0 PNLIP LIPP_PIG 5.10630404644072 4.78333333333333 4.78333333333333 2 Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 SMN 3 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.78333333333333 4.78333333333333 4.78333333333333 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 AL1A1 2 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 4.78333333333333 4.78333333333333 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 Q7ZJM1 4 0 pol Q7ZJM1_9HIV1 4.92 4.78333333333333 4.78333333333333 4 Integrase (Fragment) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 RORG 3 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.83333333333333 4.78333333333333 4.78333333333333 3 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 KMT2A 12 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.71666666666667 4.78333333333333 4.78333333333333 12 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 MEN1 12 0 MEN1 SCG2 MEN1_HUMAN 4.71666666666667 4.78333333333333 4.78333333333333 12 Menin 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 MITF 3 0 Mitf Bw Mi Vit MITF_MOUSE 5 4.78333333333333 4.78333333333333 3 Microphthalmia-associated transcription factor, Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.7 4.78333333333333 4.78333333333333 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 EHMT2 3 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.17460765619977 4.78333333333333 4.78333333333333 3 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71139001277257 4.78333333333333 4.78333333333333 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 AK1BA 2 0 AKR1B10 AKR1B11 AK1BA_HUMAN 7.22 4.78333333333333 4.78333333333333 2 Aldo-keto reductase family 1 member B10 (EC 1.1.1.-) (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein) (ARP) (hARP) (Small intestine reductase) (SI reductase) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 KDM4E 2 0 KDM4E KDM4DL KDM4E_HUMAN 4.65 4.78333333333333 4.78333333333333 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 CAC1C 1 0 CACNA1C CACH2 CACN2 CACNL1A1 CCHL1A1 CAC1C_CAVPO 5.96 4.78333333333333 4.396875 1 Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Rat brain class C) (RBC) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Smooth muscle calcium channel blocker receptor) (CACB-receptor) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2), Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2) (Fragment) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 ATX2 2 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.94999995482486 4.78333333333333 4.78333333333333 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 GEMI 3 0 GMNN GEMI_HUMAN 5.14080892793649 4.78333333333333 4.78333333333333 3 Geminin 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 6.64994590642097 4.78333333333333 4.78333333333333 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 O97447 2 0 ald O97447_GIAIN 4.775 4.78333333333333 4.78333333333333 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 MTOR 3 0 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.56333333333333 4.78333333333333 4.78333333333333 3 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 LMNA 2 0 LMNA LMN1 LMNA_HUMAN 5.4 4.78333333333333 4.78333333333333 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 AK1C3 1 0 AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS AK1C3_HUMAN 5.77 4.78333333333333 4.78333333333333 1 Aldo-keto reductase family 1 member C3 (EC 1.-.-.-) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Indanol dehydrogenase) (EC 1.1.1.112) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 LCK 1 0 LCK LCK_HUMAN 5.54 4.78333333333333 4.78333333333333 1 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 TAU 7 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.05 4.78333333333333 4.78333333333333 7 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 PGDH 2 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.625 4.78333333333333 4.78333333333333 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 RGS4 1 0 RGS4 RGS4_HUMAN 6.12424442074195 4.78333333333333 4.78333333333333 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 FRIL 2 0 FTL FRIL_HORSE 4.6 4.78333333333333 4.78333333333333 2 Ferritin light chain (Ferritin L subunit) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 AK1C4 1 0 AKR1C4 CHDR AK1C4_HUMAN 5.64 4.78333333333333 4.78333333333333 1 Aldo-keto reductase family 1 member C4 (EC 1.1.1.-) (3-alpha-HSD1) (3-alpha-hydroxysteroid dehydrogenase type I) (EC 1.1.1.357) (Chlordecone reductase) (CDR) (EC 1.1.1.225) (Dihydrodiol dehydrogenase 4) (DD-4) (DD4) (HAKRA) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 PGH1 2 0 PTGS1 COX1 PGH1_HUMAN 5.16 4.78333333333333 4.78333333333333 2 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 ALDR 2 0 AKR1B1 ALDR1, Akr1b1 Akr1b4 Aldr1 ALDR_HUMAN, ALDR_RAT 6.045 4.78333333333333 4.78333333333333 2 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.84999924507786 4.78333333333333 4.78333333333333 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 AK1C2 1 0 AKR1C2 DDH2 AK1C2_HUMAN 5.22 4.78333333333333 4.78333333333333 1 Aldo-keto reductase family 1 member C2 (EC 1.-.-.-) (3-alpha-HSD3) (Chlordecone reductase homolog HAKRD) (Dihydrodiol dehydrogenase 2) (DD-2) (DD2) (Dihydrodiol dehydrogenase/bile acid-binding protein) (DD/BABP) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20) (Type III 3-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.357) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 4.55 4.78333333333333 4.78333333333333 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 FYN 1 0 FYN FYN_HUMAN 5.38 4.78333333333333 4.78333333333333 1 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.74999985591871 4.78333333333333 4.78333333333333 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 LOX12 1 0 ALOX12 12LO LOG12 LOX12_HUMAN 4.55 4.78333333333333 4.78333333333333 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 4.8000008748032 4.78333333333333 4.78333333333333 1 TAR DNA-binding protein 43 (TDP-43) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 EGFR 1 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 6 4.78333333333333 4.78333333333333 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 GLP1R 1 0 GLP1R GLP1R_HUMAN 4.94999940171424 4.78333333333333 4.78333333333333 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 ERBB2 1 0 ERBB2 HER2 MLN19 NEU NGL ERBB2_HUMAN 5.88 4.78333333333333 4.78333333333333 1 Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Epidermal growth factor receptor-related protein) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (p185erbB2) (p185neu) (CD antigen CD340), Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340), Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (p185erbB2) (CD antigen CD340) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 RUNX1 2 0 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.84999924507786 4.78333333333333 4.78333333333333 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 PEBB 2 0 CBFB PEBB_HUMAN 4.84999924507786 4.78333333333333 4.78333333333333 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.73621248726524 4.78333333333333 4.78333333333333 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 ESR1 2 0 ESR1 ESR NR3A1 ESR1_HUMAN 5.375 4.78333333333333 4.78333333333333 2 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 AK1C1 1 0 AKR1C1 DDH DDH1 AK1C1_HUMAN 4.89 4.78333333333333 4.78333333333333 1 Aldo-keto reductase family 1 member C1 (EC 1.1.1.-) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Chlordecone reductase homolog HAKRC) (Dihydrodiol dehydrogenase 1/2) (DD1/DD2) (High-affinity hepatic bile acid-binding protein) (HBAB) (Indanol dehydrogenase) (EC 1.1.1.112) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 ABC3F 1 0 APOBEC3F ABC3F_HUMAN 5.19999817218203 4.78333333333333 4.78333333333333 1 DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 171563 LX15B 1 0 ALOX15B LX15B_HUMAN 5 4.78333333333333 4.78333333333333 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.78333333333333 actual molregno [molregno] Oc1ccc(\C=C\C(=O)OCCc2ccccc2)cc1O 172617 P53 0 4 TP53 P53 P53_HUMAN 4.7375000627859 5 5 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 0 12 NotRecorded 5.00423585957082 5 5 12 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.89999841719865 5 5 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 NPC1 0 1 NPC1 NPC1_HUMAN 5.4 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.85 5 5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.05 5 5 1 Ras-related protein Rab-9A 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 NFKB1 0 5 NFKB1 NFKB1_HUMAN 4.6 5 5 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 TF65 0 5 RELA NFKB3 TF65_HUMAN 4.6 5 5 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 4.6 5 5 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 LUCI 0 1 LUCI_PHOPY 5.62098471330652 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 8.34678748622466 5 5 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 GEMI 0 1 GMNN GEMI_HUMAN 4.63621320946427 5 5 1 Geminin 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.6 5 5 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 Q94696 0 1 luc Q94696_PHOPE 5 5 5 1 Luciferase 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.28621351775013 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 4.74999985591871 5 5 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.71810637775691 5 5 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.14999741390754 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 172617 FRIL 0 1 FTL FRIL_HORSE 4.5 5 5 1 Ferritin light chain (Ferritin L subunit) 1 5 actual molregno [molregno] Cc1ccccc1\C=C\2/CCCc3ccccc3C2=O 182899 0 18 NotRecorded, T-complex protein 1 subunit beta 4.56254660368984 5.1 5.09791666666667 18 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.23621134079217 5.1 5.1 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 LUCI 0 1 LUCI_PHOPY 5.62098471330652 5.1 5.1 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.95000714307986 5.1 5.1 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 CASP3 0 1 CASP3 CPP32 CASP3_HUMAN 4.59 5.1 5.1 1 Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 SENP8 0 1 SENP8 DEN1 NEDP1 PRSC2 FKSG8 SENP8_HUMAN 4.79 5.1 5 1 Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.675 5.1 5.1 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.1 5.1 5.1 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.1362014613195 5.1 5.1 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 GLP1R 0 1 GLP1R GLP1R_HUMAN 5 5.1 5.1 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 SENP7 0 1 SENP7 KIAA1707 SSP2 SUSP2 SENP7_HUMAN 5.11 5.1 5.1 1 Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.67382190675771 5.1 5 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 NPC1 0 1 NPC1 NPC1_HUMAN 6.2 5.1 5.1 1 Niemann-Pick C1 protein 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.05 5.1 5.1 1 Ras-related protein Rab-9A 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 P53 0 1 TP53 P53 P53_HUMAN 4.94999940171424 5.1 5.1 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 182899 SENP6 0 1 SENP6 KIAA0797 SSP1 SUSP1 FKSG6 SENP6_HUMAN 4.63 5.1 5.1 1 Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) 1 5.1 actual molregno [molregno] [O-][N+](=O)c1ccc(CSc2oc3ccccc3n2)cc1 183493 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.675 4.7 4.7 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.73621248726524 4.7 4.7 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 GLP1R 1 0 GLP1R GLP1R_HUMAN 4.65000022087346 4.7 4.7 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.95 4.7 4.8 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.65 4.7 4.7 1 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 LUCI 1 0 LUCI_PHOPY 4.72098361611599 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 NPC1 1 0 NPC1 NPC1_HUMAN 5.5 4.7 4.7 1 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 183493 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71121269343018 4.7 4.7 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] [O-][N+](=O)c1ccccc1CSc2oc3ccccc3n2 184427 AA2BR 0 6 ADORA2B AA2BR_HUMAN 7.50261398955259 5 5 6 Adenosine receptor A2b 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 AA1R 0 9 ADORA1, Adora1 AA1R_HUMAN, AA1R_RAT 6.31559664806379 5 5 9 Adenosine receptor A1 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 AA2AR 0 22 ADORA2A ADORA2, Adora2a AA2AR_HUMAN, AA2AR_RAT 8.57149448842183 5 5 22 Adenosine receptor A2a 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 0 16 NotRecorded 4.66366396005249 5 5.01078125 16 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 AA3R 0 6 ADORA3, Adora3 AA3R_HUMAN, AA3R_RAT 4.94684171983644 5 5 6 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 5 5 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.65 5 5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 CP2D6 0 2 CYP2D6 CYP2DL1 CP2D6_HUMAN 5 5 4.975 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.5 5 5 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.5 5 5 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 184427 RGS4 0 1 RGS4 RGS4_HUMAN 5.87383611119416 5 5 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5 actual molregno [molregno] Nc1nc(NCCc2ccc(O)cc2)nc3nc(nn13)c4occc4 445821 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 AOFA 8 0 MAOA AOFA_HUMAN 5.00423404109831 4.6 4.6 8 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 AOFB 8 0 MAOB AOFB_HUMAN 5.00423404109831 4.6 4.6 8 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 NPC1 1 0 NPC1 NPC1_HUMAN 5.5 4.6 4.6 1 Niemann-Pick C1 protein 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.88621457725716 4.6 4.6 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 ALDH2 2 0 ALDH2 ALDM ALDH2_HUMAN 7.25 4.6 3.95 2 Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDH1), Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.25 4.6 4.6 1 Ras-related protein Rab-9A 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 IL2 1 0 IL2 IL2_HUMAN 5.47 4.6 4.6 1 Interleukin-2 (IL-2) (T-cell growth factor) (TCGF), Interleukin-2 (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.19999817218203 4.6 4.65 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 445821 LUCI 1 0 LUCI_PHOPY 4.57098292927852 4.6 4.65 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual molregno [molregno] OC[C@H]1O[C@@H](Oc2ccc3C(=O)C(=COc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 186475 34 2 Nonstructural protein 1, NotRecorded 4.6920501115561 4.7 4.70743344907407 36 0.0555555555555556 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 FFP 4 0 ffp sfp FFP_BACIU 4.97710271971906 4.7 4.5271875 4 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 IDHC 1 0 IDH1 PICD IDHC_HUMAN 5.18621225375977 4.7 4.7 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 EHMT2 1 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.47500357153993 4.7 4.8053125 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0.5 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 SMAD3 2 0 SMAD3 MADH3 SMAD3_HUMAN 4.8931053116859 4.7 4.7 2 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 O97447 3 0 ald O97447_GIAIN 5.13333333333333 4.7 4.69104166666667 3 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 GLP1R 1 0 GLP1R GLP1R_HUMAN 6.04997609347667 4.7 4.773125 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 4.65 4.7 4.70625 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 ATAD5 4 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.06474952267038 4.7 4.7 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 RAB9A 2 0 RAB9A RAB9 RAB9A_HUMAN 5.55 4.7 4.7 2 Ras-related protein Rab-9A 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 LUCI 3 0 LUCI_PHOPY 5.0473218657298 4.7 4.7 3 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 NPSR1 4 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 6.15 4.7 4.7284375 4 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.45 4.7 4.7 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 P53 4 0 TP53 P53 P53_HUMAN 4.78749929112896 4.7 4.7 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 LYAG 2 0 GAA LYAG_HUMAN 5.1 4.7 4.7 2 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 MBNL1 2 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.67499961947117 4.7 4.7 2 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 RORG 4 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.4 4.7 4.7 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.65 4.7 4.7 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.2 4.7 4.7 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 BAZ2B 4 0 BAZ2B KIAA1476 BAZ2B_HUMAN 5.04999951742326 4.7 4.7 4 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 NFKB1 5 0 NFKB1 NFKB1_HUMAN 5.69 4.7 4.72916666666667 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 TF65 5 0 RELA NFKB3 TF65_HUMAN 5.69 4.7 4.72916666666667 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 NFKB2 5 0 NFKB2 LYT10 NFKB2_HUMAN 5.69 4.7 4.72916666666667 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 NPC1 2 0 NPC1 NPC1_HUMAN 5.675 4.7 4.7 2 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 GEMI 2 0 GMNN GEMI_HUMAN 5.0612117042625 4.7 4.7 2 Geminin 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 KDM4E 2 0 KDM4E KDM4DL KDM4E_HUMAN 4.775 4.7 4.7 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 CBX1 1 0 CBX1 CBX CBX1_HUMAN 4.89999841719865 4.7 4.7 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.14999741390754 4.7 4.7 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 ADRB2 2 0 ADRB2 ADRB2R B2AR ADRB2_HUMAN 4.61810608296115 4.7 4.7 2 Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 GLHA 1 0 CGA GLHA_HUMAN 4.84999924507786 4.7 4.7 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.05 4.7 4.7 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 KDM4A 3 0 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 5.29999760285775 4.7 4.7 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 PLK1 1 0 PLK1 PLK PLK1_HUMAN 4.57382231378381 4.7 4.7 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186475 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 5.31810734471017 4.7 4.7 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] S=C(Nc1ccccn1)c2ccccn2 186964 30 0 Aberrant vpr protein, Nonstructural protein 1, NotRecorded 4.87421655323873 4.5 4.49076041666667 30 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 CCR6 1 0 CCR6 CKRL3 CMKBR6 GPR29 STRL22 CCR6_HUMAN 4.77 4.5 4.5 1 C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (Chemokine receptor-like 3) (CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4) (GPRCY4) (LARC receptor) (CD antigen CD196) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 RAB9A 2 0 RAB9A RAB9 RAB9A_HUMAN 5.6 4.5 4.5 2 Ras-related protein Rab-9A 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 NPSR1 2 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5.45 4.5 4.496875 2 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 GEMI 1 0 GMNN GEMI_HUMAN 4.73621248726524 4.5 4.5 1 Geminin 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 RORG 4 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.8875 4.5 4.5 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.78621404606106 4.5 4.5 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 ATAD5 4 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.9863472359373 4.5 4.5 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 ABC3G 1 0 APOBEC3G MDS019 ABC3G_HUMAN 5.14999741390754 4.5 4.5 1 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 EHMT2 2 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999871791566 4.5 4.184375 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 NPC1 2 0 NPC1 NPC1_HUMAN 5.5 4.5 4.5 2 Niemann-Pick C1 protein 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 KMT2A 3 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.5 4.5 4.5 3 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5 4.5 4.5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 BAZ2B 4 0 BAZ2B KIAA1476 BAZ2B_HUMAN 4.50000046405718 4.5 4.5 4 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 LUCI 2 0 LUCI_PHOPY 5.02098328541475 4.5 4.5 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.78621404606106 4.5 4.5 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 O97447 1 0 ald O97447_GIAIN 5.5 4.5 4.5 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 GLP1R 1 0 GLP1R GLP1R_HUMAN 6.29998893767789 4.5 4.7875 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 ADRB2 1 0 ADRB2 ADRB2R B2AR ADRB2_HUMAN 4.59999938302362 4.5 4.5 1 Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 GLHA 1 0 CGA GLHA_HUMAN 4.8000008748032 4.5 4.5 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 SMAD3 1 0 SMAD3 MADH3 SMAD3_HUMAN 4.94999940171424 4.5 4.5 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 186964 TAU 1 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.7 4.5 4.5 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.5 actual molregno [molregno] S=C(Nc1ccccc1)c2ccccn2 187828 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.4362128947942 5.35 5.15776785714286 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.6 5.35 4.825 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.01803571428571 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 5.35 4.95099431818182 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 Q94696 0 1 luc Q94696_PHOPE 5 5.35 5.13511904761905 1 Luciferase 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 5.35 4.95099431818182 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 LUCI 0 2 LUCI_PHOPY 4.91049228874052 5.35 5.09724702380952 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 P53 0 2 TP53 P53 P53_HUMAN 5.05 5.35 5.24875 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.35 5.35 5.2625 1 Ras-related protein Rab-9A 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.5 5.35 4.921875 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.93621643940264 5.35 5.35 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 UBP1 0 1 USP1 UBP1_HUMAN 5.45000414846935 5.35 4.959375 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 ALR 0 1 GFER ALR HERV1 HPO ALR_HUMAN 5.89 5.35 5.16604166666667 1 Alanine racemase (EC 5.1.1.1), FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 NPC1 0 1 NPC1 NPC1_HUMAN 5.8 5.35 5.35 1 Niemann-Pick C1 protein 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 5.35 4.91875 1 Geminin 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.35 5.14318181818182 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 187828 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 5.35 4.8203125 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.35 actual molregno [molregno] Nc1ccc(cc1)c2nc3ccccc3[nH]2 188812 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.74999985591871 5.35 5.335 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 TBB2B 0 3 TUBB2B TBB2B_BOVIN 5.68 5.35 5.3625 3 Tubulin beta-2B chain 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 LUCI 0 1 LUCI_PHOPY 4.67098267640138 5.35 5.335 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.4362105089299 5.35 5.25 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.35 5.35 5.25 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 5.35 5.35 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.35 5.35 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 GEMI 0 2 GMNN GEMI_HUMAN 4.71121362776266 5.35 5.35 2 Geminin 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.35 5.35 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 TRXR1 0 2 Txnrd1 Trxr1 TRXR1_RAT 4.8999986407574 5.35 5.33625 2 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 188812 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.53621298582672 5.35 5.35 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.35 actual molregno [molregno] COc1cccc(c1)c2cc(O)c3cc(NC(=O)C)ccc3n2 189713 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 5.85 4.5 4.64916666666667 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 11 0 NotRecorded 4.68540303147976 4.5 4.55386363636364 11 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 LUCI 1 0 LUCI_PHOPY 5.12098444659037 4.5 4.5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.55 4.5 4.5 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 4.55 4.5 4.5 4 Menin 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 LX15B 1 0 ALOX15B LX15B_HUMAN 5.19999817218203 4.5 4.5 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 GEMI 2 0 GMNN GEMI_HUMAN 4.71121362776266 4.5 4.5 2 Geminin 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.9612138990678 4.5 4.5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 NF2L2 2 0 NFE2L2 NRF2 NF2L2_HUMAN 4.96810529492655 4.5 4.5 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.7999981345934 4.5 4.05958333333333 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 KDM4A 3 0 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.59999938302362 4.5 4.5 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.85 4.5 4.5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 MBNL1 1 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.84999924507786 4.5 4.5 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.725 4.5 4.5 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.45 4.5 4.5 1 Ras-related protein Rab-9A 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 POLH 1 0 POLH RAD30 RAD30A XPV POLH_HUMAN 4.74999985591871 4.5 4.5 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 5 4.5 4.5 1 TAR DNA-binding protein 43 (TDP-43) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.45 4.5 4.5 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 189713 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] CC(=O)c1sc2nc(ccc2c1N)c3cccs3 191387 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.03621195740581 5.1 4.95615384615385 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 1 20 NotRecorded 4.62555713067284 5.1 5.01428501140672 21 0.952380952380952 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 5.1 4.91615384615385 1 Geminin 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.1 5.1 5.4875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 LUCI 0 1 LUCI_PHOPY 5.17097941513958 5.1 4.94166666666667 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 DPOLB 0 1 POLB DPOLB_HUMAN 4.7 5.1 4.84615384615385 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.1 5.1 4.91615384615385 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.5 5.1 5.52083333333333 1 Ras-related protein Rab-9A 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.95 5.1 4.98333333333333 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 5.1 4.99615384615385 1 Niemann-Pick C1 protein 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191387 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 5.1 4.94318181818182 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.1 actual molregno [molregno] N#C\C(=C/c1cccs1)\c2nc3ccccc3[nH]2 191389 11 3 Nonstructural protein 1, NotRecorded 4.75509576970027 4.6 4.68228422619048 14 0.214285714285714 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.38621101521651 4.6 4.6 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.975 4.6 4.675 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 NFKB1 5 0 NFKB1 NFKB1_HUMAN 6.2 4.6 4.6 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 TF65 5 0 RELA NFKB3 TF65_HUMAN 6.2 4.6 4.6 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 NFKB2 5 0 NFKB2 LYT10 NFKB2_HUMAN 6.2 4.6 4.6 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 LUCI 1 0 LUCI_PHOPY 5.32098115059902 4.6 4.6 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 FRIL 1 0 FTL FRIL_HORSE 4.75 4.6 4.6 1 Ferritin light chain (Ferritin L subunit) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.925 4.6 4.6 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.9 4.6 4.6 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 4.9 4.6 4.6 4 Menin 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.5 4.6 4.6 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.93621243134622 4.6 4.60625 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 NPC1 1 0 NPC1 NPC1_HUMAN 6.1 4.6 4.60625 1 Niemann-Pick C1 protein 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 LX15B 1 0 ALOX15B LX15B_HUMAN 5.19999817218203 4.6 4.6 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.39999691337226 4.6 4.6 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 GEMI 1 0 GMNN GEMI_HUMAN 4.63621320946427 4.6 4.6 1 Geminin 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 6.45 4.6 4.58333333333333 1 Ras-related protein Rab-9A 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 GLSK 1 0 GLS GLS1 KIAA0838 GLSK_HUMAN 5.19999817218203 4.6 4.6 1 Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191389 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 8.4 4.6 4.6 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.6 actual molregno [molregno] Cc1ccc(\C=C(/C#N)\c2nc3ccccc3[nH]2)s1 191011 C11B1 1 0 Cyp11b1 Cyp11b-1 C11B1_RAT 5 4.8 4.8 1 Cytochrome P450 11B1, mitochondrial (CYPXIB1) (Cytochrome P-450c11) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase) (EC 1.14.15.4), Cytochrome P450 11B1, mitochondrial (CYPXIB1) (Cytochrome P450(11 beta)-DS) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase) (EC 1.14.15.4), Cytochrome P450 11B1, mitochondrial (CYPXIB1) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase) (EC 1.14.15.4) 0 4.8 actual molregno [molregno] C(c1c[nH]c2ccccc12)n3ccnc3 191011 1 2 NotRecorded 4.93947746085968 4.8 4.93333333333333 3 0.666666666666667 4.8 actual molregno [molregno] C(c1c[nH]c2ccccc12)n3ccnc3 191011 THAS 1 0 TBXAS1 CYP5 CYP5A1 THAS_HUMAN 7.6 4.8 4.6 1 Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1) 0 4.8 actual molregno [molregno] C(c1c[nH]c2ccccc12)n3ccnc3 191011 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] C(c1c[nH]c2ccccc12)n3ccnc3 194270 1 8 Nonstructural protein 1, NotRecorded 5.06580647417741 4.9 4.89263888888889 9 0.888888888888889 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.73622195097738 4.9 4.84375 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 7.45 4.9 4.84375 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.45 4.9 4.909375 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 NPC1 0 1 NPC1 NPC1_HUMAN 6.15 4.9 4.84375 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.58621349329112 4.9 4.871875 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.89999841719865 4.9 4.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.4 4.9 4.84375 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 6 4.9 4.9 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 8.25 4.9 4.84375 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 LUCI 0 1 LUCI_PHOPY 5.57097484328848 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194270 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 6.04997609347667 4.9 4.9 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 4.9 actual molregno [molregno] COc1ccc(cc1)C(=O)Nc2nc(O)c3ccccc3n2 194189 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.05 4.6 4.6 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 5.05 4.6 4.6 4 Menin 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.25000102344165 4.6 4.6 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 RORG 1 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.6 4.6 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 4 0 NotRecorded 5.42260059707169 4.6 4.6 4 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 TSHR 4 0 TSHR LGR3 TSHR_HUMAN 4.5 4.6 4.6 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.09999903484653 4.6 4.6 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 194189 ATAD5 1 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68621289959511 4.6 4.6 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.6 actual molregno [molregno] COc1cc2nc(NC(=O)c3ccccc3)nc(O)c2cc1OC 199661 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.8 5.65 5.64375 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.18621225375977 5.65 5.65 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 HD 0 1 HTT HD IT15 HD_HUMAN 5.6 5.65 5.65 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 1 16 NotRecorded 4.76991719002403 5.65 5.58161764705882 17 0.941176470588235 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.725 5.65 5.65 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.03640103740276 5.65 5.65 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.65 5.65 5.65 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 LUCI 0 1 LUCI_PHOPY 6.22098102808513 5.65 5.65 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.25 5.65 5.65 1 Ras-related protein Rab-9A 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.55 5.65 5.65 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 GLP1R 0 1 GLP1R GLP1R_HUMAN 5 5.65 5.64375 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 NPC1 0 1 NPC1 NPC1_HUMAN 6.15 5.65 5.65 1 Niemann-Pick C1 protein 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.55005901122666 5.65 5.65 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 Q94696 0 1 luc Q94696_PHOPE 5 5.65 5.65 1 Luciferase 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 199661 P53 0 1 TP53 P53 P53_HUMAN 4.89999841719865 5.65 5.65 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.65 actual molregno [molregno] [O-][N+](=O)c1ccc(\C=C\c2ccc3ccccc3n2)cc1 207494 AOFB 0 4 MAOB, Maob AOFB_HUMAN, AOFB_RAT 6.4875 5.6 5.578125 4 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.5 5.6 5.6 1 Ras-related protein Rab-9A 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 NPC1 0 1 NPC1 NPC1_HUMAN 6.4 5.6 5.6 1 Niemann-Pick C1 protein 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 SENP8 0 2 SENP8 DEN1 NEDP1 PRSC2 FKSG8 SENP8_HUMAN 5.69 5.6 5.6 2 Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 SENP7 0 1 SENP7 KIAA1707 SSP2 SUSP2 SENP7_HUMAN 5.72 5.6 5.6 1 Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 6.19997064075587 5.6 5.55625 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 0 7 NotRecorded 5.20241440566823 5.6 5.51473214285714 7 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.70000050388302 5.6 5.4625 1 Uncharacterized protein 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 5.6 5.575 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 POLI 0 1 POLI RAD30B POLI_HUMAN 4.8000008748032 5.6 5.575 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.35 5.6 5.55625 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 Q94696 0 1 luc Q94696_PHOPE 5.3 5.6 5.6 1 Luciferase 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 CASP3 0 1 CASP3 CPP32 CASP3_HUMAN 5.59 5.6 5.6 1 Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.91140351576984 5.6 5.6 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 AOFA 0 1 Maoa AOFA_RAT 4.51 5.6 5.6 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.6 5.6 5.525 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 SENP6 0 1 SENP6 KIAA0797 SSP1 SUSP1 FKSG6 SENP6_HUMAN 5.6 5.6 5.58 1 Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207494 LUCI 0 1 LUCI_PHOPY 6.37099838071301 5.6 5.6 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.6 actual molregno [molregno] Fc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 LMBL1 0 1 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 5.5 5.95 5.95 1 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 Q94696 0 1 luc Q94696_PHOPE 5.3 5.95 5.95 1 Luciferase 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 GTR1 0 1 SLC2A1 GLUT1 GTR1_HUMAN 4.92081875395237 5.95 5.95 1 Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1), Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 GEMI 0 2 GMNN GEMI_HUMAN 5.46119339254187 5.95 5.95 2 Geminin 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.6 5.95 6.0175 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 MITF 0 5 MITF BHLHE32 MITF_HUMAN 5.16 5.95 5.95 5 Microphthalmia-associated transcription factor, Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.836212690038 5.95 5.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 CDPK1 0 1 CPK1 CDPK1 PFB0815w CDPK1_PLAF7 6 5.95 5.95 1 Calcium-dependent protein kinase 1 (EC 2.7.11.1) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 AOFA 0 1 Maoa AOFA_RAT 5 5.95 5.95 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 LUCI 0 2 LUCI_PHOPY 6.59554329700265 5.95 5.98375 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.62382285083096 5.95 5.95 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.7999981345934 5.95 5.95 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 RGS4 0 1 RGS4 RGS4_HUMAN 4.70000050388302 5.95 5.95 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.65000022087346 5.95 5.95 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.74999985591871 5.95 5.95 1 Uncharacterized protein 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 AOFB 0 4 MAOB, Maob AOFB_HUMAN, AOFB_RAT 5.9 5.95 5.98375 4 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.575 5.95 5.95 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 Q25917 0 1 map-2 Q25917_PLAFA 6 5.95 5.95 1 Mitogen-activated protein kinase (EC 2.7.11.24) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.95 5.95 5.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 NPC1 0 1 NPC1 NPC1_HUMAN 6.5 5.95 5.95 1 Niemann-Pick C1 protein 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.72382322328385 5.95 5.95 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 AGTR1 0 1 AGTR1 AGTR1A AGTR1B AT2R1 AT2R1B AGTR1_HUMAN 5.16 5.95 5.95 1 Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1), Type-1 angiotensin II receptor (Angiotensin II type-1 receptor) (AT1) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 7 5.95 5.95 1 Ras-related protein Rab-9A 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 PGKC 0 1 PGKC_TRYBB 4.8000008748032 5.95 5.95 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.7499949715131 5.95 5.65625 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 CDPK4 0 1 CPK4 CDPK4 PF07_0072 CDPK4_PLAF7 6 5.95 5.95 1 Calcium-dependent protein kinase 4 (EC 2.7.11.1) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.7 5.95 5.95 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 Q4GZG4 0 1 PGKC TB927.1.700 Q4GZG4_TRYB2 5.3366666375883 5.95 5.95 1 Phosphoglycerate kinase (EC 2.7.2.3) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207458 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.28642546222793 5.95 5.95 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.95 actual molregno [molregno] COc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.6862171168448 5.2 5.16875 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.075 5.2 5.2 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 Q94696 0 1 luc Q94696_PHOPE 4.95 5.2 5.2 1 Luciferase 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.925 5.2 5.2 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 AOFB 0 4 MAOB, Maob AOFB_HUMAN, AOFB_RAT 5.3925 5.2 5.1453125 4 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 2 7 NotRecorded 5.15662954791248 5.2 4.99981481481482 9 0.777777777777778 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.7 5.2 5.2 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.7 5.2 5.2 4 Menin 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 ATAD5 1 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.68640053886184 5.2 4.89166666666667 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0.5 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.2 5.2 5.2 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 NPC1 0 1 NPC1 NPC1_HUMAN 6.2 5.2 5.44375 1 Niemann-Pick C1 protein 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.94999940171424 5.2 5.2 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 LUCI 0 1 LUCI_PHOPY 6.27099729072781 5.2 5.12291666666667 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 5.2 5.2 1 Geminin 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 FRIL 0 1 FTL FRIL_HORSE 4.6 5.2 5.2 1 Ferritin light chain (Ferritin L subunit) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 HPGDS 0 1 HPGDS GSTS PGDS PTGDS2 HPGDS_HUMAN 5.42 5.2 5.2 1 Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase) 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 RECA 1 0 recA Rv2737c MTV002.02c RECA_MYCTU 5.95 5.2 4.32916666666667 1 Protein RecA (Recombinase A) [Cleaved into: Endonuclease PI-MtuI (EC 3.1.-.-) (Mtu RecA intein)] 0 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207509 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.3 5.2 5.44375 1 Ras-related protein Rab-9A 1 5.2 actual molregno [molregno] Oc1ccc(cc1)c2cc3C(=O)c4ccccc4c3nn2 207681 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.35 4.85 4.85 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 LUCI 0 1 LUCI_PHOPY 6.32102662408024 4.85 4.925 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 AGTR1 0 1 AGTR1 AGTR1A AGTR1B AT2R1 AT2R1B AGTR1_HUMAN 5.13 4.85 4.85 1 Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1), Type-1 angiotensin II receptor (Angiotensin II type-1 receptor) (AT1) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5 4.85 4.85 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 PGKC 0 1 PGKC_TRYBB 4.74999985591871 4.85 4.85 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.25 4.85 4.85 1 Ras-related protein Rab-9A 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.7999981345934 4.85 4.90125 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 Q94696 0 2 luc Q94696_PHOPE 5.24332755038263 4.85 4.85 2 Luciferase 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 NPC1 0 1 NPC1 NPC1_HUMAN 5.9 4.85 4.85 1 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 Q4GZG4 0 1 PGKC TB927.1.700 Q4GZG4_TRYB2 4.93666288743887 4.85 4.85 1 Phosphoglycerate kinase (EC 2.7.2.3) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 5.05000045714008 4.85 4.85 1 Uncharacterized protein 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.85 4.85 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 AOFB 0 5 MAOB, Maob AOFB_HUMAN, AOFB_RAT 5.094 4.85 4.86 5 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 AOFA 0 1 Maoa AOFA_RAT 4.6 4.85 4.85 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.53621149304416 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.836212690038 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207681 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] O=C1c2ccccc2c3nnc(cc13)c4ccccc4 207910 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.58636500280144 5.55 5.55 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 0 15 Aberrant vpr protein, NotRecorded 5.14139360360523 5.55 5.54633333333333 15 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.025 5.55 5.55 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.65000022087346 5.55 5.55 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.9 5.55 5.55 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 GEMI 0 2 GMNN GEMI_HUMAN 4.63621273654598 5.55 5.55 2 Geminin 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.5 5.55 5.54375 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 RGAP1 0 1 RACGAP1 KIAA1478 MGCRACGAP RGAP1_HUMAN 4.55330753362847 5.55 5.55 1 Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 LUCI 0 2 LUCI_PHOPY 6.83047747005602 5.55 5.345 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.55 5.55 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 NPC1 0 1 NPC1 NPC1_HUMAN 6.1 5.55 5.4 1 Niemann-Pick C1 protein 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 Q94696 0 1 luc Q94696_PHOPE 5 5.55 5.55 1 Luciferase 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 ASM 0 1 SMPD1 ASM ASM_HUMAN 4.59999938302362 5.55 5.55 1 Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.55 5.55 5.3125 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.55 5.55 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.9 5.55 5.4 1 Ras-related protein Rab-9A 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.94999940171424 5.55 5.55 1 TAR DNA-binding protein 43 (TDP-43) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 207910 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.14999741390754 5.55 5.55 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.55 actual molregno [molregno] Oc1ccc(\C=C\c2ccc3ccccc3n2)cc1 209510 0 52 NotRecorded 4.98839549745035 5.25 5.18826121794872 52 DILAZEP CARDIOVASCULAR DISEASE 0 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.25 5.25 4.91666666666667 1 DILAZEP CARDIOVASCULAR DISEASE 0 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 LX15B 0 3 ALOX15B LX15B_HUMAN 4.89999947262338 5.25 5.25 3 DILAZEP CARDIOVASCULAR DISEASE 0 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 TPO 0 2 THPO MGDF TPO_HUMAN 5 5.25 5.04166666666667 2 DILAZEP CARDIOVASCULAR DISEASE 0 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 CP2C9 0 6 CYP2C9 CYP2C10 CP2C9_HUMAN 4.96666666666667 5.25 5.25 6 DILAZEP CARDIOVASCULAR DISEASE 0 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.4 5.25 5.16666666666667 2 DILAZEP CARDIOVASCULAR DISEASE 0 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.2857727183338 5.25 5.14583333333333 2 DILAZEP CARDIOVASCULAR DISEASE 0 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.1 5.25 5.25 4 DILAZEP CARDIOVASCULAR DISEASE 0 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 TRXR1 0 1 Txnrd1 Trxr1 TRXR1_RAT 6.04997609347667 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 MTOR 0 2 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 4.605 5.25 5.25 2 DILAZEP CARDIOVASCULAR DISEASE 0 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 SCN1A 0 6 SCN1A NAC1 SCN1 SCN1A_HUMAN 6.68592560424056 5.25 5.25 6 DILAZEP CARDIOVASCULAR DISEASE 0 Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 SCN2A 0 6 SCN2A NAC2 SCN2A1 SCN2A2 SCN2A_HUMAN 6.68592560424056 5.25 5.25 6 DILAZEP CARDIOVASCULAR DISEASE 0 Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2), Sodium channel protein type 2 subunit alpha (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 SCN3A 0 6 SCN3A KIAA1356 NAC3 SCN3A_HUMAN 6.68592560424056 5.25 5.25 6 DILAZEP CARDIOVASCULAR DISEASE 0 Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 GEMI 0 1 GMNN GEMI_HUMAN 4.50531121835959 5.25 5.125 1 DILAZEP CARDIOVASCULAR DISEASE 0 Geminin 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.92509948691138 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 S29A1 0 1 SLC29A1 ENT1 S29A1_HUMAN 7.76 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.7 5.25 5.125 1 DILAZEP CARDIOVASCULAR DISEASE 0 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 PMP22 0 2 Pmp22 Cd25 Pmp-22 PMP22_RAT 4.72125845145051 5.25 5.25 2 DILAZEP CARDIOVASCULAR DISEASE 0 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 MK01 0 2 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.65 5.25 5.25 2 DILAZEP CARDIOVASCULAR DISEASE 0 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 MRP4 0 1 ABCC4 MRP4 MRP4_HUMAN 4.7 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 PFKA 0 1 pfk PFKA_TRYBB 5.07098490037598 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 ACM1 0 2 Chrm1 Chrm-1 ACM1_RAT 5.925 5.25 5.25 2 DILAZEP CARDIOVASCULAR DISEASE 0 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.84999924507786 5.25 5.04166666666667 1 DILAZEP CARDIOVASCULAR DISEASE 0 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 S29A2 0 1 Slc29a2 Ent2 S29A2_RAT 5.06 5.25 5.125 1 DILAZEP CARDIOVASCULAR DISEASE 0 Equilibrative nucleoside transporter 2 (36 kDa hydrophobic nucleolar protein) (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2), Equilibrative nucleoside transporter 2 (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2), Equilibrative nucleoside transporter 2 (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.92134022027307 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209510 RGS4 0 1 RGS4 RGS4_HUMAN 4.72382322328385 5.25 5.25 1 DILAZEP CARDIOVASCULAR DISEASE 0 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5.25 actual drug [drugName] COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 209968 TYRO3 0 2 TYRO3 BYK DTK RSE SKY TIF TYRO3_HUMAN 4.72964021311141 4.86666666666667 4.86666666666667 2 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Etk2/tyro3) (TK19-2) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase TIF), Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CLK3 0 2 CLK3 CLK3_HUMAN 5.32252186234896 4.86666666666667 4.86666666666668 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CDK7 0 4 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 4.5698309967145 4.86666666666667 4.86666666666668 4 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CCNH 0 4 CCNH CCNH_HUMAN 4.5698309967145 4.86666666666667 4.86666666666668 4 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NLK 0 2 NLK LAK1 NLK_HUMAN 5.48305110505168 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KC1G3 0 2 CSNK1G3 KC1G3_HUMAN 4.81453941702932 4.86666666666667 4.86666666666668 2 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PGFRA 0 2 PDGFRA PDGFR2 RHEPDGFRA PGFRA_HUMAN 5.2972185374626 4.86666666666667 4.86666666666668 2 Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a), Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (Platelet-derived growth factor alpha receptor) (CD antigen CD140a) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CD5R1 0 15 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 5.07010195264994 4.86666666666667 4.86666666666668 15 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CDK5 0 14 CDK5 CDKN5 CDK5_HUMAN 4.93225209212493 4.86666666666667 4.86666666666668 14 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 LIMK1 0 2 LIMK1 LIMK LIMK1_HUMAN 4.80942871571388 4.86666666666667 4.86666666666668 2 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TLK2 0 2 TLK2 TLK2_HUMAN 4.69386042174517 4.86666666666667 4.86666666666667 2 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SGK2 0 2 SGK2 SGK2_HUMAN 4.84683143870754 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KC1G1 0 2 CSNK1G1 KC1G1_HUMAN 4.74633749108354 4.86666666666667 4.86666666666668 2 Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CSK 0 1 CSK CSK_HUMAN 5.54967192186827 4.86666666666667 4.86666666666668 1 Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase), Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.75 4.86666666666667 4.86666666666668 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KMT2A 0 11 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.06363636363636 4.86666666666667 4.86666666666668 11 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 5.275 4.86666666666667 4.86666666666668 8 Menin 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TIE2 0 1 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 4.84193184507759 4.86666666666667 4.86666666666668 1 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.01139344984053 4.86666666666667 4.86666666666668 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MTOR 0 4 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.99654768075047 4.86666666666667 4.86666666666668 4 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PRKX 0 2 PRKX PKX1 PRKX_HUMAN 4.82883851545892 4.86666666666667 4.86666666666668 2 cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 7.5 4.86666666666667 4.86666666666667 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCB 0 3 PRKCB PKCB PRKCB1 KPCB_HUMAN 6.19903837090286 4.86666666666667 4.86666666666668 3 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCL 0 2 PRKCH PKCL PRKCL KPCL_HUMAN 5.84671402693979 4.86666666666667 4.86666666666668 2 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 AKT3 0 2 AKT3 PKBG AKT3_HUMAN 5.76431553708471 4.86666666666667 4.86666666666668 2 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MET 0 2 MET MET_HUMAN 4.98139725762677 4.86666666666667 4.86666666666667 2 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NFKB1 0 4 NFKB1 NFKB1_HUMAN 5.45 4.86666666666667 4.86666666666668 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TAOK3 0 2 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 5.17157660078478 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 6.95 4.86666666666667 4.86666666666668 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.86666666666667 4.86666666666667 4.86666666666668 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NEK11 0 2 NEK11 NEK11_HUMAN 4.85471771900709 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SRPK2 0 2 SRPK2 SRPK2_HUMAN 5.84388605226727 4.86666666666667 4.86666666666668 2 SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MAPK3 0 1 MAPKAPK3 MAPK3_HUMAN 5.86530142610254 4.86666666666667 4.86666666666668 1 MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GSK3B 0 11 GSK3B GSK3B_HUMAN 6.90819293599665 4.86666666666667 4.86666666666667 11 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CCNB3 0 16 CCNB3 CYCB3 CCNB3_HUMAN 5.8953558174454 4.86666666666667 4.87187500000001 16 G2/mitotic-specific cyclin-B3 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CDK1 0 17 CDK1 CDC2 CDC28A CDKN1 P34CDC2 CDK1_HUMAN 5.94504076936037 4.86666666666667 4.87156862745099 17 Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (Cell division control protein 28) (Cell division protein kinase 1), Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CCNB1 0 16 CCNB1 CCNB CCNB1_HUMAN 5.8953558174454 4.86666666666667 4.87187500000001 16 G2/mitotic-specific cyclin-B1 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CCNB2 0 16 CCNB2 CCNB2_HUMAN 5.8953558174454 4.86666666666667 4.87187500000001 16 G2/mitotic-specific cyclin-B2 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TEC 0 2 TEC PSCTK4 TEC_HUMAN 4.85010277567416 4.86666666666667 4.86666666666668 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ULK3 0 2 ULK3 ULK3_HUMAN 4.61092437480818 4.86666666666667 4.86666666666667 2 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FES 0 2 FES FPS FES_HUMAN 5.02109883989723 4.86666666666667 4.86666666666668 2 Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 IKKA 0 2 CHUK IKKA TCF16 IKKA_HUMAN 5.31150437533105 4.86666666666667 4.86666666666668 2 Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA), Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 LEF 0 2 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.05 4.86666666666667 4.86666666666667 2 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 5.05 4.86666666666667 4.86666666666668 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA7 0 2 EPHA7 EHK3 HEK11 EPHA7_HUMAN 4.80732455931799 4.86666666666667 4.86666666666667 2 Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MARK2 0 2 MARK2 EMK1 MARK2_HUMAN 4.58843373908773 4.86666666666667 4.86666666666667 2 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 LOX5 0 5 ALOX5 LOG5 LOX5_HUMAN 5.29849972597933 4.86666666666667 4.86666666666668 5 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NEK2 0 2 NEK2 NEK2A NLK1 NEK2_HUMAN 5.90600703976874 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA3 0 2 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 4.56768991014163 4.86666666666667 4.86666666666667 2 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCD1 0 1 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.26884531229258 4.86666666666667 4.86666666666668 1 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CP2CJ 0 3 CYP2C19 CP2CJ_HUMAN 4.66666666666667 4.86666666666667 4.86666666666668 3 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FFP 0 1 ffp sfp FFP_BACIU 5.3 4.86666666666667 4.86666666666668 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 E2AK2 0 1 EIF2AK2 PKR PRKR E2AK2_HUMAN 7 4.86666666666667 4.86666666666668 1 Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Serine/threonine-protein kinase TIK) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase), Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 P53 0 2 TP53 P53 P53_HUMAN 4.6 4.86666666666667 4.86666666666668 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PAK3 0 2 PAK3 OPHN3 PAK3_HUMAN 5.49385391309772 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PASK 0 1 PASK KIAA0135 PASK_HUMAN 5.50060235056919 4.86666666666667 4.86666666666668 1 PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KCC4 0 2 CAMK4 CAMK CAMK-GR CAMKIV KCC4_HUMAN 4.66691125453014 4.86666666666667 4.86666666666667 2 Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RAF1 0 2 RAF1 RAF RAF1_HUMAN 5.59803116999315 4.86666666666667 4.86666666666668 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA5 0 2 EPHA5 BSK EHK1 HEK7 TYRO4 EPHA5_HUMAN 4.57663463602032 4.86666666666667 4.86666666666667 2 Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHB1 0 2 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 4.66624612730531 4.86666666666667 4.86666666666667 2 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PIM2 0 2 PIM2 PIM2_HUMAN 5.05737542075244 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NEK6 0 1 NEK6 NEK6_HUMAN 6.00479888288177 4.86666666666667 4.86666666666668 1 Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ABL2 0 2 ABL2 ABLL ARG ABL2_HUMAN 4.61092437480818 4.86666666666667 4.86666666666668 2 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TAU 0 12 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.175 4.86666666666667 4.86666666666668 12 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 IGF1R 0 4 IGF1R IGF1R_HUMAN 4.6341128881174 4.86666666666667 4.86666666666668 4 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK08 0 2 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 5.29955780534059 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 STK11 0 2 STK11 LKB1 PJS STK11_HUMAN 5.2919469102389 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHB4 0 2 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 4.74099248125558 4.86666666666667 4.86666666666667 2 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 5.9 4.86666666666667 4.86666666666668 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 UBP2 0 1 USP2 UBP41 UBP2_HUMAN 4.6 4.86666666666667 4.86666666666668 1 Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 5.9330035795503 4.86666666666667 4.86666666666668 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PLK2 0 2 PLK2 SNK PLK2_HUMAN 6.0840959134135 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCA 0 2 PRKCA PKCA PRKACA KPCA_HUMAN 5.9558776620525 4.86666666666667 4.86666666666668 2 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KAPCA 0 2 PRKACA PKACA KAPCA_HUMAN 5.51193921879036 4.86666666666667 4.86666666666668 2 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 5.6886291709978 4.86666666666667 4.86666666666668 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KS6A5 0 4 RPS6KA5 MSK1 KS6A5_HUMAN 4.80942871571388 4.86666666666667 4.86666666666668 4 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CSK2B 0 3 CSNK2B CK2N G5A CSK2B_HUMAN 5.54967192186827 4.86666666666667 4.83125000000001 3 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CSK22 0 4 CSNK2A2 CK2A2 CSK22_HUMAN 5.44729861719246 4.86666666666667 4.84010416666668 4 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CSK21 0 3 CSNK2A1 CK2A1 CSK21_HUMAN 5.54967192186827 4.86666666666667 4.83125000000001 3 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RON 0 2 MST1R PTK8 RON RON_HUMAN 5.58861538319272 4.86666666666667 4.86666666666668 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DRD1 0 2 DRD1 DRD1_HUMAN 5.31811882056531 4.86666666666667 4.86666666666668 2 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 APEX1 0 2 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.57500049015417 4.86666666666667 4.86666666666668 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK14 0 2 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.87232426254216 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 AURKC 0 3 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 5.56563037730495 4.86666666666667 4.86666666666668 3 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 4.50242625139721 4.86666666666667 4.86666666666667 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FKB1A 0 2 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.90799732148669 4.86666666666667 4.86666666666668 2 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 5.58621423228026 4.86666666666667 4.86666666666668 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 4.8000008748032 4.86666666666667 4.86666666666668 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PEBB 0 2 CBFB PEBB_HUMAN 4.8000008748032 4.86666666666667 4.86666666666668 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TPO 0 2 THPO MGDF TPO_HUMAN 6 4.86666666666667 4.86666666666668 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KGP1 0 4 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 5.33014534320386 4.86666666666667 4.86666666666668 4 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ZAP70 0 2 ZAP70 SRK ZAP70_HUMAN 5.79010333971915 4.86666666666667 4.86666666666668 2 Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA4 0 2 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 6.0344202063547 4.86666666666667 4.86666666666668 2 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 HD 0 2 HTT HD IT15 HD_HUMAN 6.025 4.86666666666667 4.86666666666668 2 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCD 0 2 PRKCD KPCD_HUMAN 5.67769382899328 4.86666666666667 4.86666666666668 2 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DDR2 0 2 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.01027625176392 4.86666666666667 4.86666666666668 2 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCT 0 2 PRKCQ PRKCT KPCT_HUMAN 5.35844079682236 4.86666666666667 4.86666666666668 2 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.39999691337226 4.86666666666667 4.86666666666668 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 HIPK1 0 2 HIPK1 KIAA0630 MYAK NBAK2 HIPK1_HUMAN 5.6931008027004 4.86666666666667 4.86666666666668 2 Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHB2 0 2 EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5 EPHB2_HUMAN 5.08961149128499 4.86666666666667 4.86666666666667 2 Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3), Ephrin type-B receptor 2 (EC 2.7.10.1) (Neural kinase) (Nuk receptor tyrosine kinase) (Tyrosine-protein kinase receptor EPH-3) (Tyrosine-protein kinase receptor SEK-3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SGK3 0 2 SGK3 CISK SGKL SGK3_HUMAN 5.50636633600335 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FGFR4 0 1 FGFR4 JTK2 TKF FGFR4_HUMAN 4.9128498242811 4.86666666666667 4.86666666666668 1 Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334), Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (Protein-tyrosine kinase receptor MPK-11) (CD antigen CD334) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK09 0 2 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 4.69926050236055 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PGFRB 0 2 PDGFRB PDGFR PDGFR1 PGFRB_HUMAN 5.1329504658229 4.86666666666667 4.86666666666668 2 Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ROS1 0 1 ROS1 MCF3 ROS ROS1_HUMAN 5.86530142610254 4.86666666666667 4.86666666666668 1 Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MP2K1 0 2 MAP2K1 MEK1 PRKMK1 MP2K1_HUMAN 5.16851382446775 4.86666666666667 4.86666666666668 2 Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1), Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KCC1D 0 2 CAMK1D CAMKID KCC1D_HUMAN 5.24679785067007 4.86666666666667 4.86666666666668 2 Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GSK3A 0 8 GSK3A GSK3A_HUMAN 6.5857014005562 4.86666666666667 4.86666666666667 8 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.63621320946427 4.86666666666667 4.86666666666668 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FLT3 0 2 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.24218240270122 4.86666666666667 4.86666666666667 2 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NEK3 0 2 NEK3 NEK3_HUMAN 5.9916735093907 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TSSK1 0 2 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 5.30092496676667 4.86666666666667 4.86666666666668 2 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ALK 0 2 ALK ALK_HUMAN 4.6881103794894 4.86666666666667 4.86666666666668 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SRPK3 0 2 SRPK3 MSSK1 STK23 SRPK3_HUMAN 5.34184586925861 4.86666666666667 4.86666666666668 2 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KSYK 0 2 SYK KSYK_HUMAN 5.07935858149313 4.86666666666667 4.86666666666668 2 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 HIPK3 0 2 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 5.11778500408836 4.86666666666667 4.86666666666668 2 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 4.6 4.86666666666667 4.86666666666668 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA8 0 2 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 5.29887645165653 4.86666666666667 4.86666666666668 2 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK11 0 1 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 5.95424250943933 4.86666666666667 4.86666666666668 1 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MINK1 0 2 MINK1 B55 MAP4K6 MINK YSK2 ZC3 MINK1_HUMAN 4.55769670935103 4.86666666666667 4.86666666666667 2 Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DCLK2 0 1 DCLK2 DCAMKL2 DCDC3B DCK2 DCLK2_HUMAN 5.45425837176016 4.86666666666667 4.86666666666668 1 Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PAK6 0 2 PAK6 PAK5 PAK6_HUMAN 5 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KCC1A 0 2 CAMK1 KCC1A_HUMAN 4.91738333426627 4.86666666666667 4.86666666666668 2 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 5.65617987285236 4.86666666666667 4.86666666666668 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TAOK1 0 2 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 5.24718197150676 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 M3K7 0 2 MAP3K7 TAK1 M3K7_HUMAN 5.31936891201836 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PKN2 0 2 PKN2 PRK2 PRKCL2 PKN2_HUMAN 5.48501838831128 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 AKT2 0 2 AKT2 AKT2_HUMAN 6.37544696019106 4.86666666666667 4.86666666666668 2 RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 VRK2 0 2 VRK2 VRK2_HUMAN 4.98934294286553 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SRPK1 0 2 SRPK1 SRPK1_HUMAN 5.62115376396947 4.86666666666667 4.86666666666668 2 SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PAK5 0 2 PAK5 KIAA1264 PAK7 PAK5_HUMAN 4.97115830519683 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 AKT1 0 1 AKT1 PKB RAC AKT1_HUMAN 6.69019608002851 4.86666666666667 4.86666666666668 1 RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (AKT1 kinase) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) (Thymoma viral proto-oncogene), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha), RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (RAC-PK-alpha) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ULK2 0 2 ULK2 KIAA0623 ULK2_HUMAN 5.64072653173104 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MKNK2 0 2 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 4.77703337280052 4.86666666666667 4.86666666666668 2 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FRIL 0 1 FTL FRIL_HORSE 4.6 4.86666666666667 4.86666666666668 1 Ferritin light chain (Ferritin L subunit) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA2 0 2 EPHA2 ECK EPHA2_HUMAN 4.73705296228916 4.86666666666667 4.86666666666668 2 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FEN1 0 1 FEN1 RAD2 FEN1_HUMAN 4.57382231378381 4.86666666666667 4.86666666666668 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ROCK1 0 1 ROCK1 ROCK1_HUMAN 6.06069784035361 4.86666666666667 4.86666666666668 1 Rho-associated protein kinase 1 (EC 2.7.11.1) (Liver regeneration-related protein LRRG199) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p150 RhoA-binding kinase ROK beta) (p160 ROCK-1) (p160ROCK), Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PAK4 0 2 PAK4 KIAA1142 PAK4_HUMAN 4.64938988007679 4.86666666666667 4.86666666666667 2 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 JAK2 0 4 JAK2 JAK2_HUMAN 5.07635025943346 4.86666666666667 4.86666666666668 4 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK12 0 2 MAPK12 ERK6 SAPK3 MK12_HUMAN 5.99945645217939 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PAK2 0 1 PAK2 PAK2_HUMAN 5.06963592814139 4.86666666666667 4.86666666666668 1 Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CP2C9 0 3 CYP2C9 CYP2C10 CP2C9_HUMAN 4.56666666666667 4.86666666666667 4.86666666666668 3 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ABL1 0 2 ABL1 ABL JTK7 ABL1_HUMAN 4.63123330026231 4.86666666666667 4.86666666666668 2 Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MP2K6 0 2 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 5.02752378316545 4.86666666666667 4.86666666666668 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KC1G2 0 2 CSNK1G2 CK1G2 KC1G2_HUMAN 4.82390874094432 4.86666666666667 4.86666666666668 2 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.4 4.86666666666667 4.86666666666668 1 Ras-related protein Rab-9A 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MAPK5 0 2 MAPKAPK5 PRAK MAPK5_HUMAN 5.02453478564954 4.86666666666667 4.86666666666668 2 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 IKKB 0 2 IKBKB IKKB IKKB_HUMAN 5.56656838156736 4.86666666666667 4.86666666666668 2 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCG 0 2 PRKCG PKCG KPCG_HUMAN 5.74632846815754 4.86666666666667 4.86666666666668 2 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 WNK3 0 2 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 5.54204429027118 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ROCK2 0 2 ROCK2 KIAA0619 ROCK2_HUMAN 5.70593450696951 4.86666666666667 4.86666666666668 2 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 CHK1 0 2 CHEK1 CHK1 CHK1_HUMAN 4.95043426349899 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DAPK3 0 2 DAPK3 ZIPK DAPK3_HUMAN 5.19929629626962 4.86666666666667 4.86666666666668 2 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EF2K 0 1 EEF2K EF2K_HUMAN 6.12338490853968 4.86666666666667 4.86666666666668 1 Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PLK3 0 2 PLK3 CNK FNK PRK PLK3_HUMAN 6.19250506229669 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK13 0 2 MAPK13 PRKM13 SAPK4 MK13_HUMAN 5.80639192835987 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PTK6 0 2 PTK6 BRK PTK6_HUMAN 5.24001799686344 4.86666666666667 4.86666666666668 2 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DAPK2 0 2 DAPK2 DAPK2_HUMAN 4.95359810340329 4.86666666666667 4.86666666666668 2 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MYLK 0 2 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 4.55239408577341 4.86666666666667 4.86666666666667 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.64999994345332 4.86666666666667 4.86666666666668 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 WNK2 0 2 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.52069634257911 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SIR2 0 1 SIRT2 SIR2L SIR2L2 SIR2_HUMAN 5.17609125905568 4.86666666666667 4.86666666666668 1 NAD-dependent histone deacetylase SIR2 (EC 3.5.1.-) (Regulatory protein SIR2) (Silent information regulator 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2), NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2) (mSIR2L2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 SGK1 0 2 SGK1 SGK SGK1_HUMAN 4.87394684491668 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MK01 0 2 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.8 4.86666666666667 4.86666666666668 2 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 NPC1 0 1 NPC1 NPC1_HUMAN 5.34 4.86666666666667 4.86666666666668 1 Niemann-Pick C1 protein 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 LUCI 0 1 LUCI_PHOPY 4.6 4.86666666666667 4.86666666666668 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TSSK2 0 2 TSSK2 DGSG SPOGA2 STK22B TSSK2_HUMAN 5.91421276141055 4.86666666666667 4.86666666666668 2 Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GRK5 0 2 GRK5 GPRK5 GRK5_HUMAN 5.60043827175932 4.86666666666667 4.86666666666668 2 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCD2 0 1 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.69019608002851 4.86666666666667 4.86666666666668 1 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 END4 0 1 nfo b2159 JW2146 END4_ECOLI 4.95 4.86666666666667 4.86666666666667 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 IRAK1 0 2 IRAK1 IRAK IRAK1_HUMAN 4.6340469687845 4.86666666666667 4.86666666666667 2 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GRK7 0 2 GRK7 GPRK7 GRK7_HUMAN 4.88670887434053 4.86666666666667 4.86666666666668 2 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TGFR1 0 1 TGFBR1 ALK5 SKR4 TGFR1_HUMAN 5.43195909596147 4.86666666666667 4.86666666666668 1 TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I), TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (ESK2) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCZ 0 1 PRKCZ PKC2 KPCZ_HUMAN 6.69019608002851 4.86666666666667 4.86666666666668 1 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 5.41017446508905 4.86666666666667 4.86666666666668 1 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 AURKA 0 2 AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6 AURKA_HUMAN 4.63830754573016 4.86666666666667 4.86666666666668 2 Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora family kinase 1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Ipl1- and aurora-related kinase 1) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase Ayk1) (Serine/threonine-protein kinase aurora-A), Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PIM3 0 2 PIM3 PIM3_HUMAN 6.07460955632769 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 DYRK2 0 2 DYRK2 DYRK2_HUMAN 4.98667390261428 4.86666666666667 4.86666666666668 2 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCE 0 1 PRKCE PKCE KPCE_HUMAN 6.00479888288177 4.86666666666667 4.86666666666668 1 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MPP8 0 2 MPHOSPH8 MPP8 MPP8_HUMAN 5.16191037991005 4.86666666666667 4.86666666666668 2 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PLK1 0 1 PLK1 PLK PLK1_HUMAN 5.6886291709978 4.86666666666667 4.86666666666668 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RIPK2 0 2 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 4.87206608154711 4.86666666666667 4.86666666666668 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.86666666666667 4.86666666666668 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 ERBB4 0 1 ERBB4 HER4 ERBB4_HUMAN 6.99563519459755 4.86666666666667 4.86666666666668 1 Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)] 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PDPK1 0 2 PDPK1 PDK1 PDPK1_HUMAN 4.52368956439165 4.86666666666667 4.86666666666667 2 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 PIM1 0 2 PIM1 PIM1_HUMAN 5.22421216945206 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 KPCI 0 1 PRKCI DXS1179E KPCI_HUMAN 6.38021124171161 4.86666666666667 4.86666666666668 1 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999893552381 4.86666666666667 4.86666666666668 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 TAOK2 0 2 TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431 TAOK2_HUMAN 5.01143144147975 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2), Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.65000022087346 4.86666666666667 4.86666666666668 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 FER 0 2 FER TYK3 FER_HUMAN 5.21007739847983 4.86666666666667 4.86666666666668 2 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GRK6 0 2 GRK6 GPRK6 GRK6_HUMAN 5.61589570462689 4.86666666666667 4.86666666666668 2 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 MAPK2 0 1 MAPKAPK2 MAPK2_HUMAN 5.50060235056919 4.86666666666667 4.86666666666668 1 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 STK10 0 2 STK10 LOK STK10_HUMAN 5.33846268465986 4.86666666666667 4.86666666666668 2 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 RECQ1 0 1 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.5 4.86666666666667 4.86666666666668 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.14070770185159 4.86666666666667 4.86666666666668 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 209968 GEMI 0 1 GMNN GEMI_HUMAN 5.2 4.86666666666667 4.86666666666668 1 Geminin 1 4.86666666666667 actual molregno [molregno] Oc1[nH]c2ccccc2c1c3[nH]c4ccccc4c3N=O 208790 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 5.5 5.425 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 0 13 Nonstructural protein 1, NotRecorded 4.8775038241862 5.5 5.30672928786899 13 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.9 5.5 5.5 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 5.9 5.5 5.5 4 Menin 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 HD 0 1 HTT HD IT15 HD_HUMAN 4.6 5.5 5.35661764705882 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 GEMI 0 2 GMNN GEMI_HUMAN 4.63621273654598 5.5 5.35661764705882 2 Geminin 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 POLI 0 1 POLI RAD30B POLI_HUMAN 4.8000008748032 5.5 5.32291666666667 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.14999741390754 5.5 5.35416666666667 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.675 5.5 5.38143382352941 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 6.45001638884031 5.5 5.325 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 DNAB 0 2 dnaB Rv0058 MTCY21D4.21 DNAB_MYCTU 5.12 5.5 5.453125 2 Replicative DNA helicase (EC 3.6.4.12) [Cleaved into: Endonuclease PI-MtuHIP (EC 3.1.-.-) (Mtu dnaB intein)] 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 LUCI 0 1 LUCI_PHOPY 5.87098720687396 5.5 5.50625 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.7499949715131 5.5 5.41875 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 Q94696 0 1 luc Q94696_PHOPE 5.3 5.5 5.5 1 Luciferase 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.9 5.5 5.425 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5.19999817218203 5.5 5.41666666666667 1 TAR DNA-binding protein 43 (TDP-43) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 AOFB 0 3 MAOB, Maob AOFB_HUMAN, AOFB_RAT 5.08 5.5 5.425 3 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.4 5.5 5.5 1 Ras-related protein Rab-9A 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 GLP1R 0 1 GLP1R GLP1R_HUMAN 5 5.5 5.43181818181818 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.26121218107622 5.5 5.45955882352941 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 AOFA 0 1 Maoa AOFA_RAT 5 5.5 5.40625 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.5 5.5 5.3875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.6862171168448 5.5 5.3875 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 RECA 0 1 recA Rv2737c MTV002.02c RECA_MYCTU 6.05 5.5 5.45 1 Protein RecA (Recombinase A) [Cleaved into: Endonuclease PI-MtuI (EC 3.1.-.-) (Mtu RecA intein)] 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.025 5.5 5.35093582887701 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 O97447 0 1 ald O97447_GIAIN 6.4 5.5 5.45625 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5 5.5 5.25718582887701 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 208790 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 5.5 5.3875 1 Niemann-Pick C1 protein 1 5.5 actual molregno [molregno] Cc1ccccc1c2cc3C(=O)c4ccccc4c3nn2 211620 0 46 NotRecorded 5.12213972283858 6.05 6.03879076086957 46 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.09999903484653 6.05 6.05 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.98621430602854 6.05 6.05 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 POLI 0 1 POLI RAD30B POLI_HUMAN 5.05000045714008 6.05 6.05 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.97510403989252 6.05 6.05 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.225 6.05 6.05 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 5.225 6.05 6.05 8 Menin 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 LUCI 0 2 LUCI_PHOPY 6.23160592305462 6.05 6.05 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.05 6.05 6.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 ANDR 0 2 AR DHTR NR3C4 ANDR_HUMAN 5.15006683997325 6.05 6.05 2 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 6.05 6.05 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.1 6.05 6.05 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 NFKB1 0 5 NFKB1 NFKB1_HUMAN 6.05 6.05 6.0375 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 TF65 0 5 RELA NFKB3 TF65_HUMAN 6.05 6.05 6.0375 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 6.05 6.05 6.0375 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 6.05 6.05 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5 6.05 6.05 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 7.14206473528057 6.05 6.05 1 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 UBP1 0 1 USP1 UBP1_HUMAN 6.19997064075587 6.05 6.05 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.84999924507786 6.05 6.05 1 TAR DNA-binding protein 43 (TDP-43) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 6.05 6.05 1 Geminin 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.15 6.05 6.05 1 Ras-related protein Rab-9A 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 6.05 6.05 1 Niemann-Pick C1 protein 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 JUN 0 1 JUN JUN_HUMAN 4.5713388619675 6.05 6.05 1 Transcription factor AP-1 (AH119) (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (Jun A), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog), Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39), Transcription factor AP-1 (Proto-oncogene c-Jun) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 DPOLB 0 1 POLB DPOLB_HUMAN 4.65 6.05 6.05 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 211620 HSPB1 0 1 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.87509817999164 6.05 6.05 1 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 1 6.05 actual molregno [molregno] COc1ccc2nc(NC(=O)Nc3ccccc3)sc2c1 220354 ANDR 7 0 AR DHTR NR3C4 ANDR_HUMAN 4.97018304544096 4.725 4.725 7 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 DHB2 2 0 HSD17B2 EDH17B2 SDR9C2 DHB2_HUMAN 4.5252808410247 4.725 4.725 2 Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239), Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 DHB1 1 0 HSD17B1 E17KSR EDH17B1 EDH17B2 EDHB17 SDR28C1 DHB1_HUMAN 4.9128498242811 4.725 4.725 1 Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1), Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CBR1 3 0 CBR1 CBR CRN SDR21C1 CBR1_HUMAN 4.86695855383128 4.725 4.725 3 Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 KMT2A 16 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.5875 4.725 4.725 16 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 MEN1 16 0 MEN1 SCG2 MEN1_HUMAN 4.5875 4.725 4.725 16 Menin 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 ATAD5 4 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.08148447167454 4.725 4.725 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.55 4.725 4.725 1 Ras-related protein Rab-9A 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 AOFA 8 0 MAOA AOFA_HUMAN 6.08159204034818 4.725 4.5546875 8 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 AOFB 8 0 MAOB AOFB_HUMAN 6.08159204034818 4.725 4.5546875 8 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CP19A 8 0 CYP19A1 ARO1 CYAR CYP19 CP19A_HUMAN 5.37596811387754 4.725 4.7359375 8 Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 RECQ1 1 0 RECQL RECQ1 RECQL1 RECQ1_HUMAN 5.9 4.725 4.725 1 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.15 4.725 4.725 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 MK01 1 0 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.8 4.725 4.725 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 GRP78 1 0 HSPA5 GRP78 GRP78_HUMAN 4.89999841719865 4.725 4.725 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 SO1B1 1 0 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.78443283589535 4.725 4.725 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 TAU 8 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.90625 4.725 4.725 8 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CAH12 1 0 CA12 CAH12_HUMAN 7.28 4.725 4.715 1 Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.59999765407204 4.725 4.725 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.675 4.725 4.725 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 P53 3 0 TP53 P53 P53_HUMAN 4.71666675038119 4.725 4.725 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.55 4.725 4.725 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 PTH1R 2 0 PTH1R PTHR PTHR1 PTH1R_HUMAN 4.8000008748032 4.725 4.725 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 GLCM 1 0 GBA GC GLUC GLCM_HUMAN 5.65000410073714 4.725 4.725 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 GLP1R 1 0 GLP1R GLP1R_HUMAN 6.29998893767789 4.725 4.70625 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 PPARD 2 0 PPARD NR1C2 PPARB PPARD_HUMAN 4.88504800003824 4.725 4.725 2 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 GEMI 2 0 GMNN GEMI_HUMAN 5.13621199052065 4.725 4.725 2 Geminin 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CAH7 1 0 CA7 CAH7_HUMAN 6.43 4.725 4.70625 1 Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CP2CJ 1 0 CYP2C19 CP2CJ_HUMAN 5.1 4.725 4.725 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 FRIL 1 0 FTL FRIL_HORSE 4.5 4.725 4.725 1 Ferritin light chain (Ferritin L subunit) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CAH2 1 0 CA2 CAH2_HUMAN 5 4.725 4.725 1 Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II), Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase II) (CA-II) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 MRP2 1 0 ABCC2 CMOAT CMOAT1 CMRP MRP2 MRP2_HUMAN 5.72015930340596 4.725 4.725 1 Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2), Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CAH1 1 0 CA1 CAH1_HUMAN 5 4.725 4.725 1 Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 PIM1 2 0 PIM1 PIM1_HUMAN 5.47477369411547 4.725 4.725 2 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 LOX12 1 0 ALOX12 12LO LOG12 LOX12_HUMAN 4.8 4.725 4.725 1 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.725 4.725 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 Q965D7 1 0 fabZ Q965D7_PLAFA 5.1 4.725 4.725 1 Beta-hydroxyacyl-ACP dehydratase (Fatty acid synthesis protein) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CAH4 1 0 CA4 CAH4_HUMAN 5.15 4.725 4.725 1 Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 CP2D6 1 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.5 4.725 4.725 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 STAT1 1 0 STAT1 STAT1_HUMAN 5.68613277963085 4.725 4.725 1 Signal transducer and activator of transcription 1, Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.725 4.725 4.725 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 5.49999693194831 4.725 4.725 1 TAR DNA-binding protein 43 (TDP-43) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.725 4.725 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 LUCI 1 0 LUCI_PHOPY 5.22098102808513 4.725 4.725 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 220354 NPC1 1 0 NPC1 NPC1_HUMAN 5.65 4.725 4.725 1 Niemann-Pick C1 protein 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)cc(O)c3C2=O 222529 0 3 NotRecorded 4.62147942505301 4.9 4.875 3 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 MBNL1 1 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.65000022087346 4.9 4.16666666666667 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.78638928471529 4.9 4.9 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.85 4.9 4.9 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 9.15490195998574 4.9 5.3125 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 NPC1 0 1 NPC1 NPC1_HUMAN 6.15 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 222529 Q962Y6 0 1 TGR Q962Y6_SCHMA 4.65 4.9 4.9 1 Thioredoxin glutathione reductase (EC 1.6.4.5) 1 4.9 actual molregno [molregno] COC1=CC=Cc2cc(OC)c(OC)c(OC)c2C1=O 229384 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 5.22098102808513 6.95 6.95 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.95 6.95 6.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 0 12 Nonstructural protein 1, NotRecorded 4.81900855028061 6.95 6.95 12 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.88333333333333 6.95 6.95 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.85 6.95 6.95 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 OPRK 0 2 OPRK1 OPRK OPRK_HUMAN 4.76796597782486 6.95 6.95 2 Kappa-type opioid receptor (K-OR-1) (KOR-1), Kappa-type opioid receptor (K-OR-1) (KOR-1) (MSL-1) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.68621289959511 6.95 6.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 5.19999817218203 6.95 6.95 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 CYSP 0 1 CYSP_TRYCR 5.5 6.95 6.95 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.5 6.95 6.95 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.53621298582672 6.95 6.95 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.94999940171424 6.95 6.95 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 229384 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.93621268968233 6.95 6.95 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 6.95 actual molregno [molregno] Nc1ccc(cc1)C2(c3ccc(N)cc3)c4ccccc4c5ccccc25 235325 NPC1 0 2 NPC1 NPC1_HUMAN 5.55 4.85 4.8628125 2 Niemann-Pick C1 protein 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 ATAD5 0 3 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.71966417093679 4.85 4.85 3 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.84999924507786 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 6.45001638884031 4.85 4.89208333333333 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 GLCM 0 2 GBA GC GLUC GLCM_HUMAN 4.67500066324611 4.85 4.85 2 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 LUCI 0 2 LUCI_PHOPY 4.89598281250847 4.85 4.85 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 RAB9A 0 2 RAB9A RAB9 RAB9A_HUMAN 5.425 4.85 4.8628125 2 Ras-related protein Rab-9A 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 235325 FLT3 0 1 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.5 4.85 4.84 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.85 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccn2 240652 1 24 NotRecorded 5.30416529207593 4.9 4.86905 25 0.96 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.64310686235906 4.9 4.9 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.09999903484653 4.9 4.9 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 LOX5 0 1 Alox5 LOX5_RAT 5 4.9 4.9 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93639101807974 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.75 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.94999940171424 4.9 4.9 1 TAR DNA-binding protein 43 (TDP-43) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.75 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 4.9 4.9 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 4.9 4.9 1 Geminin 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 5.69999179744619 4.9 4.90625 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 LUCI 0 1 LUCI_PHOPY 5.62098471330652 4.9 4.90625 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 240652 GLP1R 0 1 GLP1R GLP1R_HUMAN 5 4.9 4.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.9 actual molregno [molregno] COc1ccc(\C=C\C(=O)c2ccccc2)c(OC)c1 245279 27 0 GABA-A receptor; anion channel, NotRecorded 5.09405726961949 4.65 4.60201388888889 27 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRA3 21 0 GABRA3, Gabra3 Gabra-3 GBRA3_BOVIN, GBRA3_MOUSE 5.78671128755152 4.65 4.64910714285714 21 Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRG2 21 0 GABRG2, Gabrg2 GBRG2_BOVIN, GBRG2_MOUSE 5.78671128755152 4.65 4.64910714285714 21 Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRT 15 0 Gabrq GBRT_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRA2 21 0 GABRA2, Gabra2 Gabra-2 GBRA2_BOVIN, GBRA2_MOUSE 5.78671128755152 4.65 4.64910714285714 21 Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRA6 15 0 Gabra6 Gabra-6 GBRA6_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRG1 15 0 Gabrg1 GBRG1_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRB1 21 0 GABRB1, Gabrb1 GBRB1_BOVIN, GBRB1_MOUSE 5.78671128755152 4.65 4.64910714285714 21 Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRA4 21 0 GABRA4, Gabra4 GBRA4_BOVIN, GBRA4_MOUSE 5.78671128755152 4.65 4.64910714285714 21 Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRP 15 0 Gabrp GBRP_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRD 15 0 Gabrd GBRD_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRG3 15 0 Gabrg3 GBRG3_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRB3 15 0 Gabrb3 Gabrb-3 GBRB3_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRA1 21 0 GABRA1, Gabra1 Gabra-1 GBRA1_BOVIN, GBRA1_MOUSE 5.78671128755152 4.65 4.64910714285714 21 Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 GBRA5 15 0 Gabra5 GBRA5_MOUSE 5.08539580257213 4.65 4.65 15 Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 6.8 4.65 4.715 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 FRIL 1 0 FTL FRIL_HORSE 4.85 4.65 4.65 1 Ferritin light chain (Ferritin L subunit) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.65 4.65 4.65 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 LUCI 1 0 LUCI_PHOPY 4.6 4.65 4.65 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 TAU 3 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.83333333333333 4.65 4.65 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.55005901122666 4.65 4.681875 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 AL1A1 3 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.63333333333333 4.65 4.65 3 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.6 4.65 4.65 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 CYSP 1 0 CYSP_TRYCR 4.6 4.65 4.65 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.65 4.65 4.65 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 CP2CJ 2 0 CYP2C19 CP2CJ_HUMAN 5.3 4.65 4.65 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 CP2C9 2 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.1 4.65 4.65 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 POLK 1 0 POLK DINB1 POLK_HUMAN 5.29999760285775 4.65 4.65 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 245279 UBP1 1 0 USP1 UBP1_HUMAN 5.45000414846935 4.65 4.65 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 0 4.65 actual molregno [molregno] CCCCOC(=O)c1cc2c(c[nH]1)nc3ccccc23 247562 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.4 4.5 4.5 1 Ras-related protein Rab-9A 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.8 4.5 4.5 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 6.2500319164906 4.5 4.5875 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 NFKB1 5 0 NFKB1 NFKB1_HUMAN 5.39 4.5 4.75 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 TF65 5 0 RELA NFKB3 TF65_HUMAN 5.39 4.5 4.75 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 NFKB2 5 0 NFKB2 LYT10 NFKB2_HUMAN 5.39 4.5 4.75 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.68621209154108 4.5 4.56 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5 4.5 4.5 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 LUCI 3 1 LUCI_PHOPY 5.35439059301859 4.5 4.6359375 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0.25 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 GLP1R 2 0 GLP1R GLP1R_HUMAN 4.50000046405718 4.5 4.5 2 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 P53 3 0 TP53 P53 P53_HUMAN 4.7333333761114 4.5 4.5 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.49999693194831 4.5 4.760625 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.836212690038 4.5 4.5 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 4.94999940171424 4.5 4.5 1 TAR DNA-binding protein 43 (TDP-43) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 Q57TT1 1 0 Tb927.8.6820 Q57TT1_TRYB2 4.55000045168903 4.5 4.5 1 Uncharacterized protein 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.8 4.5 4.5 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 247562 SYUA 1 0 SNCA NACP PARK1 SYUA_HUMAN 4.65000022087346 4.5 4.5 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.5 actual molregno [molregno] Oc1cccc(c1)c2nc3ccccc3s2 246716 13 1 NotRecorded 5.13936250077602 4.8 4.75145833333333 14 0.0714285714285714 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LOX15 2 0 ALOX15 LOG15 LOX15_HUMAN 5.26941209342213 4.8 4.8 2 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 WRN 2 0 WRN RECQ3 RECQL2 WRN_HUMAN 4.75855236204039 4.8 4.8 2 Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 APEX1 1 0 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.59999938302362 4.8 4.8 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LOX12 2 0 ALOX12 12LO LOG12 LOX12_HUMAN 5.25773369225288 4.8 4.8 2 Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12), Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12) (P-12LO) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 PPBT 2 0 ALPL PPBT_HUMAN 4.835 4.8 4.44583333333333 2 Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase 2) (Alkaline phosphatase liver/bone/kidney isozyme), Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.74999985591871 4.8 4.8 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LYAG 1 0 GAA LYAG_HUMAN 5 4.8 4.8 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 BLM 1 0 BLM RECQ2 RECQL3 BLM_HUMAN 4.71710384927758 4.8 4.8 1 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 Q8IL11 1 0 LAP PF14_0439 PF3D7_1446200 Q8IL11_PLAF7 5.08 4.8 4.8 1 M17 leucyl aminopeptidase (EC 3.4.11.1) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LX15B 1 0 ALOX15B LX15B_HUMAN 4.8000008748032 4.8 4.8 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 RECQ1 2 0 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.52499980173157 4.8 4.8 2 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 HS90B 2 0 HSP90AB1 HSP90B HSPC2 HSPCB HS90B_HUMAN 5.11 4.8 4.8 2 Heat shock protein HSP 90-beta, Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 HS90A 2 0 HSP90AA1 HSP90A HSPC1 HSPCA HS90A_HUMAN 5.11 4.8 4.8 2 Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38), Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Tumor-specific transplantation 86 kDa antigen) (TSTA) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 DPOLB 3 0 POLB DPOLB_HUMAN 4.63333302056023 4.8 4.8 3 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 O97447 1 0 ald O97447_GIAIN 5.05 4.8 4.8 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 4.74999985591871 4.8 4.8 1 TAR DNA-binding protein 43 (TDP-43) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.6 4.8 4.8 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LUCI 1 0 LUCI_PHOPY 4.57098292927852 4.8 4.8 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.45 4.8 4.8 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.9 4.8 4.8 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.8 4.8 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 LT 2 0 LT_SV40 4.56016539718398 4.8 4.8 2 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 NR4A1 1 0 NR4A1 GFRP1 HMR NAK1 NR4A1_HUMAN 4.5 4.8 3.4 1 Nuclear receptor subfamily 4 group A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77) (Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 6.15 4.8 4.8 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 POLK 1 0 POLK DINB1 POLK_HUMAN 4.59999938302362 4.8 4.8 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.09999903484653 4.8 4.8 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 TAU 1 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.5 4.8 3.4 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 246716 POLI 1 0 POLI RAD30B POLI_HUMAN 4.74999985591871 4.8 4.8 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 0 4.8 actual molregno [molregno] Oc1ccc(cc1O)C(=O)CSc2nnc([nH]2)c3ccccc3 250703 14 0 NotRecorded 4.56521947300462 4.7 4.7 14 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.7 4.7 4.7 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 LUCI 1 0 LUCI_PHOPY 4.77098149412752 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 VDR 1 0 VDR NR1I1 VDR_HUMAN 4.65000022087346 4.7 4.7 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 4.7 4.7 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 4.85 4.7 4.7 4 Menin 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 4.7 4.7 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.15 4.7 4.7 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.73621347282809 4.7 4.7 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.14999741390754 4.7 4.7 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 TNR1A 1 0 TNFRSF1A TNFAR TNFR1 TNR1A_HUMAN 5.47 4.7 4.7 1 Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)] 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.7 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 GEMI 2 0 GMNN GEMI_HUMAN 4.63621273654598 4.7 4.7 2 Geminin 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 KDM4A 3 0 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.59999938302362 4.7 4.7 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 4.84999924507786 4.7 4.7 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 POLH 1 0 POLH RAD30 RAD30A XPV POLH_HUMAN 4.59999938302362 4.7 4.7 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.05 4.7 4.7 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 GLP1R 1 0 GLP1R GLP1R_HUMAN 4.55000045168903 4.7 4.7 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 NPC1 1 0 NPC1 NPC1_HUMAN 5.45 4.7 4.7 1 Niemann-Pick C1 protein 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 PLK1 1 0 PLK1 PLK PLK1_HUMAN 6.27384353382724 4.7 4.7 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.73621248726524 4.7 4.7 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 250703 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 5.5 4.7 4.7 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.7 actual molregno [molregno] CCN1C(=O)C(=Cc2ccc(C)s2)C(=O)N(CC)C1=S 705711 0 25 NotRecorded 4.85539697029641 9.04575749056067 9.04575749056067 25 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 9.04575749056067 9.04575749056067 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.85 9.04575749056067 9.04575749056067 4 Menin 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.65 9.04575749056067 9.04575749056067 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.51178795875555 9.04575749056067 9.04575749056067 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 TRXR1 0 3 Txnrd1 Trxr1 TRXR1_RAT 4.68254756474321 9.04575749056067 9.04575749056067 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 SYUA 0 2 SNCA NACP PARK1 SYUA_HUMAN 4.71810713346726 9.04575749056067 9.04575749056067 2 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 END4 0 1 nfo b2159 JW2146 END4_ECOLI 5.45 9.04575749056067 9.04575749056067 1 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 9.04575749056067 9.04575749056067 9.04575749056067 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 GEMI 0 1 GMNN GEMI_HUMAN 4.95 9.04575749056067 9.04575749056067 1 Geminin 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5 9.04575749056067 9.04575749056067 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.94999940171424 9.04575749056067 9.04575749056067 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 705711 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.9 9.04575749056067 9.04575749056067 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 9.04575749056067 actual molregno [molregno] CCCC[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 261920 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.05 6.65 6.65 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 6.65 actual molregno [molregno] OC(=O)c1cnc2cc(OCc3ccccc3)ccc2c1O 261920 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.5 6.65 6.65 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 6.65 actual molregno [molregno] OC(=O)c1cnc2cc(OCc3ccccc3)ccc2c1O 261920 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.65 6.65 6.65 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.65 actual molregno [molregno] OC(=O)c1cnc2cc(OCc3ccccc3)ccc2c1O 674274 0 44 NotRecorded 4.7817491004832 5.25 5.25 44 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADA2C 0 30 ADRA2C ADRA2L2 ADRA2RL2, Adra2c ADA2C_HUMAN, ADA2C_RAT 6.8808469307632 5.25 5.25 30 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADA2A 0 30 ADRA2A ADRA2R ADRAR, Adra2a ADA2A_HUMAN, ADA2A_RAT 6.8808469307632 5.25 5.25 30 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor), Alpha-2A adrenergic receptor (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) (Alpha-2D adrenergic receptor) (CA2-47) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADA1B 0 30 ADRA1B, Adra1b ADA1B_HUMAN, ADA1B_RAT 6.8808469307632 5.25 5.25 30 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADA1A 0 30 ADRA1A ADRA1C, Adra1a Adra1c ADA1A_HUMAN, ADA1A_RAT 6.8808469307632 5.25 5.25 30 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor), Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADA1D 0 30 ADRA1D ADRA1A, Adra1d Adra1a ADA1D_HUMAN, ADA1D_RAT 6.8808469307632 5.25 5.25 30 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor), Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a), Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (RA42) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADA2B 0 30 ADRA2B ADRA2L1 ADRA2RL1, Adra2b ADA2B_HUMAN, ADA2B_RAT 6.8808469307632 5.25 5.25 30 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR), Alpha-2B adrenergic receptor (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 6.16171303427447 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 KDM4E 0 3 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.25 5.25 3 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.25 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADRB3 0 6 ADRB3 ADRB3R B3AR ADRB3_HUMAN 8.205 5.25 5.25 6 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADRB1 0 7 ADRB1 ADRB1R B1AR ADRB1_HUMAN 7.86060543861102 5.25 5.25 7 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ADRB2 0 7 ADRB2, ADRB2 ADRB2R B2AR ADRB2_CANLF, ADRB2_HUMAN 7.86060543861102 5.25 5.25 7 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 NFKB1 0 2 NFKB1 NFKB1_HUMAN 5.86005797693002 5.25 5.25 2 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 LYAG 0 2 GAA LYAG_HUMAN 5.75 5.25 5.25 2 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 4.8000008748032 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 6.4 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 RCE1 0 1 RCE1 YMR274C YM8156.16C RCE1_YEAST 4.82 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 CAAX prenyl protease 2 (EC 3.4.22.-) (Prenyl protein-specific endoprotease 2) (PPSEP 2) (Ras and A-factor-converting enzyme) (RACE) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 STE24 0 1 STE24 AFC1 YJR117W J2032 STE24_YEAST 5.11 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 CAAX prenyl protease 1 (EC 3.4.24.84) (A-factor-converting enzyme) (Prenyl protein-specific endoprotease 1) (PPSEP 1) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.01374345640117 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 674274 ANDR 0 1 AR DHTR NR3C4 ANDR_HUMAN 4.66004995296398 5.25 5.25 1 LABETALOL HYDROCHLORIDE PREECLAMPSIA Adrenergic receptor antagonist ANTAGONIST 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.25 actual drug [drugName] Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 268289 NPC1 0 1 NPC1 NPC1_HUMAN 5.65 5.45 5.45 1 Niemann-Pick C1 protein 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.56121381288735 5.45 5.45 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 NFKB1 0 5 NFKB1 NFKB1_HUMAN 5.78 5.45 5.45 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 TF65 0 5 RELA NFKB3 TF65_HUMAN 5.78 5.45 5.45 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 5.78 5.45 5.45 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.7 5.45 5.45 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 LUCI 0 1 LUCI_PHOPY 5.47098052029176 5.45 5.45 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.85 5.45 5.45 1 Ras-related protein Rab-9A 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 P53 0 1 TP53 P53 P53_HUMAN 5 5.45 5.45 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 SENP7 0 1 SENP7 KIAA1707 SSP2 SUSP2 SENP7_HUMAN 5.07 5.45 5.45 1 Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 CASP3 0 1 CASP3 CPP32 CASP3_HUMAN 4.76 5.45 5.45 1 Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.29999760285775 5.45 5.45 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.23619777592541 5.45 5.45 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.69999179744619 5.45 5.45 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 SENP6 0 1 SENP6 KIAA0797 SSP1 SUSP1 FKSG6 SENP6_HUMAN 4.55 5.45 5.45 1 Sentrin-specific protease 6 (EC 3.4.22.-) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 268289 SENP8 0 1 SENP8 DEN1 NEDP1 PRSC2 FKSG8 SENP8_HUMAN 4.62 5.45 5.45 1 Sentrin-specific protease 8 (EC 3.4.22.-) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8) 1 5.45 actual molregno [molregno] Nc1ccc(cc1)c2nc3cc(ccc3[nH]2)[N+](=O)[O-] 273921 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.05 5.5 5.5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.525 5.5 5.5 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 5.46210828573557 5.5 5.5 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 5.35000349253396 5.5 5.5 1 TAR DNA-binding protein 43 (TDP-43) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 LUCI 0 4 LUCI_PHOPY 5.59603798597017 5.5 5.5 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 SENP7 0 1 SENP7 KIAA1707 SSP2 SUSP2 SENP7_HUMAN 5.27 5.5 5.5 1 Sentrin-specific protease 7 (EC 3.4.22.-) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.31121320246735 5.5 5.5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 RAB9A 0 2 RAB9A RAB9 RAB9A_HUMAN 6.2 5.5 5.5 2 Ras-related protein Rab-9A 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 KMT2A 0 12 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.51666666666667 5.5 5.5 12 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 MEN1 0 12 MEN1 SCG2 MEN1_HUMAN 4.51666666666667 5.5 5.5 12 Menin 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.2 5.5 5.5075 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 5.74844187546804 5.5 5.5 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 PGH1 0 1 PTGS1 COX1 PGH1_HUMAN 5.53 5.5 5.5 1 Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 HD 0 1 HTT HD IT15 HD_HUMAN 5.8 5.5 5.5 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.25000102344165 5.5 5.5 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 SC6A2 0 2 SLC6A2 NAT1 NET1 SLC6A5 SC6A2_HUMAN 5.6 5.5 5.5 2 Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.5 5.5 5.3875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 LYAG 0 1 GAA LYAG_HUMAN 5.85 5.5 5.5 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 NPC1 0 2 NPC1 NPC1_HUMAN 6.2 5.5 5.5 2 Niemann-Pick C1 protein 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 CASP3 0 1 CASP3 CPP32 CASP3_HUMAN 4.71 5.5 5.5 1 Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 STAT1 0 1 STAT1 STAT1_HUMAN 6.38 5.5 5.5 1 Signal transducer and activator of transcription 1, Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 6.19997064075587 5.5 5.5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 273921 DPOLB 0 1 POLB DPOLB_HUMAN 4.6 5.5 5.5 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 5.5 actual molregno [molregno] CC(C)Oc1ccc2C(=O)C(=COc2c1)c3ccccc3 552462 2 8 NotRecorded 4.775 4.95 4.8575 10 0.8 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCD1 0 22 PRKD1 PKD PKD1 PRKCM KPCD1_HUMAN 5.22 4.95 4.95 22 Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCI 0 22 PRKCI DXS1179E KPCI_HUMAN 5.22 4.95 4.95 22 Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCL 0 22 PRKCH PKCL PRKCL KPCL_HUMAN 5.22 4.95 4.95 22 Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCB 0 22 PRKCB PKCB PRKCB1 KPCB_HUMAN 5.22 4.95 4.95 22 Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCG 0 22 PRKCG PKCG KPCG_HUMAN 5.22 4.95 4.95 22 Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCD 0 22 PRKCD KPCD_HUMAN 5.22 4.95 4.95 22 Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)], Protein kinase C delta type (EC 2.7.11.13) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)] 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCA 0 22 PRKCA PKCA PRKACA KPCA_HUMAN 5.22 4.95 4.95 22 Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCD3 0 22 PRKD3 EPK2 PRKCN KPCD3_HUMAN 5.22 4.95 4.95 22 Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCE 0 22 PRKCE PKCE KPCE_HUMAN 5.22 4.95 4.95 22 Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCT 0 22 PRKCQ PRKCT KPCT_HUMAN 5.22 4.95 4.95 22 Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KPCZ 0 22 PRKCZ PKC2 KPCZ_HUMAN 5.22 4.95 4.95 22 Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KAPCG 3 3 PRKACG KAPCG_HUMAN 5.49 4.95 4.72875 6 cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11) 0.5 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KAPCA 3 3 PRKACA PKACA KAPCA_HUMAN 5.49 4.95 4.72875 6 cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11) 0.5 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KAPCB 3 3 PRKACB KAPCB_HUMAN 5.49 4.95 4.72875 6 cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11) 0.5 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.57847222222222 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 MPP8 1 0 MPHOSPH8 MPP8 MPP8_HUMAN 6.10001543745061 4.95 4.18472222222222 1 M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) 0 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 KCNH2 0 1 KCNH2 ERG ERG1 HERG KCNH2_HUMAN 5.45000414846935 4.95 4.92222222222222 1 Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (DERG) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (c-ERG) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (RERG) (ra-erg) (Voltage-gated potassium channel subunit Kv11.1), Potassium voltage-gated channel subfamily H member 2 (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (gp-erg) (Voltage-gated potassium channel subunit Kv11.1) (Fragment) 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 552462 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 4.65 4.95 4.84930555555556 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.95 actual molregno [molregno] Cl.Cl.CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 282288 MK14 0 1 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.05217801166507 4.925 4.925 1 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 P53 0 2 TP53 P53 P53_HUMAN 5.15 4.925 4.925 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 HYEP 0 1 EPHX1 EPHX EPOX HYEP_HUMAN 5.92 4.925 5.00625 1 Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 2 42 NotRecorded 4.97864948145095 4.925 4.90582386363636 44 0.954545454545455 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.55000045168903 4.925 4.925 1 Uncharacterized protein 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 KSYK 1 1 SYK KSYK_HUMAN 4.50301598238496 4.925 4.81640625 2 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 0.5 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 EPHB 1 0 MT1988 EPHB_MYCTO 7.72 4.925 4.4555 1 Epoxide hydrolase B (EHB) (EC 3.3.2.10) 0 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 ANDR 0 2 AR DHTR NR3C4 ANDR_HUMAN 5.00599080499613 4.925 4.925 2 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.925 4.925 4.91875 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 AURKB 0 1 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 4.63202321470541 4.925 4.925 1 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 CDK9 0 2 CDK9 CDC2L4 TAK CDK9_HUMAN 5.4 4.925 4.925 2 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.32506541186105 4.925 4.89375 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 UBP1 1 0 USP1 UBP1_HUMAN 5.90000876645532 4.925 4.7078125 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 0 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 Q94696 0 1 luc Q94696_PHOPE 4.95 4.925 4.925 1 Luciferase 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.8000008748032 4.925 4.925 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.81274678299481 4.925 4.925 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 RORG 0 2 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.76252455554219 4.925 4.965625 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 GEMI 0 1 GMNN GEMI_HUMAN 6.1362014613195 4.925 5.00625 1 Geminin 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 HYES 0 2 EPHX2 HYES_HUMAN 6.405 4.925 5.00625 2 Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)] 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 AHR 0 1 AHR BHLHE76 AHR_HUMAN 4.89999841719865 4.925 4.925 1 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 FAK1 0 1 PTK2 FAK FAK1 FAK1_HUMAN 4.63202321470541 4.925 4.925 1 Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK), Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (p41/p43FRNK) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282288 CLK4 0 2 CLK4 CLK4_HUMAN 5.1 4.925 4.925 2 Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) 1 4.925 actual molregno [molregno] O=C(Nc1ccccc1)Nc2ccccc2 282571 0 8 NotRecorded 4.53366198029119 4.9 4.9003125 8 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 282571 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68639005935126 4.9 4.853125 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 282571 KMT2A 0 3 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.5 4.9 4.853125 3 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 282571 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.7862167006647 4.9 4.9625 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 282571 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.853125 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 282571 LUCI 0 1 LUCI_PHOPY 4.77098149412752 4.9 4.853125 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 282571 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 4.65 4.9 4.853125 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.9 actual molregno [molregno] Cc1cccc(NC(=O)Nc2ccncc2)c1 284398 1 10 NotRecorded 5.13908661870868 4.95 4.96717803030303 11 0.909090909090909 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.48639065599167 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 PFKA 0 1 pfk PFKA_TRYBB 4.62098289875995 4.95 4.9375 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.49999693194831 4.95 4.9375 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.84999924507786 4.95 4.95 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 LUCI 0 1 LUCI_PHOPY 5.47098052029176 4.95 4.9375 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 CP2B1 0 1 Cyp2b1 Cyp2b-1 CP2B1_RAT 4.6 4.95 4.95 1 Cytochrome P450 2B1 (EC 1.14.14.1) (CYPIIB1) (Cytochrome P450-B) (Cytochrome P450b) (Cytochrome P450-LM2) (Cytochrome P450-PB1) (Cytochrome P450-PB2) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 NPC1 0 1 NPC1 NPC1_HUMAN 5.7 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.95 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.08623911358768 4.95 4.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284398 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.3 4.95 4.9375 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] Clc1ccc(OCc2nc3ccccc3[nH]2)cc1 284823 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.03621217265444 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.49999693194831 4.9 4.90625 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 P53 0 3 TP53 P53 P53_HUMAN 4.86666666666667 4.9 4.9 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.54999736982681 4.9 4.98125 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 NPC1 0 1 NPC1 NPC1_HUMAN 5.55 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 LUCI 0 2 LUCI_PHOPY 4.76049082246353 4.9 4.9 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 5.2 4.9 4.9 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.18621225375977 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 284823 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.4 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3[nH]2 285437 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 DYR1A 0 1 Dyrk1a Dyrk DYR1A_RAT 4.61 4.95 4.95 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.45 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.89999841719865 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.65 4.95 4.8625 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 0 4 NotRecorded 4.73521469210289 4.95 4.93875 4 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 HD 0 1 HTT HD IT15 HD_HUMAN 4.8 4.95 4.95 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 CP2B1 0 1 Cyp2b1 Cyp2b-1 CP2B1_RAT 4.7 4.95 4.8625 1 Cytochrome P450 2B1 (EC 1.14.14.1) (CYPIIB1) (Cytochrome P450-B) (Cytochrome P450b) (Cytochrome P450-LM2) (Cytochrome P450-PB1) (Cytochrome P450-PB2) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 285437 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.39999691337226 4.95 4.9475 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.95 actual molregno [molregno] O=C(c1ccccc1)c2ccc3[nH]cnc3c2 284153 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.38621101521651 5.45 5.45 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 0 10 NotRecorded 4.89581299064867 5.45 5.319875 10 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 LUCI 0 1 LUCI_PHOPY 5.87098720687396 5.45 5.45 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 4.55 5.45 5.46666666666667 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 4.55000045168903 5.45 5.45 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.83622020841383 5.45 5.45 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.8000008748032 5.45 5.45 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7 5.45 5.45 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 NPC1 0 1 NPC1 NPC1_HUMAN 5.85 5.45 5.45 1 Niemann-Pick C1 protein 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.45 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.90000876645532 5.45 5.45 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 284153 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.2 5.45 5.345 1 Ras-related protein Rab-9A 1 5.45 actual molregno [molregno] Cc1ccc(OCc2nc3ccccc3[nH]2)cc1 286896 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.67344434626893 4.85 4.85 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.85 actual molregno [molregno] C=CCSCC=C 286896 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.35993623990624 4.85 4.85 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.85 actual molregno [molregno] C=CCSCC=C 286896 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] C=CCSCC=C 292308 2 5 Nonstructural protein 1, NotRecorded 4.61817371276561 4.6 5.07232142857143 7 0.714285714285714 4.6 actual molregno [molregno] CC(C)(C)c1ccc(OCC(=O)O)cc1 292308 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.85001154350852 4.6 4.85625 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.6 actual molregno [molregno] CC(C)(C)c1ccc(OCC(=O)O)cc1 292308 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5 4.6 5.00625 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.6 actual molregno [molregno] CC(C)(C)c1ccc(OCC(=O)O)cc1 292308 LUCI 0 2 LUCI_PHOPY 4.67098267640138 4.6 4.9625 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.6 actual molregno [molregno] CC(C)(C)c1ccc(OCC(=O)O)cc1 292308 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 5.34375 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.6 actual molregno [molregno] CC(C)(C)c1ccc(OCC(=O)O)cc1 296487 GRM1 1 5 GRM1 GPRC1A MGLUR1, Grm1 Gprc1a Mglur1 GRM1_HUMAN, GRM1_RAT 8.415 4.9 4.77916666666667 6 Metabotropic glutamate receptor 1 (mGluR1) 0.833333333333333 4.9 actual molregno [molregno] CO[C@@H]1CC[C@@H](CC1)C(=O)c2ccc3nc4OCCCc4cc3c2 296487 0 2 NotRecorded 7.125 4.9 4.9025 2 1 4.9 actual molregno [molregno] CO[C@@H]1CC[C@@H](CC1)C(=O)c2ccc3nc4OCCCc4cc3c2 296487 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] CO[C@@H]1CC[C@@H](CC1)C(=O)c2ccc3nc4OCCCc4cc3c2 296487 P53 0 1 TP53 P53 P53_HUMAN 5 4.9 4.9 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] CO[C@@H]1CC[C@@H](CC1)C(=O)c2ccc3nc4OCCCc4cc3c2 311345 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.9 4.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.5 4.9 4.9 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.65 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.9 4.9 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 4.9 4.9 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 CASP7 0 1 CASP7 MCH3 CASP7_HUMAN 4.6 4.9 4.9 1 Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 AGAL 0 2 GLA AGAL_HUMAN 4.50000022584451 4.9 4.9 2 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 AOFA 0 1 MAOA AOFA_HUMAN 6.08 4.9 4.9 1 Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.59999938302362 4.9 4.9 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 CASP1 0 1 CASP1 IL1BC IL1BCE CASP1_HUMAN 4.6 4.9 4.9 1 Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311345 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] O=C1c2ccccc2Oc3ccccc13 311462 PGDH 1 0 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 4.6 4.6 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 P53 2 0 TP53 P53 P53_HUMAN 5.05 4.6 4.6 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.49999693194831 4.6 4.69375 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 GLP1R 1 0 GLP1R GLP1R_HUMAN 4.55000045168903 4.6 4.6 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.625 4.6 4.6 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 GEMI 2 0 GMNN GEMI_HUMAN 4.53621298582672 4.6 4.6 2 Geminin 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 KDM4E 1 0 KDM4E KDM4DL KDM4E_HUMAN 4.6 4.6 4.6 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 KMT2A 4 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 4.6 4.6 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 MEN1 4 0 MEN1 SCG2 MEN1_HUMAN 4.85 4.6 4.6 4 Menin 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 UBP2 1 0 USP2 UBP41 UBP2_HUMAN 4.6 4.6 4.6 1 Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.6 4.6 4.6 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 IDHC 1 0 IDH1 PICD IDHC_HUMAN 4.53621298582672 4.6 4.6 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 SYUA 1 0 SNCA NACP PARK1 SYUA_HUMAN 4.55000045168903 4.6 4.6 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 SO1B3 1 0 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.03204206409997 4.6 4.5925 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.45000414846935 4.6 4.6 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311462 HCD2 1 0 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.7 4.6 4.6 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 0 4.6 actual molregno [molregno] COc1cc(O)cc(\C=C\c2ccccc2)c1 311570 CCNE1 1 1 CCNE1 CCNE CCNE1_HUMAN 7.01 4.75 4.62604166666666 2 G1/S-specific cyclin-E1 0.5 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 311570 CDK2 1 1 CDK2 CDKN2 CDK2_HUMAN 7.01 4.75 4.62604166666666 2 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 0.5 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 311570 FRIL 1 0 FTL FRIL_HORSE 4.55 4.75 4.75 1 Ferritin light chain (Ferritin L subunit) 0 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 311570 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.75 4.75 4.75 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 311570 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.94999940171424 4.75 4.75 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 311570 3 0 NotRecorded 4.8574753489244 4.75 4.0625 3 0 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 311570 CDK5 1 0 CDK5 CDKN5 CDK5_HUMAN 7.19 4.75 4.04375 1 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.75 actual molregno [molregno] CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 378218 349 0 Cerebroside-sulfatase, Nonstructural protein 1, NotRecorded 5.59278739736285 4.5 4.50014326647565 349 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 GEMI 7 0 GMNN GEMI_HUMAN 6.30555751962182 4.5 4.5 7 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Geminin 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 RAB9A 2 0 RAB9A RAB9 RAB9A_HUMAN 7.05 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Ras-related protein Rab-9A 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 FGFR1 1 0 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 4.88 4.5 4.525 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 PMP22 3 0 PMP22 GAS3, Pmp22 Cd25 Pmp-22 PMP22_HUMAN, PMP22_RAT 5.60417141494534 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 AL1A1 3 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.8 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 KMT2A 16 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.2 4.5 4.5 16 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 MEN1 16 0 MEN1 SCG2 MEN1_HUMAN 5.2 4.5 4.5 16 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Menin 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 LMNA 5 0 LMNA LMN1 LMNA_HUMAN 6.08 4.5 4.5 5 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 KIT 1 0 KIT SCFR KIT_HUMAN 4.56 4.5 4.525 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117), Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (CD antigen CD117) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 FRIL 1 0 FTL FRIL_HORSE 4.55 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Ferritin light chain (Ferritin L subunit) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 SRC 2 0 SRC SRC1 SRC_HUMAN 4.99 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 PPARD 6 0 PPARD NR1C2 PPARB PPARD_HUMAN 5.65713743259535 4.5 4.5 6 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 TSHR 14 0 TSHR LGR3 TSHR_HUMAN 5.58756002486559 4.5 4.5 14 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 VGFR2 1 0 KDR FLK1 VEGFR2 VGFR2_HUMAN 4.64 4.5 4.525 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase NYK) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309), Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1b) (FLK-1b) (Kinase insert domain receptor) (Kinase insert domain receptor-B) (Protein-tyrosine kinase receptor flk-1b) (Vascular endothelial growth factor receptor 2 homolog B) (VEGFR-2 homolog B) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 EGFR 1 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 4.98 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 LUCI 4 0 LUCI_PHOPY 6.17833576016018 4.5 4.5 4 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 LYN 1 0 LYN JTK8 LYN_HUMAN 4.62 4.5 4.525 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 RORG 6 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.525 4.5 4.5 6 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 LEF 2 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 6.45 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 P53 7 0 TP53 P53 P53_HUMAN 5.76428229906809 4.5 4.5 7 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 HIF1A 4 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5.65 4.5 4.5 4 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 NPC1 2 0 NPC1 NPC1_HUMAN 7.295 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Niemann-Pick C1 protein 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 8.27572413039921 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 ANDR 5 0 AR DHTR NR3C4 ANDR_HUMAN 6.57397174416051 4.5 4.5 5 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 TAU 4 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.225 4.5 4.5 4 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 STAT3 11 0 STAT3 APRF STAT3_HUMAN 4.87272727272727 4.5 4.5 11 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Signal transducer and activator of transcription 3, Signal transducer and activator of transcription 3 (Acute-phase response factor) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 HD 1 0 HTT HD IT15 HD_HUMAN 6.1 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 CYSP 1 0 CYSP_TRYCR 5.25 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 MTOR 2 0 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 5.805 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 SMN 3 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 RXRA 2 0 RXRA NR2B1 RXRA_HUMAN 5.9749908508001 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 NF2L2 3 0 NFE2L2 NRF2 NF2L2_HUMAN 5.50456524684559 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 EHMT2 2 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.29999798339742 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 CP2CJ 3 0 CYP2C19 CP2CJ_HUMAN 4.93333333333333 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 GRP78 1 0 HSPA5 GRP78 GRP78_HUMAN 5.73299263033565 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 DRD1 2 0 DRD1 DRD1_HUMAN 6.46813205058442 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 CP2C9 4 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.9 4.5 4.5 4 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 ACM1 2 0 Chrm1 Chrm-1 ACM1_RAT 6.945 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 ATAD5 3 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.34099019536196 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 END4 1 0 nfo b2159 JW2146 END4_ECOLI 4.95 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Endonuclease 4 (EC 3.1.21.2) (Endodeoxyribonuclease IV) (Endonuclease IV) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 HSPB1 2 0 HSPB1 HSP27 HSP28 HSPB1_HUMAN 6.14822210207649 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 ATX2 3 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5.80001218151731 4.5 4.5 3 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 NR1H4 2 0 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 6.20003527736759 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 LX15B 1 0 ALOX15B LX15B_HUMAN 6.79997073344623 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 JAK2 4 0 JAK2 JAK2_HUMAN 4.5 4.5 4.5 4 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 PTH1R 2 0 PTH1R PTHR PTHR1 PTH1R_HUMAN 6.11537453674377 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 5.69999179744619 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 CP1A2 2 0 CYP1A2 CP1A2_HUMAN 5.65 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 FZD1 1 0 FZD1 FZD1_HUMAN 5 4.5 4.25 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Frizzled-1 (Fz-1) (hFz1) (FzE1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 TPO 2 0 THPO MGDF TPO_HUMAN 7 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 BLM 2 0 BLM RECQ2 RECQL3 BLM_HUMAN 4.7 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 VDR 1 0 VDR NR1I1 VDR_HUMAN 5.69999179744619 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 GCR 1 0 NR3C1 GRL GCR_HUMAN 5.45000414846935 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 AHR 1 0 AHR BHLHE76 AHR_HUMAN 5.85001154350852 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 THB 1 0 THRB ERBA2 NR1A2 THR1 THB_HUMAN 5.85001154350852 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 6.04997609347667 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 TAR DNA-binding protein 43 (TDP-43) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 RGS4 1 0 RGS4 RGS4_HUMAN 4.77382299674291 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Regulator of G-protein signaling 4 (RGP4) (RGS4) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 FEN1 1 0 FEN1 RAD2 FEN1_HUMAN 5.37382393584527 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 SYUA 2 0 SNCA NACP PARK1 SYUA_HUMAN 6.14302678053271 4.5 4.5 2 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 IDHC 1 0 IDH1 PICD IDHC_HUMAN 6.43616308133546 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.7999981345934 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 378218 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 5.25 4.5 4.5 1 NICLOSAMIDE COLORECTAL ADENOCARCINOMA DNA inhibitor INHIBITOR 4 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.5 actual drug [drugName] Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 318595 SKN1 0 3 skn-1 T19E7.2 SKN1_CAEEL 4.87020540743826 4.9 4.9 3 Protein skinhead-1 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.05 4.9 4.9 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 4.65000022087346 4.9 4.9 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.36810805118947 4.9 4.885 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 NFKB1 0 5 NFKB1 NFKB1_HUMAN 5.64 4.9 4.9 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 TF65 0 5 RELA NFKB3 TF65_HUMAN 5.64 4.9 4.9 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 5.64 4.9 4.9 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 LUCI 0 3 LUCI_PHOPY 5.57366034269504 4.9 4.8975 3 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.21120834887567 4.9 4.8503125 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 PTH1R 0 2 PTH1R PTHR PTHR1 PTH1R_HUMAN 5.49999693194831 4.9 4.984375 2 Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.70000050388302 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.1 4.9 4.85 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 Q94696 0 1 luc Q94696_PHOPE 5 4.9 4.9 1 Luciferase 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.725 4.9 4.9 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 CASP3 0 3 CASP3 CPP32 CASP3_HUMAN 4.59862667244803 4.9 4.9 3 Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12], Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 P53 0 2 TP53 P53 P53_HUMAN 4.97499970085712 4.9 4.9 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.5 4.9 4.9 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 NPC1 0 1 NPC1 NPC1_HUMAN 5.55 4.9 4.83875 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 318595 GLP1R 0 1 GLP1R GLP1R_HUMAN 6.29998893767789 4.9 4.883125 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.9 actual molregno [molregno] Cc1ccc(cc1)c2noc(n2)c3cccs3 321183 3 30 NotRecorded 4.87770027382452 4.9 4.85606060606061 33 0.909090909090909 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.25 4.9 4.9 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.05 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 EST1 0 2 CES1 CES2 SES1 EST1_HUMAN, EST1_RABIT 4.995 4.9 4.9 2 Liver carboxylesterase (EC 3.1.1.1) (Proline-beta-naphthylamidase) (Retinyl ester hydrolase) (REH), Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (CE-1) (hCE-1) (EC 3.1.1.1) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH), Liver carboxylesterase 1 (EC 3.1.1.1) (Acyl-coenzyme A:cholesterol acyltransferase) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 TYDP1 0 1 TDP1 TYDP1_HUMAN 4.65 4.9 4.9 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.94999940171424 4.9 4.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 5 4.9 4.9 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.74126109291752 4.9 4.9 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 LIPS 0 1 Lipe LIPS_RAT 4.58982553491095 4.9 4.9 1 Hormone-sensitive lipase (HSL) (EC 3.1.1.79) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 4.9 4.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 ANDR 0 2 AR DHTR NR3C4 ANDR_HUMAN 4.55575083210199 4.9 4.9 2 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321183 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] O=C(CC(=O)c1ccccc1)c2ccccc2 321326 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.895 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 4.85 4.9 4.895 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 DYR1A 0 1 Dyrk1a Dyrk DYR1A_RAT 4.92 4.9 4.9225 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 6.89997426989214 4.9 4.9 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.65 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 MEX5 0 1 mex-5 W02A2.7 MEX5_CAEEL 4.62 4.9 4.9 1 Zinc finger protein mex-5 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 4.55000045168903 4.9 4.895 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321326 GEMI 0 1 GMNN GEMI_HUMAN 5.4362105089299 4.9 4.895 1 Geminin 1 4.9 actual molregno [molregno] COc1ccc(Nc2[nH]cnc3ncnc23)cc1OC 321806 LUCI 0 2 LUCI_PHOPY 4.78549083522676 4.95 4.94375 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5 4.95 4.95 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.36121573860683 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 P53 0 2 TP53 P53 P53_HUMAN 4.92499870695377 4.95 4.95 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 HYES 0 2 EPHX2, Ephx2 Eph2 HYES_HUMAN, HYES_MOUSE 7.01 4.95 4.9375 2 Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)] 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 HYEP 0 2 EPHX1 EPHX EPOX, Ephx1 HYEP_HUMAN, HYEP_MOUSE 7.01 4.95 4.9375 2 Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.25 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 4.5 4.95 4.95 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 NPC1 0 1 NPC1 NPC1_HUMAN 5.95 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 321806 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 6.19997064075587 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] O=C(NCCc1ccccc1)NC2CCCCC2 322518 1 5 NotRecorded 4.94806918548791 5.1 5.02065972222222 6 0.833333333333333 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.1 5.1 5.1 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.88621369024218 5.1 5.1 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68621289959511 5.1 5.1 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 LUCI 0 1 LUCI_PHOPY 4.72098361611599 5.1 5.1 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 HYES 0 2 EPHX2, Ephx2 Eph2 HYES_HUMAN, HYES_MOUSE 5.99 5.1 5.1 2 Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)] 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 6.95000714307986 5.1 5.1 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 HYEP 0 2 EPHX1 EPHX EPOX, Ephx1 HYEP_HUMAN, HYEP_MOUSE 5.99 5.1 5.1 2 Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 4.8000008748032 5.1 5.1 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 322518 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.25 5.1 5.1 1 Ras-related protein Rab-9A 1 5.1 actual molregno [molregno] O=C(NC1CCCCC1)Nc2ccccc2 323410 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.18641901143181 5.95 5.8125 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.7 5.95 5.884375 4 Menin 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 0 15 Aberrant vpr protein, Mitochondrial import inner membrane translocase subunit TIM23, Nonstructural protein 1, NotRecorded 4.97695942489532 5.95 6.06808333333333 15 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.95 5.95 5.43125 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.33620487778059 5.95 5.8125 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.95 5.95 5.95 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 TRPV1 0 2 TRPV1 VR1 TRPV1_HUMAN 5.39794000867204 5.95 5.95 2 Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1), Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1) (Vanilloid receptor type 1-like), Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.35 5.95 5.8125 1 Ras-related protein Rab-9A 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 6.19997064075587 5.95 5.8125 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 LUCI 1 0 LUCI_PHOPY 6.67100914455057 5.95 4.740625 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 NPC1 0 1 NPC1 NPC1_HUMAN 6.3 5.95 5.8125 1 Niemann-Pick C1 protein 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 323410 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.55 5.95 5.95 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.95 actual molregno [molregno] O=C(Nc1ccc2OCCOc2c1)\C=C\c3ccccc3 329136 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.475 6.3 6.3 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 0 17 NotRecorded 4.80033953580911 6.3 6.28566176470588 17 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 4.7 6.3 6.3 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.525 6.3 6.3 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 ATAD5 0 6 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.72952902790628 6.3 6.3 6 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 P53 0 3 TP53 P53 P53_HUMAN 5.5 6.3 6.3 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 Q94696 0 1 luc Q94696_PHOPE 4.9 6.3 6.3 1 Luciferase 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 SMN 0 3 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7 6.3 6.3 3 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.8 6.3 6.3 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.825 6.3 6.3 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 LUCI 0 2 LUCI_PHOPY 6.95 6.3 6.3 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 6.3 6.3 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.9 6.3 6.3 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 UBP1 0 1 USP1 UBP1_HUMAN 5.09999903484653 6.3 6.3 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.59999938302362 6.3 6.3 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.8 6.3 6.3 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329136 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.49999693194831 6.3 6.3 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 6.3 actual molregno [molregno] Cc1ccc(cc1)C(=O)CN2C(=N)SC3=C2CCCC3 329418 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.975 5.9 5.9 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.55 5.9 5.8 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 LUCI 0 2 LUCI_PHOPY 6.43550457227528 5.9 5.74875 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.3 5.9 5.9 1 Ras-related protein Rab-9A 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 O97447 0 1 ald O97447_GIAIN 4.8 5.9 5.645 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.38621101521651 5.9 5.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.9 5.9 4.925 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 ALR 0 1 GFER ALR HERV1 HPO ALR_HUMAN 6.49 5.9 5.8225 1 Alanine racemase (EC 5.1.1.1), FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 NFKB1 0 5 NFKB1 NFKB1_HUMAN 6.19 5.9 5.86875 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 TF65 0 5 RELA NFKB3 TF65_HUMAN 6.19 5.9 5.86875 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 6.19 5.9 5.86875 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 LYAG 0 2 GAA LYAG_HUMAN 4.5 5.9 5.9 2 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 NPC1 0 1 NPC1 NPC1_HUMAN 6 5.9 5.65625 1 Niemann-Pick C1 protein 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 P53 0 2 TP53 P53 P53_HUMAN 5.25 5.9 5.9 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 329418 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.16807483454807 5.9 5.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.9 actual molregno [molregno] COc1ccc(cc1)c2cn3c4CCCCc4sc3n2 330803 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 4.9 4.885 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 I23O1 0 3 IDO1 IDO INDO I23O1_HUMAN 4.66333333333333 4.9 4.895 3 Indoleamine 2,3-dioxygenase 1 (IDO-1) (EC 1.13.11.52) (Indoleamine-pyrrole 2,3-dioxygenase) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.4 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 RIPK1 0 1 RIPK1 RIP RIP1 RIPK1_HUMAN 6.74 4.9 4.9 1 Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) (Serine/threonine-protein kinase RIP) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 RORG 0 3 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.1 4.9 4.91145833333333 3 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 FFP 0 1 ffp sfp FFP_BACIU 7 4.9 4.865 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 AGAL 0 1 GLA AGAL_HUMAN 6.95 4.9 4.9 1 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 7.1 4.9 4.9 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 330803 P53 0 2 TP53 P53 P53_HUMAN 4.7 4.9 4.8925 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] CN1C(=S)NC(Cc2c[nH]c3ccccc23)C1=O 331656 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.84999924507786 5.45 5.45 1 TAR DNA-binding protein 43 (TDP-43) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.3 5.45 5.45 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 0 10 Nonstructural protein 1, NotRecorded 5.08873987087832 5.45 5.45 10 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 P53 0 1 TP53 P53 P53_HUMAN 6 5.45 5.45 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.19999817218203 5.45 5.45 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 5.2375 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.68621289959511 5.45 5.45 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 PIN1 0 1 PIN1 PIN1_HUMAN 4.59999938302362 5.45 5.45 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.35000349253396 5.45 5.2375 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.48620993498024 5.45 5.45 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.65 5.45 5.45 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 UBP1 0 1 USP1 UBP1_HUMAN 5.69999179744619 5.45 5.45 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 331656 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.5 5.45 5.45 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.45 actual molregno [molregno] CCN(CC)C(=O)C1CCCc2c1[nH]c3ccc(Cl)cc23 439813 RUNX1 0 10 RUNX1 AML1 CBFA2 RUNX1_HUMAN 5.09000584364619 4.95 4.95 10 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 PEBB 0 10 CBFB PEBB_HUMAN 5.09000584364619 4.95 4.95 10 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 BAZ2B 0 4 BAZ2B KIAA1476 BAZ2B_HUMAN 6.00001981558984 4.95 4.95 4 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.7362139662234 4.95 5.0671875 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 0 24 ATP-dependent Clp protease proteolytic subunit, Nonstructural protein 1, NotRecorded 4.93416404022631 4.95 4.976171875 24 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 RORG 0 3 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.95 4.95 3 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 GNAS2 0 2 GNAS GNAS1 GSP GNAS2_HUMAN 4.74999983932853 4.95 4.95 2 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 ATAD5 0 4 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.06474899978316 4.95 4.95 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 LUCI 0 2 LUCI_PHOPY 4.72098284380986 4.95 4.95 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 KDM4A 0 6 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 5.74999846597416 4.95 4.95 6 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 P53 0 1 TP53 P53 P53_HUMAN 5.45000414846935 4.95 4.95 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 LMBL1 0 2 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 5.85 4.95 4.95 2 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 NPC1 0 2 NPC1 NPC1_HUMAN 5.475 4.95 4.9921875 2 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 AA1R 0 2 ADORA1 AA1R_HUMAN 5 4.95 4.95 2 Adenosine receptor A1 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.7999981345934 4.95 4.95 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 POLI 0 2 POLI RAD30B POLI_HUMAN 4.74999846597416 4.95 4.9921875 2 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.85001154350852 4.95 4.95 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 O97447 0 2 ald O97447_GIAIN 4.925 4.95 4.9453125 2 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 AA2AR 0 2 ADORA2A ADORA2 AA2AR_HUMAN 5 4.95 4.95 2 Adenosine receptor A2a 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 TYDP1 0 1 TDP1 TYDP1_HUMAN 6.85 4.95 4.955 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.6 4.95 4.9375 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 APEX1 1 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 6.14742503720927 4.95 4.58125 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 0.5 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 RAB9A 0 2 RAB9A RAB9 RAB9A_HUMAN 5.5 4.95 4.9921875 2 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 FFP 0 2 ffp sfp FFP_BACIU 4.8 4.95 4.95 2 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 PPBT 0 1 ALPL PPBT_HUMAN 4.58 4.95 4.95 1 Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase 2) (Alkaline phosphatase liver/bone/kidney isozyme), Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 AA3R 0 2 ADORA3 AA3R_HUMAN 6 4.95 4.955 2 Adenosine receptor A3, Adenosine receptor A3 (A3AR), Adenosine receptor A3 (TGPCR1) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 Q94696 0 1 luc Q94696_PHOPE 5 4.95 4.95 1 Luciferase 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 439813 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.95 4.95 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] c1ccc(nc1)c2nnc([nH]2)c3ccccn3 332124 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.6 5.05 5.05 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.58639013631121 5.05 5.05 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 5.05 5.05 1 Niemann-Pick C1 protein 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 0 8 NotRecorded 4.85460714432021 5.05 5.05 8 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 LUCI 0 1 LUCI_PHOPY 4.57098292927852 5.05 5.05 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.2 5.05 5.05 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7 5.05 5.05 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 POLI 0 1 POLI RAD30B POLI_HUMAN 4.84999924507786 5.05 5.05 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 Q962Y6 0 1 TGR Q962Y6_SCHMA 5 5.05 5.05 1 Thioredoxin glutathione reductase (EC 1.6.4.5) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 DPOLB 0 1 POLB DPOLB_HUMAN 4.65 5.05 5.05 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 5.05 5.05 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.4 5.05 5.05 1 Ras-related protein Rab-9A 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 332124 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.08621262979452 5.05 5.05 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] Oc1ccccc1NC(=S)NC(=O)\C=C\c2occc2 430068 FAK2 1 0 PTK2B FAK2 PYK2 RAFTK FAK2_HUMAN 5.06 4.5 4.5625 1 Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2), Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.5 4.5 4.5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 14 0 Nonstructural protein 1, NotRecorded 4.91624421687716 4.5 4.49047619047619 14 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 CD5R1 2 0 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.57 4.5 3.875 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 CDK5 2 0 CDK5 CDKN5 CDK5_HUMAN 6.57 4.5 3.875 2 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 5.13621334693594 4.5 4.5 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 GEMI 2 0 GMNN GEMI_HUMAN 4.81121279463872 4.5 4.5 2 Geminin 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 RORG 1 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.75 4.5 4.6625 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 HSF1 2 0 Hsf1 HSF1_MOUSE 4.67251332601459 4.5 4.5 2 Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 MBNL1 1 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.84999924507786 4.5 4.5 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 EGFR 1 0 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 5.06963592814139 4.5 4.5625 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 430068 TAU 1 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.85 4.5 4.5 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.5 actual molregno [molregno] O=C1Nc2ccccc2/C/1=C/c3cnc[nH]3 336658 QPCT 0 1 QPCT QPCT_HUMAN 6.05 6.15 5.1125 1 Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (sQC) (Glutaminyl-tRNA cyclotransferase) (Glutamyl cyclase) (EC) 1 6.15 actual molregno [molregno] CCOc1ccc(N\C(=N\CCCn2ccnc2)\S)cc1 336658 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.15 6.15 6.15 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.15 actual molregno [molregno] CCOc1ccc(N\C(=N\CCCn2ccnc2)\S)cc1 335812 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.6 4.9 4.9 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.85 4.9 4.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.14999741390754 4.9 4.9 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 LUCI 0 2 LUCI_PHOPY 4.56049106525116 4.9 4.9 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.5 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 P53 0 1 TP53 P53 P53_HUMAN 5 4.9 4.9 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.78621404606106 4.9 4.9 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 4.9 4.9 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 335812 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.68621289959511 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] c1ccc2[nH]c(nc2c1)c3cccs3 336019 NPSR1 1 0 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.6 4.8 4.8 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 18 1 ATP-dependent Clp protease proteolytic subunit, NotRecorded 4.95584333964636 4.8 4.7266447368421 19 0.0526315789473684 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 LUCI 1 0 LUCI_PHOPY 4.87098398008989 4.8 4.8 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 P53 3 0 TP53 P53 P53_HUMAN 4.70000008371453 4.8 4.8 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 ATAD5 1 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.6862171168448 4.8 4.8 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.45 4.8 4.8 1 Ras-related protein Rab-9A 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.575 4.8 4.8 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 LMBL1 2 0 L3MBTL1 KIAA0681 L3MBT L3MBTL LMBL1_HUMAN 4.83691129381904 4.8 4.8 2 Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 SMAD3 1 0 SMAD3 MADH3 SMAD3_HUMAN 5 4.8 4.8 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.49999693194831 4.8 4.8 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.9 4.8 4.8 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 5.49999693194831 4.8 4.790625 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.55 4.8 4.8 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 MAP2 2 0 METAP2 MNPEP P67EIF2 MAP2_HUMAN 5.5453489201768 4.8 4.79583333333333 2 Methionine aminopeptidase (MAP) (MetAP) (EC 3.4.11.18) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M), Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Peptidase M) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 NPC1 1 0 NPC1 NPC1_HUMAN 5.6 4.8 4.8 1 Niemann-Pick C1 protein 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 Q94696 1 0 luc Q94696_PHOPE 4.95 4.8 4.8 1 Luciferase 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 HSF1 1 0 Hsf1 HSF1_MOUSE 4.63 4.8 4.8 1 Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.94999940171424 4.8 4.8 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 336019 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] Nc1ccc2[nH]c(nc2c1)c3ccccn3 335781 0 20 Aberrant vpr protein, NotRecorded 4.64362823809289 5.15 5.207 20 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.13620497428992 5.15 5.1125 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.5 5.15 5.1275 1 Ras-related protein Rab-9A 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 NFKB1 0 5 NFKB1 NFKB1_HUMAN 6.06 5.15 5.15 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 TF65 0 5 RELA NFKB3 TF65_HUMAN 6.06 5.15 5.15 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 6.06 5.15 5.15 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 LUCI 0 11 LUCI_PHOPY 6.16529761621852 5.15 5.16079545454545 11 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.23619777592541 5.15 5.075 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 VDR 0 1 VDR NR1I1 VDR_HUMAN 4.89999841719865 5.15 5.15 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 GEMI 0 1 GMNN GEMI_HUMAN 4.63621320946427 5.15 5.15 1 Geminin 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 NPC1 0 1 NPC1 NPC1_HUMAN 6.25 5.15 5.075 1 Niemann-Pick C1 protein 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.70000050388302 5.15 5.15 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.15 5.15 5.15 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 4.74999985591871 5.15 5.15 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 4.70000050388302 5.15 5.15 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 P53 0 4 TP53 P53 P53_HUMAN 5.24655574897212 5.15 5.15 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.275 5.15 5.15 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 6.2 5.15 4.2875 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 Q94696 0 1 luc Q94696_PHOPE 4.9 5.15 5.15 1 Luciferase 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.95 5.15 5.15 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 PGKC 0 1 PGKC_TRYBB 4.55000045168903 5.15 5.15 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 5.15 5.15 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.75 5.15 5.15 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.15 5.15 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 5.15 5.15 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 335781 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5.25000102344165 5.15 5.15 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 5.15 actual molregno [molregno] C1Oc2ccc(cc2O1)c3nc4ccccc4s3 337445 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.94999940171424 5.2 5.2 1 TAR DNA-binding protein 43 (TDP-43) 1 5.2 actual molregno [molregno] FC(F)(F)c1cccc(c1)N2CCN(CC2)C3CC(=O)N(C3=O)c4ccccc4 337445 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 6.04997609347667 5.2 5.2 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 5.2 actual molregno [molregno] FC(F)(F)c1cccc(c1)N2CCN(CC2)C3CC(=O)N(C3=O)c4ccccc4 337445 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.2 5.2 5.2 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.2 actual molregno [molregno] FC(F)(F)c1cccc(c1)N2CCN(CC2)C3CC(=O)N(C3=O)c4ccccc4 337445 MAOX 0 1 ME1 MAOX_HUMAN 5.5 5.2 5.2 1 NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1) 1 5.2 actual molregno [molregno] FC(F)(F)c1cccc(c1)N2CCN(CC2)C3CC(=O)N(C3=O)c4ccccc4 337445 0 2 Aberrant vpr protein, NotRecorded 4.94999855900245 5.2 5.12 2 1 5.2 actual molregno [molregno] FC(F)(F)c1cccc(c1)N2CCN(CC2)C3CC(=O)N(C3=O)c4ccccc4 338383 NPC1 0 1 NPC1 NPC1_HUMAN 6.45 5.9 5.9 1 Niemann-Pick C1 protein 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 0 10 NotRecorded 4.8090854514312 5.9 5.86875 10 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.26121189980326 5.9 5.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 LUCI 0 1 LUCI_PHOPY 5.87098720687396 5.9 5.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.35000349253396 5.9 5.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.45 5.9 5.9 1 Ras-related protein Rab-9A 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.9 5.9 5.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.84999924507786 5.9 5.9 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338383 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.88605664769316 5.9 5.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.9 actual molregno [molregno] O=C(NCc1ccccc1)c2cccc(COc3ccc4CCCc4c3)c2 338934 1 700 NotRecorded 4.94036996125768 4.9 4.8989087018545 701 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 0.998573466476462 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 NPC1 0 1 NPC1 NPC1_HUMAN 6.3 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Niemann-Pick C1 protein 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 GEMI 0 1 GMNN GEMI_HUMAN 4.87497766974956 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Geminin 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.7 4.9 4.90000000000001 8 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.7 4.9 4.90000000000001 8 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Menin 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 P53 0 2 TP53 P53 P53_HUMAN 4.94999920859932 4.9 4.90000000000001 2 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 ANDR 0 6 AR DHTR NR3C4 ANDR_HUMAN 5.19708044593288 4.9 4.90000000000001 6 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 PMP22 0 1 Pmp22 Cd25 Pmp-22 PMP22_RAT 6.3421795439843 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3), Peripheral myelin protein 22 (PMP-22) (Protein CD25) (SR13 myelin protein) (Schwann cell membrane glycoprotein) (SAG) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.3 4.9 4.90000000000001 4 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.9 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 NR1H4 0 2 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 5.14999860351428 4.9 4.90000000000001 2 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 RORG 0 4 RORC NR1F3 RORG RZRG, Rorc Nr1f3 Rorg Thor RORG_HUMAN, RORG_MOUSE 5.01876712389686 4.9 4.90000000000001 4 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5.5 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 HSPB1 0 1 HSPB1 HSP27 HSP28 HSPB1_HUMAN 4.60115933054629 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 POLK 0 1 POLK DINB1 POLK_HUMAN 4.52382218831237 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 ALDR 0 1 AKR1B1 ALDR1 ALDR_HUMAN 5.09 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Aldose reductase (AR) (EC 1.1.1.21) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase), Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.67499979388541 4.9 4.90000000000001 2 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 LUCI 0 2 LUCI_PHOPY 5.65658231858428 4.9 4.90000000000001 2 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 RXRA 0 1 RXRA NR2B1 RXRA_HUMAN 5.05000045714008 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.3 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Ras-related protein Rab-9A 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.95 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 AHR 0 1 AHR BHLHE76 AHR_HUMAN 6.15002808767115 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.05 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 NFKB1 0 2 NFKB1 NFKB1_HUMAN 5.02134024263036 4.9 4.90000000000001 2 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 GCR 0 1 NR3C1 GRL GCR_HUMAN 5.59999765407204 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 PPARD 0 3 PPARD NR1C2 PPARB PPARD_HUMAN 4.60875244280207 4.9 4.90000000000001 3 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 ESR1 0 1 ESR1 ESR NR3A1 ESR1_HUMAN 4.89999841719865 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1), Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1) (Fragment) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.9 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 HD 0 1 HTT HD IT15 HD_HUMAN 4.6 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.72506665764136 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 O97447 0 1 ald O97447_GIAIN 4.85 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.05000045714008 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 338934 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 5.54999736982681 4.9 4.90000000000001 1 NITAZOXANIDE BRONCHIOLITIS, CROHN'S DISEASE, DIARRHEA, HEPATIC ENCEPHALOPATHY, HEPATITIS C INFECTION, INFLUENZA INFECTION, ROTAVIRUS INFECTION, TUBERCULOSIS Pyruvate:ferredoxin oxidoreductase inhibitor INHIBITOR 4 Uncharacterized protein 1 4.9 actual drug [drugName] CC(=O)Oc1ccccc1C(=O)Nc2ncc(s2)[N+](=O)[O-] 549409 LMNA 0 2 LMNA LMN1 LMNA_HUMAN 5.025 5.25 5.25 2 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.25 5.25 5.25 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 GEMI 0 2 GMNN GEMI_HUMAN 5.36811432345744 5.25 5.25 2 Geminin 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.35 5.25 5.25 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 BLM 0 2 BLM RECQ2 RECQL3 BLM_HUMAN 4.9 5.25 5.25 2 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.7862167006647 5.25 5.25 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.9 5.25 5.25 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 549409 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.84999924507786 5.25 5.25 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 5.25 actual molregno [molregno] Cl.NCCCC(N)(C(F)F)C(=O)O 346255 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.93621333792779 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 8.55284196865778 4.9 4.886875 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.89999841719865 4.9 4.9 1 TAR DNA-binding protein 43 (TDP-43) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.95 4.9 4.9 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 IKKB 0 1 IKBKB IKKB IKKB_HUMAN 4.80966830182971 4.9 4.9 1 Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.9 4.9 4.90416666666667 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.45 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.54999736982681 4.9 4.82916666666667 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 346255 LUCI 0 1 LUCI_PHOPY 4.92098164492706 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] Oc1ncnc2cc(sc12)c3ccccc3 349336 GLHA 0 1 CGA GLHA_HUMAN 5 4.95 4.95 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 0 12 NotRecorded 4.90148448706737 4.95 4.95953125 12 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 LUCI 0 1 LUCI_PHOPY 4.97098167045352 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.35 4.95 4.95 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 NPC1 0 1 NPC1 NPC1_HUMAN 5.45 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.85 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 NF2L2 0 4 NFE2L2 NRF2 NF2L2_HUMAN 5.61084936855601 4.95 4.95 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 IRAK4 0 1 IRAK4 IRAK4_HUMAN 5.4 4.95 4.95 1 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6.075 4.95 4.955 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.08639275144419 4.95 4.95 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 349336 GRM5 0 1 Grm5 Gprc1e Mglur5 GRM5_MOUSE 4.54 4.95 4.94583333333333 1 Metabotropic glutamate receptor 5 (mGluR5) 1 4.95 actual molregno [molregno] [O-][N+](=O)c1cccc(c1)C(=O)Nc2nc3ccccc3[nH]2 350046 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.405 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.15 5.4 5.405 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 0 17 Aberrant vpr protein, Nonstructural protein 1, NotRecorded 4.83640694197891 5.4 5.3446568627451 17 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 Q94696 0 1 luc Q94696_PHOPE 4.95 5.4 5.5875 1 Luciferase 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.98621510845326 5.4 5.4 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 LUCI 0 2 LUCI_PHOPY 6.2599821483856 5.4 5.3140625 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 5.4 5.4 1 Niemann-Pick C1 protein 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.8 5.4 5.2825 1 Ras-related protein Rab-9A 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.28617357561948 5.4 5.4 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.14999741390754 5.4 5.4 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 6.09309756865134 5.4 5.428125 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 350046 LX15B 0 1 ALOX15B LX15B_HUMAN 4.8000008748032 5.4 5.4 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 5.4 actual molregno [molregno] O=C(Nc1nc2ccccc2[nH]1)c3ccccc3 347934 1 9 NotRecorded 4.81668892018882 5.05 5.004625 10 0.9 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 NPC1 0 1 NPC1 NPC1_HUMAN 5.65 5.05 5.1 1 Niemann-Pick C1 protein 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6.7 5.05 5.2 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.91120600410284 5.05 5.15 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.81666666666667 5.05 5.05 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.62382285083096 5.05 5.05 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.8 5.05 5.1 1 Ras-related protein Rab-9A 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 HS90B 0 2 HSP90AB1 HSP90B HSPC2 HSPCB HS90B_HUMAN 5.15 5.05 5.05 2 Heat shock protein HSP 90-beta, Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 HS90A 0 2 HSP90AA1 HSP90A HSPC1 HSPCA HS90A_HUMAN 5.15 5.05 5.05 2 Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38), Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Tumor-specific transplantation 86 kDa antigen) (TSTA) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 CYSP 0 2 CYSP_TRYCR 4.75 5.05 5.05 2 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 5.05 5.05 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.7 5.05 5.05 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.7 5.05 5.05 4 Menin 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 O97447 0 1 ald O97447_GIAIN 5.9 5.05 5.05 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 LUCI 0 2 LUCI_PHOPY 5.03548970756979 5.05 5.05 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.75 5.05 5.05 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.6862171168448 5.05 5.1 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5 5.05 5.05 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 LYAG 0 1 GAA LYAG_HUMAN 4.6 5.05 5.05 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 347934 P53 0 1 TP53 P53 P53_HUMAN 4.84999924507786 5.05 5.05 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.05 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccn3)n2 391222 TF65 0 1 Rela Nfkb3 TF65_MOUSE 5 4.95 4.95 1 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 P53 0 4 TP53 P53 P53_HUMAN 5.2 4.95 4.94125 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 ANDR 0 4 AR DHTR NR3C4 ANDR_HUMAN 4.88692174169806 4.95 4.95020833333333 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.65000410073714 4.95 5.00104166666667 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 PGDH 0 2 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.525 4.95 4.95 2 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 PPARA 0 1 Ppara Nr1c1 Ppar PPARA_MOUSE 5 4.95 4.95 1 Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 5.1 4.95 4.95 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 SC5A1 0 1 SLC5A1 NAGT SGLT1 SC5A1_HUMAN 4.52287874528034 4.95 4.95 1 Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.3 4.95 4.95 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 SC5A2 1 0 SLC5A2 SGLT2 SC5A2_HUMAN 5.4864362387664 4.95 4.705625 1 Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2) 0 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 4.95 5.055 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 TNF11 0 3 Tnfsf11 Opgl Rankl Trance TNF11_MOUSE 5 4.95 4.95 3 Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form] 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 KDM4E 0 2 KDM4E KDM4DL KDM4E_HUMAN 4.525 4.95 4.95 2 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.72497824816563 4.95 4.95 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 IL2 0 1 IL2 IL2_HUMAN 5.26 4.95 4.95 1 Interleukin-2 (IL-2) (T-cell growth factor) (TCGF), Interleukin-2 (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 4.89999841719865 4.95 4.95 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 391222 CP2D6 0 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 5 4.95 4.95 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.95 actual molregno [molregno] COc1ccc(cc1)C2=COc3cc(O)ccc3C2=O 351191 0 9 Aberrant vpr protein, NotRecorded 5.14938124275242 4.95 4.91125 9 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 LOX5 0 2 ALOX5 LOG5 LOX5_HUMAN 5.14629841406356 4.95 5.003125 2 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.8 4.95 4.95 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.35000349253396 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 LUCI 0 1 LUCI_PHOPY 5.17097941513958 4.95 5.075 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 GRM5 0 1 Grm5 Gprc1e Mglur5 GRM5_RAT 5.04 4.95 4.9375 1 Metabotropic glutamate receptor 5 (mGluR5) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.29999760285775 4.95 4.94583333333333 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 P53 0 1 TP53 P53 P53_HUMAN 5.54999736982681 4.95 4.9075 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 5.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 4.95 4.9 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.03621217265444 4.95 4.94583333333333 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 351191 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.95 4.9 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] COc1cccc(c1)C(=O)Nc2nc(C)cs2 352494 0 21 NotRecorded 5.21144031825275 4.825 4.83531549551639 21 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.65000022087346 4.825 4.835 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 GRP78 0 1 HSPA5 GRP78 GRP78_HUMAN 4.58300022518067 4.825 4.83697916666667 1 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.74999985591871 4.825 4.83541666666667 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.675 4.825 4.835 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 TRXR1 0 3 Txnrd1 Trxr1 TRXR1_RAT 4.84127489947151 4.825 4.83614583333333 3 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 DRD1 0 2 DRD1 DRD1_HUMAN 5.34312083239609 4.825 4.83390625 2 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 SCNNA 0 1 SCNN1A SCNN1 SCNNA_HUMAN 6.4 4.825 4.830625 1 Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA), Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 SMN 0 2 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.825 4.825 4.835 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 NPC1 0 1 NPC1 NPC1_HUMAN 5.69 4.825 4.8353125 1 Niemann-Pick C1 protein 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 PFKA 0 1 pfk PFKA_TRYBB 5.07098490037598 4.825 4.843125 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.69 4.825 4.8353125 1 Ras-related protein Rab-9A 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 352494 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.41140806291223 4.825 4.83536458333333 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.825 actual molregno [molregno] Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 354412 0 44 ATP-dependent Clp protease proteolytic subunit, Aberrant vpr protein, Mitochondrial import inner membrane translocase subunit TIM23, Nonstructural protein 1, NotRecorded 4.61125636305046 5.6 5.56133793290043 44 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5 5.6 5.6 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.6 5.6 5.11428571428571 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.6 5.6 5.6 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.21118751846949 5.6 5.5953125 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.89999841719865 5.6 5.6 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 SYUA 0 1 SNCA NACP PARK1 SYUA_HUMAN 4.94999940171424 5.6 5.6 1 Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 LUCI 0 2 LUCI_PHOPY 5.56478048899429 5.6 5.49958333333334 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.7862167006647 5.6 5.590625 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 NPC1 0 1 NPC1 NPC1_HUMAN 6.3 5.6 5.590625 1 Niemann-Pick C1 protein 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.94999940171424 5.6 5.6 1 TAR DNA-binding protein 43 (TDP-43) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.075 5.6 5.5359375 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.2 5.6 5.590625 1 Ras-related protein Rab-9A 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 Q94696 0 1 luc Q94696_PHOPE 5.05 5.6 5.5875 1 Luciferase 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 354412 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.59999938302362 5.6 5.5075 1 Uncharacterized protein 1 5.6 actual molregno [molregno] COc1ccc(cc1)c2nc3ccccc3[nH]2 357797 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.65 5.9 5.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 VDR 0 1 VDR NR1I1 VDR_HUMAN 5.09999903484653 5.9 5.9 1 Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 0 8 ATP-dependent Clp protease proteolytic subunit, NotRecorded 4.68155323381261 5.9 5.790234375 8 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.05000045714008 5.9 5.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 P53 0 4 TP53 P53 P53_HUMAN 5.275 5.9 5.82578125 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 LUCI 0 10 LUCI_PHOPY 6.25179358765815 5.9 5.9 10 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 PGKC 0 1 PGKC_TRYBB 4.89999841719865 5.9 5.9 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.08623911358768 5.9 5.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.49999693194831 5.9 5.9 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 5 5.9 5.9 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 357797 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.9 5.9 5.64583333333334 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.9 actual molregno [molregno] CCOc1ccc2nc(NC(=O)c3ccccc3)sc2c1 360257 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 5.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] O=C(Nc1ccccc1)C2CN(C3CCCCC3)C(=O)C2 360257 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.84999924507786 4.9 5.35 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.9 actual molregno [molregno] O=C(Nc1ccccc1)C2CN(C3CCCCC3)C(=O)C2 360257 INHA 0 1 inhA Rv1484 MTCY277.05 INHA_MYCTU 4.97 4.9 4.9 1 Enoyl-[acyl-carrier-protein] reductase [NADH] (ENR) (Enoyl-ACP reductase) (EC 1.3.1.9) (FAS-II enoyl-ACP reductase) (NADH-dependent 2-trans-enoyl-ACP reductase) 1 4.9 actual molregno [molregno] O=C(Nc1ccccc1)C2CN(C3CCCCC3)C(=O)C2 360257 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 8.45593195564972 4.9 5.125 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.9 actual molregno [molregno] O=C(Nc1ccccc1)C2CN(C3CCCCC3)C(=O)C2 371796 0 11 NotRecorded 4.91759626309859 5.05 5.05 11 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.65 5.05 5.05 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 4.9875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 HD 0 1 HTT HD IT15 HD_HUMAN 5.5 5.05 5.05 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 KLF5 0 1 KLF5 BTEB2 CKLF IKLF KLF5_HUMAN 6.02 5.05 5.05 1 Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2) 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 GEMI 0 1 GMNN GEMI_HUMAN 5.48620993498024 5.05 5.05 1 Geminin 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 PTBP1 0 1 PTBP1 PTB PTBP1_HUMAN 5.05 5.05 5.05 1 Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I) 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.25000102344165 5.05 5.05 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 371796 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.53621298582672 5.05 5.05 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.05 actual molregno [molregno] O=C(Nc1cccnc1)c2cccs2 373563 SIAT1 0 2 ST6GAL1 SIAT1, St6gal1 Siat1 SIAT1_HUMAN, SIAT1_RAT 5.22 4.85 4.85 2 Beta-galactoside alpha-2,6-sialyltransferase 1 (Alpha 2,6-ST 1) (EC 2.4.99.1) (B-cell antigen CD75) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I) (ST6GalI) (Sialyltransferase 1), Beta-galactoside alpha-2,6-sialyltransferase 1 (Alpha 2,6-ST 1) (EC 2.4.99.1) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I) (ST6GalI) (Sialyltransferase 1) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 LOX1 0 6 LOX1.1 LOX1 LOX1_SOYBN 5.4574672657868 4.85 4.84819444444444 6 Seed linoleate 13S-lipoxygenase-1 (EC 1.13.11.12) (Lipoxygenase-1) (L-1) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 TNKS1 0 2 TNKS PARP5A PARPL TIN1 TINF1 TNKS1 TNKS1_HUMAN 6.65 4.85 5.0625 2 Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I), Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (TRF1-interacting ankyrin-related ADP-ribose polymerase 1) (Tankyrase I) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.05 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.55 4.85 4.85 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 4 12 Dihydroorotate dehydrogenase, NotRecorded 4.80751720330077 4.85 4.83203125 16 0.75 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 4.85 4.85 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 POLK 0 1 POLK DINB1 POLK_HUMAN 4.84999924507786 4.85 4.85 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 SIAT6 0 1 St3gal3 Siat6 SIAT6_RAT 5.85 4.85 4.85 1 CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6), CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) [Cleaved into: CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase soluble form] 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.5 4.85 4.85 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 LOX5 0 1 ALOX5 LOG5 LOX5_HUMAN 5.77 4.85 4.85 1 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 LX15B 0 1 ALOX15B LX15B_HUMAN 5 4.85 4.85 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 PARP1 0 2 PARP1 ADPRT PPOL PARP1_HUMAN 5.895 4.85 4.85 2 Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1), Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (msPARP) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 TNKS2 0 2 TNKS2 PARP5B TANK2 TNKL TNKS2_HUMAN 6.76 4.85 5.0625 2 Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-like protein) (Tankyrase-related protein), Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 PYRD 0 1 DHODH PYRD_HUMAN 4.91 4.85 4.85 1 Dihydroorotate dehydrogenase (fumarate) (DHOD) (DHODase) (DHOdehase) (EC 1.3.98.1) (Dihydroorotate oxidase), Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 O97447 0 1 ald O97447_GIAIN 4.8 4.85 4.85 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.3 4.85 4.85 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5.1 4.85 4.85 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 5.8 4.85 4.85 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373563 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.15 4.85 4.85 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] Oc1ccc(cc1O)C2=CC(=O)c3ccccc3O2 373684 CYSP 0 1 CYSP_TRYCR 5.4 5.4 5.4 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.4 5.4 5.4 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 PUR9 0 1 ATIC PURH OK/SW-cl.86 PUR9_HUMAN 4.77 5.4 5.4 1 Bifunctional purine biosynthesis protein PURH [Cleaved into: Bifunctional purine biosynthesis protein PURH, N-terminally processed] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)], Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.55 5.4 5.4 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.45 5.4 5.4 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.45 5.4 5.4 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.5 5.4 5.4 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 373684 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.4 5.4 5.3875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.4 actual molregno [molregno] Cc1ccc2nc(sc2c1)c3ccc(NC(=O)c4ccc(N)cc4)c(c3)S(=O)(=O)O 377692 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.825 4.85 4.85 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 0 10 Nonstructural protein 1, NotRecorded 5.1049456602657 4.85 4.85 10 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 CBX1 0 1 CBX1 CBX CBX1_HUMAN 5.29999760285775 4.85 4.85 1 Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 AMPC 0 2 ampC ampA b4150 JW4111 AMPC_ECOLI 4.55 4.85 4.85 2 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 P53 0 1 TP53 P53 P53_HUMAN 4.74999985591871 4.85 4.85 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.78621404606106 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377692 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.63621320946427 4.85 4.85 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.85 actual molregno [molregno] O=C(Nc1ccc(Oc2ccc(NC(=O)c3occc3)c(NC(=O)c4occc4)c2)cc1)c5occc5 377701 DPOLB 0 1 POLB DPOLB_HUMAN 5.5 5 5 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 0 6 NotRecorded 5.25747289431639 5 5.07083333333333 6 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.5 5 5 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.19999817218203 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 CYSP 0 1 CYSP_TRYCR 4.6 5 5 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 AMPC 0 3 ampC ampA b4150 JW4111 AMPC_ECOLI 4.85681868815271 5 5 3 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.63621320946427 5 5 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.9 5 5 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 P53 0 1 TP53 P53 P53_HUMAN 4.9 5 5 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 5 5 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 377701 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.45 5 5 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5 actual molregno [molregno] Cc1cccc(OCC(=O)Nc2cccc(c2)c3oc(nn3)c4ccccc4)c1C 379780 0 30 Aberrant vpr protein, Latent membrane protein 1, NotRecorded, Paired box protein Pax-8 5.26798091510203 6.5 6.42013888888889 30 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.8 6.5 6.4875 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.95000714307986 6.5 6.5 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.5 6.5 5.375 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 Q9BHT9 0 3 G6PD-6PGL Q9BHT9_PLABE 4.64563667100269 6.5 6.125 3 Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 GLHA 0 1 CGA GLHA_HUMAN 5.95000714307986 6.5 6.5 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 PGKC 0 1 PGKC_TRYBB 4.89999841719865 6.5 6.5 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.6 6.5 6.4875 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.59999938302362 6.5 6.5 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 Q962Y6 0 1 TGR Q962Y6_SCHMA 5.45 6.5 6.5 1 Thioredoxin glutathione reductase (EC 1.6.4.5) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 Q94696 0 1 luc Q94696_PHOPE 5.55 6.5 6.5 1 Luciferase 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 FACE2 0 1 RCE1 FACE2 RCE1A RCE1B FACE2_HUMAN 5.15 6.5 6.4875 1 CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog), CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 CD5R1 0 2 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 4.78 6.5 6.5 2 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 CDK5 0 2 CDK5 CDKN5 CDK5_HUMAN 4.78 6.5 6.5 2 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.3 6.5 6.5 1 Ras-related protein Rab-9A 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 Q57TT1 0 1 Tb927.8.6820 Q57TT1_TRYB2 4.89999841719865 6.5 5.375 1 Uncharacterized protein 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 PFKA 0 1 pfk PFKA_TRYBB 4.67098267640138 6.5 6.5 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 NPC1 0 1 NPC1 NPC1_HUMAN 6.25 6.5 6.5 1 Niemann-Pick C1 protein 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 Q4GZG4 0 1 PGKC TB927.1.700 Q4GZG4_TRYB2 5.38666567976731 6.5 6.5 1 Phosphoglycerate kinase (EC 2.7.2.3) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 7.11131559204313 6.5 6.5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 6.5 6.5 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5.28621554657693 6.5 6.5 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 O97447 0 1 ald O97447_GIAIN 4.8 6.5 5.375 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 379780 LUCI 0 2 LUCI_PHOPY 6.50047747005602 6.5 6.453125 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 6.5 actual molregno [molregno] COc1ccc(\C=C\c2nc3ccccc3n2C)cc1 378517 0 6 NotRecorded 5.57413592820066 5.2 5.2025 6 1 5.2 actual molregno [molregno] COc1cc(cc(OC)c1OC)C(=O)Nc2nccs2 378517 LOX5 0 2 ALOX5 LOG5 LOX5_HUMAN 5.27483596093414 5.2 5.7625 2 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 1 5.2 actual molregno [molregno] COc1cc(cc(OC)c1OC)C(=O)Nc2nccs2 378517 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.84999924507786 5.2 5.2 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.2 actual molregno [molregno] COc1cc(cc(OC)c1OC)C(=O)Nc2nccs2 378517 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.7 5.2 5.35 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.2 actual molregno [molregno] COc1cc(cc(OC)c1OC)C(=O)Nc2nccs2 378517 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 5.2 5.2 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.2 actual molregno [molregno] COc1cc(cc(OC)c1OC)C(=O)Nc2nccs2 378517 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.2 5.2 5.2 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.2 actual molregno [molregno] COc1cc(cc(OC)c1OC)C(=O)Nc2nccs2 380371 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.65 4.95 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 P53 0 1 TP53 P53 P53_HUMAN 5.09999903484653 4.95 4.95 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6.15 4.95 4.95625 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.65 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 NF2L2 0 4 NFE2L2 NRF2 NF2L2_HUMAN 5.92333476389592 4.95 4.966875 4 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.25000102344165 4.95 4.95 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 FFP 0 1 ffp sfp FFP_BACIU 4.55 4.95 4.95 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 GLHA 0 1 CGA GLHA_HUMAN 5.35000349253396 4.95 4.95 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.74999985591871 4.95 4.9 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 4.95 4.95 1 Geminin 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.74999985591871 4.95 4.95 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.89999841719865 4.95 4.95 1 TAR DNA-binding protein 43 (TDP-43) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.9875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.38621324302001 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 NPC1 0 1 NPC1 NPC1_HUMAN 5.4 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5.3 4.95 4.9875 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.85 4.95 4.95 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 380371 LUCI 0 1 LUCI_PHOPY 5.22098102808513 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] O=C1C=C(Oc2ccccc12)\C=C\c3ccccc3 385412 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.48620993498024 8.35 8.35 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 8.35 actual molregno [molregno] N#CCCN1CCNCC1 385412 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 8.35 8.35 8.35 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 8.35 actual molregno [molregno] N#CCCN1CCNCC1 385633 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 4.9 4.9 4.9 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.9 4.9 4.9 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.85 4.9 4.9 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.85 4.9 4.9 4 Menin 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 NOD1 0 1 NOD1 CARD4 NOD1_HUMAN 4.69897000433602 4.9 4.9 1 Nucleotide-binding oligomerization domain-containing protein 1 (Caspase recruitment domain-containing protein 4) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.55000045168903 4.9 4.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 NOD2 0 1 NOD2 CARD15 IBD1 NOD2_HUMAN 4.69897000433602 4.9 4.9 1 Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 POLI 0 1 POLI RAD30B POLI_HUMAN 5.49999693194831 4.9 4.9 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.58621423228026 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.95 4.9 4.9 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 DPOLB 0 1 POLB DPOLB_HUMAN 5.85 4.9 4.9 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.6 4.9 4.9 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 LUCI 0 1 LUCI_PHOPY 4.77098149412752 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 TNFA 0 1 TNF TNFA TNFSF2 TNFA_HUMAN 4.69897000433602 4.9 4.9 1 Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form] 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 385633 HCD2 0 1 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.9 4.9 1 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.9 actual molregno [molregno] OC(=O)c1c2CCCCc2sc1NC(=O)c3cccs3 390246 NFKB1 35 0 NFKB1 NFKB1_HUMAN 5 4.725 4.725 35 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 TF65 35 0 RELA NFKB3 TF65_HUMAN 5 4.725 4.725 35 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 NFKB2 35 0 NFKB2 LYT10 NFKB2_HUMAN 5 4.725 4.725 35 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CP1B1 5 0 CYP1B1 CP1B1_HUMAN 6.844 4.725 4.723 5 Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CP1A1 8 0 CYP1A1 CP1A1_HUMAN 5.72457514106532 4.725 4.725 8 Cytochrome P450 1A1 (CYP1A1) (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-C) (Cytochrome P450MT2) [Cleaved into: Cytochrome P450MT2A; Cytochrome P450MT2B], Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1), Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450-P1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 KMT2A 12 0 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.71666666666667 4.725 4.725 12 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 MEN1 12 0 MEN1 SCG2 MEN1_HUMAN 4.71666666666667 4.725 4.725 12 Menin 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 AL1A1 2 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 5.625 4.725 4.725 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CDK8 1 0 CDK8 CDK8_HUMAN 6.2 4.725 4.725 1 Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CP2D6 2 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 4.9 4.725 4.725 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 P53 2 0 TP53 P53 P53_HUMAN 4.55 4.725 4.725 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 SMAD3 1 0 SMAD3 MADH3 SMAD3_HUMAN 5 4.725 4.725 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 TAU 5 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.86 4.725 4.725 5 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 LUCI 2 0 LUCI_PHOPY 5.36048609718864 4.725 4.725 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CP1A2 3 0 CYP1A2 CP1A2_HUMAN 6.96666666666667 4.725 4.725 3 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 SMN 2 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.725 4.725 4.725 2 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 RORG 1 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.55 4.725 4.725 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CP2C9 2 0 CYP2C9 CYP2C10 CP2C9_HUMAN 5.9 4.725 4.725 2 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 LOX5 3 0 ALOX5 LOG5, Alox5 LOX5_HUMAN, LOX5_RAT 4.81633433169854 4.725 4.725 3 Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 XDH 2 0 XDH XDH_BOVIN 4.97472573447533 4.725 4.725 2 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 HIF1A 2 0 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 6.1 4.725 4.74625 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 LMNA 1 0 LMNA LMN1 LMNA_HUMAN 4.85 4.725 4.725 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CP2CJ 2 0 CYP2C19 CP2CJ_HUMAN 6 4.725 4.725 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.39319584351909 4.725 4.725 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 ATX2 2 0 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.79999981129385 4.725 4.725 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 TYDP1 1 0 TDP1 TYDP1_HUMAN 4.6 4.725 4.725 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.5 4.725 4.725 1 Ras-related protein Rab-9A 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 4.74999985591871 4.725 4.725 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 6.50003813440381 4.725 4.7125 1 TAR DNA-binding protein 43 (TDP-43) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 CDK9 1 0 CDK9 CDC2L4 TAK CDK9_HUMAN 5.9 4.725 4.725 1 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 LOX1 1 0 LOX1.1 LOX1 LOX1_SOYBN 5 4.725 4.725 1 Seed linoleate 13S-lipoxygenase-1 (EC 1.13.11.12) (Lipoxygenase-1) (L-1) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 ANDR 1 0 AR DHTR NR3C4 ANDR_HUMAN 5.67778070526608 4.725 4.725 1 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 390246 NPC1 1 0 NPC1 NPC1_HUMAN 5.25 4.725 4.725 1 Niemann-Pick C1 protein 0 4.725 actual molregno [molregno] COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)cc3O2 391247 0 13 NotRecorded 4.57852741574541 4.95 4.92980769230769 13 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.75 4.95 4.95 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.57382231378381 4.95 4.95 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.55 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 LYAG 0 1 GAA LYAG_HUMAN 4.55 4.95 4.95 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 LUCI 0 1 LUCI_PHOPY 4.97098167045352 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.98619407265941 4.95 4.95 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 CYSP 0 2 CYSP_TRYCR 4.75 4.95 4.95 2 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 TAU 0 3 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.71666666666667 4.95 4.95 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 GEMI 0 2 GMNN GEMI_HUMAN 4.85000074993349 4.95 4.95 2 Geminin 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 CLK1 0 1 CLK1 CLK CLK1_HUMAN 4.74 4.95 4.95 1 Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1), Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1) (Protein kinase STY) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.65000022087346 4.95 4.95 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 5.15 4.95 4.95 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.89999841719865 4.95 4.95 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.7 4.95 4.95 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.6 4.95 4.9225 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 391247 DYR1A 0 1 Dyrk1a Dyrk DYR1A_RAT 4.84 4.95 4.95 1 Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (MP86) (Protein kinase minibrain homolog) (MNBH), Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.2) (Dual specificity YAK1-related kinase) (Protein kinase minibrain homolog) (MNBH) (RP86) 1 4.95 actual molregno [molregno] Cc1nc(N)sc1c2csc(Nc3ccccc3)n2 395530 P53 0 4 TP53 P53 P53_HUMAN 5.2874993424567 4.9 4.9 4 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.16121385961569 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 3 10 NotRecorded 4.75588069844545 4.9 4.77836538461538 13 0.769230769230769 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 LUCI 0 1 LUCI_PHOPY 5.57097484328848 4.9 4.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.90000876645532 4.9 4.7875 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5 4.9 4.896875 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.65000022087346 4.9 4.9 1 TAR DNA-binding protein 43 (TDP-43) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.18621225375977 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP3A4 0 1 CYP3A4 CYP3A3 CP3A4_HUMAN 6.06069784035361 4.9 4.9 1 Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.875 4.9 4.9 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.9 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP2C8 0 1 CYP2C8 CP2C8_HUMAN 6.99563519459755 4.9 4.9 1 Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP2CJ 0 1 CYP2C19 CP2CJ_HUMAN 6.38021124171161 4.9 4.9 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 NPC1 0 1 NPC1 NPC1_HUMAN 5.6 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP2C9 0 1 CYP2C9 CYP2C10 CP2C9_HUMAN 5.62973141792582 4.9 4.845 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 5.30756086282294 4.9 4.896875 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP2B6 0 1 CYP2B6 CP2B6_HUMAN 6.69019608002851 4.9 4.9 1 Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 5.54999736982681 4.9 4.86875 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 395530 CP2D6 0 1 CYP2D6 CYP2DL1 CP2D6_HUMAN 6.27875360095283 4.9 4.9 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.9 actual molregno [molregno] O=C(N\N=C\c1cccs1)c2ccc3OCOc3c2 392370 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.34310459285404 4.8 4.9075 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392370 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.1931943813659 4.8 4.925 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392370 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.65 4.8 4.8575 1 Ras-related protein Rab-9A 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392370 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.935 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392370 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.49999693194831 4.8 4.90875 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392370 LUCI 0 1 LUCI_PHOPY 5.57097484328848 4.8 4.85375 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392370 NPC1 0 1 NPC1 NPC1_HUMAN 5.65 4.8 4.8575 1 Niemann-Pick C1 protein 1 4.8 actual molregno [molregno] [O-][N+](=O)c1ccc2oc(nc2c1)c3ccccc3 392391 0 13 ATP-dependent Clp protease proteolytic subunit, NotRecorded 4.5447779065803 4.95 4.94711538461539 13 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 LUCI 0 3 LUCI_PHOPY 6.32322982322829 4.95 4.96 3 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 4.95 4.95 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.5 4.95 4.95 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 Q94696 0 1 luc Q94696_PHOPE 4.95 4.95 4.95 1 Luciferase 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.69999179744619 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.9 4.95 4.95 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 NPC1 0 1 NPC1 NPC1_HUMAN 6.5 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.31118922670004 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 P53 0 2 TP53 P53 P53_HUMAN 5 4.95 4.95 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 6.03621217265444 4.95 4.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392391 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.2 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Cc1ccc(cc1)c2oc3ccc(C)cc3n2 392613 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.89999841719865 4.9 4.9 1 TAR DNA-binding protein 43 (TDP-43) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 EHMT2 0 1 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 4.65000022087346 4.9 4.89375 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 NPC1 0 1 NPC1 NPC1_HUMAN 5.6 4.9 4.9 1 Niemann-Pick C1 protein 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 0 10 NotRecorded 4.894077605029 4.9 5.03775 10 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 BAZ2B 0 2 BAZ2B KIAA1476 BAZ2B_HUMAN 4.65000022087346 4.9 4.89375 2 Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.14310777328846 4.9 4.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 LUCI 0 2 LUCI_PHOPY 5.18549026014588 4.9 4.9 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.33621429654423 4.9 4.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.55 4.9 4.9 1 Ras-related protein Rab-9A 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 P53 0 1 TP53 P53 P53_HUMAN 5.05000045714008 4.9 4.9 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392613 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.59999765407204 4.9 4.9 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.9 actual molregno [molregno] C(Oc1ccccc1)c2nc3ccccc3s2 392709 LUCI 1 0 LUCI_PHOPY 4.92098164492706 4.65 4.65 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.65 4.65 4.61 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 CP3A4 1 0 CYP3A4 CYP3A3 CP3A4_HUMAN 4.9 4.65 4.65 1 Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 BRCA1 1 0 BRCA1 RNF53 BRCA1_HUMAN 5.69999179744619 4.65 4.64375 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.01121351858906 4.65 4.65 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.65 4.65 4.675 1 Ras-related protein Rab-9A 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 5.85 4.65 4.675 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 CP2CJ 1 0 CYP2C19 CP2CJ_HUMAN 5.85 4.65 4.64375 1 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 GLP1R 1 0 GLP1R GLP1R_HUMAN 5.59999765407204 4.65 4.68541666666667 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 FRIL 1 0 FTL FRIL_HORSE 4.55 4.65 4.61 1 Ferritin light chain (Ferritin L subunit) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 CP2C9 1 0 CYP2C9 CYP2C10 CP2C9_HUMAN 4.95 4.65 4.65 1 Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 CP2D6 1 0 CYP2D6 CYP2DL1 CP2D6_HUMAN 5 4.65 4.65 1 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 CP1A2 1 0 CYP1A2 CP1A2_HUMAN 4.95 4.65 4.65 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 392709 NPC1 1 0 NPC1 NPC1_HUMAN 5.6 4.65 4.675 1 Niemann-Pick C1 protein 0 4.65 actual molregno [molregno] C(Sc1ccccc1)c2nc3ccccc3[nH]2 390095 AGAL 0 6 GLA AGAL_HUMAN 4.6083333206581 4.95 4.95 6 Alpha-galactosidase (EC 3.2.1.22) (Alpha-D-galactoside galactohydrolase) (Melibiase), Alpha-galactosidase (EC 3.2.1.22) (Melibiase), Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.65 4.95 4.95 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 5 4.95 4.95 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 4.9 4.95 4.95 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 HIF1A 0 2 HIF1A BHLHE78 MOP1 PASD8 HIF1A_HUMAN 5 4.95 4.95 2 Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein), Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 GEMI 0 2 GMNN GEMI_HUMAN 5.34312053674893 4.95 4.95 2 Geminin 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 XDH 0 1 XDH XDHA XDH_HUMAN 5.09 4.95 4.95 1 Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)] 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 CASP7 0 2 CASP7 MCH3 CASP7_HUMAN 5.25 4.95 4.95 2 Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11] 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 PGDH 0 3 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.63333333333333 4.95 4.95 3 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 ATX2 0 2 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.72499943444384 4.95 4.95 2 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 HCD2 0 3 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.8 4.95 4.95 3 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 MBNL1 0 1 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.59999938302362 4.95 4.95 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 O97447 0 3 ald O97447_GIAIN 4.9 4.95 4.925 3 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 AL1A1 0 3 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.66666666666667 4.95 4.95 3 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 LYAG 0 3 GAA LYAG_HUMAN 4.7 4.95 4.95 3 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 KDM4E 0 3 KDM4E KDM4DL KDM4E_HUMAN 4.66666666666667 4.95 4.95 3 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 CASP1 0 2 CASP1 IL1BC IL1BCE CASP1_HUMAN 5.15 4.95 4.95 2 Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10] 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.53621298582672 4.95 4.95 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.55000045168903 4.95 4.95 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 ERAP2 0 1 ERAP2 LRAP ERAP2_HUMAN 5.48545224733971 4.95 4.825 1 Endoplasmic reticulum aminopeptidase 2 (EC 3.4.11.-) (Leukocyte-derived arginine aminopeptidase) (L-RAP) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 LT 0 1 LT_SV40 4.58603002825194 4.95 4.95 1 Large T antigen (LT) (LT-AG) (EC 3.6.4.-) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.95 4.95 4.95 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 KDM4A 0 3 KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 KDM4A_HUMAN 5.35000349253396 4.95 4.95 3 Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.8 4.95 4.95 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 POLK 0 2 POLK DINB1 POLK_HUMAN 5.51191730071701 4.95 4.95 2 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390095 ERAP1 0 1 ERAP1 APPILS ARTS1 KIAA0525 UNQ584/PRO1154 ERAP1_HUMAN 5.01233373507373 4.95 4.95 1 Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator), Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (VEGF-induced aminopeptidase) 1 4.95 actual molregno [molregno] Oc1cc2OC(=O)C=Cc2cc1O 390097 0 39 Glucose transporter, Hexose transporter 1, NotRecorded 4.87436941552422 4.85 4.85 39 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 GRP78 0 2 HSPA5 GRP78 GRP78_HUMAN 4.50800047125621 4.85 4.85 2 78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP), 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 TPO 0 2 THPO MGDF TPO_HUMAN 4.9 4.85 4.85 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 POLK 0 1 POLK DINB1 POLK_HUMAN 5.02382432408324 4.85 4.85 1 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 4.65000022087346 4.85 4.85 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.85 4.85 4.85 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 PGKC 0 1 PGKC_TRYBB 4.87098398008989 4.85 4.85 1 Phosphoglycerate kinase, glycosomal (Phosphoglycerate kinase C) (EC 2.7.2.3) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 4.8 4.85 4.85 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 EGFR 0 1 EGFR ERBB ERBB1 HER1 EGFR_HUMAN 5.12 4.85 4.85 1 Epidermal growth factor receptor (EC 2.7.10.1), Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 POLI 0 1 POLI RAD30B POLI_HUMAN 4.62382285083096 4.85 4.85 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 HCD2 0 2 HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2 HCD2_HUMAN 4.75 4.85 4.85 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.6 4.85 4.85 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 APEX1 0 2 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.82499920859932 4.85 4.85 2 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.22369747435205 4.85 4.85 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 GEMI 0 1 GMNN GEMI_HUMAN 4.63621320946427 4.85 4.85 1 Geminin 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.75 4.85 4.85 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 EHMT2 0 2 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.06189402218473 4.85 4.85 2 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 5.15 4.85 4.85 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.6 4.85 4.85 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 DRD1 0 1 DRD1 DRD1_HUMAN 5.98623614526607 4.85 4.85 1 D(1) dopamine receptor (Dopamine D1 receptor), D(1A) dopamine receptor (Dopamine D1 receptor) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 FEN1 0 2 FEN1 RAD2 FEN1_HUMAN 5.07382345586066 4.85 4.85 2 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 RGS4 0 1 RGS4 RGS4_HUMAN 4.72382322328385 4.85 4.85 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 PIN1 0 1 PIN1 PIN1_HUMAN 4.67098267640138 4.85 4.85 1 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 RUNX1 0 2 RUNX1 AML1 CBFA2 RUNX1_HUMAN 5.05000045714008 4.85 4.85 2 Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 PEBB 0 2 CBFB PEBB_HUMAN 5.05000045714008 4.85 4.85 2 Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 DPOLB 0 1 POLB DPOLB_HUMAN 4.85 4.85 4.85 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 PFKA 0 1 pfk PFKA_TRYBB 5.12098444659037 4.85 4.85 1 ATP-dependent 6-phosphofructokinase (ATP-PFK) (Phosphofructokinase) (EC 2.7.1.11) (Phosphohexokinase) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.85 4.85 4.85 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.18639232749079 4.85 4.85 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 4.6 4.85 4.85 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 ACM1 0 1 Chrm1 Chrm-1 ACM1_RAT 4.65 4.85 4.85 1 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 LX15B 0 1 ALOX15B LX15B_HUMAN 5.09999903484653 4.85 4.85 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 O97447 0 1 ald O97447_GIAIN 5 4.85 4.85 1 Putative fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 THB 0 1 THRB ERBA2 NR1A2 THR1 THB_HUMAN 5.55 4.85 4.85 1 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 SO1B1 0 1 SLCO1B1 LST1 OATP1B1 OATP2 OATPC SLC21A6 SO1B1_HUMAN 5.29461712328916 4.85 4.85 1 Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6) 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 390097 LUXP 0 1 luxP LUXP_VIBHA 4.92 4.85 4.85 1 Autoinducer 2-binding periplasmic protein LuxP 1 4.85 actual molregno [molregno] Oc1ccc2C=CC(=O)Oc2c1O 402361 0 19 NotRecorded 4.85583020513011 5.25 5.22213815789474 19 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 KMT2A 0 11 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.33181818181818 5.25 5.25 11 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 5.1 5.25 5.25 8 Menin 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 NPC1 0 1 NPC1 NPC1_HUMAN 5.4 5.25 5.25 1 Niemann-Pick C1 protein 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 ABC3F 0 3 APOBEC3F ABC3F_HUMAN 5.62873552454006 5.25 5.25 3 DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 POLH 0 3 POLH RAD30 RAD30A XPV POLH_HUMAN 4.74032723778405 5.25 5.25 3 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 POLK 0 2 POLK DINB1 POLK_HUMAN 4.6369116526567 5.25 5.25 2 DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.43638840855221 5.25 5.25 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 PIN1 0 2 PIN1 PIN1_HUMAN 5.03549013658149 5.25 5.25 2 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 RECQ1 0 2 RECQL RECQ1 RECQL1 RECQ1_HUMAN 4.57500010122271 5.25 5.25 2 ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 UBP1 0 2 USP1 UBP1_HUMAN 5.00000230007919 5.25 5.25 2 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 5.39999691337226 5.25 5.25 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 DPOLB 0 1 POLB DPOLB_HUMAN 5.55 5.25 5.25 1 DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 SMAD3 0 2 SMAD3 MADH3 SMAD3_HUMAN 5.50000075914808 5.25 5.25 2 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 ABC3G 0 3 APOBEC3G MDS019 ABC3G_HUMAN 5.40747532097176 5.25 5.25 3 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5 5.25 5.25 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 RGS4 0 1 RGS4 RGS4_HUMAN 4.59999938302362 5.25 5.25 1 Regulator of G-protein signaling 4 (RGP4) (RGS4) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 LUCI 0 2 LUCI_PHOPY 5.02098457748104 5.25 5.25 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 PLK1 0 1 PLK1 PLK PLK1_HUMAN 5.57383045296467 5.25 5.25 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 POLI 0 2 POLI RAD30B POLI_HUMAN 4.65000027673013 5.25 5.25 2 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.55 5.25 5.25 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 4.86121319014009 5.25 5.25 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 WRN 0 2 WRN RECQ3 RECQL2 WRN_HUMAN 4.75855236204039 5.25 5.25 2 Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 THB 0 2 THRB ERBA2 NR1A2 THR1 THB_HUMAN 5 5.25 5.25 2 Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 BLM 0 1 BLM RECQ2 RECQL3 BLM_HUMAN 4.61710264689219 5.25 5.25 1 Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.25 5.25 5.25 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 5.25 5.25 1 Geminin 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 4.59999938302362 5.25 5.25 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.7 5.25 5.25 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.95 5.25 5.25 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 402361 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 5.25 5.25 1 Ras-related protein Rab-9A 1 5.25 actual molregno [molregno] OC(=O)c1ccc(cc1)c2oc(\C=C(/C#N)\c3nc4ccccc4[nH]3)cc2 406362 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.8000008748032 5.15 5.15 1 TAR DNA-binding protein 43 (TDP-43) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 1 11 Nonstructural protein 1, NotRecorded 4.72599217225926 5.15 5.10885416666667 12 0.916666666666667 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 GEMI 0 2 GMNN GEMI_HUMAN 4.83621258847379 5.15 5.15 2 Geminin 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.55000045168903 5.15 5.15 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.65000022087346 5.15 5.15 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 TSHR 0 2 TSHR LGR3 TSHR_HUMAN 4.9 5.15 5.15 2 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 HD 0 1 HTT HD IT15 HD_HUMAN 4.55 5.15 5.15 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 LEF 0 1 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 5.1 5.15 5.15 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 5.8 5.15 5.15 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.63621320946427 5.15 5.15 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.15 5.15 5.15 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 INHA 0 1 inhA Rv1484 MTCY277.05 INHA_MYCTU 6 5.15 4.99791666666667 1 Enoyl-[acyl-carrier-protein] reductase [NADH] (ENR) (Enoyl-ACP reductase) (EC 1.3.1.9) (FAS-II enoyl-ACP reductase) (NADH-dependent 2-trans-enoyl-ACP reductase) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 4.9 5.15 5.15 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 406362 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 5.15 5.15 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.15 actual molregno [molregno] Cc1ccc(cc1C)C(=O)N2CCN(CC2)c3cccc(Cl)c3 399751 12 0 NotRecorded 5.32253429289142 4.7 4.70364583333333 12 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 PPO2 2 0 PPO2 PPO2_AGABI 4.9650133778696 4.7 4.7 2 Polyphenol oxidase 2 (PPO2) (Phenolase 2) (EC 1.14.18.1) (Cresolase 2) (Tyrosinase 2) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 TADBP 1 0 TARDBP TDP43 TADBP_HUMAN 5.09999903484653 4.7 4.7 1 TAR DNA-binding protein 43 (TDP-43) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 CYSP 1 0 CYSP_TRYCR 4.6 4.7 4.7 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 MBNL1 1 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 6.50003813440381 4.7 4.715625 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 GNAS2 1 0 GNAS GNAS1 GSP GNAS2_HUMAN 4.94999940171424 4.7 4.7 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 4.836212690038 4.7 4.7 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 TAU 2 0 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5 4.7 4.7 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 ATAD5 1 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.28621554657693 4.7 4.7 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.7 4.7 4.53125 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.425 4.7 4.6921875 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 LUCI 1 0 LUCI_PHOPY 4.67098267640138 4.7 4.7 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399751 LYAG 1 0 GAA LYAG_HUMAN 5.05 4.7 4.7 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 0 4.7 actual molregno [molregno] C\C(=N/NC(=S)Nc1cccc(C)c1)\c2cccc(N)c2 399479 KS6A6 0 2 RPS6KA6 RSK4 KS6A6_HUMAN 6.38021124171161 4.9 4.90000000000001 2 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 NEK11 0 2 NEK11 NEK11_HUMAN 5.24182606093931 4.9 4.9 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CSK2B 0 6 CSNK2B CK2N G5A CSK2B_HUMAN 6.28517415995009 4.9 4.9 6 Casein kinase II subunit beta (CK II beta) (Phosvitin), Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CSK22 0 6 CSNK2A2 CK2A2 CSK22_HUMAN 6.28517415995009 4.9 4.9 6 Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CSK21 0 6 CSNK2A1 CK2A1 CSK21_HUMAN 6.28517415995009 4.9 4.9 6 Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK08 0 2 MAPK8 JNK1 PRKM8 SAPK1 SAPK1C MK08_HUMAN 6.84291563731303 4.9 4.90000000000001 2 Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (SAPK gamma) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) (p54 gamma), Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KPCD2 0 1 PRKD2 PKD2 HSPC187 KPCD2_HUMAN 6.69019608002851 4.9 4.90000000000001 1 Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 M3K7 0 2 MAP3K7 TAK1 M3K7_HUMAN 6.09204137444664 4.9 4.90000000000001 2 Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KCC2D 0 1 CAMK2D CAMKD KCC2D_HUMAN 5.54967192186827 4.9 4.9 1 Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK14 0 2 MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A MK14_HUMAN 5.58143351890209 4.9 4.90000000000001 2 Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (CRK1) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha), Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TBK1 0 2 TBK1 NAK TBK1_HUMAN 5.6931008027004 4.9 4.90000000000001 2 Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1), Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (T2K) (TANK-binding kinase 1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PAK6 0 1 PAK6 PAK5 PAK6_HUMAN 6.38021124171161 4.9 4.90000000000001 1 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 LCK 0 4 LCK LCK_HUMAN 6.24918762961567 4.9 4.90000000000001 4 Proto-oncogene tyrosine-protein kinase LCK (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (p56-LCK), Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MELK 0 1 MELK KIAA0175 MELK_HUMAN 5.52476288915489 4.9 4.9 1 Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FYN 0 2 FYN FYN_HUMAN 5.53435790618473 4.9 4.9 2 Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn), Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene c-Fyn) (p59-Fyn) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CDK2 0 9 CDK2 CDKN2 CDK2_HUMAN 6.37703505403124 4.9 4.9 9 Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CCNA1 0 6 CCNA1 CCNA1_HUMAN 6.53520366087006 4.9 4.9 6 Cyclin-A1 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CCNA2 0 6 CCNA2 CCN1 CCNA CCNA2_HUMAN 6.53520366087006 4.9 4.9 6 Cyclin-A2 (Cyclin-A) (Cyclin A) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK11 0 1 MAPK11 PRKM11 SAPK2 SAPK2B MK11_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38B), Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ULK2 0 1 ULK2 KIAA0623 ULK2_HUMAN 6.69019608002851 4.9 4.90000000000001 1 Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK09 0 2 MAPK9 JNK2 PRKM9 SAPK1A MK09_HUMAN 6.55951005156861 4.9 4.90000000000001 2 Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2), Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 DMPK 0 1 DMPK DM1PK MDPK DMPK_HUMAN 6.50965047954658 4.9 4.90000000000001 1 Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PIM1 0 1 PIM1 PIM1_HUMAN 6.50965047954658 4.9 4.90000000000001 1 Serine/threonine-protein kinase pim-1 (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KCC2B 0 1 CAMK2B CAM2 CAMK2 CAMKB KCC2B_HUMAN 5.90799732148669 4.9 4.90000000000001 1 Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ITK 0 2 ITK EMT LYK ITK_HUMAN 6.32221929473392 4.9 4.90000000000001 2 Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 5.5 4.9 4.9 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 BMX 0 2 BMX BMX_HUMAN 5.88519219988629 4.9 4.90000000000001 2 Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein homolog), Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 BRSK1 0 1 BRSK1 KIAA1811 SAD1 SADB BRSK1_HUMAN 5.6886291709978 4.9 4.9 1 Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PLK1 0 1 PLK1 PLK PLK1_HUMAN 6.12338490853968 4.9 4.90000000000001 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FGR 0 2 FGR SRC2 FGR_HUMAN 6.09204137444664 4.9 4.90000000000001 2 Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr), Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Proto-oncogene c-Fgr) (p55-Fgr) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHA3 0 1 EPHA3 ETK ETK1 HEK TYRO4 EPHA3_HUMAN 6.99563519459755 4.9 4.90000000000001 1 Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1), Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (mEK4) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CCNE2 0 6 CCNE2 CCNE2_HUMAN 6.12783722178483 4.9 4.9 6 G1/S-specific cyclin-E2 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CCNE1 0 6 CCNE1 CCNE CCNE1_HUMAN 6.12783722178483 4.9 4.9 6 G1/S-specific cyclin-E1 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FGFR2 0 2 FGFR2 BEK KGFR KSAM FGFR2_HUMAN 6.99563519459755 4.9 4.90000000000001 2 Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332), Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (Keratinocyte growth factor receptor) (KGFR) (CD antigen CD332) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TAOK1 0 1 TAOK1 KIAA1361 MAP3K16 MARKK TAOK1_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 IGF1R 0 1 IGF1R IGF1R_HUMAN 6.06069784035361 4.9 4.90000000000001 1 Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 WNK3 0 2 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 6.09988774304892 4.9 4.90000000000001 2 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 NUAK1 0 2 NUAK1 ARK5 KIAA0537 OMPHK1 NUAK1_HUMAN 5.96494158178994 4.9 4.90000000000001 2 NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 IRAK1 0 1 IRAK1 IRAK IRAK1_HUMAN 5.54967192186827 4.9 4.9 1 Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 WNK2 0 1 WNK2 KIAA1760 PRKWNK2 SDCCAG43 P/OKcl.13 WNK2_HUMAN 5.86530142610254 4.9 4.90000000000001 1 Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MUSK 0 2 MUSK MUSK_HUMAN 6.05018527255879 4.9 4.90000000000001 2 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 HCK 0 3 HCK HCK_HUMAN 5.83360555202658 4.9 4.90000000000001 3 Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHB3 0 1 EPHB3 ETK2 HEK2 TYRO6 EPHB3_HUMAN 6.50965047954658 4.9 4.90000000000001 1 Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 LEF 1 0 lef pXO1-107 BXA0172 GBAA_pXO1_0172 LEF_BACAN 6 4.9 4.1875 1 Lethal factor (LF) (EC 3.4.24.83) (Anthrax lethal toxin endopeptidase component) 0 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 GRK5 0 1 GRK5 GPRK5 GRK5_HUMAN 6.00479888288177 4.9 4.90000000000001 1 G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KGP1 0 3 PRKG1 PRKG1B PRKGR1A PRKGR1B KGP1_HUMAN 6.20334034155471 4.9 4.90000000000001 3 cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 INSRR 0 2 INSRR IRR INSRR_HUMAN 6.27774875306553 4.9 4.90000000000001 2 Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 M4K2 0 2 MAP4K2 GCK RAB8IP M4K2_HUMAN 6.14410428159915 4.9 4.90000000000001 2 Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PIM3 0 2 PIM3 PIM3_HUMAN 6.44493086062909 4.9 4.90000000000001 2 Serine/threonine-protein kinase pim-3 (EC 2.7.11.1), Serine/threonine-protein kinase pim-3 (EC 2.7.11.1) (Kinase induced by depolarization) (Protein kinase Kid-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 STK4 0 1 STK4 KRS2 MST1 STK4_HUMAN 5.60205999132796 4.9 4.9 1 Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 BLK 0 1 BLK BLK_HUMAN 5.75332766665861 4.9 4.90000000000001 1 Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 M3K9 0 2 MAP3K9 MLK1 PRKE1 M3K9_HUMAN 5.95639810218423 4.9 4.90000000000001 2 Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TAU 1 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.08333333333333 4.9 4.78125 3 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 0.666666666666667 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 GSK3B 0 1 GSK3B GSK3B_HUMAN 5.57540779655652 4.9 4.9 1 Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1), Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PAK5 0 1 PAK5 KIAA1264 PAK7 PAK5_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 LYN 0 2 LYN JTK8 LYN_HUMAN 6.13148907310259 4.9 4.90000000000001 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHB4 0 1 EPHB4 HTK MYK1 TYRO11 EPHB4_HUMAN 6.12338490853968 4.9 4.90000000000001 1 Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.575 4.9 4.90625 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AURKC 0 2 AURKC AIE2 AIK3 AIRK3 ARK3 STK13 AURKC_HUMAN 6.2851741599501 4.9 4.90000000000001 2 Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PAK4 0 1 PAK4 KIAA1142 PAK4_HUMAN 6.00479888288177 4.9 4.90000000000001 1 Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KC1G3 0 1 CSNK1G3 KC1G3_HUMAN 6.12338490853968 4.9 4.90000000000001 1 Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MAPK2 0 3 MAPKAPK2 MAPK2_HUMAN 6.08645198384067 4.9 4.90000000000001 3 MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ALK 0 2 ALK ALK_HUMAN 5.38028303779126 4.9 4.90000000000001 2 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KS6A1 0 4 RPS6KA1 MAPKAPK1A RSK1 KS6A1_HUMAN 5.93111991546301 4.9 4.90000000000001 4 Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ACK1 0 2 TNK2 ACK1 ACK1_HUMAN 5.69255928810317 4.9 4.90000000000001 2 Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Non-receptor protein tyrosine kinase Ack) (Tyrosine kinase non-receptor protein 2), Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHB1 0 1 EPHB1 ELK EPHT2 HEK6 NET EPHB1_HUMAN 6.69019608002851 4.9 4.90000000000001 1 Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.8493963525481 4.9 4.90000000000001 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 SRPK3 0 1 SRPK3 MSSK1 STK23 SRPK3_HUMAN 6.19497660321606 4.9 4.90000000000001 1 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 HASP 0 1 HASPIN GSG2 HASP_HUMAN 6.69019608002851 4.9 4.90000000000001 1 Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 RON 0 2 MST1R PTK8 RON RON_HUMAN 5.90701275350611 4.9 4.90000000000001 2 Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain], Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (Stem cell-derived tyrosine kinase) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 DAPK2 0 1 DAPK2 DAPK2_HUMAN 6.99563519459755 4.9 4.90000000000001 1 Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 NTRK1 0 1 NTRK1 MTC TRK TRKA NTRK1_HUMAN 5.06963592814139 4.9 4.9 1 High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (Slow nerve growth factor receptor) (p140-TrkA) (Trk-A), High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TSSK1 0 1 TSSK1B SPOGA1 SPOGA4 STK22A STK22D TSSK1 FKSG81 TSSK1_HUMAN 6.99563519459755 4.9 4.90000000000001 1 Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 DYRK2 0 1 DYRK2 DYRK2_HUMAN 6.00479888288177 4.9 4.90000000000001 1 Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KC1D 0 2 CSNK1D HCKID KC1D_HUMAN 6.37544696019106 4.9 4.90000000000001 2 Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26), Casein kinase I isoform delta (CKI-delta) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FRK 0 1 FRK PTK5 RAK FRK_HUMAN 6.50965047954658 4.9 4.90000000000001 1 Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MARK1 0 1 MARK1 KIAA1477 MARK MARK1_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 INSR 0 2 INSR INSR_HUMAN 6.50965047954658 4.9 4.90000000000001 2 Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PKN2 0 1 PKN2 PRK2 PRKCL2 PKN2_HUMAN 5.57540779655652 4.9 4.9 1 Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PLK3 0 2 PLK3 CNK FNK PRK PLK3_HUMAN 6.84291563731303 4.9 4.90000000000001 2 Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 DDR2 0 1 DDR2 NTRKR3 TKT TYRO10 DDR2_HUMAN 6.99563519459755 4.9 4.90000000000001 1 Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CLK3 0 2 CLK3 CLK3_HUMAN 5.98434758092015 4.9 4.90000000000001 2 Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 IRAK4 0 2 IRAK4 IRAK4_HUMAN 5.89096312791004 4.9 4.90000000000001 2 Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ULK3 0 1 ULK3 ULK3_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 BTK 0 1 BTK AGMX1 ATK BPK BTK_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase), Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase) (Kinase EMB) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PDPK1 0 1 PDPK1 PDK1 PDPK1_HUMAN 5.95424250943933 4.9 4.90000000000001 1 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 DAPK3 0 2 DAPK3 ZIPK DAPK3_HUMAN 6.69019608002851 4.9 4.90000000000001 2 Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MKNK2 0 1 MKNK2 GPRK7 MNK2 MKNK2_HUMAN 5.75332766665861 4.9 4.90000000000001 1 MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ABL2 0 1 ABL2 ABLL ARG ABL2_HUMAN 5.78837041556533 4.9 4.90000000000001 1 Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAKG2 0 7 PRKAG2 AAKG2_HUMAN 6.99563519459755 4.9 4.9 7 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAKB2 0 7 PRKAB2 AAKB2_HUMAN 6.99563519459755 4.9 4.9 7 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAPK1 0 10 PRKAA1 AMPK1 AAPK1_HUMAN 6.66934383266429 4.9 4.9 10 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAPK2 0 7 PRKAA2 AMPK AMPK2 AAPK2_HUMAN 6.99563519459755 4.9 4.9 7 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAKB1 0 10 PRKAB1 AMPK AAKB1_HUMAN 6.66934383266429 4.9 4.9 10 5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAKG1 0 10 PRKAG1 AAKG1_HUMAN 6.66934383266429 4.9 4.9 10 5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AAKG3 0 7 PRKAG3 AMPKG3 AAKG3_HUMAN 6.99563519459755 4.9 4.9 7 5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CCND3 0 2 CCND3 CCND3_HUMAN 6.69019608002851 4.9 4.9 2 G1/S-specific cyclin-D3 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CDK6 0 2 CDK6 CDKN6 CDK6_HUMAN 6.69019608002851 4.9 4.9 2 Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CHK1 0 1 CHEK1 CHK1 CHK1_HUMAN 6.12338490853968 4.9 4.90000000000001 1 Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TXK 0 2 TXK PTK4 RLK TXK_HUMAN 6.45181625804212 4.9 4.90000000000001 2 Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MTOR 2 1 MTOR FRAP FRAP1 FRAP2 RAFT1 RAPT1 MTOR_HUMAN 6.00242625819644 4.9 4.6625 3 Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1), Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) 0.333333333333333 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 VRK2 0 1 VRK2 VRK2_HUMAN 6.38021124171161 4.9 4.90000000000001 1 Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHA1 0 2 EPHA1 EPH EPHT EPHT1 EPHA1_HUMAN 5.9558776620525 4.9 4.90000000000001 2 Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TIE2 0 2 TEK TIE2 VMCM VMCM1 TIE2_HUMAN 6.0344202063547 4.9 4.90000000000001 2 Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (HYK) (STK1) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (mTIE2) (p140 TEK) (CD antigen CD202b), Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KCC1A 0 2 CAMK1 KCC1A_HUMAN 5.74632846815754 4.9 4.90000000000001 2 Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ROCK2 0 1 ROCK2 KIAA0619 ROCK2_HUMAN 6.38021124171161 4.9 4.90000000000001 1 Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2), Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (RhoA-binding kinase 2) (p150 ROK-alpha) (ROKalpha) (p164 ROCK-2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MP2K6 0 2 MAP2K6 MEK6 MKK6 PRKMK6 SKK3 MP2K6_HUMAN 6.08365866737408 4.9 4.90000000000001 2 Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHA8 0 1 EPHA8 EEK HEK3 KIAA1459 EPHA8_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KCC2G 0 1 CAMK2G CAMK CAMK-II CAMKG KCC2G_HUMAN 5.47712125471966 4.9 4.9 1 Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 GRK6 0 1 GRK6 GPRK6 GRK6_HUMAN 5.95424250943933 4.9 4.90000000000001 1 G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 STK24 0 2 STK24 MST3 STK3 STK24_HUMAN 6.25179807512565 4.9 4.90000000000001 2 Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CDK3 0 3 CDK3 CDKN3 CDK3_HUMAN 6.19497660321606 4.9 4.9 3 Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 VGFR3 0 1 FLT4 VEGFR3 VGFR3_HUMAN 5.6886291709978 4.9 4.9 1 Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 M3K5 0 1 MAP3K5 ASK1 MAPKKK5 MEKK5 M3K5_HUMAN 6.99563519459755 4.9 4.90000000000001 1 Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 HIPK3 0 1 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 6.69019608002851 4.9 4.90000000000001 1 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TAOK3 0 1 TAOK3 DPK JIK KDS MAP3K18 TAOK3_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MYLK 0 1 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 5.65854134728041 4.9 4.9 1 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MP2K7 0 2 MAP2K7 JNKK2 MEK7 MKK7 PRKMK7 SKK4 MP2K7_HUMAN 5.83066249407265 4.9 4.90000000000001 2 Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CDK7 0 2 CDK7 CAK CAK1 CDKN7 MO15 STK1 CDK7_HUMAN 6.69019608002851 4.9 4.9 2 Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (P39 Mo15) (CDK-activating kinase) (CR4 protein kinase) (CRK4) (Cell division protein kinase 7) (Protein-tyrosine kinase MPK-7) (TFIIH basal transcription factor complex kinase subunit), Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CCNH 0 2 CCNH CCNH_HUMAN 6.69019608002851 4.9 4.9 2 Cyclin-H (MO15-associated protein) (p34) (p37) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 TLK2 0 1 TLK2 TLK2_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 LIMK1 0 2 LIMK1 LIMK LIMK1_HUMAN 6.06676945418511 4.9 4.90000000000001 2 LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CHK2 0 2 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 5.70748667398541 4.9 4.90000000000001 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK10 0 1 MAPK10 JNK3 JNK3A PRKM10 SAPK1B MK10_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3), Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (SAPK-beta) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3) (p54-beta) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 SGK1 0 1 SGK1 SGK SGK1_HUMAN 5.6886291709978 4.9 4.9 1 Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AKT3 0 1 AKT3 PKBG AKT3_HUMAN 5.82557590031178 4.9 4.90000000000001 1 RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK03 0 1 MAPK3 ERK1 PRKM3 MK03_HUMAN 5.86530142610254 4.9 4.90000000000001 1 Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (MNK1) (Microtubule-associated protein 2 kinase) (p44-ERK1), Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 STK3 0 2 STK3 KRS1 MST2 STK3_HUMAN 6.06107758799499 4.9 4.90000000000001 2 Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)], Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MAPK5 0 1 MAPKAPK5 PRAK MAPK5_HUMAN 5.2498774732166 4.9 4.9 1 MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MARK2 0 1 MARK2 EMK1 MARK2_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FER 0 1 FER TYK3 FER_HUMAN 6.00479888288177 4.9 4.90000000000001 1 Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KS6A2 0 4 RPS6KA2 MAPKAPK1C RSK3 KS6A2_HUMAN 6.14901044755595 4.9 4.90000000000001 4 Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Protein-tyrosine kinase Mpk-9) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3), Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 RAF1 0 2 RAF1 RAF RAF1_HUMAN 5.69152954229221 4.9 4.90000000000001 2 RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.9 4.9 4.9 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.9 4.9 4.9 4 Menin 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CSF1R 0 2 CSF1R FMS CSF1R_HUMAN 5.69362203972684 4.9 4.90000000000001 2 Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KSYK 0 1 SYK KSYK_HUMAN 5.57540779655652 4.9 4.9 1 Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk), Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72Syk) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 DAPK1 0 1 DAPK1 DAPK DAPK1_HUMAN 6.27875360095283 4.9 4.90000000000001 1 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHA2 0 1 EPHA2 ECK EPHA2_HUMAN 6.50965047954658 4.9 4.90000000000001 1 Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK13 0 1 MAPK13 PRKM13 SAPK4 MK13_HUMAN 6.38021124171161 4.9 4.90000000000001 1 Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 NTRK2 0 1 NTRK2 TRKB NTRK2_HUMAN 6.12338490853968 4.9 4.90000000000001 1 BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B), BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Trk-B) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 NEK3 0 1 NEK3 NEK3_HUMAN 5.90799732148669 4.9 4.90000000000001 1 Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 RIPK2 0 2 RIPK2 CARDIAK RICK RIP2 UNQ277/PRO314/PRO34092 RIPK2_HUMAN 6.23686510208444 4.9 4.90000000000001 2 Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 RET 0 2 RET CDHF12 CDHR16 PTC RET51 RET_HUMAN 5.89658464922355 4.9 4.90000000000001 2 Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment], Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FLT3 0 1 FLT3 CD135 FLK2 STK1 FLT3_HUMAN 5.82557590031178 4.9 4.90000000000001 1 Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase 2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Tyrosine-protein kinase receptor flk-2) (CD antigen CD135), Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FKB1A 2 0 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 5.65854134728041 4.9 4.54375 2 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 0 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 STK11 0 1 STK11 LKB1 PJS STK11_HUMAN 6.50965047954658 4.9 4.90000000000001 1 Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 PTK6 0 1 PTK6 BRK PTK6_HUMAN 6.38021124171161 4.9 4.90000000000001 1 Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CD5R1 0 4 CDK5R1 CDK5R NCK5A CD5R1_HUMAN 6.99563519459755 4.9 4.9 4 Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)] 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 CDK5 0 4 CDK5 CDKN5 CDK5_HUMAN 6.99563519459755 4.9 4.9 4 Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 GSK3A 0 1 GSK3A GSK3A_HUMAN 5.72015930340596 4.9 4.90000000000001 1 Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Factor A) (FA) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1), Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 EPHA4 0 1 EPHA4 HEK8 SEK TYRO1 EPHA4_HUMAN 6.38021124171161 4.9 4.90000000000001 1 Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK), Ephrin type-A receptor 4 (EC 2.7.10.1) (Tyrosine-protein kinase receptor MPK-3) (Tyrosine-protein kinase receptor SEK-1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 ACV1B 0 1 ACVR1B ACVRLK4 ALK4 ACV1B_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MET 0 1 MET MET_HUMAN 5.90799732148669 4.9 4.90000000000001 1 Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MERTK 0 1 MERTK MER MERTK_HUMAN 5.6886291709978 4.9 4.9 1 Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 FGFR1 0 1 FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR FGFR1_HUMAN 6.00479888288177 4.9 4.90000000000001 1 Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331), Fibroblast growth factor receptor 1 (FGFR-1) (bFGF-R-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (MFR) (Proto-oncogene c-Fgr) (CD antigen CD331) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 STK10 0 1 STK10 LOK STK10_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 KC1G2 0 1 CSNK1G2 CK1G2 KC1G2_HUMAN 6.19497660321606 4.9 4.90000000000001 1 Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 6.06069784035361 4.9 4.90000000000001 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 AURKB 0 1 AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 AURKB_HUMAN 6.00479888288177 4.9 4.90000000000001 1 Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B), Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399479 GRK7 0 1 GRK7 GPRK7 GRK7_HUMAN 5.78837041556533 4.9 4.90000000000001 1 Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) 1 4.9 actual molregno [molregno] Oc1ccc(NC(=O)CCCc2ccc(cc2)c3ccccc3F)cc1 399641 GEMI 0 1 GMNN GEMI_HUMAN 7.13608262304214 8.35 6.90625 1 Geminin 1 8.35 actual molregno [molregno] COc1ccccc1NC(=O)Cc2cccs2 399641 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 8.35 8.35 5.81875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 8.35 actual molregno [molregno] COc1ccccc1NC(=O)Cc2cccs2 399658 PLK1 0 1 PLK1 PLK PLK1_HUMAN 4.67382190675771 6.1 5.8125 1 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 6.1 actual molregno [molregno] Clc1ccc(NC(=O)Cc2cccs2)cc1 399658 POLI 0 1 POLI RAD30B POLI_HUMAN 4.59999938302362 6.1 5.8125 1 DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B), DNA polymerase iota (EC 2.7.7.7) (Rad30 homolog B) 1 6.1 actual molregno [molregno] Clc1ccc(NC(=O)Cc2cccs2)cc1 399658 GEMI 0 1 GMNN GEMI_HUMAN 5.18621225375977 6.1 6.1 1 Geminin 1 6.1 actual molregno [molregno] Clc1ccc(NC(=O)Cc2cccs2)cc1 399658 LUCI 0 1 LUCI_PHOPY 4.77098149412752 6.1 5.8125 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 6.1 actual molregno [molregno] Clc1ccc(NC(=O)Cc2cccs2)cc1 399658 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.1 6.1 5.21458333333333 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.1 actual molregno [molregno] Clc1ccc(NC(=O)Cc2cccs2)cc1 399658 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.78621404606106 6.1 5.8125 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.1 actual molregno [molregno] Clc1ccc(NC(=O)Cc2cccs2)cc1 403521 0 6 NotRecorded 4.58537101830121 4.95 5.04114583333333 6 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.2125 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 P53 0 2 TP53 P53 P53_HUMAN 5.39999969151181 4.95 4.95 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 LUCI 0 1 LUCI_PHOPY 4.77098149412752 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 FKB1A 0 1 FKBP1A FKBP1 FKBP12 FKB1A_HUMAN 4.82 4.95 4.9375 1 Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.73621347282809 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5.7499949715131 4.95 4.95 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 CYSP 0 1 CYSP_TRYCR 5.5 4.95 4.95 1 Cruzipain (EC 3.4.22.51) (Cruzaine) (Major cysteine proteinase), Trophozoite cysteine proteinase (TCP) (EC 3.4.22.-) 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403521 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.5 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] Cc1ccc(SCC(=O)N2CCOCC2)cc1 403642 10 2 ATP-dependent Clp protease proteolytic subunit, NotRecorded 4.64257287287598 4.8 4.7496875 12 0.166666666666667 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 TRXR1 1 0 Txnrd1 Trxr1 TRXR1_RAT 6.95000714307986 4.8 4.8 1 Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1), Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (NADPH-dependent thioredoxin reductase) (Thioredoxin reductase TR1) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 NF2L2 1 0 NFE2L2 NRF2 NF2L2_HUMAN 6.43616308133546 4.8 4.8 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.8 4.8 4.8 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 RORG 2 0 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.8 4.8 4.8 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 P53 2 0 TP53 P53 P53_HUMAN 4.85 4.8 4.8 2 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 LX15B 1 0 ALOX15B LX15B_HUMAN 4.59999938302362 4.8 4.8 1 Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 ATAD5 1 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.53621406603065 4.8 4.921 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0.5 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 NPC1 1 0 NPC1 NPC1_HUMAN 5.9 4.8 4.8 1 Niemann-Pick C1 protein 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 LUCI 2 0 LUCI_PHOPY 5.08549053998174 4.8 4.8 2 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 403642 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.95 4.8 4.8 1 Ras-related protein Rab-9A 0 4.8 actual molregno [molregno] Nc1nc(cs1)c2nc3ccccc3[nH]2 407965 0 10 ATP-dependent Clp protease proteolytic subunit, NotRecorded 4.84666213619324 7.9 7.699 10 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.25000102344165 7.9 7.9 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 AL1A1 0 2 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.525 7.9 7.9 2 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 LUCI 0 1 LUCI_PHOPY 4.67098267640138 7.9 7.9 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5.19999817218203 7.9 7.9 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.61121294271091 7.9 7.9 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.88621369024218 7.9 7.9 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 5.1 7.9 7.9 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 7.9 7.9 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.3 7.9 7.9 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 7.9 7.9 7.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 POLH 0 1 POLH RAD30 RAD30A XPV POLH_HUMAN 4.89999841719865 7.9 7.9 1 DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 7.9 7.9 1 Ras-related protein Rab-9A 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.70000050388302 7.9 7.9 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 P53 0 1 TP53 P53 P53_HUMAN 5 7.9 7.9 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 407965 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 7.9 7.9 1 Niemann-Pick C1 protein 1 7.9 actual molregno [molregno] OC(=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 411427 0 20 NotRecorded 5.82415297539441 5.1 5.100875 20 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 P53 0 3 TP53 P53 P53_HUMAN 5.33333333333333 5.1 5.1 3 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 HD 0 1 HTT HD IT15 HD_HUMAN 4.85 5.1 5.1 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 ATAD5 0 4 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.00648551644619 5.1 5.1 4 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 KMT2A 0 8 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.525 5.1 5.04375 8 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 4.525 5.1 5.04375 8 Menin 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5.2 5.1 5.1 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.8 5.1 5.1 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 GEMI 0 2 GMNN GEMI_HUMAN 5.7931129952495 5.1 5.1 2 Geminin 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 NFKB1 0 5 NFKB1 NFKB1_HUMAN 5.63 5.1 5.1 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 TF65 0 5 RELA NFKB3 TF65_HUMAN 5.63 5.1 5.1 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 5.63 5.1 5.1 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.29999760285775 5.1 5.1 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 AMPC 0 1 ampC ampA b4150 JW4111 AMPC_ECOLI 4.5 5.1 5.1 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 GLHA 0 1 CGA GLHA_HUMAN 5.69999179744619 5.1 5.1 1 Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.7499949715131 5.1 5.1 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 ABC3F 0 1 APOBEC3F ABC3F_HUMAN 5.54999736982681 5.1 5.1 1 DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 LUCI 0 1 LUCI_PHOPY 4.97098167045352 5.1 5.1 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 IDHC 0 1 IDH1 PICD IDHC_HUMAN 5.88622371616297 5.1 5.1 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 5.85001154350852 5.1 5.1 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 ATX2 0 1 ATXN2 ATX2 SCA2 TNRC13 ATX2_HUMAN 7.5003129173816 5.1 5.1 1 Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.1 5.1 5.025 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.925 5.1 5.1 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 LOX15 0 1 ALOX15 LOG15 LOX15_HUMAN 5.5 5.1 5.1 1 Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (12/15-LO) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Arachidonate 15-lipoxygenase (15-LOX) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (L-12LO) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase) (Erythroid cell-specific 15-lipoxygenase), Probable linoleate 9S-lipoxygenase 5 (EC 1.13.11.58) (Leaf lipoxygenase) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 4.94999940171424 5.1 5.1 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 NPC1 0 1 NPC1 NPC1_HUMAN 5.25 5.1 5.1 1 Niemann-Pick C1 protein 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 5.35 5.1 5.1 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.825 5.1 5.1 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 411427 ABC3G 0 1 APOBEC3G MDS019 ABC3G_HUMAN 5.7999981345934 5.1 5.1 1 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 5.1 actual molregno [molregno] COc1ccc(C2CC(=NCCS2)C3=C(O)C=C(C)OC3=O)c(OC)c1 418715 3 47 NotRecorded 4.84696645266193 5.05 5.00425 50 0.94 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.05 5.05 5.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 NF2L2 0 3 NFE2L2 NRF2 NF2L2_HUMAN 4.88302058986466 5.05 5.05 3 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 RORG 0 1 RORC NR1F3 RORG RZRG RORG_HUMAN 5.82506840647156 5.05 5.05 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 NR1H4 0 1 NR1H4 BAR FXR HRR1 RIP14 NR1H4_HUMAN 4.55000045168903 5.05 5.05 1 Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 AHR 0 1 AHR BHLHE76 AHR_HUMAN 5.14999741390754 5.05 5.05 1 Aryl hydrocarbon receptor (Ah receptor) (AhR), Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 ANDR 0 4 AR DHTR NR3C4 ANDR_HUMAN 4.91080036988226 5.05 5.05 4 Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.5 5.05 5.05 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 PPARD 0 2 PPARD NR1C2 PPARB PPARD_HUMAN 4.54766444145895 5.05 5.05 2 Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta), Peroxisome proliferator-activated receptor delta (PPAR-delta) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 P53 0 1 TP53 P53 P53_HUMAN 4.9 5.05 5.05 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.95 5.05 5.05 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 418715 RXRA 0 1 RXRA NR2B1 RXRA_HUMAN 4.59999938302362 5.05 5.05 1 Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha) 1 5.05 actual molregno [molregno] COC1=CC(=O)OC(=C1)\C=C\c2ccccc2 421439 SO1B3 0 1 SLCO1B3 LST2 OATP1B3 OATP8 SLC21A8 SO1B3_HUMAN 6.25130928708149 4.95 4.95 1 Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccc4OCOc4c3 421439 2 2 NotRecorded 4.7624989870547 4.95 4.71328125 4 0.5 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccc4OCOc4c3 421439 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccc4OCOc4c3 421439 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 5.4 4.95 4.93125 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccc4OCOc4c3 421439 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.95 4.95 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccc4OCOc4c3 421439 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.95 4.95 4.95 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 4.95 actual molregno [molregno] COc1cc(OC)c2C(=O)C(=COc2c1)c3ccc4OCOc4c3 418432 0 14 NotRecorded 4.56626379700784 4.95 4.94879464285714 14 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.81121415895876 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 LUCI 0 1 LUCI_PHOPY 4.97098167045352 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 GEMI 0 1 GMNN GEMI_HUMAN 4.78621404606106 4.95 4.95 1 Geminin 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.45 4.95 4.95 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 5.45 4.95 4.95 4 Menin 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 EHMT2 1 0 EHMT2 BAT8 C6orf30 G9A KMT1C NG36 EHMT2_HUMAN 6.15002808767115 4.95 4.466875 1 Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a), Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Protein G9a) 0 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.75 4.95 4.95 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 NPC1 0 1 NPC1 NPC1_HUMAN 5.55 4.95 5.225 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 P53 0 1 TP53 P53 P53_HUMAN 5.54999736982681 4.95 5.225 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.45 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 FFP 0 1 ffp sfp FFP_BACIU 5.15 4.95 4.95 1 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 418432 APEX1 0 1 APEX1 APE APE1 APEX APX HAP1 REF1 APEX1_HUMAN 9.69897000433602 4.95 4.95 1 DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial] 1 4.95 actual molregno [molregno] O=C(N\N=C\c1ccccn1)c2ccccc2 422997 NPSR1 0 1 NPSR1 GPR154 GPRA PGR14 NPSR1_HUMAN 5.3 5 5 1 Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14), Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility) 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 NPC1 0 1 NPC1 NPC1_HUMAN 5.4 5 5 1 Niemann-Pick C1 protein 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 ADRB2 0 1 ADRB2 ADRB2R B2AR ADRB2_HUMAN 5.09999903484653 5 5 1 Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.9 5 5 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.9 5 5 4 Menin 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 0 10 NotRecorded 4.96808214681829 5 5 10 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 6.9 5 5 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 LUCI 0 1 LUCI_PHOPY 4.97098167045352 5 5 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.36139149554366 5 5 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.4 5 5 1 Ras-related protein Rab-9A 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 422997 LYAG 0 1 GAA LYAG_HUMAN 4.95 5 5 1 Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase), Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase] 1 5 actual molregno [molregno] COc1ccc(\C=N\NC(=S)Nc2ccccc2)cc1 421774 19 0 Nonstructural protein 1, NotRecorded 4.77016728377069 4.65 4.64802631578947 19 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 ATAD5 2 0 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.11121298836523 4.65 4.65 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.65 4.65 4.65 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 RAB9A 1 0 RAB9A RAB9 RAB9A_HUMAN 5.45 4.65 4.65 1 Ras-related protein Rab-9A 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 TSHR 4 0 TSHR LGR3 TSHR_HUMAN 4.8 4.65 4.65 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 NPC1 1 0 NPC1 NPC1_HUMAN 5.55 4.65 4.65 1 Niemann-Pick C1 protein 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 AMPC 1 0 ampC ampA b4150 JW4111 AMPC_ECOLI 6.2 4.65 4.65 1 Beta-lactamase (EC 3.5.2.6) (Cephalosporinase) 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 421774 AL1A1 1 0 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.6 4.65 4.65 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 0 4.65 actual molregno [molregno] C(Sc1nnc(c2occc2)n1Cc3ccccc3)c4ccccc4 423626 0 13 NotRecorded 5.36325320008968 9.04575749056067 9.04575749056067 13 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 GEMI 0 2 GMNN GEMI_HUMAN 5.88621706181591 9.04575749056067 9.04575749056067 2 Geminin 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.65000022087346 9.04575749056067 9.04575749056067 1 TAR DNA-binding protein 43 (TDP-43) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5.05000045714008 9.04575749056067 9.04575749056067 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 TSHR 0 4 TSHR LGR3 TSHR_HUMAN 4.5 9.04575749056067 9.04575749056067 4 Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 FRIL 0 3 FTL FRIL_HORSE 4.56666674029115 9.04575749056067 8.39979790880056 3 Ferritin light chain (Ferritin L subunit) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 FFP 0 2 ffp sfp FFP_BACIU 4.525 9.04575749056067 9.04575749056067 2 4'-phosphopantetheinyl transferase ffp (EC 2.7.8.-) (Fengycin synthase-activating enzyme) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 5.14999741390754 9.04575749056067 9.04575749056067 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 9.04575749056067 9.04575749056067 9.04575749056067 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 5 9.04575749056067 9.04575749056067 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 ABC3G 0 1 APOBEC3G MDS019 ABC3G_HUMAN 6.04997609347667 9.04575749056067 9.04575749056067 1 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.39999691337226 9.04575749056067 9.04575749056067 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 HD 0 1 HTT HD IT15 HD_HUMAN 6.7 9.04575749056067 9.04575749056067 1 Huntingtin (Huntington disease protein homolog) (HD protein homolog), Huntingtin (Huntington disease protein) (HD protein) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.7 9.04575749056067 9.04575749056067 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.4362105089299 9.04575749056067 9.04575749056067 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 423626 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.73621248726524 9.04575749056067 9.04575749056067 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 9.04575749056067 actual molregno [molregno] COc1ccc(cc1)C2=Nn3c(SC2)nnc3c4ccc(OC)cc4 424164 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.75 6.05 6.05 1 Ras-related protein Rab-9A 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 0 15 NotRecorded 5.22457558598399 6.05 6.03647222222222 15 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.05 6.05 5.6875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 LUCI 0 1 LUCI_PHOPY 6.37099838071301 6.05 5.7875 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 NF2L2 0 2 NFE2L2 NRF2 NF2L2_HUMAN 5.59311304972337 6.05 6.05 2 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 RORG 0 2 Rorc Nr1f3 Rorg Thor RORG_MOUSE 5.3 6.05 5.925 2 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 GLP1R 0 1 GLP1R GLP1R_HUMAN 5.09999903484653 6.05 6.05 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 6.53637396450678 6.05 6.05 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 NPC1 0 1 NPC1 NPC1_HUMAN 6.4 6.05 6.05 1 Niemann-Pick C1 protein 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 Q94696 0 1 luc Q94696_PHOPE 4.95 6.05 6.05 1 Luciferase 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 424164 AOFB 0 1 MAOB AOFB_HUMAN 6.12 6.05 6.05 1 Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B) 1 6.05 actual molregno [molregno] O=C(NC1=Cc2ccccc2OC1=O)c3ccccc3 400199 TADBP 0 1 TARDBP TDP43 TADBP_HUMAN 4.89999841719865 5 5 1 TAR DNA-binding protein 43 (TDP-43) 1 5 actual molregno [molregno] Cc1ccc2N=C(CC(=O)Nc2c1)c3ccccc3 400199 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 5 5 1 Ras-related protein Rab-9A 1 5 actual molregno [molregno] Cc1ccc2N=C(CC(=O)Nc2c1)c3ccccc3 400199 ATAD5 0 1 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.23621273895602 5 5 1 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5 actual molregno [molregno] Cc1ccc2N=C(CC(=O)Nc2c1)c3ccccc3 400199 LUCI 0 1 LUCI_PHOPY 4.92098164492706 5 5.045 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5 actual molregno [molregno] Cc1ccc2N=C(CC(=O)Nc2c1)c3ccccc3 400199 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 4.8625 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] Cc1ccc2N=C(CC(=O)Nc2c1)c3ccccc3 400199 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5 5 5 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5 actual molregno [molregno] Cc1ccc2N=C(CC(=O)Nc2c1)c3ccccc3 428619 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.9 4.9 4.9 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 CP2D6 0 2 CYP2D6 CYP2DL1 CP2D6_HUMAN 5.1 4.9 4.9 2 Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 TAU 0 1 MAPT MAPTL MTBT1 TAU TAU_HUMAN 4.85 4.9 4.945 1 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 TYDP1 0 1 TDP1 TYDP1_HUMAN 4.55 4.9 4.9 1 Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 MK01 0 1 MAPK1 ERK2 PRKM1 PRKM2 MK01_HUMAN 4.5 4.9 4.9 1 Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 CP2CJ 1 1 CYP2C19 CP2CJ_HUMAN 5.6 4.9 4.65833333333334 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 0.5 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 4.95 4.9 4.945 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 CP1A2 0 1 CYP1A2 CP1A2_HUMAN 7.5 4.9 4.9 1 Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P-448) (Cytochrome P-450d) (Cytochrome P450-D), Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P450-P2) (Cytochrome P450-P3) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 CP3A4 2 1 CYP3A4 CYP3A3 CP3A4_HUMAN 4.66666666666667 4.9 4.57777777777778 3 Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97) 0.333333333333333 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 P53 0 1 TP53 P53 P53_HUMAN 5 4.9 4.90625 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.8000008748032 4.9 4.9 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 428619 UBP1 0 1 USP1 UBP1_HUMAN 4.70000050388302 4.9 4.9 1 Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1) 1 4.9 actual molregno [molregno] COc1cccc(c1)c2nccc(n2)n3ccnc3 430127 HPGDS 2 5 HPGDS GSTS PGDS PTGDS2 HPGDS_HUMAN 6.60714285714286 5.55 5.30744047619047 7 Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase) 0.714285714285714 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 5.56138915438045 5.55 5.55875 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.13621334693594 5.55 5.55 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 NPC1 0 1 NPC1 NPC1_HUMAN 5.85 5.55 5.41125 1 Niemann-Pick C1 protein 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 0 17 Mitochondrial import inner membrane translocase subunit TIM10, Mitochondrial import inner membrane translocase subunit TIM23, NotRecorded 4.58379550326167 5.55 5.56120098039216 17 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.55 5.55 5.265625 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 NFKB1 0 5 NFKB1 NFKB1_HUMAN 5.63 5.55 5.55 5 Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (NF-kappa-B1 p84/NF-kappa-B1 p98) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit], Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit] 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 TF65 0 5 RELA NFKB3 TF65_HUMAN 5.63 5.55 5.55 5 Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 NFKB2 0 5 NFKB2 LYT10 NFKB2_HUMAN 5.63 5.55 5.55 5 Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit] 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 GLP1R 0 1 GLP1R GLP1R_HUMAN 4.89999841719865 5.55 5.55 1 Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 P53 0 1 TP53 P53 P53_HUMAN 5 5.55 5.55 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 5.55 5.55 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 5.55 5.55 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 6.2500319164906 5.55 5.553125 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 LMNA 0 1 LMNA LMN1 LMNA_HUMAN 7.75 5.55 5.553125 1 Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)] 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 6.25 5.55 5.553125 1 Ras-related protein Rab-9A 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 430127 LUCI 0 1 LUCI_PHOPY 5.47098052029176 5.55 5.55 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.55 actual molregno [molregno] c1ccc(cc1)c2ncc(s2)c3cc[nH]n3 437412 1 8 NotRecorded 4.53000018120713 5.25 5.18064814814815 9 0.888888888888889 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 GLCM 0 1 GBA GC GLUC GLCM_HUMAN 4.59999938302362 5.25 5.25 1 Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase), Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Beta-glucocerebrosidase) (D-glucosyl-N-acylsphingosine glucohydrolase) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 LUCI 0 1 LUCI_PHOPY 4.62098289875995 5.25 5.2 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 IDHC 0 1 IDH1 PICD IDHC_HUMAN 4.70000050388302 5.25 5.2 1 Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.25 5.25 5.25 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 4.53621298582672 5.25 5.25 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 ACM4 0 1 Chrm4 Chrm-4 ACM4_RAT 5.29 5.25 5.25 1 Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M4 (Mm4 mAChR) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 ACM1 0 2 CHRM1, Chrm1 Chrm-1 ACM1_HUMAN, ACM1_RAT 5.655 5.25 5.046875 2 Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 NPC1 0 1 NPC1 NPC1_HUMAN 5.55 5.25 5.25 1 Niemann-Pick C1 protein 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 GNAS2 0 1 GNAS GNAS1 GSP GNAS2_HUMAN 5.49999693194831 5.25 5.25 1 Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.73621248726524 5.25 5.25 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 GEMI 0 1 GMNN GEMI_HUMAN 4.53621298582672 5.25 5.25 1 Geminin 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 RORG 0 1 Rorc Nr1f3 Rorg Thor RORG_MOUSE 4.85 5.25 5.25 1 Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma), Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma) (Thymus orphan receptor) (TOR) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 437412 SMAD3 0 1 SMAD3 MADH3 SMAD3_HUMAN 4.89999841719865 5.25 5.2 1 Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) 1 5.25 actual molregno [molregno] CCCCCC(=O)Nc1ccc(N2CCN(CC)CC2)c(Cl)c1 430513 0 3 NotRecorded 5.45853097342447 5 5.0875 3 1 5 actual molregno [molregno] CCCCCCN(C(C(=O)NCCCC)c1ccc(OCC(=O)OC)c(c1)C(=O)OC)C(=O)CCCCCN2C(=O)NC(C(=C2C)C(=O)OCc3ccccc3)c4ccc(cc4)[N+](=O)[O-] 430513 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5 5 5 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 5 actual molregno [molregno] CCCCCCN(C(C(=O)NCCCC)c1ccc(OCC(=O)OC)c(c1)C(=O)OC)C(=O)CCCCCN2C(=O)NC(C(=C2C)C(=O)OCc3ccccc3)c4ccc(cc4)[N+](=O)[O-] 430513 FRIL 0 1 FTL FRIL_HORSE 4.85 5 5 1 Ferritin light chain (Ferritin L subunit) 1 5 actual molregno [molregno] CCCCCCN(C(C(=O)NCCCC)c1ccc(OCC(=O)OC)c(c1)C(=O)OC)C(=O)CCCCCN2C(=O)NC(C(=C2C)C(=O)OCc3ccccc3)c4ccc(cc4)[N+](=O)[O-] 430513 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.7 5 5 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 5 actual molregno [molregno] CCCCCCN(C(C(=O)NCCCC)c1ccc(OCC(=O)OC)c(c1)C(=O)OC)C(=O)CCCCCN2C(=O)NC(C(=C2C)C(=O)OCc3ccccc3)c4ccc(cc4)[N+](=O)[O-] 430556 TAU 0 2 MAPT MAPTL MTBT1 TAU TAU_HUMAN 6.45 6.05 6.05 2 Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau) 1 6.05 actual molregno [molregno] CCCCNC(=O)C(N(CCC1=CCCCC1)C(=O)CCCCCN2C(=O)NC(C(=C2C)C(=O)OCc3ccccc3)c4ccc(cc4)c5ccccc5)c6ccc(OCC(=O)OC)c(c6)C(=O)OC 430556 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 6.05 6.05 6.05 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 6.05 actual molregno [molregno] CCCCNC(=O)C(N(CCC1=CCCCC1)C(=O)CCCCCN2C(=O)NC(C(=C2C)C(=O)OCc3ccccc3)c4ccc(cc4)c5ccccc5)c6ccc(OCC(=O)OC)c(c6)C(=O)OC 431772 MBNL1 1 0 MBNL1 EXP KIAA0428 MBNL MBNL1_HUMAN 4.84999924507786 5.45 3.725 1 Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein) 0 5.45 actual molregno [molregno] OC(=O)CCCCCN1C(=O)c2ccc(cc2C1=O)C(=O)O 431772 1 0 NotRecorded 5.28222135283381 5.45 3.725 1 0 5.45 actual molregno [molregno] OC(=O)CCCCCN1C(=O)c2ccc(cc2C1=O)C(=O)O 431772 GEMI 1 0 GMNN GEMI_HUMAN 4.836212690038 5.45 4.5875 1 Geminin 0 5.45 actual molregno [molregno] OC(=O)CCCCCN1C(=O)c2ccc(cc2C1=O)C(=O)O 431772 SMN 1 0 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 5.45 5.45 4.5875 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 0 5.45 actual molregno [molregno] OC(=O)CCCCCN1C(=O)c2ccc(cc2C1=O)C(=O)O 431346 ABC3F 0 3 APOBEC3F ABC3F_HUMAN 4.70167008335331 4.95 4.95 3 DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 SMN 0 1 SMN1 SMN SMNT; SMN2 SMNC SMN_HUMAN 4.95 4.95 4.95 1 Survival motor neuron protein, Survival motor neuron protein (Component of gems 1) (Gemin-1) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 ATAD5 0 2 ATAD5 C17orf41 FRAG1 ATAD5_HUMAN 4.76121326666315 4.95 4.95 2 ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 KMT2A 0 4 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 4.65 4.95 4.95 4 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 MEN1 0 4 MEN1 SCG2 MEN1_HUMAN 4.65 4.95 4.95 4 Menin 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 P53 0 1 TP53 P53 P53_HUMAN 4.55000045168903 4.95 4.95 1 Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53), Cellular tumor antigen p53 (Tumor suppressor p53) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 ABC3G 0 3 APOBEC3G MDS019 ABC3G_HUMAN 4.8016701195648 4.95 4.95 3 DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 1 6 NotRecorded 4.7543576452743 4.95 4.89166666666667 7 0.857142857142857 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 LUCI 0 1 LUCI_PHOPY 5.02098457748104 4.95 4.95 1 Coelenterazine h 2-monooxygenase (EC 1.13.12.5) (Renilla-luciferin 2-monooxygenase) (Renilla-type luciferase), Luciferin 4-monooxygenase (Luciferase) (EC 1.13.12.7) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 NF2L2 0 1 NFE2L2 NRF2 NF2L2_HUMAN 5.03621217265444 4.95 4.95 1 Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2), Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nuclear factor, erythroid derived 2, like 2) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 RAB9A 0 1 RAB9A RAB9 RAB9A_HUMAN 5.6 4.95 4.95 1 Ras-related protein Rab-9A 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 AL1A1 0 1 ALDH1A1 ALDC ALDH1 PUMB1 AL1A1_HUMAN 4.55 4.95 4.95 1 Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 KDM4E 0 1 KDM4E KDM4DL KDM4E_HUMAN 4.5 4.95 4.95 1 Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 NPC1 0 1 NPC1 NPC1_HUMAN 5.5 4.95 4.95 1 Niemann-Pick C1 protein 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 PGDH 0 1 HPGD PGDH1 SDR36C1 PGDH_HUMAN 4.55 4.95 4.95 1 15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 431346 BRCA1 0 1 BRCA1 RNF53 BRCA1_HUMAN 5.35000349253396 4.95 4.95 1 Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1) 1 4.95 actual molregno [molregno] CS(=O)(=O)Nc1ccc(cc1)C2=NN(C(C2)c3ccc4OCOc4c3)S(=O)(=O)C 597216 3 57 Cerebroside-sulfatase, Hemoglobin beta chain, NotRecorded 5.14925657400656 4.94999999999999 4.93114583333333 60 0.95 4.94999999999999 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 MUSK 0 2 MUSK MUSK_HUMAN 5 4.95 4.95000000000001 2 Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 ALK 0 4 ALK ALK_HUMAN 5.07910107466497 4.95 4.95000000000001 4 ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 NEK11 0 2 NEK11 NEK11_HUMAN 5.08948040686076 4.95 4.95000000000001 2 Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 WNK3 0 1 WNK3 KIAA1566 PRKWNK3 WNK3_HUMAN 5.90799732148669 4.95 4.95 1 Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 SRC 2 5 SRC, SRC SRC1 SRC_CHICK, SRC_HUMAN 5.26512394440819 4.95 4.84464285714286 7 Neuronal proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src), Tyrosine-protein kinase transforming protein Src (EC 2.7.10.2) (pp60v-src) (p60-Src) (v-Src) 0.714285714285714 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 KS6A6 0 4 RPS6KA6 RSK4 KS6A6_HUMAN 5.81407831244633 4.95 4.95 4 Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 CDK9 0 4 CDK9 CDC2L4 TAK CDK9_HUMAN 6.09204137444664 4.95 4.95 4 Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 CCNT1 0 4 CCNT1 CCNT1_HUMAN 6.09204137444664 4.95 4.95 4 Cyclin-T1 (CycT1) (Cyclin-T) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 PIM2 0 1 PIM2 PIM2_HUMAN 6.27875360095283 4.95 4.95 1 Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 KMT2A 0 11 KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 KMT2A_HUMAN 5.21363636363636 4.95 4.95272727272727 11 Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 MEN1 0 8 MEN1 SCG2 MEN1_HUMAN 5.35 4.95 4.95375 8 Menin 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 LYN 0 2 LYN JTK8 LYN_HUMAN 5.19017476022671 4.95 4.95 2 Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn), Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 MYLK 0 2 MYLK MLCK MLCK1 MYLK1 MYLK_HUMAN 6.0301390146593 4.95 4.95 2 Myosin light chain kinase, smooth muscle (MLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form], Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 SRPK3 0 2 SRPK3 MSSK1 STK23 SRPK3_HUMAN 6.1074794845917 4.95 4.95 2 SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 CP2CJ 0 2 CYP2C19 CP2CJ_HUMAN 5.1 4.95 4.95 2 Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 MARK3 0 1 MARK3 CTAK1 EMK2 MARK3_HUMAN 4.89526464947999 4.95 4.95000000000001 1 MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 PLK1 0 3 PLK1 PLK PLK1_HUMAN 6.18898738805038 4.95 4.95 3 Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 PAK6 0 3 PAK6 PAK5 PAK6_HUMAN 5.36755411396572 4.95 4.95 3 Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 DAPK1 0 2 DAPK1 DAPK DAPK1_HUMAN 6.47493885201844 4.95 4.95 2 Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 HIPK3 0 3 HIPK3 DYRK6 FIST3 PKY HIPK3_HUMAN 6.3542530703719 4.95 4.95 3 Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 TEC 0 2 TEC PSCTK4 TEC_HUMAN 5.69521520344665 4.95 4.95 2 Tyrosine-protein kinase Tec (EC 2.7.10.2) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 KS6A5 0 2 RPS6KA5 MSK1 KS6A5_HUMAN 5.86530142610254 4.95 4.95 2 Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 CHK2 0 3 CHEK2 CDS1 CHK2 RAD53 CHK2_HUMAN 4.58896218011026 4.95 4.95000000000001 3 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) 1 4.95 actual molregno [molregno] CN(C)S(=O)(=O)c1ccc2NC(=O)\C(=C/c3cc4CCCCc4[nH]3)\c2c1 597216 AAKG2 0 14 PRKAG2 AAKG2_HUMAN 4.84085549944726 4.95 4.95 14 5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gam